data_2exn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2exn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.8 ' HB1' ' HB2' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -80.69 141.5 34.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.804 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -115.25 85.74 13.26 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.287 -0.165 . . . . 0.0 110.894 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 49.0 Cg_endo -74.45 -35.87 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.885 1.724 . . . . 0.0 111.082 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.761 HD11 HD13 ' A' ' 57' ' ' LEU . 2.4 mt -114.52 145.28 20.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.208 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.88 -70.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 111.941 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.836 ' HG2' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -56.73 -50.09 73.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.457 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.785 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 73.8 m -53.48 -45.57 69.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.303 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.71 -127.52 9.18 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.782 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.8 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . . . -85.13 138.37 32.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.436 0.636 . . . . 0.0 112.506 -169.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.502 HG21 HD12 ' A' ' 52' ' ' LEU . 17.0 m -123.96 123.69 40.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.789 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.07 22.03 2.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.139 0.495 . . . . 0.0 111.495 -175.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -110.83 135.53 51.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.864 0.364 . . . . 0.0 110.15 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.8 t -70.29 -18.95 63.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.3 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.75 -26.86 68.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.618 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.545 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -71.23 -20.23 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.859 -176.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.68 -9.53 58.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.724 0.297 . . . . 0.0 111.455 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.2 -1.45 16.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.736 0.303 . . . . 0.0 111.627 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -129.66 12.02 5.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.671 0.272 . . . . 0.0 111.144 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.4 pt20 -68.57 153.67 43.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.133 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HG3' ' H ' ' A' ' 26' ' ' ARG . 3.8 tppt? -165.26 179.79 6.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.441 ' H ' ' HG3' ' A' ' 25' ' ' LYS . 73.7 mtt85 -83.26 60.83 5.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.842 0.829 . . . . 0.0 109.291 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.591 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -78.01 147.67 34.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.143 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.603 ' HA ' ' OE2' ' A' ' 11' ' ' GLU . 2.0 pp -176.92 177.42 1.3 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.119 0.485 . . . . 0.0 111.882 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.836 HG23 ' HG2' ' A' ' 11' ' ' GLU . 88.3 t -107.42 146.75 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.43 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.442 ' CB ' ' HE3' ' A' ' 84' ' ' MET . . . -128.26 145.15 51.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.54 HD22 ' HB3' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -96.53 168.84 10.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.774 -174.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -46.49 -34.16 4.59 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.735 0.814 . . . . 0.0 113.078 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.84 -4.33 4.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.688 ' HA2' ' HE2' ' A' ' 84' ' ' MET . . . 83.88 3.39 89.32 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.778 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.54 ' HB3' HD22 ' A' ' 31' ' ' ASN . 26.0 tt0 -100.57 152.61 20.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.48 -175.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.675 ' CH2' ' HB ' ' A' ' 124' ' ' VAL . 39.3 m0 -66.71 145.0 56.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 175.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.0 tp -106.61 143.4 34.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -134.41 165.69 24.57 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.006 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.419 ' CD ' ' H ' ' A' ' 39' ' ' ARG . 0.2 OUTLIER -69.03 -32.08 71.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -67.34 -25.02 65.79 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.93 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -91.19 -52.41 4.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.376 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.18 99.85 17.42 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.564 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.17 -16.92 45.17 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.325 2.683 . . . . 0.0 113.155 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -58.7 -32.42 69.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.213 0.53 . . . . 0.0 111.011 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 48' ' ' VAL . 7.0 mp -72.91 -19.86 61.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.849 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -68.21 -11.36 59.17 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.092 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -95.66 46.0 1.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.531 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.785 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 64.7 t -104.8 135.49 42.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.704 0.288 . . . . 0.0 110.667 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 m -94.74 117.54 30.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.581 HG23 ' HB3' ' A' ' 12' ' ' CYS . 11.2 t -99.2 137.45 26.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.063 -172.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -136.08 141.45 44.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.099 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.545 HD22 ' HA ' ' A' ' 20' ' ' ALA . 6.9 mp -123.39 133.84 54.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.895 0.378 . . . . 0.0 110.414 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.418 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 2.6 mmp_? -121.95 169.38 10.87 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 87.5 mtp -67.5 84.15 0.17 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 110.709 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.76 -21.24 9.11 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.923 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -130.21 137.89 50.29 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.616 0.708 . . . . 0.0 112.212 -173.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.761 HD13 HD11 ' A' ' 9' ' ' ILE . 53.4 tp -96.52 107.09 19.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.808 174.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.6 t -101.02 100.69 10.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.317 0.58 . . . . 0.0 111.055 -173.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.4 mp -86.34 146.05 26.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.37 177.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -137.58 132.61 33.36 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 64' ' ' MET . . . -115.01 142.24 28.17 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 119.273 -0.971 . . . . 0.0 112.167 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.98 81.23 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.233 1.955 . . . . 0.0 110.5 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.2 -31.83 2.74 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.587 ' HB2' ' HB1' ' A' ' 61' ' ' ALA . 13.8 mmt -114.79 153.41 30.42 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.428 ' H ' HD21 ' A' ' 65' ' ' LEU . 2.8 mm? -68.67 -158.64 0.02 OUTLIER 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.508 0.67 . . . . 0.0 111.714 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 13.2 ptm180 -89.4 151.2 22.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.925 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 100' ' ' ALA . 60.7 tp -137.44 103.94 5.21 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.753 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 2.2 p-10 -99.21 112.75 24.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.649 0.738 . . . . 0.0 111.016 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.497 HG21 ' HB3' ' A' ' 96' ' ' GLU . 34.2 mt -110.67 138.83 21.15 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.503 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.29 119.71 7.08 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 121.931 1.754 . . . . 0.0 111.446 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 57' ' ' LEU . 64.3 mt . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 121.206 0.527 . . . . 0.0 111.462 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 41.0 t . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 121.143 0.497 . . . . 0.0 111.392 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -85.39 105.08 15.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -95.39 132.53 40.33 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.827 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -80.19 102.68 9.57 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.688 ' HE2' ' HA2' ' A' ' 34' ' ' GLY . 2.7 tpt -102.93 159.29 15.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.213 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp -133.01 87.61 2.42 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.632 0.73 . . . . 0.0 109.727 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.541 HG12 ' HD3' ' A' ' 127' ' ' PRO . 5.0 t -83.63 93.55 3.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.388 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.37 -89.43 1.31 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.78 11.81 2.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.05 0.452 . . . . 0.0 110.214 171.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.484 HE21 HG12 ' A' ' 124' ' ' VAL . 15.3 tt0 -96.5 112.9 24.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.544 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.7 m -83.23 114.48 21.4 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.156 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.507 HG11 HG22 ' A' ' 124' ' ' VAL . 3.6 m -136.25 147.24 28.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.031 0.443 . . . . 0.0 111.973 -174.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.07 117.09 20.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.252 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.473 HG22 HD11 ' A' ' 115' ' ' LEU . 36.0 m -120.23 148.85 23.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 93.5 t -94.94 129.85 44.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.35 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.517 ' OD1' ' HD3' ' A' ' 113' ' ' ARG . 33.3 t70 -82.6 132.33 35.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.303 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HB3' HG21 ' A' ' 69' ' ' ILE . 17.8 mm-40 -82.64 -6.49 59.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.713 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.11 157.01 11.93 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.225 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -53.68 -31.57 48.28 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 122.744 0.418 . . . . 0.0 111.345 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.715 ' H ' HD22 ' A' ' 99' ' ' LEU . 1.4 pt? -62.18 -36.96 83.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.811 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.425 ' HA ' HD23 ' A' ' 67' ' ' LEU . . . -76.3 -35.18 58.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.056 0.455 . . . . 0.0 110.221 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -59.96 -57.23 13.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.67 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.71 -42.65 99.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.437 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.52 ' CZ2' ' HB2' ' A' ' 61' ' ' ALA . 76.3 t90 -54.14 -47.53 71.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.055 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.558 HD13 ' HB3' ' A' ' 107' ' ' HIS . 3.1 tp -85.26 -23.91 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.198 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.3 m -64.96 -16.44 63.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.403 -0.81 . . . . 0.0 109.996 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -88.68 -51.09 5.86 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.2 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.558 ' HB3' HD13 ' A' ' 104' ' ' ILE . 57.5 t60 -72.71 -44.48 61.68 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.445 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -76.17 -36.64 58.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.24 -32.4 7.52 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.849 171.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.642 HG21 ' SG ' ' A' ' 112' ' ' CYS . 16.1 m -100.43 158.76 31.34 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 25.1 Cg_endo -62.64 90.88 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.649 2.232 . . . . 0.0 112.108 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.642 ' SG ' HG21 ' A' ' 110' ' ' VAL . 76.5 m -135.21 164.73 27.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.277 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 10.9 ptp180 -140.48 143.37 35.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.404 175.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.587 HG12 HG21 ' A' ' 29' ' ' VAL . 37.6 mt -73.27 131.92 34.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.473 HD11 HG22 ' A' ' 93' ' ' VAL . 71.7 mt -134.87 139.54 45.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.176 0.512 . . . . 0.0 110.55 -176.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -108.16 110.78 22.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.273 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.5 t -63.26 132.94 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.602 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.423 ' CG ' ' HD2' ' A' ' 119' ' ' PRO . 0.5 OUTLIER -86.81 139.45 33.05 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.076 -177.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 118' ' ' HIS . 48.9 Cg_endo -68.36 -2.13 8.53 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.303 2.669 . . . . 0.0 114.531 -173.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -71.7 -51.61 22.08 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.21 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 95.3 mmm -73.52 -44.81 56.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 67.42 -77.97 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.733 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.88 139.87 30.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.368 0.604 . . . . 0.0 111.544 -172.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.675 ' HB ' ' CH2' ' A' ' 36' ' ' TRP . 52.8 t -133.9 -30.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.902 175.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 78.13 -37.97 0.24 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.549 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 19.7 t90 77.73 138.35 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.549 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 21.0 Cg_endo . . . . . 0 C--N 1.351 0.699 0 C-N-CA 123.544 2.829 . . . . 0.0 113.422 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.326 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.493 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.6 m-85 -94.31 134.4 36.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.33 91.75 20.6 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 6.1 Cg_exo -82.11 -55.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.937 2.425 . . . . 0.0 113.413 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.702 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -114.88 132.24 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 123.741 0.651 . . . . 0.0 110.555 -174.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.63 -55.14 36.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -170.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.79 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -62.32 -49.22 76.46 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -171.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.702 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 9.9 p -74.0 -35.75 64.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.771 0.319 . . . . 0.0 110.693 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.05 -140.52 14.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.807 170.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.75 152.15 23.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.309 0.576 . . . . 0.0 111.64 -172.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.8 m -134.5 134.43 41.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.256 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 p -94.63 66.41 3.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.49 0.662 . . . . 0.0 110.94 176.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -133.58 128.39 35.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.066 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.7 m -56.87 -33.09 66.5 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.65 -16.18 56.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.473 ' HB3' ' HG3' ' A' ' 8' ' ' PRO . . . -65.61 -22.67 66.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.361 . . . . 0.0 111.378 -176.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.61 -25.63 67.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.472 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.91 0.26 48.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.425 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -129.51 20.97 5.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.707 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 5.3 pp0? -91.16 150.79 21.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.191 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -162.51 -179.58 7.04 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.646 ' NH1' ' HA ' ' A' ' 123' ' ' GLU . 50.5 mtt85 -82.82 65.38 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 165.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.547 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 2.0 t90 -88.7 144.98 25.91 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.919 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -177.78 -177.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.552 0.691 . . . . 0.0 112.317 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.557 HG22 HG12 ' A' ' 114' ' ' ILE . 17.6 t -106.04 142.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.009 175.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.72 155.25 39.58 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.818 HD22 ' HB3' ' A' ' 35' ' ' GLN . 0.3 OUTLIER -99.8 160.44 14.3 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.779 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.515 ' HB2' ' HB2' ' A' ' 111' ' ' PRO . 14.2 t70 -45.7 -34.74 3.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.55 0.74 . . . . 0.0 112.81 -176.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.79 -7.17 3.26 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.604 ' HA2' ' HE2' ' A' ' 84' ' ' MET . . . 88.59 7.18 72.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.614 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.818 ' HB3' HD22 ' A' ' 31' ' ' ASN . 22.6 tt0 -100.03 140.22 34.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.553 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -61.71 129.02 39.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.6 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.47 HD22 ' SG ' ' A' ' 112' ' ' CYS . 20.9 tp -90.27 144.86 25.45 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -137.13 167.44 21.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.24 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -67.7 -21.09 65.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.93 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -77.37 -26.37 51.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.77 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 78.2 mt -90.72 -51.22 5.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.277 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.422 ' HG ' HD23 ' A' ' 37' ' ' LEU . 74.7 m -122.94 93.83 47.95 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.645 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.68 -30.27 91.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.004 2.469 . . . . 0.0 112.461 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 47.7 mtm105 -69.19 -13.38 62.38 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.939 0.399 . . . . 0.0 111.156 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.79 ' HG ' ' HB2' ' A' ' 11' ' ' GLU . 32.5 tp -79.5 -18.86 51.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.57 -17.1 64.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.165 0.507 . . . . 0.0 109.944 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.69 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 57.5 mm-40 -82.95 58.8 4.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.418 177.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.0 t -129.39 139.22 52.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.7 m -105.49 142.28 35.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.67 0.272 . . . . 0.0 110.801 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.641 HG23 ' SG ' ' A' ' 12' ' ' CYS . 1.5 t -96.73 143.35 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.867 -174.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 3.8 tp10 -146.56 137.33 24.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 167.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 mp -119.25 125.47 49.21 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.885 0.374 . . . . 0.0 110.279 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -105.31 175.59 5.44 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.2 ttm -68.38 91.85 0.41 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.39 -0.28 65.73 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.136 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.459 ' C ' ' HG ' ' A' ' 71' ' ' LEU . 59.4 m-85 -136.21 148.36 48.06 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 117.59 0.695 . . . . 0.0 112.313 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.458 ' HB2' HD21 ' A' ' 71' ' ' LEU . 42.1 tp -109.32 118.51 36.87 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.128 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 66.8 t -109.05 111.05 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.228 0.537 . . . . 0.0 110.513 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 3.8 mp -97.07 137.19 36.52 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.947 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -129.3 130.39 46.09 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' A' ' 64' ' ' MET . . . -122.27 134.03 24.64 Favored Pre-proline 0 C--O 1.215 -0.718 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.879 -173.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.69 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 82.5 Cg_exo -46.16 107.08 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.272 1.981 . . . . 0.0 111.178 166.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.17 -10.51 61.75 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.951 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.574 ' HB2' ' HB2' ' A' ' 61' ' ' ALA . 76.8 mmm -136.4 156.53 48.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.768 0.794 . . . . 0.0 111.53 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.46 HD22 ' H ' ' A' ' 65' ' ' LEU . 2.6 mm? -67.7 -165.87 0.05 Allowed 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.816 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 33.6 ptt85 -88.33 169.22 12.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.448 173.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.47 ' HG ' HG13 ' A' ' 69' ' ' ILE . 55.3 tp -147.48 111.33 5.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.761 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.22 99.82 12.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 110.587 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.47 HG13 ' HG ' ' A' ' 67' ' ' LEU . 70.0 mt -105.93 138.72 19.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.42 139.19 23.02 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.189 1.926 . . . . 0.0 112.509 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' A' ' 71' ' ' LEU . 8.7 mt . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.573 0.702 . . . . 0.0 111.428 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -77.53 99.18 5.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.613 0.72 . . . . 0.0 109.783 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -86.13 126.66 34.38 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.589 -175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -76.61 112.03 12.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.604 ' HE2' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -98.94 145.84 26.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.8 -175.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.851 ' HG ' ' HA ' ' A' ' 88' ' ' GLU . 12.9 tp -126.35 79.07 1.82 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.498 0.666 . . . . 0.0 109.501 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.426 HG11 ' HD3' ' A' ' 127' ' ' PRO . 4.6 t -85.92 96.97 5.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.306 -174.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.69 31.95 70.64 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.851 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.9 OUTLIER 69.39 18.19 7.98 Favored 'General case' 0 N--CA 1.46 0.051 0 CA-C-N 114.504 -0.848 . . . . 0.0 111.296 -176.124 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -92.84 107.76 19.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.8 m -78.84 99.88 6.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.909 -172.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 m -132.32 142.57 42.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.713 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -91.78 140.5 29.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.19 0.519 . . . . 0.0 110.721 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.9 m -131.15 153.72 39.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.691 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.2 t -88.87 132.84 32.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.894 0.378 . . . . 0.0 111.221 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.668 ' OD2' ' HD3' ' A' ' 113' ' ' ARG . 26.3 t0 -77.42 127.11 31.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.312 175.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -92.65 -3.15 55.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.315 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.29 129.84 1.34 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.685 -1.245 . . . . 0.0 114.511 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.42 -36.29 71.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.29 0.567 . . . . 0.0 110.144 171.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.86 -35.7 81.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.436 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -65.54 -37.71 87.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.489 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.69 84.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.73 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.72 83.46 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.993 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -51.48 -44.66 62.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.274 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.541 HD13 ' HB3' ' A' ' 107' ' ' HIS . 3.2 tp -86.94 -23.17 6.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.635 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 94.6 p -65.02 -17.99 64.92 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.357 -0.839 . . . . 0.0 109.301 175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -81.97 -57.84 3.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.342 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.541 ' HB3' HD13 ' A' ' 104' ' ' ILE . 75.5 t60 -69.04 -45.5 70.27 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.12 -42.67 59.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.62 -30.68 8.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.586 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.659 HG22 ' SG ' ' A' ' 112' ' ' CYS . 16.5 m -99.78 163.45 18.41 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 17.8 Cg_endo -60.26 96.71 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.533 2.156 . . . . 0.0 112.155 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.659 ' SG ' HG22 ' A' ' 110' ' ' VAL . 72.1 m -134.05 158.15 44.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.721 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.668 ' HD3' ' OD2' ' A' ' 95' ' ' ASP . 48.9 ttm-85 -143.15 132.83 23.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.138 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.557 HG12 HG22 ' A' ' 29' ' ' VAL . 41.7 mt -80.06 120.91 32.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' A' ' 95' ' ' ASP . 70.4 mt -131.51 155.96 46.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.747 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.559 ' HB3' ' HZ3' ' A' ' 116' ' ' LYS . 7.2 ttpm? -121.56 138.67 54.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.155 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.13 135.17 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.69 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -73.1 119.54 76.19 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.796 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.07 -24.68 20.44 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.627 2.885 . . . . 0.0 113.704 -173.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.97 -39.79 82.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 110.714 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -117.75 -175.47 2.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.12 -170.62 3.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.137 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.646 ' HA ' ' NH1' ' A' ' 26' ' ' ARG . 8.0 mm-40 65.79 -140.07 0.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.793 0.683 . . . . 0.0 111.142 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.1 t 65.67 100.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -167.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -108.28 27.25 9.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.532 -169.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.701 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 5.2 t90 72.58 151.5 0.14 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -174.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.701 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 10.6 Cg_endo . . . . . 0 C--N 1.352 0.722 0 C-N-CA 123.272 2.648 . . . . 0.0 114.135 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.834 0.349 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.697 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 55.5 m-85 -112.46 141.33 46.34 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.994 -177.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -99.68 97.25 5.49 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.012 0.195 . . . . 0.0 110.7 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.805 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 2.6 Cg_exo -77.07 -54.4 0.06 OUTLIER 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.874 2.383 . . . . 0.0 111.735 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.806 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 4.9 mm -107.22 150.88 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.462 -175.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.74 -54.73 8.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.017 -174.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.59 -53.18 60.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.5 -175.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.806 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 25.9 p -70.51 -47.27 61.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.95 -127.79 9.26 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.533 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.83 139.3 30.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.3 0.571 . . . . 0.0 112.207 -173.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.498 HG23 HD11 ' A' ' 52' ' ' LEU . 16.9 m -113.5 138.84 49.55 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.94 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -87.41 31.66 0.73 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -119.96 136.35 54.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.085 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.413 ' HA ' ' HE2' ' A' ' 6' ' ' TYR . 20.1 m -65.85 -28.76 69.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.791 0.329 . . . . 0.0 111.618 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -65.32 -23.6 67.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.498 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.805 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -58.47 -30.98 67.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.566 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.11 -24.8 67.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.69 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.19 -14.71 28.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.589 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -112.77 -0.94 14.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.695 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.642 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 3.7 pp0? -67.58 150.8 48.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.568 0.223 . . . . 0.0 110.562 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 24' ' ' GLN . 38.5 mmtm -165.54 -178.7 5.04 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.175 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -81.82 79.13 8.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.896 0.855 . . . . 0.0 109.482 170.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -100.63 147.14 26.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.907 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 pp -173.99 178.88 2.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.63 0.729 . . . . 0.0 112.246 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.867 HG22 HD11 ' A' ' 114' ' ' ILE . 60.3 t -111.5 136.42 47.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.488 175.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.562 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -124.85 144.94 50.04 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -77.6 142.75 38.76 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -48.02 -25.64 1.48 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.24 -18.38 15.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.651 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.768 ' HA2' ' HE2' ' A' ' 84' ' ' MET . . . 103.61 18.67 13.69 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -176.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -112.87 127.45 56.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.938 -173.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -56.64 123.64 15.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.432 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 45' ' ' LEU . 10.5 tp -82.47 154.31 25.18 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -140.88 164.3 30.61 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.498 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -69.06 -24.57 64.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 110.074 176.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.8 -27.66 61.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.879 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.2 mt -87.79 -51.47 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.611 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.6 m -130.25 95.68 26.96 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.64 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.58 -28.87 69.99 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.771 2.314 . . . . 0.0 112.139 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -67.76 -14.11 62.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.233 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 37' ' ' LEU . 33.0 tp -74.47 -23.12 58.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.746 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.2 -13.35 61.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.232 0.539 . . . . 0.0 110.384 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -92.68 54.62 2.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.69 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 12' ' ' CYS . 92.0 t -110.88 134.26 53.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.038 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.8 m -100.56 148.77 24.44 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.12 148.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.177 0.513 . . . . 0.0 111.722 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.509 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 28.8 tt0 -152.05 139.75 19.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.498 HD11 HG23 ' A' ' 15' ' ' THR . 9.2 mp -106.93 125.39 50.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.682 0.753 . . . . 0.0 111.443 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -112.42 154.4 25.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.38 -1.282 . . . . 0.0 107.671 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' MET . . . . . 0.424 ' O ' ' HG3' ' A' ' 54' ' ' MET . 23.6 ptt? -60.66 100.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.939 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.59 0.07 64.95 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.117 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -143.14 137.62 29.21 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 117.403 0.601 . . . . 0.0 111.536 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.502 ' HB2' HD23 ' A' ' 71' ' ' LEU . 28.1 tp -100.21 114.39 27.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.176 175.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 70.8 t -96.4 96.45 5.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.892 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.1 mp -87.53 143.44 27.21 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -140.28 130.95 25.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 64' ' ' MET . . . -115.67 144.96 33.54 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.453 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.95 98.03 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.061 1.841 . . . . 0.0 110.487 170.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.09 -32.2 6.08 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.302 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.592 ' HB2' ' HB1' ' A' ' 61' ' ' ALA . 13.1 mmt -116.04 154.64 29.53 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.437 0.637 . . . . 0.0 110.218 -177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.741 ' H ' HD12 ' A' ' 65' ' ' LEU . 2.5 mp -69.71 -154.38 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.755 -171.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 12.4 ptm180 -94.33 145.14 24.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.652 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 53.4 tp -121.67 114.61 21.38 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.234 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.99 102.22 14.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.716 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 70.1 mt -97.8 116.47 65.73 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.739 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.62 119.5 6.62 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.321 2.014 . . . . 0.0 112.168 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.502 HD23 ' HB2' ' A' ' 57' ' ' LEU . 96.1 mt . . . . . 0 C--N 1.324 -0.51 0 CA-C-O 121.182 0.515 . . . . 0.0 110.028 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.447 -0.609 0 CA-C-O 121.135 0.493 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.53 ' HG2' HG22 ' A' ' 94' ' ' VAL . 74.1 mtp180 -86.5 112.98 22.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.89 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.516 ' HE2' ' HB2' ' A' ' 95' ' ' ASP . 98.0 m-85 -101.13 133.15 46.11 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.388 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -80.06 98.77 7.38 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.768 ' HE2' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -90.17 153.46 20.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.283 -171.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.27 86.41 2.45 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.75 0.786 . . . . 0.0 109.449 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.523 HG11 ' HD3' ' A' ' 127' ' ' PRO . 4.0 t -76.57 84.6 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.497 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.73 -78.34 1.67 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -175.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.81 16.08 1.77 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.018 0.437 . . . . 0.0 110.441 174.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.401 ' HG2' HG11 ' A' ' 91' ' ' VAL . 10.0 tt0 -111.26 108.93 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 110.725 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 84' ' ' MET . 7.5 m -80.29 113.97 18.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.494 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.529 HG12 ' HG2' ' A' ' 121' ' ' MET . 5.9 m -134.63 159.33 41.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.336 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.65 113.13 25.32 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 -174.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.484 HG22 HD23 ' A' ' 115' ' ' LEU . 34.9 m -120.03 136.96 55.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.97 177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.53 HG22 ' HG2' ' A' ' 81' ' ' ARG . 6.4 t -99.25 129.96 48.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.063 -176.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.516 ' HB2' ' HE2' ' A' ' 82' ' ' TYR . 53.8 t0 -74.48 119.92 19.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.695 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -74.4 -7.83 54.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.982 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.76 146.31 4.45 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.111 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -62.2 -30.45 71.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.22 0.533 . . . . 0.0 110.217 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.7 tp -67.78 -33.94 75.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.913 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.488 ' HB1' HG13 ' A' ' 114' ' ' ILE . . . -71.41 -40.63 70.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.111 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.26 -41.81 94.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.528 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.482 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -62.76 -43.03 99.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.984 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.444 ' CZ2' ' HB2' ' A' ' 61' ' ' ALA . 38.1 t90 -55.66 -39.43 70.9 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.654 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.571 HG22 ' HB2' ' A' ' 112' ' ' CYS . 9.8 mm -89.41 -26.12 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 80.1 p -65.41 -14.96 62.06 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.466 -0.771 . . . . 0.0 109.356 172.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -90.23 -52.76 4.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.466 170.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.426 ' HB3' HD12 ' A' ' 104' ' ' ILE . 82.9 t60 -65.23 -40.69 94.4 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.43 -33.89 14.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.146 0.498 . . . . 0.0 110.142 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.44 -29.6 11.16 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.649 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.509 HG22 ' HG ' ' A' ' 112' ' ' CYS . 24.2 m -106.13 156.65 36.45 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.2 97.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.792 2.328 . . . . 0.0 112.622 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.571 ' HB2' HG22 ' A' ' 104' ' ' ILE . 58.1 m -129.03 147.65 50.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.9 176.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.461 ' HD3' ' CG ' ' A' ' 95' ' ' ASP . 41.6 ttm-85 -126.43 130.76 51.32 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.188 -171.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.867 HD11 HG22 ' A' ' 29' ' ' VAL . 25.6 mm -68.37 118.14 11.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.562 HD12 ' HB3' ' A' ' 30' ' ' ALA . 18.4 mt -133.1 129.88 38.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.732 0.777 . . . . 0.0 111.896 -173.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.594 ' HB3' ' HZ3' ' A' ' 116' ' ' LYS . 7.9 ttpm? -103.68 120.51 41.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.322 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.3 t -62.75 132.0 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.694 0.283 . . . . 0.0 110.343 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -69.22 139.2 89.76 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -51.02 -15.84 2.19 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.55 2.833 . . . . 0.0 114.219 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -60.09 -34.36 73.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.142 0.496 . . . . 0.0 110.584 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.529 ' HG2' HG12 ' A' ' 91' ' ' VAL . 2.4 mpt? -112.29 124.56 52.73 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.248 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.53 36.46 4.37 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.335 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -140.37 -135.0 0.11 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.73 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.486 HG12 HG23 ' A' ' 86' ' ' VAL . 4.3 t 67.34 94.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.387 0.613 . . . . 0.0 110.06 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.449 ' O ' ' HG2' ' A' ' 125' ' ' ARG . 11.5 ttp180 -99.15 20.07 14.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.586 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.582 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 6.3 t90 70.61 151.56 0.14 Allowed Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 5.7 Cg_exo . . . . . 0 C--N 1.359 1.1 0 C-N-CA 123.151 2.568 . . . . 0.0 112.486 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 120.864 0.364 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.679 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 24.6 m-85 -86.98 133.92 33.54 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 10.3 tt0 -105.66 94.23 8.41 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.888 0.375 . . . . 0.0 111.031 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.835 ' HG3' ' HB3' ' A' ' 20' ' ' ALA . 7.0 Cg_endo -87.11 -41.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.283 2.655 . . . . 0.0 112.317 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 3.6 mp -100.97 145.15 11.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.89 -73.03 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -172.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.624 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -58.93 -50.01 75.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.89 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 66.5 m -54.95 -47.33 74.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.965 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.8 -140.87 15.11 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.363 175.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 7' ' ' GLN . . . -94.67 151.91 18.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.459 0.647 . . . . 0.0 112.212 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.489 HG23 HD11 ' A' ' 52' ' ' LEU . 15.2 m -125.42 139.3 53.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.005 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -86.78 23.33 1.73 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.44 ' HG3' HG22 ' A' ' 15' ' ' THR . 9.3 mt-30 -114.83 145.63 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.672 0.272 . . . . 0.0 110.31 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 t -61.97 -35.15 77.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.292 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.432 ' CD ' ' H ' ' A' ' 19' ' ' GLU . 2.1 mp0 -52.76 -34.13 51.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.465 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.835 ' HB3' ' HG3' ' A' ' 8' ' ' PRO . . . -61.5 -27.6 68.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.459 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.55 -2.76 18.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.801 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.43 18.8 4.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.97 14.9 3.07 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.337 0.589 . . . . 0.0 110.44 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -64.12 143.56 57.78 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.095 177.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 24' ' ' GLN . 68.5 mmtt -161.88 166.9 25.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -172.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.465 ' CB ' ' HB ' ' A' ' 117' ' ' VAL . 4.8 mpt_? -86.64 82.53 7.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.233 0.54 . . . . 0.0 110.156 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.17 153.0 21.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.123 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.59 164.24 32.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.023 0.439 . . . . 0.0 110.512 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.574 HG21 ' HG2' ' A' ' 11' ' ' GLU . 89.4 t -126.48 136.87 59.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.66 ' HB3' ' HE2' ' A' ' 84' ' ' MET . . . -111.97 133.63 54.03 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.602 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.678 HD22 ' HB3' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -79.48 179.52 7.41 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 172.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -46.07 -40.02 10.14 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.27 -5.72 43.75 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.85 11.64 84.37 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.761 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.678 ' HB3' HD22 ' A' ' 31' ' ' ASN . 26.0 tt0 -85.2 144.16 28.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.594 -0.303 . . . . 0.0 110.753 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.642 ' CD1' HG23 ' A' ' 86' ' ' VAL . 2.2 m0 -53.54 122.4 9.69 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 124.14 0.9 . . . . 0.0 111.67 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 tp -104.91 130.97 52.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -122.74 170.19 10.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.083 0.468 . . . . 0.0 111.79 -173.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -71.52 -19.44 62.18 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -70.65 -26.25 63.38 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.5 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.9 mt -94.74 -47.45 6.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.458 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.0 m -124.95 98.53 36.25 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.911 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.15 -31.02 75.45 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.891 2.394 . . . . 0.0 111.677 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -60.52 -30.06 69.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.968 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.624 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 63.2 tp -72.84 -28.09 62.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.261 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -71.39 -12.97 61.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.175 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -85.69 38.97 0.77 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.743 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.89 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 78.4 t -92.77 130.84 41.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.553 0.216 . . . . 0.0 110.473 173.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.631 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . 18.1 m -86.89 117.09 25.39 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.584 HG13 HD13 ' A' ' 9' ' ' ILE . 1.4 t -99.0 144.56 11.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.384 -172.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.601 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 78.9 tt0 -148.86 144.02 26.64 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.489 HD11 HG23 ' A' ' 15' ' ' THR . 8.2 mp -123.74 129.75 51.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.015 0.435 . . . . 0.0 109.914 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.83 156.98 28.48 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.81 98.13 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.149 0.5 . . . . 0.0 110.998 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.25 -12.09 44.06 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.391 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -138.65 137.88 37.29 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 117.839 0.82 . . . . 0.0 112.145 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.8 tp -95.87 110.31 22.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 59.7 t -96.48 95.67 4.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.925 -173.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 7.6 mp -88.25 152.01 22.26 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.631 ' HG3' ' HB2' ' A' ' 49' ' ' SER . 11.1 ptpp? -159.89 143.17 14.05 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 172.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' A' ' 64' ' ' MET . . . -132.25 147.37 65.45 Favored Pre-proline 0 C--O 1.218 -0.557 0 C-N-CA 118.665 -1.214 . . . . 0.0 113.413 -173.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.71 102.74 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.875 1.717 . . . . 0.0 110.45 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.78 -6.9 33.32 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.278 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.544 ' HB2' ' HB1' ' A' ' 61' ' ' ALA . 83.7 mmm -140.61 151.96 45.07 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.336 0.588 . . . . 0.0 110.879 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.99 -159.1 0.03 OUTLIER 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.294 0.569 . . . . 0.0 111.18 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 45.4 mtp180 -80.36 149.38 30.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.597 174.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 68.6 tp -121.83 107.99 12.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 171.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -91.66 106.91 18.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.063 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 62.1 mt -115.66 116.65 40.89 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.441 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.45 131.74 48.03 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.636 2.224 . . . . 0.0 111.925 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 111.055 -178.389 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 57.7 t . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.905 0.383 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 81' ' ' ARG . 28.3 mtp180 -88.08 110.97 21.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.266 0.555 . . . . 0.0 109.849 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -101.28 132.35 46.85 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.239 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -78.47 104.7 9.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.246 0.546 . . . . 0.0 110.241 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.66 ' HE2' ' HB3' ' A' ' 30' ' ' ALA . 8.7 tpt -86.18 146.38 26.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.803 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp -125.57 92.24 3.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.854 0.835 . . . . 0.0 110.408 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.642 HG23 ' CD1' ' A' ' 36' ' ' TRP . 3.7 t -79.29 83.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.638 176.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.93 -74.89 1.14 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.19 4.95 1.86 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.265 0.555 . . . . 0.0 109.7 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -91.51 110.04 21.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.14 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 m -84.48 114.83 22.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.123 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' A' ' 84' ' ' MET . 2.2 m -134.84 144.54 34.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.921 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.69 119.89 23.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.435 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.534 HG13 ' HA ' ' A' ' 117' ' ' VAL . 27.7 m -122.39 153.79 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.747 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.6 t -96.55 128.01 48.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.0 110.66 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.531 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 56.9 t0 -71.78 129.0 37.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.265 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -82.52 -20.05 37.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.863 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.21 156.45 9.68 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.856 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -78.64 -5.82 54.0 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.763 -0.257 . . . . 0.0 111.5 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.8 pt? -68.38 -38.93 81.84 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 172.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.25 -36.47 63.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.75 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.504 ' HB1' ' HG3' ' A' ' 113' ' ' ARG . . . -59.27 -52.51 65.36 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.31 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.434 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -63.0 -40.03 96.54 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.346 0.593 . . . . 0.0 111.08 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.414 ' HA ' ' HE2' ' A' ' 64' ' ' MET . 82.2 t90 -57.35 -35.71 70.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.538 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.525 HD13 ' HB3' ' A' ' 107' ' ' HIS . 2.3 tp -95.41 -22.65 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.862 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 86.2 p -66.86 -20.27 65.89 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.251 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -87.9 -46.2 9.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.332 173.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.525 ' HB3' HD13 ' A' ' 104' ' ' ILE . 76.3 t60 -75.17 -48.43 23.67 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.04 -38.15 57.51 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.51 -23.49 35.61 Favored Glycine 0 C--N 1.329 0.161 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.325 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.445 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 27.7 m -103.52 159.32 29.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 O-C-N 122.824 -0.221 . . . . 0.0 110.659 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 37.2 Cg_endo -66.48 90.53 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.466 2.111 . . . . 0.0 111.829 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.475 ' SG ' HG23 ' A' ' 104' ' ' ILE . 2.2 p -134.76 157.18 47.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.969 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.504 ' HG3' ' HB1' ' A' ' 101' ' ' ALA . 21.9 ttm180 -132.55 137.48 47.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.331 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.518 HG13 HG22 ' A' ' 29' ' ' VAL . 2.0 mp -77.16 128.92 37.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.442 ' CD2' ' HA ' ' A' ' 95' ' ' ASP . 80.0 mt -131.8 142.82 49.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.227 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -107.34 120.68 42.82 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.534 ' HA ' HG13 ' A' ' 93' ' ' VAL . 60.2 t -65.58 116.34 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.071 0.463 . . . . 0.0 110.051 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.542 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 2.2 t-80 -77.2 133.56 68.37 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.542 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 10.8 Cg_endo -57.58 -5.36 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.492 2.794 . . . . 0.0 114.472 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -54.71 -44.47 73.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.458 0.647 . . . . 0.0 109.353 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.1 mmt -93.59 -56.76 2.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.617 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 60.26 -173.38 0.12 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.867 0.729 . . . . 0.0 110.493 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 124' ' ' VAL . 1.8 tm-20 57.65 -141.64 0.75 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.595 ' CG1' HG21 ' A' ' 86' ' ' VAL . 48.4 t 71.3 113.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.511 0.672 . . . . 0.0 111.783 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -124.48 150.08 46.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.021 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.496 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 6.7 t90 -45.12 142.17 2.97 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.093 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.548 ' HD3' HG12 ' A' ' 86' ' ' VAL . 3.2 Cg_endo . . . . . 0 C--N 1.355 0.89 0 C-N-CA 123.643 2.895 . . . . 0.0 112.824 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.607 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 9.6 m-85 -97.76 141.15 31.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.449 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 75.6 mt-30 -105.23 95.93 10.48 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.45 0.167 . . . . 0.0 111.262 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 11.0 Cg_exo -72.41 -62.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.161 2.574 . . . . 0.0 112.619 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.816 HD11 HD21 ' A' ' 57' ' ' LEU . 8.0 mt -113.81 159.79 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.658 0.599 . . . . 0.0 110.912 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.424 ' H ' HG21 ' A' ' 9' ' ' ILE . . . -71.17 -56.73 5.47 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -66.08 -45.02 82.72 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -171.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.785 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 4.7 p -68.48 -42.21 79.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.755 0.312 . . . . 0.0 111.011 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.74 -127.74 9.34 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.362 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . . . -96.82 145.1 26.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.377 0.608 . . . . 0.0 111.794 -173.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.6 m -137.38 127.79 26.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.691 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.6 m -86.68 83.5 7.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.397 0.618 . . . . 0.0 110.732 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -147.39 126.63 13.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.059 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.8 p -55.76 -28.2 54.78 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -174.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.89 -22.37 53.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.717 0.294 . . . . 0.0 111.267 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.527 ' HA ' HD21 ' A' ' 52' ' ' LEU . . . -65.42 -28.25 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.346 . . . . 0.0 111.556 -176.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.67 -22.03 64.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.113 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.92 -23.64 17.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -109.71 4.42 21.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.484 -172.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.19 141.62 38.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 64.4 mttm -163.86 -169.75 1.97 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -78.74 72.68 5.27 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.697 0.76 . . . . 0.0 110.372 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.698 ' HB3' HG23 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -101.42 145.15 29.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.418 178.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -176.19 179.2 1.29 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.348 0.594 . . . . 0.0 112.265 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 HG12 ' A' ' 114' ' ' ILE . 16.8 t -110.84 148.07 14.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.199 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.58 ' HB1' ' HE2' ' A' ' 84' ' ' MET . . . -134.22 156.55 48.18 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.534 ' ND2' ' H ' ' A' ' 33' ' ' ALA . 2.6 p-10 -112.46 173.15 6.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.272 0.558 . . . . 0.0 112.143 -171.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 111' ' ' PRO . 9.9 p-10 -46.24 -33.62 3.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.264 -1.335 . . . . 0.0 113.669 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.534 ' H ' ' ND2' ' A' ' 31' ' ' ASN . . . -72.64 2.03 7.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.421 ' HA2' ' HE1' ' A' ' 84' ' ' MET . . . 80.58 8.68 87.28 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -106.71 152.16 24.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.114 -0.543 . . . . 0.0 110.022 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -64.3 146.72 53.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.293 173.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.78 HD22 ' HG ' ' A' ' 42' ' ' CYS . 20.3 tp -98.65 166.26 11.41 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -147.95 158.18 43.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 43' ' ' PRO . 54.5 mtm180 -73.25 -14.95 61.42 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.97 -18.89 35.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.189 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.3 mt -92.7 -51.82 4.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.78 ' HG ' HD22 ' A' ' 37' ' ' LEU . 77.2 m -114.78 94.27 36.84 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.996 173.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 51.7 Cg_exo -54.83 -44.53 48.78 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.723 2.949 . . . . 0.0 113.608 -171.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -77.52 8.38 4.38 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 108' ' ' ALA . 2.4 mp -76.16 -21.65 56.31 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.2 -22.62 61.3 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.983 170.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.523 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 52.5 mt-10 -86.06 63.16 7.87 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.225 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 12' ' ' CYS . 73.3 t -123.18 127.93 74.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.136 169.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 60' ' ' LYS . 5.8 t -91.24 140.19 30.03 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 2.7 t -121.39 128.29 75.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.0 111.821 -172.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 15.4 mt-10 -120.86 129.41 53.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.559 169.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 20' ' ' ALA . 5.7 mp -110.57 133.58 53.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.52 0.676 . . . . 0.0 110.013 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.1 ttm105 -135.91 148.14 48.44 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 70.0 mtm -62.98 93.68 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.433 0.635 . . . . 0.0 110.741 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.37 -16.03 11.71 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.938 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -143.28 138.42 29.56 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 117.828 0.814 . . . . 0.0 111.776 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.816 HD21 HD11 ' A' ' 9' ' ' ILE . 39.0 tp -113.1 112.46 23.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.702 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.552 ' HB ' ' HB2' ' A' ' 51' ' ' GLU . 61.0 t -100.68 110.6 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.055 0.455 . . . . 0.0 111.251 -173.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 mp -98.67 132.5 44.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.996 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.543 ' HG2' ' HB3' ' A' ' 66' ' ' ARG . 44.3 mtmt -129.52 136.81 50.31 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 64' ' ' MET . . . -116.45 142.28 29.25 Favored Pre-proline 0 C--O 1.222 -0.372 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.449 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.523 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 26.8 Cg_exo -62.89 94.74 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.93 1.753 . . . . 0.0 110.225 168.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.29 -28.33 6.33 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.042 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.58 ' HB2' ' HB1' ' A' ' 61' ' ' ALA . 16.7 mmt -122.4 152.65 40.0 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.34 -166.89 0.02 OUTLIER 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.856 0.836 . . . . 0.0 112.561 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.543 ' HB3' ' HG2' ' A' ' 60' ' ' LYS . 12.2 ptt180 -95.71 146.63 24.36 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.45 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 tp -124.54 115.36 20.73 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.793 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.76 109.75 21.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.619 0.723 . . . . 0.0 110.788 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.4 mt -104.73 113.81 64.55 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.361 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.47 123.04 12.7 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.258 1.972 . . . . 0.0 111.957 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 57' ' ' LEU . 95.9 mt . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.631 0.729 . . . . 0.0 109.12 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 45.1 t . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.499 ' HG2' ' HB2' ' A' ' 92' ' ' ASP . 52.7 ttp180 -88.8 90.68 8.51 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -93.11 130.0 38.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.895 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -79.07 114.91 18.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.843 0.354 . . . . 0.0 110.405 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.58 ' HE2' ' HB1' ' A' ' 30' ' ' ALA . 2.4 tpt -105.22 154.94 19.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.754 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.25 87.61 2.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.689 0.757 . . . . 0.0 109.559 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 t -81.46 92.88 2.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.736 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.27 -81.24 1.08 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.57 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -140.06 9.48 2.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.793 -0.203 . . . . 0.0 110.788 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -111.48 110.53 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.359 . . . . 0.0 110.506 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 m -84.29 109.61 17.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.224 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.417 ' HB ' ' HE2' ' A' ' 121' ' ' MET . 5.0 m -131.85 149.21 32.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.806 -176.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.499 ' HB2' ' HG2' ' A' ' 81' ' ' ARG . 7.1 p-10 -87.22 128.71 35.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.442 0.639 . . . . 0.0 111.06 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 115' ' ' LEU . 29.5 m -124.91 153.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.011 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.486 HG21 ' HD2' ' A' ' 118' ' ' HIS . 98.8 t -96.33 137.3 24.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.596 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 32.0 t70 -86.8 123.79 32.34 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.415 ' HG3' ' HE1' ' A' ' 27' ' ' TRP . 16.3 mm-40 -83.38 5.73 22.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 -174.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.78 126.65 2.41 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.211 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -67.47 -19.54 65.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.037 0.446 . . . . 0.0 110.244 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.03 -33.47 74.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 173.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.11 79.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.875 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -57.94 -54.26 48.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.5 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.93 87.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.447 ' CZ2' ' HB2' ' A' ' 61' ' ' ALA . 55.8 t90 -54.32 -46.49 72.86 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.966 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 107' ' ' HIS . 1.5 tp -84.93 -21.54 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.692 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.4 m -67.12 -15.66 63.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.167 0.508 . . . . 0.0 109.699 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.39 -52.02 5.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.276 171.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.539 ' HB3' HD12 ' A' ' 104' ' ' ILE . 72.5 t60 -67.63 -46.66 71.84 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.02 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.425 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.29 -42.22 19.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.046 0.45 . . . . 0.0 109.807 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.06 -12.36 62.2 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.055 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.533 HG22 ' SG ' ' A' ' 112' ' ' CYS . 15.4 m -112.78 159.42 34.49 Favored Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 122.788 -0.242 . . . . 0.0 110.353 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.413 ' HB2' ' HB3' ' A' ' 32' ' ' ASP . 25.4 Cg_exo -63.18 93.11 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.831 2.354 . . . . 0.0 112.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.533 ' SG ' HG22 ' A' ' 110' ' ' VAL . 68.6 m -134.8 155.86 49.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.955 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.455 HH21 ' CG ' ' A' ' 95' ' ' ASP . 10.5 ptm180 -141.16 146.8 37.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.534 HG12 HG23 ' A' ' 29' ' ' VAL . 35.2 mt -85.15 122.78 38.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.107 -177.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.54 HD22 ' HA ' ' A' ' 95' ' ' ASP . 35.8 mt -126.06 152.23 46.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.139 -171.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.598 ' HZ1' ' HB3' ' A' ' 116' ' ' LYS . 7.8 ttpm? -119.09 123.16 43.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.104 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.67 137.55 24.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.764 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.497 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -76.49 134.25 70.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.653 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 118' ' ' HIS . 3.7 Cg_exo -74.53 -8.05 20.17 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.231 2.621 . . . . 0.0 113.242 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.79 -52.48 56.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.338 . . . . 0.0 111.077 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -91.98 -45.43 8.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.959 178.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.429 ' N ' ' SD ' ' A' ' 121' ' ' MET . . . 58.94 -174.36 0.09 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.078 0.551 . . . . 0.0 112.142 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 49.78 84.03 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 122.096 0.951 . . . . 0.0 112.992 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.7 t -132.19 131.8 60.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.891 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -131.3 133.22 45.15 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.883 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.519 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 8.3 t90 -45.28 140.74 3.78 Favored Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 124.196 0.935 . . . . 0.0 110.772 175.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 9.5 Cg_endo . . . . . 0 C--N 1.353 0.768 0 C-N-CA 123.607 2.871 . . . . 0.0 112.745 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.611 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 36.5 m-85 -103.25 140.37 37.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.25 95.76 14.06 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.947 0.404 . . . . 0.0 110.048 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.879 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 7.5 Cg_endo -90.06 -35.65 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.449 2.766 . . . . 0.0 113.395 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 2.4 mm -115.93 135.78 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 O-C-N 123.9 0.75 . . . . 0.0 110.231 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.433 ' O ' ' HD2' ' A' ' 39' ' ' ARG . . . -68.22 -56.23 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -70.86 -53.53 14.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.489 -178.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.824 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 39.7 m -56.48 -47.59 78.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.146 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.37 -130.39 10.16 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.115 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.73 150.46 21.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.321 0.581 . . . . 0.0 112.034 -172.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.579 ' HG1' HG12 ' A' ' 50' ' ' VAL . 10.7 m -121.65 139.09 53.98 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.491 176.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m -90.44 8.47 33.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.36 0.6 . . . . 0.0 111.201 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -95.63 142.19 28.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.779 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.8 m -67.68 -15.95 63.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.081 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HB3' ' HE2' ' A' ' 23' ' ' TYR . 7.2 mm-40 -64.3 -36.1 83.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.288 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.879 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -62.08 -25.01 67.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.768 -171.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.03 -23.93 67.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.03 0.443 . . . . 0.0 111.093 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.05 1.04 22.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.685 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.406 ' HE2' ' HB3' ' A' ' 19' ' ' GLU . 35.3 m-85 -126.44 12.4 7.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.723 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 14.0 pt20 -70.26 143.07 52.22 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -160.67 173.14 15.9 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -172.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -78.73 75.64 5.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.351 0.596 . . . . 0.0 109.742 173.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.76 152.9 19.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.178 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 pp -175.58 177.39 1.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.468 0.651 . . . . 0.0 112.184 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.513 HG22 HG12 ' A' ' 114' ' ' ILE . 64.6 t -122.0 138.16 53.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HB2' ' HE2' ' A' ' 84' ' ' MET . . . -122.81 141.63 51.64 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 122.174 -0.328 . . . . 0.0 110.16 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -88.51 172.78 9.08 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.117 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -47.79 -31.7 5.2 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.677 0.791 . . . . 0.0 112.631 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.93 -14.79 63.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.709 0.29 . . . . 0.0 111.736 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.702 ' HA2' ' HE1' ' A' ' 84' ' ' MET . . . 90.53 5.85 68.81 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.559 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -94.06 144.97 25.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.562 -176.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.59 ' CH2' ' HB ' ' A' ' 124' ' ' VAL . 31.0 m0 -68.99 125.29 26.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.844 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.445 ' HG ' ' SG ' ' A' ' 42' ' ' CYS . 29.5 tp -96.24 131.67 42.49 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -119.76 157.97 27.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.871 0.367 . . . . 0.0 111.126 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.433 ' HD2' ' O ' ' A' ' 10' ' ' ALA . 11.4 ptm180 -64.64 -15.41 61.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.46 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.04 -37.66 61.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.487 0.66 . . . . 0.0 109.461 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.3 mt -77.64 -50.4 12.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.885 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.445 ' SG ' ' HG ' ' A' ' 37' ' ' LEU . 13.1 p -116.7 92.98 39.62 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.371 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.58 -25.02 69.68 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.068 2.512 . . . . 0.0 113.214 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -71.36 -17.64 62.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 111.734 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.441 HD13 ' SG ' ' A' ' 42' ' ' CYS . 7.7 mp -72.46 -21.67 61.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.0 0.429 . . . . 0.0 110.599 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.81 -5.18 32.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.514 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 6.7 mm-40 -84.67 3.9 35.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.338 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.824 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 95.3 t -79.77 118.74 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.87 0.367 . . . . 0.0 110.969 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.9 p -87.18 119.12 27.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.669 ' HB ' ' HB3' ' A' ' 12' ' ' CYS . 12.0 p -117.71 128.26 74.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.315 -171.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.472 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 35.2 mm-40 -120.87 129.84 53.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.561 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 20' ' ' ALA . 10.1 mp -97.78 125.89 42.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.499 0.666 . . . . 0.0 110.66 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.502 HH21 HG21 ' A' ' 58' ' ' VAL . 28.0 ttm-85 -110.09 164.66 12.41 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.373 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.43 88.9 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.483 0.658 . . . . 0.0 110.257 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.39 -13.7 36.3 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.933 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.75 138.3 48.56 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.621 0.724 . . . . 0.0 112.345 -174.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.3 tp -100.59 107.87 19.65 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.695 173.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.502 HG21 HH21 ' A' ' 53' ' ' ARG . 46.2 t -99.56 102.78 13.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.928 0.394 . . . . 0.0 110.685 -175.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 5.8 mp -90.88 140.54 29.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.715 176.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HE2' ' HG2' ' A' ' 51' ' ' GLU . 39.6 mtmt -136.44 130.1 32.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 64' ' ' MET . . . -114.74 153.09 46.88 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 119.211 -0.995 . . . . 0.0 112.829 -176.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 20.0 Cg_exo -67.14 98.25 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.236 1.957 . . . . 0.0 110.618 170.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.7 -18.31 32.2 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.267 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.637 ' HB2' ' HB1' ' A' ' 61' ' ' ALA . 14.3 mmt -121.73 144.84 48.56 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.2 mt -68.15 -149.93 0.01 OUTLIER 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.407 0.622 . . . . 0.0 111.971 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -69.77 170.25 11.36 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.745 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 60.2 tp -151.71 87.72 1.38 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.894 166.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -84.0 104.98 14.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.447 -175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.0 mt -115.81 136.75 22.93 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.393 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.22 139.72 91.58 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 121.66 1.573 . . . . 0.0 110.613 171.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.2 mt . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -175.819 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 41.1 t . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 120.769 0.319 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.7 104.33 16.34 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.373 0.606 . . . . 0.0 111.139 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.541 ' O ' HG22 ' A' ' 93' ' ' VAL . 39.5 m-85 -94.95 116.4 28.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 173.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . 0.487 ' HG2' HG23 ' A' ' 90' ' ' THR . 31.6 tt0 -80.87 99.28 8.25 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.702 ' HE1' ' HA2' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -86.96 159.31 19.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.881 -169.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.8 tp -117.99 87.36 2.7 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.885 0.85 . . . . 0.0 109.554 -173.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.484 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 2.8 t -78.99 86.84 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.874 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.85 -68.9 2.48 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.592 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -145.41 2.95 0.99 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.777 0.322 . . . . 0.0 110.367 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.42 ' HG2' HG11 ' A' ' 91' ' ' VAL . 15.8 tt0 -109.95 109.61 20.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.925 0.393 . . . . 0.0 111.025 -170.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -85.13 104.83 15.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.655 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.52 HG21 HG21 ' A' ' 124' ' ' VAL . 2.7 m -118.93 144.99 25.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.062 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.09 112.68 16.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.034 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 82' ' ' TYR . 16.8 m -120.07 152.47 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.48 176.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -103.22 135.37 41.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.767 0.317 . . . . 0.0 111.176 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.565 ' HA ' HD22 ' A' ' 115' ' ' LEU . 43.5 t0 -83.2 126.13 32.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -81.32 -5.91 58.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.495 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.5 136.92 2.95 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.378 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.478 ' HG2' ' NH1' ' A' ' 113' ' ' ARG . 14.6 mt-10 -69.15 -23.13 63.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.826 0.346 . . . . 0.0 110.573 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -64.56 -30.91 71.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.082 0.467 . . . . 0.0 109.86 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.502 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -74.35 -37.95 63.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.9 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.451 ' HB3' ' HD3' ' A' ' 113' ' ' ARG . . . -59.51 -46.39 88.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.621 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.489 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -66.69 -36.5 82.66 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.351 0.596 . . . . 0.0 111.027 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.613 ' CZ2' ' HB2' ' A' ' 61' ' ' ALA . 76.1 t90 -57.45 -40.27 78.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.311 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.549 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.2 tp -93.23 -21.1 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.528 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.489 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 90.5 p -66.87 -19.87 65.82 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.488 -0.757 . . . . 0.0 109.237 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -83.65 -48.66 9.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.135 172.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.549 ' HB3' HD12 ' A' ' 104' ' ' ILE . 75.1 t60 -74.28 -51.98 13.66 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.78 -41.39 68.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 109.739 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.13 -22.94 38.03 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.74 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.22 157.03 35.58 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 120.532 0.206 . . . . 0.0 110.671 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.17 92.89 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.464 2.11 . . . . 0.0 111.469 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.417 ' HB2' HG13 ' A' ' 29' ' ' VAL . 5.0 p -134.25 156.5 48.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.015 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.479 ' HD2' ' CG ' ' A' ' 95' ' ' ASP . 7.3 tpp180 -117.77 128.44 54.88 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.172 -175.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.513 HG12 HG22 ' A' ' 29' ' ' VAL . 54.5 mt -79.1 118.33 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 95' ' ' ASP . 23.2 mt -130.46 142.1 50.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.286 0.565 . . . . 0.0 112.061 -168.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.1 117.33 29.33 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.206 175.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.91 137.56 23.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.522 -174.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.99 125.69 79.22 Favored Pre-proline 0 C--O 1.234 0.243 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.5 -4.46 6.86 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.377 2.718 . . . . 0.0 114.881 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -51.03 -57.33 8.91 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.347 0.594 . . . . 0.0 110.785 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 18.6 ptp -107.17 -54.19 2.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.077 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 54.7 -106.85 0.34 Allowed 'General case' 0 CA--C 1.531 0.23 0 O-C-N 123.489 0.493 . . . . 0.0 110.887 -174.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 66.72 -59.13 0.37 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.816 0.846 . . . . 0.0 113.233 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.59 ' HB ' ' CH2' ' A' ' 36' ' ' TRP . 3.4 t -54.57 122.69 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 112.504 -168.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -112.41 36.45 3.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.092 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.678 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 11.7 t90 72.35 152.41 0.14 Allowed Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -169.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.678 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 41.8 Cg_exo . . . . . 0 C--N 1.365 1.399 0 C-N-CA 124.523 3.482 . . . . 0.0 114.438 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.619 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.443 -0.791 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.702 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 61.8 m-85 -87.45 117.66 26.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 13' ' ' GLY . 10.3 tt0 -96.39 98.85 4.61 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.266 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.742 ' HA ' ' CB ' ' A' ' 24' ' ' GLN . 21.4 Cg_exo -64.69 -60.59 0.13 Allowed 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 122.67 2.247 . . . . 0.0 110.9 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.645 ' HA ' ' HB3' ' A' ' 27' ' ' TRP . 44.9 mt -114.54 136.01 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.951 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.02 -58.74 5.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.745 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 16.9 mm-40 -70.61 -22.43 62.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.794 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.839 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 73.6 m -73.6 -48.08 35.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.133 0.492 . . . . 0.0 110.087 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . 120.33 -153.72 16.63 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.231 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.619 ' HB2' ' HB2' ' A' ' 5' ' ' ALA . . . -113.33 142.73 45.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.106 0.479 . . . . 0.0 111.909 -172.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.3 m -118.87 137.57 53.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.699 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m -86.49 76.29 9.62 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.144 0.497 . . . . 0.0 110.126 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -160.19 120.7 2.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.858 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -68.49 -10.33 54.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.922 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -68.35 -28.54 67.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.287 0.565 . . . . 0.0 109.72 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.559 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -67.94 -24.22 65.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.624 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.84 -15.75 63.19 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.23 -3.84 50.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.631 0.253 . . . . 0.0 111.419 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.416 ' CD2' HD13 ' A' ' 71' ' ' LEU . 74.3 m-85 -130.56 -25.67 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.742 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -66.0 155.35 36.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.989 -177.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -172.65 -160.63 0.14 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.219 0.324 . . . . 0.0 110.169 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -74.95 69.06 1.86 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 122.122 0.963 . . . . 0.0 109.729 175.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.645 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 1.3 t90 -100.51 144.84 29.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.452 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -170.31 -173.79 1.55 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.575 0.625 . . . . 0.0 112.243 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.486 HG21 HG12 ' A' ' 114' ' ' ILE . 80.7 t -113.2 144.23 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.758 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.02 150.13 37.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 0.0 111.281 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.485 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 27.5 t30 -98.89 156.81 16.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.137 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -46.13 -37.11 6.53 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.758 0.823 . . . . 0.0 112.683 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.09 -6.97 37.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 111.401 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.63 4.53 63.77 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.582 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -98.44 160.35 14.34 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.413 ' HB2' ' HD1' ' A' ' 126' ' ' TRP . 28.2 m0 -68.07 134.79 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 172.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.62 HD21 ' SG ' ' A' ' 112' ' ' CYS . 28.4 tp -99.19 131.59 45.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.39 152.86 42.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.351 0.596 . . . . 0.0 112.597 -173.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.2 ttm105 -48.8 -32.11 8.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.736 164.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.77 -17.8 64.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.492 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 75.5 mt -105.6 -39.6 6.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.12 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 50.5 t -132.29 101.59 14.71 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.029 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.72 -29.45 59.85 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.653 2.236 . . . . 0.0 112.138 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -59.34 -30.74 68.59 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.398 0.618 . . . . 0.0 110.473 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.745 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 37.3 tp -66.79 -34.03 76.92 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.566 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.643 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -73.98 9.21 1.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -98.26 24.26 7.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.844 0.354 . . . . 0.0 111.203 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.839 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 55.4 t -84.79 113.79 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.714 0.292 . . . . 0.0 110.409 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.8 t -77.54 132.06 38.17 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.28 138.25 53.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.559 0.695 . . . . 0.0 112.074 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 35.3 tt0 -140.86 149.12 41.56 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.458 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.559 HD22 ' HA ' ' A' ' 20' ' ' ALA . 5.5 mp -128.61 158.03 39.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.687 0.756 . . . . 0.0 112.238 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -158.45 149.06 20.24 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.501 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 tpt -49.26 98.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.516 0.51 . . . . 0.0 110.992 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.51 -31.19 6.07 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.486 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.88 137.76 52.44 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.092 0.946 . . . . 0.0 112.963 -172.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.481 ' HB2' ' CD2' ' A' ' 71' ' ' LEU . 37.9 tp -100.72 108.59 20.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.213 170.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 42.5 t -96.96 99.82 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.977 0.418 . . . . 0.0 110.95 -172.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 8.0 mp -91.86 141.74 28.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.048 175.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -137.44 130.27 30.24 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 64' ' ' MET . . . -126.0 151.67 71.88 Favored Pre-proline 0 C--O 1.221 -0.41 0 C-N-CA 118.68 -1.208 . . . . 0.0 113.247 -175.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -62.81 107.19 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.986 1.79 . . . . 0.0 110.228 168.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.23 -24.29 25.01 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.169 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.594 ' HB2' ' HB1' ' A' ' 61' ' ' ALA . 95.1 mmm -122.39 147.57 46.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 0.0 110.327 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.3 mt -68.34 -144.58 0.01 OUTLIER 'General case' 0 C--O 1.247 0.937 0 CA-C-O 121.548 0.69 . . . . 0.0 110.756 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 5.8 ptt180 -86.75 151.63 23.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.066 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 60.3 tp -124.32 93.53 3.94 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 168.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.59 97.95 10.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.891 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.438 HG13 ' HG ' ' A' ' 67' ' ' LEU . 65.9 mt -100.21 122.52 49.98 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.922 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.94 123.97 15.11 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.006 1.804 . . . . 0.0 110.77 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 57' ' ' LEU . 64.7 mt . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.898 0.38 . . . . 0.0 110.707 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 61.2 t . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 120.607 0.241 . . . . 0.0 110.416 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 81' ' ' ARG . 39.0 ttt-85 -66.58 112.63 4.24 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.531 ' O ' HG21 ' A' ' 93' ' ' VAL . 3.1 t80 -105.15 107.97 19.24 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -80.11 113.82 18.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.913 ' HE3' ' HA ' ' A' ' 84' ' ' MET . 5.3 mmt -103.68 169.59 8.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.195 -175.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.2 tp -139.38 88.04 2.23 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 t -89.39 103.24 13.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.785 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.61 -77.76 1.4 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -146.27 4.19 0.92 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.51 0.195 . . . . 0.0 110.933 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.577 ' HG2' HG12 ' A' ' 91' ' ' VAL . 10.2 tt0 -105.26 120.48 41.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.849 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 84' ' ' MET . 0.2 OUTLIER -79.93 116.33 20.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.264 174.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.577 HG12 ' HG2' ' A' ' 89' ' ' GLN . 3.6 m -129.74 164.29 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.39 112.69 24.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.754 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 82' ' ' TYR . 7.1 m -125.81 152.13 32.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.7 t -106.21 142.17 19.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 122.237 -0.289 . . . . 0.0 110.743 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.637 ' OD1' ' HD3' ' A' ' 113' ' ' ARG . 26.4 t70 -92.94 125.86 37.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.56 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.98 -14.03 62.21 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.708 0.289 . . . . 0.0 111.652 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 137.46 149.21 5.53 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.999 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -64.68 -13.54 54.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.934 0.397 . . . . 0.0 111.001 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.4 tp -66.04 -43.55 87.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.49 -36.53 76.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.388 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.09 67.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.131 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.472 ' HA ' ' HG ' ' A' ' 105' ' ' SER . . . -62.95 -39.35 94.37 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.247 0.546 . . . . 0.0 111.103 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.453 ' CH2' ' HB2' ' A' ' 61' ' ' ALA . 49.8 t90 -57.81 -44.33 86.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.019 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' A' ' 104' ' ' ILE . 1.6 tp -87.12 -25.17 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.571 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.472 ' HG ' ' HA ' ' A' ' 102' ' ' ALA . 16.5 p -68.49 -15.85 63.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.533 -0.729 . . . . 0.0 109.959 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -88.99 -45.25 9.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.448 171.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -74.4 -49.51 22.29 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.64 -40.87 55.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.48 -38.22 3.38 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.614 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.503 HG23 ' SG ' ' A' ' 112' ' ' CYS . 18.7 m -87.64 157.85 51.88 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.84 88.63 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.761 2.307 . . . . 0.0 111.923 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.62 ' SG ' HD21 ' A' ' 37' ' ' LEU . 73.8 m -134.83 168.73 18.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.939 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.637 ' HD3' ' OD1' ' A' ' 95' ' ' ASP . 11.1 ptp180 -149.14 151.23 34.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.606 0.241 . . . . 0.0 110.634 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 29' ' ' VAL . 52.3 mt -82.85 131.88 32.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 95' ' ' ASP . 64.7 mt -138.23 133.34 33.07 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 120.926 0.393 . . . . 0.0 111.214 -174.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -99.89 120.47 39.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.785 173.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.1 t -64.16 133.85 29.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.557 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 5.0 t-160 -55.99 126.65 67.08 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.88 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.557 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 6.1 Cg_endo -47.78 -32.49 17.09 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.679 2.919 . . . . 0.0 113.45 -175.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.21 -53.24 58.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.391 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 51.7 ttm -89.78 121.41 31.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.462 0.649 . . . . 0.0 110.636 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -115.4 -35.5 4.6 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.405 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -82.63 103.23 11.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.227 0.537 . . . . 0.0 111.364 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.489 HG12 HG11 ' A' ' 91' ' ' VAL . 51.4 t -130.47 -66.86 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.297 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 68.28 121.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.605 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.48 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 2.9 t90 -58.37 145.62 74.61 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.47 165.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 4.9 Cg_endo . . . . . 0 C--N 1.351 0.688 0 C-N-CA 123.732 2.955 . . . . 0.0 113.386 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.436 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 36.8 m-85 -89.98 138.17 31.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -114.54 93.24 31.71 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 120.735 0.302 . . . . 0.0 110.452 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.575 ' HA ' ' CB ' ' A' ' 24' ' ' GLN . 1.1 Cg_endo -84.8 -38.23 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.871 2.38 . . . . 0.0 112.213 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.633 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 0.7 OUTLIER -114.75 147.12 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.381 -176.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.13 -69.22 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.821 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -65.46 -39.9 92.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.283 -176.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.848 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 34.2 m -60.55 -47.92 84.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.846 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.55 -130.38 10.03 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.625 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.6 147.8 32.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.305 0.574 . . . . 0.0 112.112 -171.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.8 m -139.51 125.66 19.99 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.357 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -86.8 88.87 7.78 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.91 0.862 . . . . 0.0 110.639 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -148.19 135.97 20.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.194 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 p -56.46 -38.03 71.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -74.95 -23.35 58.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.417 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . . . -62.13 -27.35 68.88 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.47 67.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.86 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.2 3.11 27.48 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -118.31 13.83 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.71 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.575 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -77.07 153.54 34.24 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.08 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -162.95 171.31 16.76 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.48 ' HD2' ' O ' ' A' ' 122' ' ' ALA . 58.6 mtt180 -76.81 76.84 3.42 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 122.145 0.974 . . . . 0.0 109.314 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -91.39 152.3 20.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.351 -1.749 . . . . 0.0 108.913 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 pp 179.49 -176.9 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.184 0.516 . . . . 0.0 111.097 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.824 HG22 ' HB3' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -118.87 140.73 41.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.573 178.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.871 ' HB1' ' HE1' ' A' ' 84' ' ' MET . . . -119.31 140.05 50.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 175.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 10.1 p30 -95.88 -177.52 4.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.438 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -46.53 -41.44 14.24 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.81 0.694 . . . . 0.0 112.765 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.47 -8.13 48.73 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.09 8.78 87.33 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.704 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -88.63 142.76 27.42 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.423 ' HB2' ' HD1' ' A' ' 126' ' ' TRP . 29.8 m0 -62.36 128.31 35.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.824 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.824 ' HB3' HG22 ' A' ' 29' ' ' VAL . 8.5 tp -87.42 131.45 34.31 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -120.64 162.8 19.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.47 -169.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -71.58 -21.55 61.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.258 0.551 . . . . 0.0 109.778 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.9 -27.16 61.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.825 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.9 mt -90.18 -45.39 9.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.525 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.693 ' SG ' ' HG ' ' A' ' 37' ' ' LEU . 1.7 p -130.44 96.83 23.22 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.105 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.27 -37.14 52.55 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.948 2.432 . . . . 0.0 112.859 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -73.24 -6.29 44.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.231 0.539 . . . . 0.0 111.003 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.821 ' HG ' ' HB2' ' A' ' 11' ' ' GLU . 33.8 tp -73.02 -24.23 60.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.919 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -72.19 -6.3 41.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.426 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.74 31.24 0.77 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.484 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.848 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 88.8 t -93.49 127.86 45.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.644 0.259 . . . . 0.0 110.418 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.2 t -86.47 137.54 32.46 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -119.41 144.7 27.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.182 0.515 . . . . 0.0 111.239 -173.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -148.7 140.36 23.58 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -111.36 125.04 53.44 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.734 0.778 . . . . 0.0 110.578 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.578 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 2.4 tpm_? -105.1 154.89 19.56 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.09 -1.414 . . . . 0.0 107.487 176.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.1 ttt -64.0 89.18 0.05 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.917 0.389 . . . . 0.0 110.544 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.35 -9.44 33.14 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.521 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.578 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 87.5 m-85 -132.24 147.85 52.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.174 0.511 . . . . 0.0 111.235 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.58 ' HB3' HG13 ' A' ' 69' ' ' ILE . 45.8 tp -104.83 111.93 24.85 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.28 101.64 12.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.011 0.434 . . . . 0.0 110.778 -174.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 11.1 mp -90.64 145.19 25.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.431 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -137.34 129.23 28.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.585 ' HB2' ' HB2' ' A' ' 64' ' ' MET . . . -120.54 144.75 39.21 Favored Pre-proline 0 C--O 1.219 -0.514 0 C-N-CA 118.946 -1.102 . . . . 0.0 113.35 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -63.35 97.32 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.743 1.628 . . . . 0.0 109.758 166.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.94 -33.98 3.88 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.768 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.585 ' HB2' ' HB2' ' A' ' 61' ' ' ALA . 91.7 mmm -122.19 149.6 43.41 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.442 ' N ' HD21 ' A' ' 65' ' ' LEU . 2.6 mm? -70.91 -144.59 0.01 OUTLIER 'General case' 0 C--O 1.246 0.873 0 CA-C-O 120.895 0.379 . . . . 0.0 110.635 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 92.2 mtt180 -79.06 155.93 28.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.107 0.479 . . . . 0.0 110.563 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 59.9 tp -127.39 103.46 7.38 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -88.76 101.77 14.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.588 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.58 HG13 ' HB3' ' A' ' 57' ' ' LEU . 8.5 pt -124.43 119.25 26.14 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.444 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.15 144.64 89.8 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.354 2.036 . . . . 0.0 111.33 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -167.27 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 120.834 0.349 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -104.31 111.17 23.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.217 0.532 . . . . 0.0 110.306 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.442 ' O ' HG21 ' A' ' 93' ' ' VAL . 33.0 m-85 -102.89 135.06 45.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.379 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -88.32 128.1 35.49 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.286 0.565 . . . . 0.0 110.76 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.871 ' HE1' ' HB1' ' A' ' 30' ' ' ALA . 52.4 mtt -95.69 171.83 8.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.3 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.5 tp -139.96 87.26 2.15 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.435 0.636 . . . . 0.0 109.636 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.85 96.28 5.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.046 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 88' ' ' GLU . . . 60.63 48.06 88.09 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.719 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 87' ' ' GLY . 8.2 mm-40 74.71 7.88 4.35 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.543 0.737 . . . . 0.0 111.708 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.515 ' HG2' HG11 ' A' ' 91' ' ' VAL . 9.8 tt0 -96.02 99.01 10.82 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 84' ' ' MET . 30.3 m -77.14 105.97 8.56 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.314 0.578 . . . . 0.0 110.402 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 84' ' ' MET . 3.6 m -122.74 162.16 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.106 -175.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.635 ' O ' ' HB2' ' A' ' 118' ' ' HIS . 8.8 t70 -108.11 127.13 53.53 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.855 HG22 ' HE3' ' A' ' 84' ' ' MET . 23.1 m -132.74 154.11 39.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.921 0.391 . . . . 0.0 111.307 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 63.6 t -91.02 135.01 27.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.734 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.53 ' HA ' ' CD2' ' A' ' 115' ' ' LEU . 18.2 t70 -88.43 133.28 34.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.799 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -80.52 -2.84 47.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.247 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.91 141.59 5.57 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.0 -13.8 62.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.881 0.341 . . . . 0.0 111.078 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . 0.631 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.1 pt? -69.7 -32.94 71.81 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 171.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.55 -33.23 58.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.787 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -57.36 -55.22 37.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.275 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.07 99.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.805 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.52 ' CZ2' ' HB3' ' A' ' 61' ' ' ALA . 84.4 t90 -49.25 -47.68 46.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.725 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 104' ' ' ILE . 3.3 tp -87.27 -22.51 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.122 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 64.5 m -66.44 -13.03 60.19 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.642 -0.661 . . . . 0.0 109.512 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -89.81 -49.93 6.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.602 173.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.494 ' HB3' HD11 ' A' ' 104' ' ' ILE . 78.1 t60 -76.18 -46.0 30.56 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.33 -36.78 71.69 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.72 -31.12 8.95 Favored Glycine 0 N--CA 1.454 -0.16 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.203 170.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.637 HG22 ' SG ' ' A' ' 112' ' ' CYS . 31.2 m -103.83 157.18 34.47 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.5 99.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.715 2.277 . . . . 0.0 112.265 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.637 ' SG ' HG22 ' A' ' 110' ' ' VAL . 57.2 m -134.56 -176.41 4.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.958 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 7.7 ptp180 -166.2 142.88 5.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.302 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.414 HG12 ' CG1' ' A' ' 29' ' ' VAL . 62.3 mt -79.44 123.03 35.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.53 ' CD2' ' HA ' ' A' ' 95' ' ' ASP . 43.3 mt -134.83 150.29 50.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.004 -173.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -117.2 139.64 50.53 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.916 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.537 ' HA ' HG12 ' A' ' 93' ' ' VAL . 33.1 t -66.0 142.08 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.421 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 0.2 OUTLIER -61.74 142.32 94.7 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.537 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.27 -19.02 65.33 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.717 2.278 . . . . 0.0 111.773 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.1 -10.56 54.95 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.985 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.432 ' HE2' ' HB3' ' A' ' 121' ' ' MET . 11.4 ptp -144.72 -44.24 0.24 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -176.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.48 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . 68.55 -64.45 0.31 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 172.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . 0.511 ' HG2' ' HG3' ' A' ' 125' ' ' ARG . 35.5 tt0 -70.47 -76.24 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -168.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 125' ' ' ARG . 58.8 t 67.43 -77.33 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 122.758 0.423 . . . . 0.0 111.658 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.511 ' HG3' ' HG2' ' A' ' 123' ' ' GLU . 36.9 mtm180 81.96 131.89 0.05 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.26 1.024 . . . . 0.0 113.647 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.509 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 5.1 t90 -56.71 150.06 38.59 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.522 170.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.509 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 2.9 Cg_endo . . . . . 0 C--N 1.354 0.833 0 C-N-CA 123.106 2.537 . . . . 0.0 112.391 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.172 0.51 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.704 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 62.4 m-85 -91.54 142.5 27.58 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.476 -176.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.25 85.57 0.9 Allowed Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.893 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 3.3 Cg_exo -81.39 -59.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.726 2.284 . . . . 0.0 112.147 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 0.4 OUTLIER -99.71 138.7 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.582 -179.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.69 -56.41 20.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -170.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.85 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -77.81 -41.53 36.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.735 -176.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.838 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 78.1 m -52.37 -45.97 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.742 0.651 . . . . 0.0 111.898 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.518 ' HA2' HH12 ' A' ' 39' ' ' ARG . . . 108.5 -151.49 17.04 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.007 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -84.7 138.31 32.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.272 0.558 . . . . 0.0 111.525 -174.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.472 HG21 HD13 ' A' ' 52' ' ' LEU . 16.1 m -118.56 132.33 56.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.61 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -91.89 14.96 14.1 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.55 139.05 37.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.814 0.34 . . . . 0.0 110.375 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 p -61.96 -36.3 81.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.65 -21.25 66.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.622 0.249 . . . . 0.0 111.632 -176.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.893 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -61.83 -27.28 68.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.649 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 -27.73 69.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.552 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.98 -13.83 26.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.375 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -113.57 6.66 17.11 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.747 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 16.1 pt20 -67.29 140.95 57.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 171.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.05 -179.29 5.09 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.905 -174.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 26' ' ' ARG . 48.0 mtt180 -77.92 77.92 4.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.5 0.667 . . . . 0.0 110.715 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.439 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -102.03 162.53 12.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.992 177.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -179.49 178.52 0.67 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.271 0.558 . . . . 0.0 111.25 172.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.52 HG22 HG12 ' A' ' 114' ' ' ILE . 60.4 t -112.69 146.34 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.028 173.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.51 ' HB2' ' HE2' ' A' ' 84' ' ' MET . . . -126.9 147.03 50.09 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.283 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.511 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 5.7 p-10 -86.79 -179.58 6.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.045 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -46.03 -36.13 5.42 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.18 0.992 . . . . 0.0 113.367 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.426 ' H ' ' ND2' ' A' ' 31' ' ' ASN . . . -79.3 -0.32 31.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.93 45.53 63.11 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.535 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.461 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 25.1 tt0 -121.66 141.47 51.11 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.33 -177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.709 ' CZ2' HG21 ' A' ' 124' ' ' VAL . 5.6 m95 -57.51 125.01 20.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.126 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.526 ' HG ' ' SG ' ' A' ' 42' ' ' CYS . 9.9 tp -113.49 132.18 55.77 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.558 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 22.4 p-10 -130.4 -177.04 4.16 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.518 HH12 ' HA2' ' A' ' 13' ' ' GLY . 10.0 mmm-85 -64.68 -15.14 60.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.575 -176.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.412 ' HB2' HD22 ' A' ' 38' ' ' ASN . 11.7 m-20 -93.33 -29.73 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.757 0.313 . . . . 0.0 110.884 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.558 ' HG ' ' OD1' ' A' ' 38' ' ' ASN . 86.8 mt -89.04 -42.71 11.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.643 ' SG ' HD23 ' A' ' 45' ' ' LEU . 24.2 p -123.85 91.53 49.54 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.609 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.4 -39.86 0.51 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.007 2.471 . . . . 0.0 113.776 -174.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.733 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 47.5 mtm-85 -67.12 -11.82 58.27 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.338 0.59 . . . . 0.0 111.745 -172.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.85 ' HB3' ' HB2' ' A' ' 11' ' ' GLU . 11.0 mp -68.59 -19.21 64.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.139 0.495 . . . . 0.0 110.402 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -67.8 -9.64 46.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.757 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.733 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 10.9 pt-20 -98.59 29.05 3.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.787 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.838 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 98.5 t -81.12 138.11 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.662 0.268 . . . . 0.0 110.556 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 t -92.24 134.54 34.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 12' ' ' CYS . 4.2 t -120.25 128.17 75.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.938 0.399 . . . . 0.0 111.598 -172.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 9.4 tp10 -123.61 143.61 50.12 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.184 172.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.472 HD13 HG21 ' A' ' 15' ' ' THR . 6.9 mp -124.75 125.82 44.67 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.546 0.689 . . . . 0.0 110.963 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.565 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 19.7 tpp180 -109.29 154.45 22.46 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 66.1 mtt -62.03 89.59 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 110.41 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.57 -7.45 26.25 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.932 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.565 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 97.9 m-85 -138.01 137.75 38.19 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.414 0.607 . . . . 0.0 111.606 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.0 tp -102.17 107.83 19.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.138 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 43.0 t -101.67 102.58 13.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.022 0.439 . . . . 0.0 111.031 -173.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.64 147.71 25.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.27 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.551 ' HZ1' ' HB3' ' A' ' 60' ' ' LYS . 10.1 mtpm? -144.47 133.21 22.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 64' ' ' MET . . . -112.35 147.73 37.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.133 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -65.43 93.33 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.273 1.982 . . . . 0.0 110.67 172.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.93 -24.48 10.1 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.44 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.591 ' HB2' ' HB1' ' A' ' 61' ' ' ALA . 13.0 mmt -120.07 157.36 29.11 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.07 -163.13 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.315 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -90.31 165.84 13.66 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.518 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.7 tp -143.51 93.68 2.51 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.967 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -88.01 114.15 24.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.526 0.679 . . . . 0.0 110.248 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.521 HD11 ' HG2' ' A' ' 96' ' ' GLU . 55.0 mt -111.65 118.9 46.05 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.396 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.72 127.91 28.13 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.252 1.968 . . . . 0.0 111.296 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 120.98 0.419 . . . . 0.0 110.589 -178.994 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 48.5 t . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.668 0.27 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . 0.698 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -97.17 97.59 9.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.797 0.808 . . . . 0.0 109.124 170.162 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -76.98 121.57 23.68 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.334 -174.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -68.91 105.24 2.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.251 0.548 . . . . 0.0 110.058 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.746 ' HE1' HG21 ' A' ' 93' ' ' VAL . 23.4 tpp -93.17 150.73 20.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.816 -175.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.45 ' N ' ' HG3' ' A' ' 84' ' ' MET . 42.3 tp -125.9 89.2 2.98 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.695 0.759 . . . . 0.0 109.241 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.758 HG22 ' HB ' ' A' ' 124' ' ' VAL . 2.1 t -80.94 87.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.099 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.31 -86.83 1.01 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.63 16.33 2.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.062 0.458 . . . . 0.0 110.763 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -102.15 119.27 38.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 110.538 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.1 m -92.98 109.5 20.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.078 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.535 HG21 HG11 ' A' ' 124' ' ' VAL . 3.9 m -142.58 139.44 28.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.605 -177.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.698 ' HB2' ' HB2' ' A' ' 81' ' ' ARG . 5.3 p-10 -83.3 141.73 31.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.163 0.506 . . . . 0.0 110.334 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.746 HG21 ' HE1' ' A' ' 84' ' ' MET . 18.6 m -128.94 152.71 37.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.571 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.0 t -81.4 123.62 38.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.949 0.404 . . . . 0.0 111.46 -174.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.622 ' HA ' HD21 ' A' ' 115' ' ' LEU . 59.3 t0 -87.07 129.26 34.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.79 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.521 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -75.73 -6.55 51.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.215 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.59 158.47 10.37 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.546 173.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.76 -11.14 60.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 0.0 110.373 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.3 mt -65.5 -41.59 93.04 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.97 -34.42 68.95 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.046 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.65 -50.22 74.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.514 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.497 ' HA ' ' HG ' ' A' ' 105' ' ' SER . . . -62.17 -44.65 96.14 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.99 0.424 . . . . 0.0 110.698 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 49.0 t90 -53.85 -44.51 70.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.39 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.541 HD11 ' HB3' ' A' ' 107' ' ' HIS . 2.1 tp -92.84 -21.01 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.987 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' SER . . . . . 0.497 ' HG ' ' HA ' ' A' ' 102' ' ' ALA . 40.5 p -68.3 -13.41 62.24 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.578 174.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -85.43 -45.62 11.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.362 170.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.541 ' HB3' HD11 ' A' ' 104' ' ' ILE . 84.4 t60 -79.68 -45.45 18.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.934 0.397 . . . . 0.0 111.692 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.87 43.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.87 -3.83 84.82 Favored Glycine 0 C--N 1.325 -0.049 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.841 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.552 HG22 ' SG ' ' A' ' 112' ' ' CYS . 13.7 m -120.47 159.61 47.31 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -67.88 87.57 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.772 2.315 . . . . 0.0 112.083 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 110' ' ' VAL . 75.1 m -134.52 154.53 51.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.128 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -135.37 151.98 51.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 29' ' ' VAL . 55.4 mt -83.11 119.79 33.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.03 0.443 . . . . 0.0 109.947 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.622 HD21 ' HA ' ' A' ' 95' ' ' ASP . 52.3 mt -122.1 133.97 54.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.74 -173.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HZ3' ' CB ' ' A' ' 116' ' ' LYS . 6.5 ttpm? -107.05 128.4 54.33 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.347 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.2 t -71.21 119.17 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.184 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 120' ' ' ASP . 35.5 t-80 -61.97 124.96 84.03 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.195 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.76 35.52 0.22 Allowed 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.723 2.948 . . . . 0.0 114.143 -172.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 118' ' ' HIS . 35.0 t70 -118.76 -32.01 4.65 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 26.3 mmt -77.49 -57.97 3.53 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.476 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 68.21 -66.99 0.21 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.084 0.865 . . . . 0.0 112.417 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.44 113.5 22.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.681 0.753 . . . . 0.0 111.288 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.758 ' HB ' HG22 ' A' ' 86' ' ' VAL . 12.3 m -115.62 -22.48 4.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.807 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 60.94 66.05 0.94 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.487 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.502 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 46.6 t90 -47.71 138.97 9.12 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 170.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.502 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 9.0 Cg_endo . . . . . 0 C--N 1.35 0.658 0 C-N-CA 123.987 3.125 . . . . 0.0 113.769 -173.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.703 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -96.04 140.42 30.8 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.479 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -100.4 97.46 6.46 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.538 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.592 ' HA ' ' CB ' ' A' ' 24' ' ' GLN . 38.5 Cg_endo -70.18 -59.81 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.825 1.684 . . . . 0.0 110.103 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.676 HD12 HD22 ' A' ' 57' ' ' LEU . 18.4 mt -103.76 146.48 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.633 173.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.24 -55.05 15.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . 0.744 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 1.4 mp0 -60.21 -42.58 95.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.689 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.817 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 52.7 m -60.84 -44.74 96.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.447 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.04 -134.25 11.78 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.003 174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.703 ' HB1' ' HB2' ' A' ' 5' ' ' ALA . . . -84.81 121.68 28.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.586 0.708 . . . . 0.0 112.331 -170.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.465 HG22 HD13 ' A' ' 52' ' ' LEU . 8.6 m -123.02 119.13 29.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.764 173.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 5' ' ' ALA . 9.8 t -85.85 -6.6 59.06 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.169 -170.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -60.74 122.38 14.63 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 t -61.45 -25.88 67.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.794 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -59.36 -30.52 68.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.835 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.41 -30.04 70.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.278 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 -17.03 64.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.936 0.398 . . . . 0.0 111.566 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.99 -22.1 15.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.233 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -105.54 -11.3 16.44 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.974 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.592 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 3.4 pt20 -64.16 155.8 30.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.137 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 51.1 mmtt -162.91 179.73 7.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.225 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.5 OUTLIER -71.13 76.21 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.166 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TRP . . . . . 0.548 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -95.06 147.75 23.08 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.359 -176.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.705 ' HA ' ' OE2' ' A' ' 11' ' ' GLU . 2.2 pp -176.83 166.58 2.54 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.395 0.616 . . . . 0.0 112.578 174.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.588 HG21 HG12 ' A' ' 104' ' ' ILE . 56.1 t -98.28 129.59 48.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.782 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.11 133.69 53.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.582 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . 0.442 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 12.0 t30 -77.59 154.45 32.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -47.18 -30.1 2.71 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.86 -23.4 60.78 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.054 0.454 . . . . 0.0 111.543 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 5.72 55.13 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.19 149.16 21.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 111.025 -174.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.518 ' CD1' HG11 ' A' ' 86' ' ' VAL . 12.0 m0 -70.79 122.27 19.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.945 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' A' ' 31' ' ' ASN . 4.4 tp -82.49 133.91 35.21 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.402 ' N ' HD13 ' A' ' 41' ' ' LEU . 1.8 t-20 -119.93 161.96 19.99 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.432 -170.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.494 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 24.7 ttm180 -65.55 -26.33 67.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.655 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -92.92 -11.33 33.67 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.492 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 38' ' ' ASN . 80.2 mt -82.64 -50.57 8.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.1 m -131.33 100.24 16.92 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.485 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -59.39 -36.39 94.12 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.987 2.458 . . . . 0.0 112.66 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -61.94 -21.63 64.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.057 0.456 . . . . 0.0 111.264 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.744 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 37.1 tp -68.54 -29.88 68.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.524 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -87.64 10.35 18.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.595 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -96.62 18.96 13.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.679 0.276 . . . . 0.0 111.299 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.817 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 56.8 t -75.84 127.46 37.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.83 0.348 . . . . 0.0 110.699 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 14.0 m -85.87 122.15 29.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -101.12 140.62 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.02 0.438 . . . . 0.0 111.263 -172.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -145.77 129.93 17.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.468 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.465 HD13 HG22 ' A' ' 15' ' ' THR . 10.9 mp -107.63 125.05 50.87 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.558 0.694 . . . . 0.0 110.677 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 36.3 ttm180 -105.29 150.85 24.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.0 ttt -65.35 97.2 0.27 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.695 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.8 33.45 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.95 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.473 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 78.5 m-85 -137.2 137.64 39.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 117.486 0.643 . . . . 0.0 111.571 -174.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 HD12 ' A' ' 9' ' ' ILE . 42.0 tp -100.65 108.38 20.24 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.072 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.01 111.35 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.154 0.502 . . . . 0.0 111.293 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.1 mp -98.06 140.16 32.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.101 176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 39.5 mttm -129.6 133.56 47.23 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . 0.591 ' HB2' ' HB2' ' A' ' 64' ' ' MET . . . -122.04 148.76 52.44 Favored Pre-proline 0 C--N 1.326 -0.44 0 C-N-CA 118.897 -1.121 . . . . 0.0 113.254 -176.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . 0.434 ' HD2' ' CE1' ' A' ' 107' ' ' HIS . 23.1 Cg_exo -65.37 85.01 0.2 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.312 2.008 . . . . 0.0 110.648 168.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.38 -26.66 4.34 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.792 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.591 ' HB2' ' HB2' ' A' ' 61' ' ' ALA . 94.8 mmm -117.47 154.12 31.96 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.3 mm? -77.12 -144.34 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 49.2 ptt85 -83.55 149.68 26.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.272 0.558 . . . . 0.0 111.14 176.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 59.9 tp -121.95 102.79 8.39 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.637 170.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.488 ' OD1' ' HD2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -81.11 100.92 9.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.758 -179.123 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 64.2 mt -100.3 105.17 34.55 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.927 176.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 68' ' ' ASP . 15.7 Cg_exo -68.3 125.4 12.87 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.172 1.915 . . . . 0.0 110.881 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 N--CA 1.465 0.295 0 O-C-N 123.513 0.508 . . . . 0.0 111.979 -172.901 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 48.0 t . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -97.38 113.94 25.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.89 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -112.11 120.1 40.69 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.701 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -78.85 118.09 20.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.457 0.646 . . . . 0.0 110.541 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.834 ' HE2' HG22 ' A' ' 93' ' ' VAL . 53.7 ttm -98.1 159.89 14.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.313 -176.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LEU . . . . . 0.422 ' HG ' ' HA ' ' A' ' 88' ' ' GLU . 14.2 tp -135.7 87.11 2.29 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.153 0.501 . . . . 0.0 110.278 -175.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.55 HG12 ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -72.3 90.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.261 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.73 -75.18 1.27 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -170.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 8.8 pt-20 -152.1 18.76 0.67 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.027 0.441 . . . . 0.0 110.242 171.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLN . . . . . 0.683 HE21 HG11 ' A' ' 124' ' ' VAL . 19.2 tt0 -92.03 107.25 19.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 m -80.36 108.61 14.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.099 -175.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 84' ' ' MET . 5.8 m -123.94 151.65 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.507 -174.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -93.82 112.8 24.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.543 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.834 HG22 ' HE2' ' A' ' 84' ' ' MET . 14.6 m -131.26 154.22 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 0.0 110.527 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 91.1 t -101.48 135.38 38.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.603 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.452 ' HA ' ' CD2' ' A' ' 115' ' ' LEU . 16.7 t70 -80.39 135.92 36.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -106.55 10.43 31.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.97 0.414 . . . . 0.0 111.703 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.81 136.74 4.21 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.401 -1.381 . . . . 0.0 114.294 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.85 -25.0 67.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.827 -0.687 . . . . 0.0 110.714 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.8 tp -62.31 -45.47 93.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.085 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 114' ' ' ILE . . . -69.33 -33.54 73.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.177 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ALA . . . . . 0.596 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -59.37 -57.96 10.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.164 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.01 -38.75 87.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.369 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' A' ' 61' ' ' ALA . 62.7 t90 -57.28 -46.01 83.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.949 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.588 HG12 HG21 ' A' ' 29' ' ' VAL . 2.8 tp -83.69 -25.81 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 73.3 m -59.93 -26.85 66.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.171 0.51 . . . . 0.0 109.713 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -88.99 -40.36 13.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.496 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.543 ' HB3' HD11 ' A' ' 104' ' ' ILE . 77.7 t60 -77.41 -53.16 7.99 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.162 -0.336 . . . . 0.0 111.789 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 104' ' ' ILE . . . -62.55 -40.21 96.11 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.32 -16.61 34.99 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.421 170.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.67 HG22 ' SG ' ' A' ' 112' ' ' CYS . 16.6 m -121.67 160.87 44.66 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.512 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 18.0 Cg_endo -58.36 96.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.81 2.34 . . . . 0.0 112.168 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' CYS . . . . . 0.67 ' SG ' HG22 ' A' ' 110' ' ' VAL . 73.9 m -135.22 173.22 11.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.708 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 9.5 ptp85 -149.95 140.15 22.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.815 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.526 HG12 HG23 ' A' ' 29' ' ' VAL . 60.8 mt -75.79 120.95 26.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.495 HD11 ' HE3' ' A' ' 84' ' ' MET . 96.5 mt -124.81 151.26 45.42 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.442 0.639 . . . . 0.0 111.097 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -108.58 105.3 14.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.131 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' VAL . . . . . 0.502 ' HA ' HG12 ' A' ' 93' ' ' VAL . 86.3 t -64.01 118.43 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.392 0.615 . . . . 0.0 110.34 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' HIS . . . . . 0.684 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 7.4 t-160 -69.9 132.3 88.75 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.103 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PRO . . . . . 0.684 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 28.5 Cg_endo -62.5 15.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.748 0 C-N-CA 123.687 2.925 . . . . 0.0 114.259 -176.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 118' ' ' HIS . 9.9 t70 -60.0 -60.77 3.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.271 0.558 . . . . 0.0 109.515 176.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' MET . . . . . 0.482 ' HG3' HG11 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -99.73 -30.4 12.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.313 173.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 69.28 -77.94 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.06 -72.17 0.11 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -170.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.683 HG11 HE21 ' A' ' 89' ' ' GLN . 58.3 t 70.99 -58.29 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.558 0.536 . . . . 0.0 111.924 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 126' ' ' TRP . 66.8 ttt180 79.03 -89.35 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.999 1.319 . . . . 0.0 111.745 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' TRP . . . . . 0.605 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 9.5 t90 162.79 142.57 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -174.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 38.0 Cg_endo . . . . . 0 C--N 1.351 0.659 0 C-N-CA 123.513 2.809 . . . . 0.0 112.777 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.5 m -69.46 162.92 26.45 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.2 m -60.43 -52.11 66.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.4 ' O ' HG23 ' A' ' 4' ' ' THR . 6.2 m 59.38 21.62 9.97 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.842 0.83 . . . . 0.0 111.551 172.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.8 ' HB1' ' HB2' ' A' ' 14' ' ' ALA . . . -99.66 95.6 7.07 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.8 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -80.69 141.5 34.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.804 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -115.25 85.74 13.26 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.287 -0.165 . . . . 0.0 110.894 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 49.0 Cg_endo -74.45 -35.87 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.885 1.724 . . . . 0.0 111.082 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.761 HD11 HD13 ' A' ' 57' ' ' LEU . 2.4 mt -114.52 145.28 20.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.208 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.88 -70.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 111.941 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.836 ' HG2' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -56.73 -50.09 73.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.457 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.785 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 73.8 m -53.48 -45.57 69.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.303 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.71 -127.52 9.18 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.782 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.8 ' HB2' ' HB1' ' A' ' 5' ' ' ALA . . . -85.13 138.37 32.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.436 0.636 . . . . 0.0 112.506 -169.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.502 HG21 HD12 ' A' ' 52' ' ' LEU . 17.0 m -123.96 123.69 40.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.789 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.07 22.03 2.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.139 0.495 . . . . 0.0 111.495 -175.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -110.83 135.53 51.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.864 0.364 . . . . 0.0 110.15 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.8 t -70.29 -18.95 63.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.3 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.75 -26.86 68.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.618 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.545 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -71.23 -20.23 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.859 -176.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.68 -9.53 58.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.724 0.297 . . . . 0.0 111.455 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.2 -1.45 16.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.736 0.303 . . . . 0.0 111.627 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -129.66 12.02 5.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.671 0.272 . . . . 0.0 111.144 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.581 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.4 pt20 -68.57 153.67 43.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.133 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.441 ' HG3' ' H ' ' A' ' 26' ' ' ARG . 3.8 tppt? -165.26 179.79 6.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.441 ' H ' ' HG3' ' A' ' 25' ' ' LYS . 73.7 mtt85 -83.26 60.83 5.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.842 0.829 . . . . 0.0 109.291 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.591 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -78.01 147.67 34.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.143 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.603 ' HA ' ' OE2' ' A' ' 11' ' ' GLU . 2.0 pp -176.92 177.42 1.3 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.119 0.485 . . . . 0.0 111.882 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.836 HG23 ' HG2' ' A' ' 11' ' ' GLU . 88.3 t -107.42 146.75 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.43 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.442 ' CB ' ' HE3' ' A' ' 84' ' ' MET . . . -128.26 145.15 51.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.54 HD22 ' HB3' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -96.53 168.84 10.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.774 -174.32 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -46.49 -34.16 4.59 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.735 0.814 . . . . 0.0 113.078 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.84 -4.33 4.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.688 ' HA2' ' HE2' ' A' ' 84' ' ' MET . . . 83.88 3.39 89.32 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.778 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.54 ' HB3' HD22 ' A' ' 31' ' ' ASN . 26.0 tt0 -100.57 152.61 20.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.48 -175.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.675 ' CH2' ' HB ' ' A' ' 124' ' ' VAL . 39.3 m0 -66.71 145.0 56.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 175.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.0 tp -106.61 143.4 34.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -134.41 165.69 24.57 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.006 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.419 ' CD ' ' H ' ' A' ' 39' ' ' ARG . 0.2 OUTLIER -69.03 -32.08 71.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -67.34 -25.02 65.79 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.93 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -91.19 -52.41 4.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.376 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.18 99.85 17.42 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.564 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.17 -16.92 45.17 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.325 2.683 . . . . 0.0 113.155 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -58.7 -32.42 69.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.213 0.53 . . . . 0.0 111.011 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.592 ' O ' HG23 ' A' ' 48' ' ' VAL . 7.0 mp -72.91 -19.86 61.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.849 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -68.21 -11.36 59.17 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.092 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -95.66 46.0 1.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.531 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.785 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 64.7 t -104.8 135.49 42.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.704 0.288 . . . . 0.0 110.667 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 m -94.74 117.54 30.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.581 HG23 ' HB3' ' A' ' 12' ' ' CYS . 11.2 t -99.2 137.45 26.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.063 -172.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -136.08 141.45 44.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.099 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.545 HD22 ' HA ' ' A' ' 20' ' ' ALA . 6.9 mp -123.39 133.84 54.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.895 0.378 . . . . 0.0 110.414 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 2.6 mmp_? -121.95 169.38 10.87 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 87.5 mtp -67.5 84.15 0.17 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 110.709 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.76 -21.24 9.11 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.923 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -130.21 137.89 50.29 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.616 0.708 . . . . 0.0 112.212 -173.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.761 HD13 HD11 ' A' ' 9' ' ' ILE . 53.4 tp -96.52 107.09 19.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.808 174.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.6 t -101.02 100.69 10.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.317 0.58 . . . . 0.0 111.055 -173.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.427 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.4 mp -86.34 146.05 26.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.37 177.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -137.58 132.61 33.36 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.587 ' HB1' ' HB2' ' A' ' 64' ' ' MET . . . -115.01 142.24 28.17 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 119.273 -0.971 . . . . 0.0 112.167 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.98 81.23 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.233 1.955 . . . . 0.0 110.5 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.2 -31.83 2.74 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.587 ' HB2' ' HB1' ' A' ' 61' ' ' ALA . 13.8 mmt -114.79 153.41 30.42 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.428 ' H ' HD21 ' A' ' 65' ' ' LEU . 2.8 mm? -68.67 -158.64 0.02 OUTLIER 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.508 0.67 . . . . 0.0 111.714 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.427 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 13.2 ptm180 -89.4 151.2 22.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.925 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 100' ' ' ALA . 60.7 tp -137.44 103.94 5.21 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.753 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 2.2 p-10 -99.21 112.75 24.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.649 0.738 . . . . 0.0 111.016 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.497 HG21 ' HB3' ' A' ' 96' ' ' GLU . 34.2 mt -110.67 138.83 21.15 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.503 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.29 119.71 7.08 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 121.931 1.754 . . . . 0.0 111.446 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.477 HD23 ' HB2' ' A' ' 57' ' ' LEU . 64.3 mt -54.21 -74.22 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.206 0.527 . . . . 0.0 111.462 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -150.73 28.84 0.69 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 30.8 m -87.56 22.73 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.506 -175.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.7 mm -112.59 137.49 45.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -144.79 23.82 1.55 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.36 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -109.38 -160.53 0.72 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.515 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -103.34 -4.67 23.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.728 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.63 -0.52 23.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.34 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 m -66.3 104.49 1.21 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 41.0 t -68.35 99.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.392 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -85.39 105.08 15.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -95.39 132.53 40.33 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.827 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -80.19 102.68 9.57 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.688 ' HE2' ' HA2' ' A' ' 34' ' ' GLY . 2.7 tpt -102.93 159.29 15.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.213 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp -133.01 87.61 2.42 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.632 0.73 . . . . 0.0 109.727 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.541 HG12 ' HD3' ' A' ' 127' ' ' PRO . 5.0 t -83.63 93.55 3.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.388 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.37 -89.43 1.31 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.78 11.81 2.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.05 0.452 . . . . 0.0 110.214 171.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.484 HE21 HG12 ' A' ' 124' ' ' VAL . 15.3 tt0 -96.5 112.9 24.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.544 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.7 m -83.23 114.48 21.4 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.156 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.507 HG11 HG22 ' A' ' 124' ' ' VAL . 3.6 m -136.25 147.24 28.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.031 0.443 . . . . 0.0 111.973 -174.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -80.07 117.09 20.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.252 177.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.473 HG22 HD11 ' A' ' 115' ' ' LEU . 36.0 m -120.23 148.85 23.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 93.5 t -94.94 129.85 44.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.35 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.517 ' OD1' ' HD3' ' A' ' 113' ' ' ARG . 33.3 t70 -82.6 132.33 35.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.303 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.497 ' HB3' HG21 ' A' ' 69' ' ' ILE . 17.8 mm-40 -82.64 -6.49 59.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.713 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.11 157.01 11.93 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.225 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -53.68 -31.57 48.28 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 122.744 0.418 . . . . 0.0 111.345 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.715 ' H ' HD22 ' A' ' 99' ' ' LEU . 1.4 pt? -62.18 -36.96 83.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.811 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.425 ' HA ' HD23 ' A' ' 67' ' ' LEU . . . -76.3 -35.18 58.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.056 0.455 . . . . 0.0 110.221 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.54 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -59.96 -57.23 13.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.67 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.71 -42.65 99.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.437 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.52 ' CZ2' ' HB2' ' A' ' 61' ' ' ALA . 76.3 t90 -54.14 -47.53 71.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.055 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.558 HD13 ' HB3' ' A' ' 107' ' ' HIS . 3.1 tp -85.26 -23.91 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.198 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.3 m -64.96 -16.44 63.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.403 -0.81 . . . . 0.0 109.996 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -88.68 -51.09 5.86 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.2 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.558 ' HB3' HD13 ' A' ' 104' ' ' ILE . 57.5 t60 -72.71 -44.48 61.68 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.445 ' HB3' HG13 ' A' ' 104' ' ' ILE . . . -76.17 -36.64 58.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.24 -32.4 7.52 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.849 171.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.642 HG21 ' SG ' ' A' ' 112' ' ' CYS . 16.1 m -100.43 158.76 31.34 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 25.1 Cg_endo -62.64 90.88 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.649 2.232 . . . . 0.0 112.108 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.642 ' SG ' HG21 ' A' ' 110' ' ' VAL . 76.5 m -135.21 164.73 27.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.277 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.54 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 10.9 ptp180 -140.48 143.37 35.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.404 175.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.587 HG12 HG21 ' A' ' 29' ' ' VAL . 37.6 mt -73.27 131.92 34.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.473 HD11 HG22 ' A' ' 93' ' ' VAL . 71.7 mt -134.87 139.54 45.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.176 0.512 . . . . 0.0 110.55 -176.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -108.16 110.78 22.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.273 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.5 t -63.26 132.94 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.602 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.423 ' CG ' ' HD2' ' A' ' 119' ' ' PRO . 0.5 OUTLIER -86.81 139.45 33.05 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.076 -177.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 118' ' ' HIS . 48.9 Cg_endo -68.36 -2.13 8.53 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.303 2.669 . . . . 0.0 114.531 -173.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -71.7 -51.61 22.08 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.21 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 95.3 mmm -73.52 -44.81 56.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 170.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 67.42 -77.97 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.733 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.88 139.87 30.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.368 0.604 . . . . 0.0 111.544 -172.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.675 ' HB ' ' CH2' ' A' ' 36' ' ' TRP . 52.8 t -133.9 -30.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.902 175.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 78.13 -37.97 0.24 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.549 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 19.7 t90 77.73 138.35 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.549 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 21.0 Cg_endo -54.59 119.15 5.95 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.544 2.829 . . . . 0.0 113.422 -175.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 m -79.01 24.12 0.33 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.018 0.437 . . . . 0.0 110.106 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.495 ' H ' ' C ' ' A' ' 127' ' ' PRO . 74.5 mt 58.05 33.8 23.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.474 -173.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--O 1.248 0.992 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.18 -177.314 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptp . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.4 p -131.55 -38.21 1.18 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.219 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 t -145.65 0.58 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.815 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m 63.84 30.22 14.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.758 0.789 . . . . 0.0 111.199 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.85 144.75 34.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.631 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.493 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.6 m-85 -94.31 134.4 36.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.33 91.75 20.6 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.586 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 6.1 Cg_exo -82.11 -55.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.937 2.425 . . . . 0.0 113.413 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.702 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -114.88 132.24 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 123.741 0.651 . . . . 0.0 110.555 -174.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.63 -55.14 36.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -170.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.79 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -62.32 -49.22 76.46 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -171.48 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.702 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 9.9 p -74.0 -35.75 64.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.771 0.319 . . . . 0.0 110.693 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.05 -140.52 14.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.807 170.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.75 152.15 23.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.309 0.576 . . . . 0.0 111.64 -172.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.8 m -134.5 134.43 41.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.256 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 p -94.63 66.41 3.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.49 0.662 . . . . 0.0 110.94 176.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -133.58 128.39 35.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.066 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.7 m -56.87 -33.09 66.5 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.65 -16.18 56.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.473 ' HB3' ' HG3' ' A' ' 8' ' ' PRO . . . -65.61 -22.67 66.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.361 . . . . 0.0 111.378 -176.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.61 -25.63 67.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.472 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.91 0.26 48.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.425 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -129.51 20.97 5.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.707 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 5.3 pp0? -91.16 150.79 21.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.191 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -162.51 -179.58 7.04 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.646 ' NH1' ' HA ' ' A' ' 123' ' ' GLU . 50.5 mtt85 -82.82 65.38 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 165.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.547 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 2.0 t90 -88.7 144.98 25.91 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.919 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -177.78 -177.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.552 0.691 . . . . 0.0 112.317 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.557 HG22 HG12 ' A' ' 114' ' ' ILE . 17.6 t -106.04 142.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.009 175.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.72 155.25 39.58 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.818 HD22 ' HB3' ' A' ' 35' ' ' GLN . 0.3 OUTLIER -99.8 160.44 14.3 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.779 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.515 ' HB2' ' HB2' ' A' ' 111' ' ' PRO . 14.2 t70 -45.7 -34.74 3.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.55 0.74 . . . . 0.0 112.81 -176.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.79 -7.17 3.26 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.604 ' HA2' ' HE2' ' A' ' 84' ' ' MET . . . 88.59 7.18 72.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.614 -178.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.818 ' HB3' HD22 ' A' ' 31' ' ' ASN . 22.6 tt0 -100.03 140.22 34.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.553 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -61.71 129.02 39.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.6 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.47 HD22 ' SG ' ' A' ' 112' ' ' CYS . 20.9 tp -90.27 144.86 25.45 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -137.13 167.44 21.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.24 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -67.7 -21.09 65.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.93 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -77.37 -26.37 51.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.77 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 78.2 mt -90.72 -51.22 5.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.277 178.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.422 ' HG ' HD23 ' A' ' 37' ' ' LEU . 74.7 m -122.94 93.83 47.95 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.645 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.68 -30.27 91.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.004 2.469 . . . . 0.0 112.461 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 47.7 mtm105 -69.19 -13.38 62.38 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.939 0.399 . . . . 0.0 111.156 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.79 ' HG ' ' HB2' ' A' ' 11' ' ' GLU . 32.5 tp -79.5 -18.86 51.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.57 -17.1 64.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.165 0.507 . . . . 0.0 109.944 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.69 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 57.5 mm-40 -82.95 58.8 4.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.418 177.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.0 t -129.39 139.22 52.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.7 m -105.49 142.28 35.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.67 0.272 . . . . 0.0 110.801 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.641 HG23 ' SG ' ' A' ' 12' ' ' CYS . 1.5 t -96.73 143.35 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.867 -174.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.534 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 3.8 tp10 -146.56 137.33 24.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 167.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 mp -119.25 125.47 49.21 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.885 0.374 . . . . 0.0 110.279 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 34.2 mmt180 -105.31 175.59 5.44 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.2 ttm -68.38 91.85 0.41 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.39 -0.28 65.73 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.136 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.459 ' C ' ' HG ' ' A' ' 71' ' ' LEU . 59.4 m-85 -136.21 148.36 48.06 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 117.59 0.695 . . . . 0.0 112.313 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.458 ' HB2' HD21 ' A' ' 71' ' ' LEU . 42.1 tp -109.32 118.51 36.87 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.128 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 66.8 t -109.05 111.05 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.228 0.537 . . . . 0.0 110.513 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.492 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 3.8 mp -97.07 137.19 36.52 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.947 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -129.3 130.39 46.09 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.574 ' HB2' ' HB2' ' A' ' 64' ' ' MET . . . -122.27 134.03 24.64 Favored Pre-proline 0 C--O 1.215 -0.718 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.879 -173.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.69 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 82.5 Cg_exo -46.16 107.08 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.272 1.981 . . . . 0.0 111.178 166.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.17 -10.51 61.75 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.951 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.574 ' HB2' ' HB2' ' A' ' 61' ' ' ALA . 76.8 mmm -136.4 156.53 48.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.768 0.794 . . . . 0.0 111.53 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.46 HD22 ' H ' ' A' ' 65' ' ' LEU . 2.6 mm? -67.7 -165.87 0.05 Allowed 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.816 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 33.6 ptt85 -88.33 169.22 12.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.448 173.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.47 ' HG ' HG13 ' A' ' 69' ' ' ILE . 55.3 tp -147.48 111.33 5.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.761 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.22 99.82 12.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 110.587 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.47 HG13 ' HG ' ' A' ' 67' ' ' LEU . 70.0 mt -105.93 138.72 19.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.42 139.19 23.02 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.189 1.926 . . . . 0.0 112.509 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' A' ' 71' ' ' LEU . 8.7 mt -71.16 94.0 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.573 0.702 . . . . 0.0 111.428 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.4 t70 75.29 88.55 0.09 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.844 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.8 121.92 15.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.8 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.527 HG12 ' H ' ' A' ' 75' ' ' GLU . 13.3 tt -82.37 -174.74 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.289 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.527 ' H ' HG12 ' A' ' 74' ' ' ILE . 6.4 mm-40 -73.53 29.72 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 123.932 0.893 . . . . 0.0 111.328 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.494 ' H ' ' C ' ' A' ' 74' ' ' ILE . 8.8 t70 -62.64 152.99 33.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.115 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.49 -25.22 67.9 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.033 -171.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.433 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . 0.8 OUTLIER -77.21 -22.79 51.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.497 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.424 ' HB2' HG13 ' A' ' 94' ' ' VAL . 85.2 p -67.29 139.75 57.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.952 0.406 . . . . 0.0 110.008 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.41 112.83 32.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.525 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.0 mtp180 -77.53 99.18 5.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.613 0.72 . . . . 0.0 109.783 176.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -86.13 126.66 34.38 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.589 -175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -76.61 112.03 12.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.604 ' HE2' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -98.94 145.84 26.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.8 -175.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.851 ' HG ' ' HA ' ' A' ' 88' ' ' GLU . 12.9 tp -126.35 79.07 1.82 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.498 0.666 . . . . 0.0 109.501 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.426 HG11 ' HD3' ' A' ' 127' ' ' PRO . 4.6 t -85.92 96.97 5.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.306 -174.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.69 31.95 70.64 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.851 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.9 OUTLIER 69.39 18.19 7.98 Favored 'General case' 0 N--CA 1.46 0.051 0 CA-C-N 114.504 -0.848 . . . . 0.0 111.296 -176.124 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -92.84 107.76 19.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.8 m -78.84 99.88 6.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.909 -172.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 m -132.32 142.57 42.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.713 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -91.78 140.5 29.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.19 0.519 . . . . 0.0 110.721 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.9 m -131.15 153.72 39.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.691 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.424 HG13 ' HB2' ' A' ' 79' ' ' SER . 93.2 t -88.87 132.84 32.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.894 0.378 . . . . 0.0 111.221 -176.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.668 ' OD2' ' HD3' ' A' ' 113' ' ' ARG . 26.3 t0 -77.42 127.11 31.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.312 175.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -92.65 -3.15 55.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.315 -175.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.29 129.84 1.34 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.685 -1.245 . . . . 0.0 114.511 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.42 -36.29 71.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.29 0.567 . . . . 0.0 110.144 171.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.86 -35.7 81.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.436 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.48 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -65.54 -37.71 87.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.489 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.69 84.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.73 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.72 83.46 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.993 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 73.8 t90 -51.48 -44.66 62.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.274 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.541 HD13 ' HB3' ' A' ' 107' ' ' HIS . 3.2 tp -86.94 -23.17 6.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.635 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 94.6 p -65.02 -17.99 64.92 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.357 -0.839 . . . . 0.0 109.301 175.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -81.97 -57.84 3.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.342 170.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.541 ' HB3' HD13 ' A' ' 104' ' ' ILE . 75.5 t60 -69.04 -45.5 70.27 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.12 -42.67 59.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.62 -30.68 8.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.586 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.659 HG22 ' SG ' ' A' ' 112' ' ' CYS . 16.5 m -99.78 163.45 18.41 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.536 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 17.8 Cg_endo -60.26 96.71 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.533 2.156 . . . . 0.0 112.155 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.659 ' SG ' HG22 ' A' ' 110' ' ' VAL . 72.1 m -134.05 158.15 44.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.721 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.668 ' HD3' ' OD2' ' A' ' 95' ' ' ASP . 48.9 ttm-85 -143.15 132.83 23.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.138 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.557 HG12 HG22 ' A' ' 29' ' ' VAL . 41.7 mt -80.06 120.91 32.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.486 HD21 ' HA ' ' A' ' 95' ' ' ASP . 70.4 mt -131.51 155.96 46.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.747 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.559 ' HB3' ' HZ3' ' A' ' 116' ' ' LYS . 7.2 ttpm? -121.56 138.67 54.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.155 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.13 135.17 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.69 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -73.1 119.54 76.19 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.796 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.07 -24.68 20.44 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.627 2.885 . . . . 0.0 113.704 -173.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.97 -39.79 82.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 110.714 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -117.75 -175.47 2.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.12 -170.62 3.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.137 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.646 ' HA ' ' NH1' ' A' ' 26' ' ' ARG . 8.0 mm-40 65.79 -140.07 0.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.793 0.683 . . . . 0.0 111.142 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.1 t 65.67 100.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -167.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -108.28 27.25 9.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.532 -169.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.701 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 5.2 t90 72.58 151.5 0.14 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -174.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.701 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 10.6 Cg_endo -51.83 -17.76 5.65 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.272 2.648 . . . . 0.0 114.135 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.8 m 57.51 46.28 18.16 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.185 0.517 . . . . 0.0 110.558 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.4 mt 64.64 79.78 0.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.232 -178.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.249 1.068 0 O-C-N 124.418 1.074 . . . . 0.0 113.254 175.658 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m 62.57 -158.72 0.32 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.473 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.9 p -59.1 -27.49 65.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.734 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m 64.42 25.48 13.37 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.81 0.814 . . . . 0.0 109.871 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -103.77 132.93 49.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.206 178.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.697 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 55.5 m-85 -112.46 141.33 46.34 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.994 -177.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -99.68 97.25 5.49 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.012 0.195 . . . . 0.0 110.7 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.805 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 2.6 Cg_exo -77.07 -54.4 0.06 OUTLIER 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.874 2.383 . . . . 0.0 111.735 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.806 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 4.9 mm -107.22 150.88 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.462 -175.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.74 -54.73 8.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.017 -174.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -56.59 -53.18 60.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.5 -175.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.806 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 25.9 p -70.51 -47.27 61.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.95 -127.79 9.26 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.533 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.83 139.3 30.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.3 0.571 . . . . 0.0 112.207 -173.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.498 HG23 HD11 ' A' ' 52' ' ' LEU . 16.9 m -113.5 138.84 49.55 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.94 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -87.41 31.66 0.73 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -119.96 136.35 54.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.085 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.413 ' HA ' ' HE2' ' A' ' 6' ' ' TYR . 20.1 m -65.85 -28.76 69.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.791 0.329 . . . . 0.0 111.618 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -65.32 -23.6 67.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.498 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.805 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -58.47 -30.98 67.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.566 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.11 -24.8 67.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.69 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.19 -14.71 28.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.589 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -112.77 -0.94 14.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.695 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.642 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 3.7 pp0? -67.58 150.8 48.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.568 0.223 . . . . 0.0 110.562 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.432 ' HG2' ' O ' ' A' ' 24' ' ' GLN . 38.5 mmtm -165.54 -178.7 5.04 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.175 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -81.82 79.13 8.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.896 0.855 . . . . 0.0 109.482 170.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -100.63 147.14 26.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.907 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 pp -173.99 178.88 2.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.63 0.729 . . . . 0.0 112.246 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.867 HG22 HD11 ' A' ' 114' ' ' ILE . 60.3 t -111.5 136.42 47.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.488 175.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.562 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -124.85 144.94 50.04 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.521 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -77.6 142.75 38.76 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.755 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -48.02 -25.64 1.48 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -57.24 -18.38 15.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.651 178.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.768 ' HA2' ' HE2' ' A' ' 84' ' ' MET . . . 103.61 18.67 13.69 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -176.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -112.87 127.45 56.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.938 -173.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -56.64 123.64 15.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.432 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 45' ' ' LEU . 10.5 tp -82.47 154.31 25.18 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -140.88 164.3 30.61 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.498 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -69.06 -24.57 64.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 110.074 176.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.8 -27.66 61.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.879 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.2 mt -87.79 -51.47 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.611 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.6 m -130.25 95.68 26.96 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.64 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.58 -28.87 69.99 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.771 2.314 . . . . 0.0 112.139 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -67.76 -14.11 62.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.233 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.63 HD22 HD22 ' A' ' 37' ' ' LEU . 33.0 tp -74.47 -23.12 58.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.746 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.2 -13.35 61.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.232 0.539 . . . . 0.0 110.384 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -92.68 54.62 2.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.69 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 12' ' ' CYS . 92.0 t -110.88 134.26 53.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.038 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.8 m -100.56 148.77 24.44 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.12 148.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.177 0.513 . . . . 0.0 111.722 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.509 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 28.8 tt0 -152.05 139.75 19.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.498 HD11 HG23 ' A' ' 15' ' ' THR . 9.2 mp -106.93 125.39 50.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.682 0.753 . . . . 0.0 111.443 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -112.42 154.4 25.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.38 -1.282 . . . . 0.0 107.671 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' MET . . . . . 0.424 ' O ' ' HG3' ' A' ' 54' ' ' MET . 23.6 ptt? -60.66 100.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.939 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.59 0.07 64.95 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.117 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -143.14 137.62 29.21 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 117.403 0.601 . . . . 0.0 111.536 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.502 ' HB2' HD23 ' A' ' 71' ' ' LEU . 28.1 tp -100.21 114.39 27.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.176 175.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.509 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 70.8 t -96.4 96.45 5.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.892 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.1 mp -87.53 143.44 27.21 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -140.28 130.95 25.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.592 ' HB1' ' HB2' ' A' ' 64' ' ' MET . . . -115.67 144.96 33.54 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.453 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.95 98.03 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.061 1.841 . . . . 0.0 110.487 170.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.09 -32.2 6.08 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.302 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.592 ' HB2' ' HB1' ' A' ' 61' ' ' ALA . 13.1 mmt -116.04 154.64 29.53 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.437 0.637 . . . . 0.0 110.218 -177.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.741 ' H ' HD12 ' A' ' 65' ' ' LEU . 2.5 mp -69.71 -154.38 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.755 -171.129 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.494 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 12.4 ptm180 -94.33 145.14 24.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.652 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 53.4 tp -121.67 114.61 21.38 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.234 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.99 102.22 14.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.716 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.438 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 70.1 mt -97.8 116.47 65.73 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.739 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.62 119.5 6.62 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.321 2.014 . . . . 0.0 112.168 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.502 HD23 ' HB2' ' A' ' 57' ' ' LEU . 96.1 mt -82.49 -24.91 33.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.182 0.515 . . . . 0.0 110.028 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -120.34 109.94 15.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.138 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.78 132.39 68.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.699 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.498 HG13 ' N ' ' A' ' 75' ' ' GLU . 1.4 tp -86.15 -85.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.033 175.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.498 ' N ' HG13 ' A' ' 74' ' ' ILE . 10.7 pt-20 -116.9 24.09 11.47 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.714 0.768 . . . . 0.0 110.208 171.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.23 -7.84 54.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.837 170.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -85.93 65.87 9.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.91 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.48 13.3 16.07 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 168.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.696 ' HB3' ' O ' ' A' ' 95' ' ' ASP . 1.4 m -50.98 132.72 27.39 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.47 177.227 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.5 t -79.59 118.69 27.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.95 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.53 ' HG2' HG22 ' A' ' 94' ' ' VAL . 74.1 mtp180 -86.5 112.98 22.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.89 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.516 ' HE2' ' HB2' ' A' ' 95' ' ' ASP . 98.0 m-85 -101.13 133.15 46.11 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.388 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -80.06 98.77 7.38 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.768 ' HE2' ' HA2' ' A' ' 34' ' ' GLY . 0.0 OUTLIER -90.17 153.46 20.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.283 -171.536 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.27 86.41 2.45 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.75 0.786 . . . . 0.0 109.449 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.523 HG11 ' HD3' ' A' ' 127' ' ' PRO . 4.0 t -76.57 84.6 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.497 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.73 -78.34 1.67 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -175.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.81 16.08 1.77 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.018 0.437 . . . . 0.0 110.441 174.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.401 ' HG2' HG11 ' A' ' 91' ' ' VAL . 10.0 tt0 -111.26 108.93 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 110.725 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.51 ' HA ' ' O ' ' A' ' 84' ' ' MET . 7.5 m -80.29 113.97 18.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.494 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.529 HG12 ' HG2' ' A' ' 121' ' ' MET . 5.9 m -134.63 159.33 41.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.336 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.65 113.13 25.32 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 -174.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.484 HG22 HD23 ' A' ' 115' ' ' LEU . 34.9 m -120.03 136.96 55.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.97 177.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.53 HG22 ' HG2' ' A' ' 81' ' ' ARG . 6.4 t -99.25 129.96 48.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.063 -176.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.696 ' O ' ' HB3' ' A' ' 79' ' ' SER . 53.8 t0 -74.48 119.92 19.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.695 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -74.4 -7.83 54.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.982 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.76 146.31 4.45 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.111 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -62.2 -30.45 71.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.22 0.533 . . . . 0.0 110.217 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.7 tp -67.78 -33.94 75.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.913 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.488 ' HB1' HG13 ' A' ' 114' ' ' ILE . . . -71.41 -40.63 70.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.111 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.26 -41.81 94.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.528 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.482 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -62.76 -43.03 99.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.984 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.444 ' CZ2' ' HB2' ' A' ' 61' ' ' ALA . 38.1 t90 -55.66 -39.43 70.9 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.654 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.571 HG22 ' HB2' ' A' ' 112' ' ' CYS . 9.8 mm -89.41 -26.12 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.482 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 80.1 p -65.41 -14.96 62.06 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.466 -0.771 . . . . 0.0 109.356 172.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -90.23 -52.76 4.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.466 170.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.426 ' HB3' HD12 ' A' ' 104' ' ' ILE . 82.9 t60 -65.23 -40.69 94.4 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.43 -33.89 14.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.146 0.498 . . . . 0.0 110.142 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.44 -29.6 11.16 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.649 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.509 HG22 ' HG ' ' A' ' 112' ' ' CYS . 24.2 m -106.13 156.65 36.45 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.2 97.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.792 2.328 . . . . 0.0 112.622 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.571 ' HB2' HG22 ' A' ' 104' ' ' ILE . 58.1 m -129.03 147.65 50.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.9 176.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.461 ' HD3' ' CG ' ' A' ' 95' ' ' ASP . 41.6 ttm-85 -126.43 130.76 51.32 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.188 -171.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.867 HD11 HG22 ' A' ' 29' ' ' VAL . 25.6 mm -68.37 118.14 11.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.562 HD12 ' HB3' ' A' ' 30' ' ' ALA . 18.4 mt -133.1 129.88 38.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.732 0.777 . . . . 0.0 111.896 -173.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.594 ' HB3' ' HZ3' ' A' ' 116' ' ' LYS . 7.9 ttpm? -103.68 120.51 41.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.322 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.3 t -62.75 132.0 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.694 0.283 . . . . 0.0 110.343 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -69.22 139.2 89.76 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -51.02 -15.84 2.19 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.55 2.833 . . . . 0.0 114.219 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -60.09 -34.36 73.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.142 0.496 . . . . 0.0 110.584 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.529 ' HG2' HG12 ' A' ' 91' ' ' VAL . 2.4 mpt? -112.29 124.56 52.73 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.248 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.53 36.46 4.37 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.335 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -140.37 -135.0 0.11 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.73 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.486 HG12 HG23 ' A' ' 86' ' ' VAL . 4.3 t 67.34 94.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.387 0.613 . . . . 0.0 110.06 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.449 ' O ' ' HG2' ' A' ' 125' ' ' ARG . 11.5 ttp180 -99.15 20.07 14.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.586 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.582 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 6.3 t90 70.61 151.56 0.14 Allowed Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 5.7 Cg_exo -37.02 120.5 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.151 2.568 . . . . 0.0 112.486 177.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.1 m -96.07 40.35 1.12 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.804 -170.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.557 HD23 ' H ' ' A' ' 129' ' ' LEU . 1.3 pt? -59.97 116.35 4.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.016 174.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.184 -175.924 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.952 0.406 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.57 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 42.2 p -127.56 172.32 10.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.059 -177.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.2 t -153.57 140.51 19.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.185 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 t 40.34 -137.61 0.12 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.138 0.899 . . . . 0.0 112.135 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.71 114.98 2.29 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.864 0.364 . . . . 0.0 110.859 174.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.679 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 24.6 m-85 -86.98 133.92 33.54 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 10.3 tt0 -105.66 94.23 8.41 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.888 0.375 . . . . 0.0 111.031 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.835 ' HG3' ' HB3' ' A' ' 20' ' ' ALA . 7.0 Cg_endo -87.11 -41.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.283 2.655 . . . . 0.0 112.317 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.661 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 3.6 mp -100.97 145.15 11.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.89 -73.03 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -172.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.624 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -58.93 -50.01 75.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.89 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 66.5 m -54.95 -47.33 74.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.965 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.8 -140.87 15.11 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.363 175.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 7' ' ' GLN . . . -94.67 151.91 18.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.459 0.647 . . . . 0.0 112.212 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.489 HG23 HD11 ' A' ' 52' ' ' LEU . 15.2 m -125.42 139.3 53.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.005 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -86.78 23.33 1.73 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.44 ' HG3' HG22 ' A' ' 15' ' ' THR . 9.3 mt-30 -114.83 145.63 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.672 0.272 . . . . 0.0 110.31 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 t -61.97 -35.15 77.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.292 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.432 ' CD ' ' H ' ' A' ' 19' ' ' GLU . 2.1 mp0 -52.76 -34.13 51.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.465 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.835 ' HB3' ' HG3' ' A' ' 8' ' ' PRO . . . -61.5 -27.6 68.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.459 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.55 -2.76 18.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.801 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.43 18.8 4.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.97 14.9 3.07 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.337 0.589 . . . . 0.0 110.44 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.515 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -64.12 143.56 57.78 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.095 177.574 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.413 ' HG2' ' O ' ' A' ' 24' ' ' GLN . 68.5 mmtt -161.88 166.9 25.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -172.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.465 ' CB ' ' HB ' ' A' ' 117' ' ' VAL . 4.8 mpt_? -86.64 82.53 7.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.233 0.54 . . . . 0.0 110.156 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.17 153.0 21.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.123 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -160.59 164.24 32.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.023 0.439 . . . . 0.0 110.512 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.574 HG21 ' HG2' ' A' ' 11' ' ' GLU . 89.4 t -126.48 136.87 59.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.282 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.66 ' HB3' ' HE2' ' A' ' 84' ' ' MET . . . -111.97 133.63 54.03 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.602 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.678 HD22 ' HB3' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -79.48 179.52 7.41 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 172.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -46.07 -40.02 10.14 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.27 -5.72 43.75 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.85 11.64 84.37 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.761 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.678 ' HB3' HD22 ' A' ' 31' ' ' ASN . 26.0 tt0 -85.2 144.16 28.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.594 -0.303 . . . . 0.0 110.753 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.642 ' CD1' HG23 ' A' ' 86' ' ' VAL . 2.2 m0 -53.54 122.4 9.69 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 124.14 0.9 . . . . 0.0 111.67 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 tp -104.91 130.97 52.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -122.74 170.19 10.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.083 0.468 . . . . 0.0 111.79 -173.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -71.52 -19.44 62.18 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -70.65 -26.25 63.38 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.5 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.9 mt -94.74 -47.45 6.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.458 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.0 m -124.95 98.53 36.25 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.911 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.15 -31.02 75.45 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.891 2.394 . . . . 0.0 111.677 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -60.52 -30.06 69.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.968 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.624 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 63.2 tp -72.84 -28.09 62.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.261 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -71.39 -12.97 61.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.175 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -85.69 38.97 0.77 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.743 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.89 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 78.4 t -92.77 130.84 41.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.553 0.216 . . . . 0.0 110.473 173.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.631 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . 18.1 m -86.89 117.09 25.39 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.584 HG13 HD13 ' A' ' 9' ' ' ILE . 1.4 t -99.0 144.56 11.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.384 -172.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.601 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 78.9 tt0 -148.86 144.02 26.64 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.489 HD11 HG23 ' A' ' 15' ' ' THR . 8.2 mp -123.74 129.75 51.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.015 0.435 . . . . 0.0 109.914 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -118.83 156.98 28.48 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.81 98.13 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.149 0.5 . . . . 0.0 110.998 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.25 -12.09 44.06 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.391 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -138.65 137.88 37.29 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 117.839 0.82 . . . . 0.0 112.145 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.8 tp -95.87 110.31 22.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.601 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 59.7 t -96.48 95.67 4.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.925 -173.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.422 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 7.6 mp -88.25 152.01 22.26 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.631 ' HG3' ' HB2' ' A' ' 49' ' ' SER . 11.1 ptpp? -159.89 143.17 14.05 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 172.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.544 ' HB1' ' HB2' ' A' ' 64' ' ' MET . . . -132.25 147.37 65.45 Favored Pre-proline 0 C--O 1.218 -0.557 0 C-N-CA 118.665 -1.214 . . . . 0.0 113.413 -173.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.71 102.74 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.875 1.717 . . . . 0.0 110.45 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.78 -6.9 33.32 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.278 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.544 ' HB2' ' HB1' ' A' ' 61' ' ' ALA . 83.7 mmm -140.61 151.96 45.07 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.336 0.588 . . . . 0.0 110.879 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -69.99 -159.1 0.03 OUTLIER 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.294 0.569 . . . . 0.0 111.18 -179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 45.4 mtp180 -80.36 149.38 30.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.597 174.13 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.403 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 68.6 tp -121.83 107.99 12.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 171.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -91.66 106.91 18.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.063 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 62.1 mt -115.66 116.65 40.89 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.441 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.45 131.74 48.03 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.636 2.224 . . . . 0.0 111.925 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt -69.31 -34.88 75.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 111.055 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.41 99.95 11.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.066 0.46 . . . . 0.0 110.637 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.3 t -102.63 125.81 56.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.601 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.425 HG12 ' N ' ' A' ' 75' ' ' GLU . 15.7 tt -81.22 162.78 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.036 0.445 . . . . 0.0 110.778 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.425 ' N ' HG12 ' A' ' 74' ' ' ILE . 45.6 mt-10 -124.67 50.73 1.69 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.367 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -87.07 -89.44 0.12 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.734 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -138.57 -22.29 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.162 0.506 . . . . 0.0 111.206 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -75.35 -3.16 31.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.27 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.4 p -72.95 95.88 2.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.359 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 57.7 t -71.38 113.23 7.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.663 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 81' ' ' ARG . 28.3 mtp180 -88.08 110.97 21.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.266 0.555 . . . . 0.0 109.849 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -101.28 132.35 46.85 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.239 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -78.47 104.7 9.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.246 0.546 . . . . 0.0 110.241 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.66 ' HE2' ' HB3' ' A' ' 30' ' ' ALA . 8.7 tpt -86.18 146.38 26.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.803 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp -125.57 92.24 3.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.854 0.835 . . . . 0.0 110.408 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.642 HG23 ' CD1' ' A' ' 36' ' ' TRP . 3.7 t -79.29 83.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.638 176.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.93 -74.89 1.14 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.19 4.95 1.86 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.265 0.555 . . . . 0.0 109.7 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -91.51 110.04 21.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.14 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 m -84.48 114.83 22.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.123 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' A' ' 84' ' ' MET . 2.2 m -134.84 144.54 34.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.921 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.69 119.89 23.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.435 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.534 HG13 ' HA ' ' A' ' 117' ' ' VAL . 27.7 m -122.39 153.79 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.747 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.6 t -96.55 128.01 48.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.0 110.66 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.531 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 56.9 t0 -71.78 129.0 37.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.265 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -82.52 -20.05 37.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.863 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.21 156.45 9.68 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.856 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -78.64 -5.82 54.0 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.763 -0.257 . . . . 0.0 111.5 -177.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.641 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.8 pt? -68.38 -38.93 81.84 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 172.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.25 -36.47 63.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.75 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.504 ' HB1' ' HG3' ' A' ' 113' ' ' ARG . . . -59.27 -52.51 65.36 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.31 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -63.0 -40.03 96.54 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.346 0.593 . . . . 0.0 111.08 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.414 ' HA ' ' HE2' ' A' ' 64' ' ' MET . 82.2 t90 -57.35 -35.71 70.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.538 177.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.525 HD13 ' HB3' ' A' ' 107' ' ' HIS . 2.3 tp -95.41 -22.65 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.862 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.434 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 86.2 p -66.86 -20.27 65.89 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.251 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -87.9 -46.2 9.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.332 173.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.525 ' HB3' HD13 ' A' ' 104' ' ' ILE . 76.3 t60 -75.17 -48.43 23.67 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.04 -38.15 57.51 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.51 -23.49 35.61 Favored Glycine 0 C--N 1.329 0.161 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.325 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.445 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 27.7 m -103.52 159.32 29.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 O-C-N 122.824 -0.221 . . . . 0.0 110.659 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.445 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 37.2 Cg_endo -66.48 90.53 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.466 2.111 . . . . 0.0 111.829 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.475 ' SG ' HG23 ' A' ' 104' ' ' ILE . 2.2 p -134.76 157.18 47.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.969 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.504 ' HG3' ' HB1' ' A' ' 101' ' ' ALA . 21.9 ttm180 -132.55 137.48 47.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.331 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.518 HG13 HG22 ' A' ' 29' ' ' VAL . 2.0 mp -77.16 128.92 37.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.442 ' CD2' ' HA ' ' A' ' 95' ' ' ASP . 80.0 mt -131.8 142.82 49.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.227 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -107.34 120.68 42.82 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.534 ' HA ' HG13 ' A' ' 93' ' ' VAL . 60.2 t -65.58 116.34 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.071 0.463 . . . . 0.0 110.051 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.542 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 2.2 t-80 -77.2 133.56 68.37 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.542 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 10.8 Cg_endo -57.58 -5.36 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.492 2.794 . . . . 0.0 114.472 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -54.71 -44.47 73.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.458 0.647 . . . . 0.0 109.353 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.1 mmt -93.59 -56.76 2.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.617 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 60.26 -173.38 0.12 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.867 0.729 . . . . 0.0 110.493 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 124' ' ' VAL . 1.8 tm-20 57.65 -141.64 0.75 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.595 ' CG1' HG21 ' A' ' 86' ' ' VAL . 48.4 t 71.3 113.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.511 0.672 . . . . 0.0 111.783 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -124.48 150.08 46.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.021 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.496 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 6.7 t90 -45.12 142.17 2.97 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.093 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.548 ' HD3' HG12 ' A' ' 86' ' ' VAL . 3.2 Cg_endo -41.67 122.27 1.89 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 123.643 2.895 . . . . 0.0 112.824 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.446 ' C ' ' H ' ' A' ' 130' ' ' GLU . 17.7 m -94.02 43.79 1.11 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.144 -173.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 129' ' ' LEU . 1.3 pt? -77.39 23.92 0.2 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.97 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.446 ' H ' ' C ' ' A' ' 128' ' ' SER . 7.9 pt-20 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.738 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.045 0.45 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -73.62 102.75 3.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.106 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 t -65.69 117.78 8.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.79 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.3 m 61.26 32.13 19.37 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.257 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.564 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . . . -98.55 119.96 38.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.54 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.607 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 9.6 m-85 -97.76 141.15 31.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.449 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.434 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 75.6 mt-30 -105.23 95.93 10.48 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.45 0.167 . . . . 0.0 111.262 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 11.0 Cg_exo -72.41 -62.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.161 2.574 . . . . 0.0 112.619 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.816 HD11 HD21 ' A' ' 57' ' ' LEU . 8.0 mt -113.81 159.79 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.658 0.599 . . . . 0.0 110.912 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.424 ' H ' HG21 ' A' ' 9' ' ' ILE . . . -71.17 -56.73 5.47 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.42 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -66.08 -45.02 82.72 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -171.964 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.785 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 4.7 p -68.48 -42.21 79.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.755 0.312 . . . . 0.0 111.011 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.74 -127.74 9.34 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.362 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.564 ' HB2' ' HB3' ' A' ' 5' ' ' ALA . . . -96.82 145.1 26.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.377 0.608 . . . . 0.0 111.794 -173.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.6 m -137.38 127.79 26.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.691 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.6 m -86.68 83.5 7.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.397 0.618 . . . . 0.0 110.732 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -147.39 126.63 13.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.059 176.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.8 p -55.76 -28.2 54.78 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -174.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -76.89 -22.37 53.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.717 0.294 . . . . 0.0 111.267 -176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.527 ' HA ' HD21 ' A' ' 52' ' ' LEU . . . -65.42 -28.25 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.346 . . . . 0.0 111.556 -176.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.67 -22.03 64.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.113 -176.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.92 -23.64 17.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -109.71 4.42 21.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.484 -172.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.556 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.19 141.62 38.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 64.4 mttm -163.86 -169.75 1.97 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -78.74 72.68 5.27 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.697 0.76 . . . . 0.0 110.372 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.698 ' HB3' HG23 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -101.42 145.15 29.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.418 178.44 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -176.19 179.2 1.29 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.348 0.594 . . . . 0.0 112.265 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.534 HG23 HG12 ' A' ' 114' ' ' ILE . 16.8 t -110.84 148.07 14.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.199 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.58 ' HB1' ' HE2' ' A' ' 84' ' ' MET . . . -134.22 156.55 48.18 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.534 ' ND2' ' H ' ' A' ' 33' ' ' ALA . 2.6 p-10 -112.46 173.15 6.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.272 0.558 . . . . 0.0 112.143 -171.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.413 ' HB3' ' HB2' ' A' ' 111' ' ' PRO . 9.9 p-10 -46.24 -33.62 3.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.264 -1.335 . . . . 0.0 113.669 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.534 ' H ' ' ND2' ' A' ' 31' ' ' ASN . . . -72.64 2.03 7.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.421 ' HA2' ' HE1' ' A' ' 84' ' ' MET . . . 80.58 8.68 87.28 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -106.71 152.16 24.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.114 -0.543 . . . . 0.0 110.022 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -64.3 146.72 53.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.293 173.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.78 HD22 ' HG ' ' A' ' 42' ' ' CYS . 20.3 tp -98.65 166.26 11.41 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.2 t-20 -147.95 158.18 43.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -173.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.617 ' O ' ' HA ' ' A' ' 43' ' ' PRO . 54.5 mtm180 -73.25 -14.95 61.42 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.97 -18.89 35.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.189 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 91.3 mt -92.7 -51.82 4.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.78 ' HG ' HD22 ' A' ' 37' ' ' LEU . 77.2 m -114.78 94.27 36.84 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.996 173.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.617 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 51.7 Cg_exo -54.83 -44.53 48.78 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.723 2.949 . . . . 0.0 113.608 -171.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -77.52 8.38 4.38 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.425 HD11 ' HB3' ' A' ' 108' ' ' ALA . 2.4 mp -76.16 -21.65 56.31 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.2 -22.62 61.3 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.983 170.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.523 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 52.5 mt-10 -86.06 63.16 7.87 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.225 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.475 ' HB ' ' HB3' ' A' ' 12' ' ' CYS . 73.3 t -123.18 127.93 74.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.136 169.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.481 ' HB3' ' HB2' ' A' ' 60' ' ' LYS . 5.8 t -91.24 140.19 30.03 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.461 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 2.7 t -121.39 128.29 75.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.0 111.821 -172.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 15.4 mt-10 -120.86 129.41 53.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.559 169.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.527 HD21 ' HA ' ' A' ' 20' ' ' ALA . 5.7 mp -110.57 133.58 53.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.52 0.676 . . . . 0.0 110.013 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.1 ttm105 -135.91 148.14 48.44 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 70.0 mtm -62.98 93.68 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.433 0.635 . . . . 0.0 110.741 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.37 -16.03 11.71 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.938 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -143.28 138.42 29.56 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 117.828 0.814 . . . . 0.0 111.776 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.816 HD21 HD11 ' A' ' 9' ' ' ILE . 39.0 tp -113.1 112.46 23.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.702 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.552 ' HB ' ' HB2' ' A' ' 51' ' ' GLU . 61.0 t -100.68 110.6 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.055 0.455 . . . . 0.0 111.251 -173.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 mp -98.67 132.5 44.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.996 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.543 ' HG2' ' HB3' ' A' ' 66' ' ' ARG . 44.3 mtmt -129.52 136.81 50.31 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.58 ' HB1' ' HB2' ' A' ' 64' ' ' MET . . . -116.45 142.28 29.25 Favored Pre-proline 0 C--O 1.222 -0.372 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.449 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.523 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 26.8 Cg_exo -62.89 94.74 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.93 1.753 . . . . 0.0 110.225 168.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.29 -28.33 6.33 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.042 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.58 ' HB2' ' HB1' ' A' ' 61' ' ' ALA . 16.7 mmt -122.4 152.65 40.0 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.34 -166.89 0.02 OUTLIER 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.856 0.836 . . . . 0.0 112.561 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.543 ' HB3' ' HG2' ' A' ' 60' ' ' LYS . 12.2 ptt180 -95.71 146.63 24.36 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.45 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 tp -124.54 115.36 20.73 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.793 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.76 109.75 21.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.619 0.723 . . . . 0.0 110.788 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.4 mt -104.73 113.81 64.55 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.361 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.47 123.04 12.7 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.258 1.972 . . . . 0.0 111.957 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.481 HD23 ' HB2' ' A' ' 57' ' ' LEU . 95.9 mt -66.04 -28.48 68.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.631 0.729 . . . . 0.0 109.12 176.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -85.01 90.55 7.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.199 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.93 143.97 10.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.048 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.2 mt -81.63 148.04 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -138.67 61.0 1.59 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.177 0.513 . . . . 0.0 110.171 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -146.03 -59.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.313 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 79' ' ' SER . 16.7 t70 -109.21 -62.61 1.46 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.666 0.269 . . . . 0.0 111.577 -175.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -83.05 32.99 0.44 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.957 0.884 . . . . 0.0 110.358 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.419 ' H ' ' C ' ' A' ' 77' ' ' ASP . 33.3 t -107.94 97.34 7.06 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 172.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.596 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 45.1 t -71.88 99.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.92 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.499 ' HG2' ' HB2' ' A' ' 92' ' ' ASP . 52.7 ttp180 -88.8 90.68 8.51 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -93.11 130.0 38.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.895 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -79.07 114.91 18.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.843 0.354 . . . . 0.0 110.405 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.58 ' HE2' ' HB1' ' A' ' 30' ' ' ALA . 2.4 tpt -105.22 154.94 19.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.754 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.25 87.61 2.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.689 0.757 . . . . 0.0 109.559 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 t -81.46 92.88 2.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.736 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.27 -81.24 1.08 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.57 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -140.06 9.48 2.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.793 -0.203 . . . . 0.0 110.788 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -111.48 110.53 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.359 . . . . 0.0 110.506 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 m -84.29 109.61 17.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.224 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.417 ' HB ' ' HE2' ' A' ' 121' ' ' MET . 5.0 m -131.85 149.21 32.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.806 -176.224 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.499 ' HB2' ' HG2' ' A' ' 81' ' ' ARG . 7.1 p-10 -87.22 128.71 35.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.442 0.639 . . . . 0.0 111.06 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.494 HG21 HD13 ' A' ' 115' ' ' LEU . 29.5 m -124.91 153.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.011 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.486 HG21 ' HD2' ' A' ' 118' ' ' HIS . 98.8 t -96.33 137.3 24.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.596 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 32.0 t70 -86.8 123.79 32.34 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.415 ' HG3' ' HE1' ' A' ' 27' ' ' TRP . 16.3 mm-40 -83.38 5.73 22.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 -174.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.78 126.65 2.41 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.211 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -67.47 -19.54 65.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.037 0.446 . . . . 0.0 110.244 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.03 -33.47 74.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 173.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.11 79.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.875 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.449 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -57.94 -54.26 48.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.5 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.93 87.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.447 ' CZ2' ' HB2' ' A' ' 61' ' ' ALA . 55.8 t90 -54.32 -46.49 72.86 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.966 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.539 HD12 ' HB3' ' A' ' 107' ' ' HIS . 1.5 tp -84.93 -21.54 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.692 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.4 m -67.12 -15.66 63.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.167 0.508 . . . . 0.0 109.699 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.39 -52.02 5.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.276 171.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.539 ' HB3' HD12 ' A' ' 104' ' ' ILE . 72.5 t60 -67.63 -46.66 71.84 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.02 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.425 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -82.29 -42.22 19.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.046 0.45 . . . . 0.0 109.807 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.06 -12.36 62.2 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.055 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.533 HG22 ' SG ' ' A' ' 112' ' ' CYS . 15.4 m -112.78 159.42 34.49 Favored Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 122.788 -0.242 . . . . 0.0 110.353 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.413 ' HB2' ' HB3' ' A' ' 32' ' ' ASP . 25.4 Cg_exo -63.18 93.11 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.831 2.354 . . . . 0.0 112.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.533 ' SG ' HG22 ' A' ' 110' ' ' VAL . 68.6 m -134.8 155.86 49.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.955 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.455 HH21 ' CG ' ' A' ' 95' ' ' ASP . 10.5 ptm180 -141.16 146.8 37.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.534 HG12 HG23 ' A' ' 29' ' ' VAL . 35.2 mt -85.15 122.78 38.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.107 -177.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.54 HD22 ' HA ' ' A' ' 95' ' ' ASP . 35.8 mt -126.06 152.23 46.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.139 -171.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.598 ' HZ1' ' HB3' ' A' ' 116' ' ' LYS . 7.8 ttpm? -119.09 123.16 43.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.104 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.67 137.55 24.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.764 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.497 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -76.49 134.25 70.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.653 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 118' ' ' HIS . 3.7 Cg_exo -74.53 -8.05 20.17 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.231 2.621 . . . . 0.0 113.242 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.79 -52.48 56.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.338 . . . . 0.0 111.077 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -91.98 -45.43 8.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.959 178.052 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.429 ' N ' ' SD ' ' A' ' 121' ' ' MET . . . 58.94 -174.36 0.09 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.078 0.551 . . . . 0.0 112.142 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 49.78 84.03 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 122.096 0.951 . . . . 0.0 112.992 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.7 t -132.19 131.8 60.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.891 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -131.3 133.22 45.15 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.883 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.519 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 8.3 t90 -45.28 140.74 3.78 Favored Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 124.196 0.935 . . . . 0.0 110.772 175.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.519 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 9.5 Cg_endo -47.73 115.42 1.43 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.607 2.871 . . . . 0.0 112.745 -176.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.4 m -85.7 37.84 0.72 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.383 0.611 . . . . 0.0 110.724 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.513 HD23 ' HB2' ' A' ' 127' ' ' PRO . 3.2 pp -77.33 171.99 14.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.178 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.4 -0.81 . . . . 0.0 109.789 177.857 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -73.41 107.97 6.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.99 0.424 . . . . 0.0 111.61 -176.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.643 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -155.68 -83.55 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.042 175.389 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.643 ' HB ' ' O ' ' A' ' 3' ' ' THR . 6.9 t 147.97 146.29 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.438 1.095 . . . . 0.0 110.522 172.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -167.21 122.59 1.08 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.077 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.611 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 36.5 m-85 -103.25 140.37 37.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.25 95.76 14.06 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.947 0.404 . . . . 0.0 110.048 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.879 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 7.5 Cg_endo -90.06 -35.65 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.449 2.766 . . . . 0.0 113.395 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.604 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 2.4 mm -115.93 135.78 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 O-C-N 123.9 0.75 . . . . 0.0 110.231 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.433 ' O ' ' HD2' ' A' ' 39' ' ' ARG . . . -68.22 -56.23 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -70.86 -53.53 14.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.489 -178.109 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.824 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 39.7 m -56.48 -47.59 78.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.146 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.37 -130.39 10.16 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.115 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.73 150.46 21.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.321 0.581 . . . . 0.0 112.034 -172.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.579 ' HG1' HG12 ' A' ' 50' ' ' VAL . 10.7 m -121.65 139.09 53.98 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.491 176.19 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m -90.44 8.47 33.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.36 0.6 . . . . 0.0 111.201 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 mp0 -95.63 142.19 28.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.779 -179.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.8 m -67.68 -15.95 63.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.081 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.406 ' HB3' ' HE2' ' A' ' 23' ' ' TYR . 7.2 mm-40 -64.3 -36.1 83.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.288 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.879 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -62.08 -25.01 67.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.768 -171.035 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.03 -23.93 67.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.03 0.443 . . . . 0.0 111.093 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.05 1.04 22.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.685 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.406 ' HE2' ' HB3' ' A' ' 19' ' ' GLU . 35.3 m-85 -126.44 12.4 7.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.723 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.531 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 14.0 pt20 -70.26 143.07 52.22 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 83.1 mttt -160.67 173.14 15.9 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -172.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -78.73 75.64 5.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.351 0.596 . . . . 0.0 109.742 173.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -92.76 152.9 19.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.178 177.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 pp -175.58 177.39 1.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.468 0.651 . . . . 0.0 112.184 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.513 HG22 HG12 ' A' ' 114' ' ' ILE . 64.6 t -122.0 138.16 53.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HB2' ' HE2' ' A' ' 84' ' ' MET . . . -122.81 141.63 51.64 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 122.174 -0.328 . . . . 0.0 110.16 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -88.51 172.78 9.08 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.117 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -47.79 -31.7 5.2 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.677 0.791 . . . . 0.0 112.631 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.93 -14.79 63.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.709 0.29 . . . . 0.0 111.736 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.702 ' HA2' ' HE1' ' A' ' 84' ' ' MET . . . 90.53 5.85 68.81 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.559 -177.577 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -94.06 144.97 25.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.562 -176.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.59 ' CH2' ' HB ' ' A' ' 124' ' ' VAL . 31.0 m0 -68.99 125.29 26.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.844 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.445 ' HG ' ' SG ' ' A' ' 42' ' ' CYS . 29.5 tp -96.24 131.67 42.49 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -119.76 157.97 27.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.871 0.367 . . . . 0.0 111.126 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.433 ' HD2' ' O ' ' A' ' 10' ' ' ALA . 11.4 ptm180 -64.64 -15.41 61.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.46 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.04 -37.66 61.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.487 0.66 . . . . 0.0 109.461 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 68.3 mt -77.64 -50.4 12.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.885 178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.445 ' SG ' ' HG ' ' A' ' 37' ' ' LEU . 13.1 p -116.7 92.98 39.62 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.371 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.58 -25.02 69.68 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.068 2.512 . . . . 0.0 113.214 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -71.36 -17.64 62.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 111.734 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.441 HD13 ' SG ' ' A' ' 42' ' ' CYS . 7.7 mp -72.46 -21.67 61.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.0 0.429 . . . . 0.0 110.599 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.81 -5.18 32.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.514 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.456 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 6.7 mm-40 -84.67 3.9 35.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.338 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.824 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 95.3 t -79.77 118.74 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.87 0.367 . . . . 0.0 110.969 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.9 p -87.18 119.12 27.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.669 ' HB ' ' HB3' ' A' ' 12' ' ' CYS . 12.0 p -117.71 128.26 74.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.315 -171.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.472 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 35.2 mm-40 -120.87 129.84 53.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.561 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.589 HD21 ' HA ' ' A' ' 20' ' ' ALA . 10.1 mp -97.78 125.89 42.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.499 0.666 . . . . 0.0 110.66 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.502 HH21 HG21 ' A' ' 58' ' ' VAL . 28.0 ttm-85 -110.09 164.66 12.41 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.373 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.43 88.9 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.483 0.658 . . . . 0.0 110.257 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.39 -13.7 36.3 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.933 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.75 138.3 48.56 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.621 0.724 . . . . 0.0 112.345 -174.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 61.3 tp -100.59 107.87 19.65 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.695 173.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.502 HG21 HH21 ' A' ' 53' ' ' ARG . 46.2 t -99.56 102.78 13.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.928 0.394 . . . . 0.0 110.685 -175.617 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.64 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 5.8 mp -90.88 140.54 29.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.715 176.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.472 ' HE2' ' HG2' ' A' ' 51' ' ' GLU . 39.6 mtmt -136.44 130.1 32.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.637 ' HB1' ' HB2' ' A' ' 64' ' ' MET . . . -114.74 153.09 46.88 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 119.211 -0.995 . . . . 0.0 112.829 -176.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.456 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 20.0 Cg_exo -67.14 98.25 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.236 1.957 . . . . 0.0 110.618 170.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.7 -18.31 32.2 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.267 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.637 ' HB2' ' HB1' ' A' ' 61' ' ' ALA . 14.3 mmt -121.73 144.84 48.56 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.2 mt -68.15 -149.93 0.01 OUTLIER 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.407 0.622 . . . . 0.0 111.971 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -69.77 170.25 11.36 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.745 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.64 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 60.2 tp -151.71 87.72 1.38 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.894 166.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -84.0 104.98 14.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.447 -175.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.0 mt -115.81 136.75 22.93 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.393 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.22 139.72 91.58 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 121.66 1.573 . . . . 0.0 110.613 171.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.2 mt -52.69 -33.41 47.37 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -175.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -140.02 110.17 6.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.4 t -59.21 123.1 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 77' ' ' ASP . 24.2 mm -57.45 145.75 7.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.911 0.386 . . . . 0.0 110.409 -176.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -74.94 -2.28 26.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.765 0.793 . . . . 0.0 110.924 -170.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -129.07 -0.01 5.23 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.097 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.568 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 25.1 t70 -85.09 -67.9 0.77 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -160.23 44.34 0.21 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.518 0.675 . . . . 0.0 109.44 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.3 t -77.06 92.44 3.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.926 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 41.1 t -85.81 122.23 38.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.502 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.7 104.33 16.34 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.373 0.606 . . . . 0.0 111.139 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.541 ' O ' HG22 ' A' ' 93' ' ' VAL . 39.5 m-85 -94.95 116.4 28.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 173.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . 0.487 ' HG2' HG23 ' A' ' 90' ' ' THR . 31.6 tt0 -80.87 99.28 8.25 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.702 ' HE1' ' HA2' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -86.96 159.31 19.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.881 -169.739 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.8 tp -117.99 87.36 2.7 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.885 0.85 . . . . 0.0 109.554 -173.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.484 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 2.8 t -78.99 86.84 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.874 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.85 -68.9 2.48 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.592 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -145.41 2.95 0.99 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.777 0.322 . . . . 0.0 110.367 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.42 ' HG2' HG11 ' A' ' 91' ' ' VAL . 15.8 tt0 -109.95 109.61 20.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.925 0.393 . . . . 0.0 111.025 -170.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -85.13 104.83 15.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.655 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.52 HG21 HG21 ' A' ' 124' ' ' VAL . 2.7 m -118.93 144.99 25.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.062 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.09 112.68 16.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.034 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.541 HG22 ' O ' ' A' ' 82' ' ' TYR . 16.8 m -120.07 152.47 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.48 176.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -103.22 135.37 41.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.767 0.317 . . . . 0.0 111.176 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.565 ' HA ' HD22 ' A' ' 115' ' ' LEU . 43.5 t0 -83.2 126.13 32.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -81.32 -5.91 58.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.495 -176.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.5 136.92 2.95 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.378 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.478 ' HG2' ' NH1' ' A' ' 113' ' ' ARG . 14.6 mt-10 -69.15 -23.13 63.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.826 0.346 . . . . 0.0 110.573 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -64.56 -30.91 71.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.082 0.467 . . . . 0.0 109.86 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.502 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -74.35 -37.95 63.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.9 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.451 ' HB3' ' HD3' ' A' ' 113' ' ' ARG . . . -59.51 -46.39 88.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.621 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.489 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -66.69 -36.5 82.66 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.351 0.596 . . . . 0.0 111.027 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.613 ' CZ2' ' HB2' ' A' ' 61' ' ' ALA . 76.1 t90 -57.45 -40.27 78.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.311 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.549 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.2 tp -93.23 -21.1 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.528 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.489 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 90.5 p -66.87 -19.87 65.82 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.488 -0.757 . . . . 0.0 109.237 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -83.65 -48.66 9.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.135 172.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.549 ' HB3' HD12 ' A' ' 104' ' ' ILE . 75.1 t60 -74.28 -51.98 13.66 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.78 -41.39 68.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 109.739 178.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.13 -22.94 38.03 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.74 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.22 157.03 35.58 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 120.532 0.206 . . . . 0.0 110.671 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.17 92.89 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.464 2.11 . . . . 0.0 111.469 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.417 ' HB2' HG13 ' A' ' 29' ' ' VAL . 5.0 p -134.25 156.5 48.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.015 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.479 ' HD2' ' CG ' ' A' ' 95' ' ' ASP . 7.3 tpp180 -117.77 128.44 54.88 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.172 -175.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.513 HG12 HG22 ' A' ' 29' ' ' VAL . 54.5 mt -79.1 118.33 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.565 HD22 ' HA ' ' A' ' 95' ' ' ASP . 23.2 mt -130.46 142.1 50.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.286 0.565 . . . . 0.0 112.061 -168.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.1 117.33 29.33 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.206 175.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.91 137.56 23.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.522 -174.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.99 125.69 79.22 Favored Pre-proline 0 C--O 1.234 0.243 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.5 -4.46 6.86 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.377 2.718 . . . . 0.0 114.881 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -51.03 -57.33 8.91 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.347 0.594 . . . . 0.0 110.785 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 18.6 ptp -107.17 -54.19 2.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.077 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 54.7 -106.85 0.34 Allowed 'General case' 0 CA--C 1.531 0.23 0 O-C-N 123.489 0.493 . . . . 0.0 110.887 -174.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 66.72 -59.13 0.37 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.816 0.846 . . . . 0.0 113.233 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.59 ' HB ' ' CH2' ' A' ' 36' ' ' TRP . 3.4 t -54.57 122.69 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 112.504 -168.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -112.41 36.45 3.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.092 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.678 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 11.7 t90 72.35 152.41 0.14 Allowed Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -169.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.678 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 41.8 Cg_exo -25.86 -54.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 124.523 3.482 . . . . 0.0 114.438 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.3 p -171.84 82.69 0.07 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.479 0.657 . . . . 0.0 110.931 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.672 ' HG ' ' HB3' ' A' ' 126' ' ' TRP . 70.3 mt -81.13 120.06 24.37 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.391 170.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.663 -176.388 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 120.763 0.316 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 t -147.6 169.76 18.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.78 0.324 . . . . 0.0 110.499 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.2 t -113.23 164.67 13.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.199 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.4 m 64.59 23.33 12.83 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 122.211 1.005 . . . . 0.0 109.878 -176.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.619 ' HB2' ' HB2' ' A' ' 14' ' ' ALA . . . -103.09 111.65 24.1 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.869 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.702 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 61.8 m-85 -87.45 117.66 26.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.422 ' HG3' ' O ' ' A' ' 13' ' ' GLY . 10.3 tt0 -96.39 98.85 4.61 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.266 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.742 ' HA ' ' CB ' ' A' ' 24' ' ' GLN . 21.4 Cg_exo -64.69 -60.59 0.13 Allowed 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 122.67 2.247 . . . . 0.0 110.9 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.645 ' HA ' ' HB3' ' A' ' 27' ' ' TRP . 44.9 mt -114.54 136.01 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.951 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.02 -58.74 5.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.745 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 16.9 mm-40 -70.61 -22.43 62.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.794 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.839 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 73.6 m -73.6 -48.08 35.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.133 0.492 . . . . 0.0 110.087 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.422 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . 120.33 -153.72 16.63 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.231 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.619 ' HB2' ' HB2' ' A' ' 5' ' ' ALA . . . -113.33 142.73 45.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.106 0.479 . . . . 0.0 111.909 -172.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.3 m -118.87 137.57 53.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.699 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m -86.49 76.29 9.62 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.144 0.497 . . . . 0.0 110.126 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -160.19 120.7 2.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.858 178.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -68.49 -10.33 54.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.922 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 22.2 tt0 -68.35 -28.54 67.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.287 0.565 . . . . 0.0 109.72 178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.559 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -67.94 -24.22 65.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.624 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.84 -15.75 63.19 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.23 -3.84 50.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.631 0.253 . . . . 0.0 111.419 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.416 ' CD2' HD13 ' A' ' 71' ' ' LEU . 74.3 m-85 -130.56 -25.67 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.742 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -66.0 155.35 36.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.989 -177.744 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -172.65 -160.63 0.14 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.219 0.324 . . . . 0.0 110.169 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -74.95 69.06 1.86 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 122.122 0.963 . . . . 0.0 109.729 175.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.645 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 1.3 t90 -100.51 144.84 29.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.452 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -170.31 -173.79 1.55 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.575 0.625 . . . . 0.0 112.243 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.486 HG21 HG12 ' A' ' 114' ' ' ILE . 80.7 t -113.2 144.23 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.758 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.02 150.13 37.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 0.0 111.281 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.485 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 27.5 t30 -98.89 156.81 16.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.137 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -46.13 -37.11 6.53 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.758 0.823 . . . . 0.0 112.683 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.09 -6.97 37.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 111.401 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.63 4.53 63.77 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.582 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -98.44 160.35 14.34 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.413 ' HB2' ' HD1' ' A' ' 126' ' ' TRP . 28.2 m0 -68.07 134.79 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 172.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.62 HD21 ' SG ' ' A' ' 112' ' ' CYS . 28.4 tp -99.19 131.59 45.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.39 152.86 42.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.351 0.596 . . . . 0.0 112.597 -173.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.2 ttm105 -48.8 -32.11 8.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.736 164.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.77 -17.8 64.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.492 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 75.5 mt -105.6 -39.6 6.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.12 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 50.5 t -132.29 101.59 14.71 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.029 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.72 -29.45 59.85 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.653 2.236 . . . . 0.0 112.138 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -59.34 -30.74 68.59 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.398 0.618 . . . . 0.0 110.473 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.745 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 37.3 tp -66.79 -34.03 76.92 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.566 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.643 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -73.98 9.21 1.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -98.26 24.26 7.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.844 0.354 . . . . 0.0 111.203 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.839 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 55.4 t -84.79 113.79 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.714 0.292 . . . . 0.0 110.409 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.8 t -77.54 132.06 38.17 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.28 138.25 53.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.559 0.695 . . . . 0.0 112.074 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.413 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 35.3 tt0 -140.86 149.12 41.56 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.458 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.559 HD22 ' HA ' ' A' ' 20' ' ' ALA . 5.5 mp -128.61 158.03 39.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.687 0.756 . . . . 0.0 112.238 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -158.45 149.06 20.24 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.501 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 tpt -49.26 98.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.516 0.51 . . . . 0.0 110.992 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.51 -31.19 6.07 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.486 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.88 137.76 52.44 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.092 0.946 . . . . 0.0 112.963 -172.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.481 ' HB2' ' CD2' ' A' ' 71' ' ' LEU . 37.9 tp -100.72 108.59 20.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.213 170.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.413 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 42.5 t -96.96 99.82 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.977 0.418 . . . . 0.0 110.95 -172.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.585 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 8.0 mp -91.86 141.74 28.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.048 175.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -137.44 130.27 30.24 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.594 ' HB1' ' HB2' ' A' ' 64' ' ' MET . . . -126.0 151.67 71.88 Favored Pre-proline 0 C--O 1.221 -0.41 0 C-N-CA 118.68 -1.208 . . . . 0.0 113.247 -175.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -62.81 107.19 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.986 1.79 . . . . 0.0 110.228 168.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.23 -24.29 25.01 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.169 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.594 ' HB2' ' HB1' ' A' ' 61' ' ' ALA . 95.1 mmm -122.39 147.57 46.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 0.0 110.327 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.3 mt -68.34 -144.58 0.01 OUTLIER 'General case' 0 C--O 1.247 0.937 0 CA-C-O 121.548 0.69 . . . . 0.0 110.756 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.445 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 5.8 ptt180 -86.75 151.63 23.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.066 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.585 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 60.3 tp -124.32 93.53 3.94 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 168.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.59 97.95 10.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.891 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.438 HG13 ' HG ' ' A' ' 67' ' ' LEU . 65.9 mt -100.21 122.52 49.98 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.922 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.94 123.97 15.11 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.006 1.804 . . . . 0.0 110.77 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.481 ' CD2' ' HB2' ' A' ' 57' ' ' LEU . 64.7 mt -67.72 -42.14 82.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.898 0.38 . . . . 0.0 110.707 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -92.39 64.3 4.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.699 0.762 . . . . 0.0 110.898 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.33 130.53 29.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.718 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' A' ' 77' ' ' ASP . 7.6 mt -67.59 136.28 26.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -91.81 12.71 20.55 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.695 0.759 . . . . 0.0 110.368 -169.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -129.15 -8.72 4.8 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.773 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.608 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 38.3 t70 -81.36 -85.32 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.378 -170.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.11 34.34 5.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.169 0.509 . . . . 0.0 109.954 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.7 p -72.31 77.63 1.0 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.281 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.578 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 61.2 t -66.92 108.2 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.416 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 81' ' ' ARG . 39.0 ttt-85 -66.58 112.63 4.24 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.531 ' O ' HG21 ' A' ' 93' ' ' VAL . 3.1 t80 -105.15 107.97 19.24 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -80.11 113.82 18.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.913 ' HE3' ' HA ' ' A' ' 84' ' ' MET . 5.3 mmt -103.68 169.59 8.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.195 -175.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.2 tp -139.38 88.04 2.23 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 t -89.39 103.24 13.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.785 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.61 -77.76 1.4 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -146.27 4.19 0.92 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.51 0.195 . . . . 0.0 110.933 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.577 ' HG2' HG12 ' A' ' 91' ' ' VAL . 10.2 tt0 -105.26 120.48 41.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.849 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.441 ' HA ' ' O ' ' A' ' 84' ' ' MET . 0.2 OUTLIER -79.93 116.33 20.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.264 174.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.577 HG12 ' HG2' ' A' ' 89' ' ' GLN . 3.6 m -129.74 164.29 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.39 112.69 24.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.754 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.531 HG21 ' O ' ' A' ' 82' ' ' TYR . 7.1 m -125.81 152.13 32.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.7 t -106.21 142.17 19.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 122.237 -0.289 . . . . 0.0 110.743 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.637 ' OD1' ' HD3' ' A' ' 113' ' ' ARG . 26.4 t70 -92.94 125.86 37.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.56 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.98 -14.03 62.21 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.708 0.289 . . . . 0.0 111.652 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 137.46 149.21 5.53 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.999 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -64.68 -13.54 54.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.934 0.397 . . . . 0.0 111.001 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.4 tp -66.04 -43.55 87.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.49 -36.53 76.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.388 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.09 67.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.131 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.472 ' HA ' ' HG ' ' A' ' 105' ' ' SER . . . -62.95 -39.35 94.37 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.247 0.546 . . . . 0.0 111.103 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.453 ' CH2' ' HB2' ' A' ' 61' ' ' ALA . 49.8 t90 -57.81 -44.33 86.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.019 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' A' ' 104' ' ' ILE . 1.6 tp -87.12 -25.17 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.571 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.472 ' HG ' ' HA ' ' A' ' 102' ' ' ALA . 16.5 p -68.49 -15.85 63.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.533 -0.729 . . . . 0.0 109.959 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -88.99 -45.25 9.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.448 171.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -74.4 -49.51 22.29 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.64 -40.87 55.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.48 -38.22 3.38 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.614 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.503 HG23 ' SG ' ' A' ' 112' ' ' CYS . 18.7 m -87.64 157.85 51.88 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.84 88.63 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.761 2.307 . . . . 0.0 111.923 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.62 ' SG ' HD21 ' A' ' 37' ' ' LEU . 73.8 m -134.83 168.73 18.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.939 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.637 ' HD3' ' OD1' ' A' ' 95' ' ' ASP . 11.1 ptp180 -149.14 151.23 34.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.606 0.241 . . . . 0.0 110.634 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.486 HG12 HG21 ' A' ' 29' ' ' VAL . 52.3 mt -82.85 131.88 32.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.536 HD22 ' HA ' ' A' ' 95' ' ' ASP . 64.7 mt -138.23 133.34 33.07 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 120.926 0.393 . . . . 0.0 111.214 -174.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -99.89 120.47 39.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.785 173.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.1 t -64.16 133.85 29.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.557 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 5.0 t-160 -55.99 126.65 67.08 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.88 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.557 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 6.1 Cg_endo -47.78 -32.49 17.09 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.679 2.919 . . . . 0.0 113.45 -175.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.21 -53.24 58.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.391 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 51.7 ttm -89.78 121.41 31.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.462 0.649 . . . . 0.0 110.636 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -115.4 -35.5 4.6 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.405 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -82.63 103.23 11.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.227 0.537 . . . . 0.0 111.364 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.489 HG12 HG11 ' A' ' 91' ' ' VAL . 51.4 t -130.47 -66.86 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.297 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 68.28 121.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.605 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.545 ' HE3' ' H ' ' A' ' 128' ' ' SER . 2.9 t90 -58.37 145.62 74.61 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.47 165.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.48 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 4.9 Cg_endo -45.37 -32.33 7.57 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.732 2.955 . . . . 0.0 113.386 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.545 ' H ' ' HE3' ' A' ' 126' ' ' TRP . 20.3 m 61.88 27.63 16.83 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.99 0.516 . . . . 0.0 111.537 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 79.9 mt 62.94 91.86 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.141 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.248 0.979 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.111 -178.934 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.5 m -90.86 98.38 11.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.102 0.477 . . . . 0.0 109.811 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.4 t -89.41 -20.06 24.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.763 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.1 m 64.29 92.03 0.07 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.592 0.71 . . . . 0.0 111.705 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -115.95 125.93 53.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.754 176.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.436 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 36.8 m-85 -89.98 138.17 31.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -114.54 93.24 31.71 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 120.735 0.302 . . . . 0.0 110.452 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.575 ' HA ' ' CB ' ' A' ' 24' ' ' GLN . 1.1 Cg_endo -84.8 -38.23 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.871 2.38 . . . . 0.0 112.213 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.633 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 0.7 OUTLIER -114.75 147.12 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.381 -176.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.13 -69.22 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.821 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -65.46 -39.9 92.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.283 -176.664 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.848 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 34.2 m -60.55 -47.92 84.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.846 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.55 -130.38 10.03 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.625 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.6 147.8 32.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.305 0.574 . . . . 0.0 112.112 -171.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.8 m -139.51 125.66 19.99 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.357 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -86.8 88.87 7.78 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.91 0.862 . . . . 0.0 110.639 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -148.19 135.97 20.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.194 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 p -56.46 -38.03 71.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -74.95 -23.35 58.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.417 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.542 ' HB2' ' HG3' ' A' ' 8' ' ' PRO . . . -62.13 -27.35 68.88 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.47 67.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.86 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.2 3.11 27.48 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -118.31 13.83 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.71 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.575 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -77.07 153.54 34.24 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.08 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -162.95 171.31 16.76 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.48 ' HD2' ' O ' ' A' ' 122' ' ' ALA . 58.6 mtt180 -76.81 76.84 3.42 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 122.145 0.974 . . . . 0.0 109.314 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -91.39 152.3 20.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.351 -1.749 . . . . 0.0 108.913 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 pp 179.49 -176.9 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.184 0.516 . . . . 0.0 111.097 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.824 HG22 ' HB3' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -118.87 140.73 41.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.573 178.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.871 ' HB1' ' HE1' ' A' ' 84' ' ' MET . . . -119.31 140.05 50.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 175.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.482 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 10.1 p30 -95.88 -177.52 4.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.438 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -46.53 -41.44 14.24 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.81 0.694 . . . . 0.0 112.765 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.47 -8.13 48.73 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.09 8.78 87.33 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.704 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -88.63 142.76 27.42 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.423 ' HB2' ' HD1' ' A' ' 126' ' ' TRP . 29.8 m0 -62.36 128.31 35.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.824 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.824 ' HB3' HG22 ' A' ' 29' ' ' VAL . 8.5 tp -87.42 131.45 34.31 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -120.64 162.8 19.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.47 -169.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -71.58 -21.55 61.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.258 0.551 . . . . 0.0 109.778 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.9 -27.16 61.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.825 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.9 mt -90.18 -45.39 9.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.525 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.693 ' SG ' ' HG ' ' A' ' 37' ' ' LEU . 1.7 p -130.44 96.83 23.22 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.105 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.27 -37.14 52.55 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.948 2.432 . . . . 0.0 112.859 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -73.24 -6.29 44.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.231 0.539 . . . . 0.0 111.003 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.821 ' HG ' ' HB2' ' A' ' 11' ' ' GLU . 33.8 tp -73.02 -24.23 60.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.919 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.512 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -72.19 -6.3 41.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.426 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.74 31.24 0.77 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.484 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.848 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 88.8 t -93.49 127.86 45.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.644 0.259 . . . . 0.0 110.418 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.2 t -86.47 137.54 32.46 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.514 HG21 ' HB3' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -119.41 144.7 27.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.182 0.515 . . . . 0.0 111.239 -173.751 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -148.7 140.36 23.58 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -111.36 125.04 53.44 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.734 0.778 . . . . 0.0 110.578 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.578 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 2.4 tpm_? -105.1 154.89 19.56 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.09 -1.414 . . . . 0.0 107.487 176.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.1 ttt -64.0 89.18 0.05 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.917 0.389 . . . . 0.0 110.544 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.35 -9.44 33.14 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.521 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.578 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 87.5 m-85 -132.24 147.85 52.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.174 0.511 . . . . 0.0 111.235 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.58 ' HB3' HG13 ' A' ' 69' ' ' ILE . 45.8 tp -104.83 111.93 24.85 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 61.5 t -100.28 101.64 12.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.011 0.434 . . . . 0.0 110.778 -174.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.564 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 11.1 mp -90.64 145.19 25.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.431 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -137.34 129.23 28.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.585 ' HB2' ' HB2' ' A' ' 64' ' ' MET . . . -120.54 144.75 39.21 Favored Pre-proline 0 C--O 1.219 -0.514 0 C-N-CA 118.946 -1.102 . . . . 0.0 113.35 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -63.35 97.32 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.743 1.628 . . . . 0.0 109.758 166.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.94 -33.98 3.88 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.768 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.585 ' HB2' ' HB2' ' A' ' 61' ' ' ALA . 91.7 mmm -122.19 149.6 43.41 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.442 ' N ' HD21 ' A' ' 65' ' ' LEU . 2.6 mm? -70.91 -144.59 0.01 OUTLIER 'General case' 0 C--O 1.246 0.873 0 CA-C-O 120.895 0.379 . . . . 0.0 110.635 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 92.2 mtt180 -79.06 155.93 28.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.107 0.479 . . . . 0.0 110.563 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.564 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 59.9 tp -127.39 103.46 7.38 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -88.76 101.77 14.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.588 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.58 HG13 ' HB3' ' A' ' 57' ' ' LEU . 8.5 pt -124.43 119.25 26.14 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.444 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.515 ' HB2' ' O ' ' A' ' 73' ' ' VAL . 39.5 Cg_exo -57.15 144.64 89.8 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.354 2.036 . . . . 0.0 111.33 176.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.0 mt -50.33 -69.22 0.12 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -167.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -88.94 -48.07 7.7 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.813 -171.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.515 ' O ' ' HB2' ' A' ' 70' ' ' PRO . 25.7 m -140.54 155.91 23.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.661 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.523 HG13 ' N ' ' A' ' 75' ' ' GLU . 7.4 tp -70.45 162.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 173.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.523 ' N ' HG13 ' A' ' 74' ' ' ILE . 26.7 mt-10 -82.28 23.8 0.72 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.34 0.59 . . . . 0.0 111.323 -175.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -132.51 156.63 46.45 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -84.62 -2.0 56.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.791 0.805 . . . . 0.0 109.885 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -88.35 29.51 0.97 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.902 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 m -60.89 102.82 0.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t -70.19 130.83 34.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.585 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -104.31 111.17 23.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.217 0.532 . . . . 0.0 110.306 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.442 ' O ' HG21 ' A' ' 93' ' ' VAL . 33.0 m-85 -102.89 135.06 45.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.379 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -88.32 128.1 35.49 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.286 0.565 . . . . 0.0 110.76 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.871 ' HE1' ' HB1' ' A' ' 30' ' ' ALA . 52.4 mtt -95.69 171.83 8.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.3 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.5 tp -139.96 87.26 2.15 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.435 0.636 . . . . 0.0 109.636 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.85 96.28 5.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.046 -177.472 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 88' ' ' GLU . . . 60.63 48.06 88.09 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.719 -178.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.405 ' HB2' ' O ' ' A' ' 87' ' ' GLY . 8.2 mm-40 74.71 7.88 4.35 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.543 0.737 . . . . 0.0 111.708 178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.515 ' HG2' HG11 ' A' ' 91' ' ' VAL . 9.8 tt0 -96.02 99.01 10.82 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 84' ' ' MET . 30.3 m -77.14 105.97 8.56 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.314 0.578 . . . . 0.0 110.402 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.526 HG21 ' HB2' ' A' ' 84' ' ' MET . 3.6 m -122.74 162.16 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.106 -175.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.635 ' O ' ' HB2' ' A' ' 118' ' ' HIS . 8.8 t70 -108.11 127.13 53.53 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.855 HG22 ' HE3' ' A' ' 84' ' ' MET . 23.1 m -132.74 154.11 39.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.921 0.391 . . . . 0.0 111.307 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 63.6 t -91.02 135.01 27.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.734 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.53 ' HA ' ' CD2' ' A' ' 115' ' ' LEU . 18.2 t70 -88.43 133.28 34.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.799 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -80.52 -2.84 47.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.247 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.91 141.59 5.57 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.0 -13.8 62.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.881 0.341 . . . . 0.0 111.078 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . 0.631 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.1 pt? -69.7 -32.94 71.81 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 171.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.55 -33.23 58.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.787 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.528 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -57.36 -55.22 37.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.275 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.07 99.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.805 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.52 ' CZ2' ' HB3' ' A' ' 61' ' ' ALA . 84.4 t90 -49.25 -47.68 46.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.725 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.533 HD11 ' HA ' ' A' ' 104' ' ' ILE . 3.3 tp -87.27 -22.51 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.122 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 64.5 m -66.44 -13.03 60.19 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.642 -0.661 . . . . 0.0 109.512 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -89.81 -49.93 6.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.602 173.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.494 ' HB3' HD11 ' A' ' 104' ' ' ILE . 78.1 t60 -76.18 -46.0 30.56 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.33 -36.78 71.69 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.72 -31.12 8.95 Favored Glycine 0 N--CA 1.454 -0.16 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.203 170.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.637 HG22 ' SG ' ' A' ' 112' ' ' CYS . 31.2 m -103.83 157.18 34.47 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.5 99.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.715 2.277 . . . . 0.0 112.265 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.637 ' SG ' HG22 ' A' ' 110' ' ' VAL . 57.2 m -134.56 -176.41 4.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.958 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.528 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 7.7 ptp180 -166.2 142.88 5.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.302 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.414 HG12 ' CG1' ' A' ' 29' ' ' VAL . 62.3 mt -79.44 123.03 35.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.53 ' CD2' ' HA ' ' A' ' 95' ' ' ASP . 43.3 mt -134.83 150.29 50.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.004 -173.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -117.2 139.64 50.53 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.916 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.537 ' HA ' HG12 ' A' ' 93' ' ' VAL . 33.1 t -66.0 142.08 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.421 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.635 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 0.2 OUTLIER -61.74 142.32 94.7 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.537 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.27 -19.02 65.33 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.717 2.278 . . . . 0.0 111.773 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.1 -10.56 54.95 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.985 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.432 ' HE2' ' HB3' ' A' ' 121' ' ' MET . 11.4 ptp -144.72 -44.24 0.24 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -176.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.48 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . 68.55 -64.45 0.31 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 172.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.511 ' HG2' ' HG3' ' A' ' 125' ' ' ARG . 35.5 tt0 -70.47 -76.24 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -168.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.461 ' O ' ' HB2' ' A' ' 125' ' ' ARG . 58.8 t 67.43 -77.33 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 122.758 0.423 . . . . 0.0 111.658 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.511 ' HG3' ' HG2' ' A' ' 123' ' ' GLU . 36.9 mtm180 81.96 131.89 0.05 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.26 1.024 . . . . 0.0 113.647 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.509 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 5.1 t90 -56.71 150.06 38.59 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.522 170.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.509 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 2.9 Cg_endo -44.14 120.29 2.44 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.106 2.537 . . . . 0.0 112.391 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 130' ' ' GLU . 14.6 m -99.91 51.02 0.91 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.73 -173.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.579 ' H ' HD22 ' A' ' 129' ' ' LEU . 1.9 pt? -65.39 -0.11 1.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.032 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.405 ' H ' ' C ' ' A' ' 128' ' ' SER . 41.7 tt0 . . . . . 0 C--N 1.312 -1.06 0 CA-C-O 118.334 -0.841 . . . . 0.0 109.141 175.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tmm? . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 m -129.11 122.59 30.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.863 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.7 m -89.01 -76.51 0.4 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 42.0 42.59 2.4 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -104.17 109.6 21.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.789 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.704 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 62.4 m-85 -91.54 142.5 27.58 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.476 -176.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.25 85.57 0.9 Allowed Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.893 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 3.3 Cg_exo -81.39 -59.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.726 2.284 . . . . 0.0 112.147 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.526 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 0.4 OUTLIER -99.71 138.7 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.582 -179.296 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.69 -56.41 20.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -170.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.85 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -77.81 -41.53 36.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.735 -176.429 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.838 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 78.1 m -52.37 -45.97 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.742 0.651 . . . . 0.0 111.898 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.518 ' HA2' HH12 ' A' ' 39' ' ' ARG . . . 108.5 -151.49 17.04 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.007 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.433 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -84.7 138.31 32.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.272 0.558 . . . . 0.0 111.525 -174.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.472 HG21 HD13 ' A' ' 52' ' ' LEU . 16.1 m -118.56 132.33 56.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.61 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -91.89 14.96 14.1 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -101.55 139.05 37.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.814 0.34 . . . . 0.0 110.375 179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 p -61.96 -36.3 81.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.65 -21.25 66.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.622 0.249 . . . . 0.0 111.632 -176.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.893 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -61.83 -27.28 68.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.649 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 -27.73 69.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.552 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.98 -13.83 26.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.375 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -113.57 6.66 17.11 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.747 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.586 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 16.1 pt20 -67.29 140.95 57.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 171.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -166.05 -179.29 5.09 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.905 -174.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 26' ' ' ARG . 48.0 mtt180 -77.92 77.92 4.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.5 0.667 . . . . 0.0 110.715 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.439 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -102.03 162.53 12.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.992 177.557 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -179.49 178.52 0.67 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.271 0.558 . . . . 0.0 111.25 172.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.52 HG22 HG12 ' A' ' 114' ' ' ILE . 60.4 t -112.69 146.34 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.028 173.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.51 ' HB2' ' HE2' ' A' ' 84' ' ' MET . . . -126.9 147.03 50.09 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.283 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.511 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 5.7 p-10 -86.79 -179.58 6.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.045 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -46.03 -36.13 5.42 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.18 0.992 . . . . 0.0 113.367 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.426 ' H ' ' ND2' ' A' ' 31' ' ' ASN . . . -79.3 -0.32 31.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.93 45.53 63.11 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.535 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.461 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 25.1 tt0 -121.66 141.47 51.11 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.33 -177.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.709 ' CZ2' HG21 ' A' ' 124' ' ' VAL . 5.6 m95 -57.51 125.01 20.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.126 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.526 ' HG ' ' SG ' ' A' ' 42' ' ' CYS . 9.9 tp -113.49 132.18 55.77 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.558 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 22.4 p-10 -130.4 -177.04 4.16 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.518 HH12 ' HA2' ' A' ' 13' ' ' GLY . 10.0 mmm-85 -64.68 -15.14 60.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.575 -176.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.412 ' HB2' HD22 ' A' ' 38' ' ' ASN . 11.7 m-20 -93.33 -29.73 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.757 0.313 . . . . 0.0 110.884 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.558 ' HG ' ' OD1' ' A' ' 38' ' ' ASN . 86.8 mt -89.04 -42.71 11.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.643 ' SG ' HD23 ' A' ' 45' ' ' LEU . 24.2 p -123.85 91.53 49.54 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.609 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.4 -39.86 0.51 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.007 2.471 . . . . 0.0 113.776 -174.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.733 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 47.5 mtm-85 -67.12 -11.82 58.27 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.338 0.59 . . . . 0.0 111.745 -172.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.85 ' HB3' ' HB2' ' A' ' 11' ' ' GLU . 11.0 mp -68.59 -19.21 64.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.139 0.495 . . . . 0.0 110.402 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -67.8 -9.64 46.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.757 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.733 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 10.9 pt-20 -98.59 29.05 3.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.787 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.838 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 98.5 t -81.12 138.11 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.662 0.268 . . . . 0.0 110.556 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 t -92.24 134.54 34.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.494 HG21 ' HB3' ' A' ' 12' ' ' CYS . 4.2 t -120.25 128.17 75.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.938 0.399 . . . . 0.0 111.598 -172.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.478 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 9.4 tp10 -123.61 143.61 50.12 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.184 172.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.472 HD13 HG21 ' A' ' 15' ' ' THR . 6.9 mp -124.75 125.82 44.67 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.546 0.689 . . . . 0.0 110.963 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.565 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 19.7 tpp180 -109.29 154.45 22.46 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 66.1 mtt -62.03 89.59 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 110.41 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.57 -7.45 26.25 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.932 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.565 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 97.9 m-85 -138.01 137.75 38.19 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.414 0.607 . . . . 0.0 111.606 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.0 tp -102.17 107.83 19.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.138 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.478 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 43.0 t -101.67 102.58 13.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.022 0.439 . . . . 0.0 111.031 -173.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.64 147.71 25.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.27 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.551 ' HZ1' ' HB3' ' A' ' 60' ' ' LYS . 10.1 mtpm? -144.47 133.21 22.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.591 ' HB1' ' HB2' ' A' ' 64' ' ' MET . . . -112.35 147.73 37.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.133 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -65.43 93.33 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.273 1.982 . . . . 0.0 110.67 172.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.93 -24.48 10.1 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.44 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.591 ' HB2' ' HB1' ' A' ' 61' ' ' ALA . 13.0 mmt -120.07 157.36 29.11 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.07 -163.13 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.315 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -90.31 165.84 13.66 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.518 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.7 tp -143.51 93.68 2.51 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.967 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -88.01 114.15 24.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.526 0.679 . . . . 0.0 110.248 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.521 HD11 ' HG2' ' A' ' 96' ' ' GLU . 55.0 mt -111.65 118.9 46.05 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.396 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.72 127.91 28.13 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.252 1.968 . . . . 0.0 111.296 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.73 -27.55 69.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.98 0.419 . . . . 0.0 110.589 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -106.47 103.12 12.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.216 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 t -84.67 162.05 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.189 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.3 mt -60.98 152.42 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.01 0.433 . . . . 0.0 111.499 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -96.49 23.0 7.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.759 0.79 . . . . 0.0 110.854 -173.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.427 ' CG ' ' H ' ' A' ' 77' ' ' ASP . 33.3 t70 -125.47 -176.45 3.6 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.328 -178.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.427 ' H ' ' CG ' ' A' ' 76' ' ' ASP . 2.9 p30 -74.69 2.7 9.33 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.674 0.274 . . . . 0.0 111.387 -174.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -60.6 -40.86 93.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 168.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.2 t -81.06 82.54 6.98 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 171.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.457 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 48.5 t -60.21 130.6 24.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.484 -174.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . 0.698 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -97.17 97.59 9.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.797 0.808 . . . . 0.0 109.124 170.162 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -76.98 121.57 23.68 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.334 -174.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -68.91 105.24 2.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.251 0.548 . . . . 0.0 110.058 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.746 ' HE1' HG21 ' A' ' 93' ' ' VAL . 23.4 tpp -93.17 150.73 20.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.816 -175.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.45 ' N ' ' HG3' ' A' ' 84' ' ' MET . 42.3 tp -125.9 89.2 2.98 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.695 0.759 . . . . 0.0 109.241 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.758 HG22 ' HB ' ' A' ' 124' ' ' VAL . 2.1 t -80.94 87.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.099 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.31 -86.83 1.01 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.63 16.33 2.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.062 0.458 . . . . 0.0 110.763 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -102.15 119.27 38.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 110.538 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.1 m -92.98 109.5 20.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.078 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.535 HG21 HG11 ' A' ' 124' ' ' VAL . 3.9 m -142.58 139.44 28.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.605 -177.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.698 ' HB2' ' HB2' ' A' ' 81' ' ' ARG . 5.3 p-10 -83.3 141.73 31.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.163 0.506 . . . . 0.0 110.334 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.746 HG21 ' HE1' ' A' ' 84' ' ' MET . 18.6 m -128.94 152.71 37.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.571 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.0 t -81.4 123.62 38.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.949 0.404 . . . . 0.0 111.46 -174.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.622 ' HA ' HD21 ' A' ' 115' ' ' LEU . 59.3 t0 -87.07 129.26 34.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.79 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.521 ' HG2' HD11 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -75.73 -6.55 51.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.215 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.59 158.47 10.37 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.546 173.022 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.76 -11.14 60.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 0.0 110.373 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.3 mt -65.5 -41.59 93.04 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.97 -34.42 68.95 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.046 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.65 -50.22 74.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.514 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.497 ' HA ' ' HG ' ' A' ' 105' ' ' SER . . . -62.17 -44.65 96.14 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.99 0.424 . . . . 0.0 110.698 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 49.0 t90 -53.85 -44.51 70.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.39 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.541 HD11 ' HB3' ' A' ' 107' ' ' HIS . 2.1 tp -92.84 -21.01 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.987 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' SER . . . . . 0.497 ' HG ' ' HA ' ' A' ' 102' ' ' ALA . 40.5 p -68.3 -13.41 62.24 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.578 174.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -85.43 -45.62 11.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.362 170.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.541 ' HB3' HD11 ' A' ' 104' ' ' ILE . 84.4 t60 -79.68 -45.45 18.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.934 0.397 . . . . 0.0 111.692 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.87 43.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.87 -3.83 84.82 Favored Glycine 0 C--N 1.325 -0.049 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.841 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.552 HG22 ' SG ' ' A' ' 112' ' ' CYS . 13.7 m -120.47 159.61 47.31 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -67.88 87.57 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.772 2.315 . . . . 0.0 112.083 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.552 ' SG ' HG22 ' A' ' 110' ' ' VAL . 75.1 m -134.52 154.53 51.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.128 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -135.37 151.98 51.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.52 HG12 HG22 ' A' ' 29' ' ' VAL . 55.4 mt -83.11 119.79 33.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.03 0.443 . . . . 0.0 109.947 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.622 HD21 ' HA ' ' A' ' 95' ' ' ASP . 52.3 mt -122.1 133.97 54.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.74 -173.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HZ3' ' CB ' ' A' ' 116' ' ' LYS . 6.5 ttpm? -107.05 128.4 54.33 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.347 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.2 t -71.21 119.17 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.184 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.411 ' C ' ' H ' ' A' ' 120' ' ' ASP . 35.5 t-80 -61.97 124.96 84.03 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.195 177.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.76 35.52 0.22 Allowed 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.723 2.948 . . . . 0.0 114.143 -172.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 118' ' ' HIS . 35.0 t70 -118.76 -32.01 4.65 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 26.3 mmt -77.49 -57.97 3.53 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.476 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 68.21 -66.99 0.21 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.084 0.865 . . . . 0.0 112.417 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.44 113.5 22.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.681 0.753 . . . . 0.0 111.288 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.758 ' HB ' HG22 ' A' ' 86' ' ' VAL . 12.3 m -115.62 -22.48 4.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.807 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 60.94 66.05 0.94 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.487 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.502 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 46.6 t90 -47.71 138.97 9.12 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 170.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.502 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 9.0 Cg_endo -44.52 127.92 7.98 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.987 3.125 . . . . 0.0 113.769 -173.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.1 m -82.61 12.95 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.232 0.539 . . . . 0.0 110.592 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.3 mt 56.27 26.13 10.12 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.28 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.638 -179.171 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.792 0.329 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 t -93.42 88.22 5.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.022 0.439 . . . . 0.0 111.047 -175.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.7 p -147.55 0.77 0.69 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.937 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.412 HG21 ' O ' ' A' ' 4' ' ' THR . 12.0 m 64.44 15.86 9.83 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.522 1.153 . . . . 0.0 109.479 -169.401 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.703 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . . . -127.79 113.2 15.65 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.869 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -96.04 140.42 30.8 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.479 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -100.4 97.46 6.46 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.538 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.592 ' HA ' ' CB ' ' A' ' 24' ' ' GLN . 38.5 Cg_endo -70.18 -59.81 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.825 1.684 . . . . 0.0 110.103 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.676 HD12 HD22 ' A' ' 57' ' ' LEU . 18.4 mt -103.76 146.48 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.633 173.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.24 -55.05 15.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.744 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 1.4 mp0 -60.21 -42.58 95.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.689 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.817 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 52.7 m -60.84 -44.74 96.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.447 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.04 -134.25 11.78 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.003 174.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.703 ' HB1' ' HB2' ' A' ' 5' ' ' ALA . . . -84.81 121.68 28.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.586 0.708 . . . . 0.0 112.331 -170.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.465 HG22 HD13 ' A' ' 52' ' ' LEU . 8.6 m -123.02 119.13 29.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.764 173.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.473 ' HA ' ' HA ' ' A' ' 5' ' ' ALA . 9.8 t -85.85 -6.6 59.06 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.169 -170.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -60.74 122.38 14.63 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 t -61.45 -25.88 67.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.794 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -59.36 -30.52 68.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.835 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.41 -30.04 70.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.278 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 -17.03 64.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.936 0.398 . . . . 0.0 111.566 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.99 -22.1 15.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.233 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -105.54 -11.3 16.44 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.974 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.592 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 3.4 pt20 -64.16 155.8 30.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.137 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.429 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 51.1 mmtt -162.91 179.73 7.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.225 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.461 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.5 OUTLIER -71.13 76.21 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.166 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TRP . . . . . 0.548 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -95.06 147.75 23.08 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.359 -176.597 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.705 ' HA ' ' OE2' ' A' ' 11' ' ' GLU . 2.2 pp -176.83 166.58 2.54 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.395 0.616 . . . . 0.0 112.578 174.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.588 HG21 HG12 ' A' ' 104' ' ' ILE . 56.1 t -98.28 129.59 48.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.782 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.11 133.69 53.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.582 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . 0.442 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 12.0 t30 -77.59 154.45 32.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -47.18 -30.1 2.71 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.86 -23.4 60.78 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.054 0.454 . . . . 0.0 111.543 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 5.72 55.13 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -174.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.19 149.16 21.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 111.025 -174.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.518 ' CD1' HG11 ' A' ' 86' ' ' VAL . 12.0 m0 -70.79 122.27 19.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.945 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' A' ' 31' ' ' ASN . 4.4 tp -82.49 133.91 35.21 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.402 ' N ' HD13 ' A' ' 41' ' ' LEU . 1.8 t-20 -119.93 161.96 19.99 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.432 -170.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.494 ' HG3' ' HB1' ' A' ' 46' ' ' ALA . 24.7 ttm180 -65.55 -26.33 67.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.655 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -92.92 -11.33 33.67 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.492 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.402 HD13 ' N ' ' A' ' 38' ' ' ASN . 80.2 mt -82.64 -50.57 8.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.1 m -131.33 100.24 16.92 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.485 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -59.39 -36.39 94.12 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.987 2.458 . . . . 0.0 112.66 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -61.94 -21.63 64.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.057 0.456 . . . . 0.0 111.264 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.744 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 37.1 tp -68.54 -29.88 68.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.524 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.689 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -87.64 10.35 18.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.595 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -96.62 18.96 13.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.679 0.276 . . . . 0.0 111.299 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.817 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 56.8 t -75.84 127.46 37.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.83 0.348 . . . . 0.0 110.699 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.523 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 14.0 m -85.87 122.15 29.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.534 HG21 ' HB3' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -101.12 140.62 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.02 0.438 . . . . 0.0 111.263 -172.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -145.77 129.93 17.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.468 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.465 HD13 HG22 ' A' ' 15' ' ' THR . 10.9 mp -107.63 125.05 50.87 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.558 0.694 . . . . 0.0 110.677 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.473 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 36.3 ttm180 -105.29 150.85 24.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.0 ttt -65.35 97.2 0.27 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.695 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.8 33.45 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.95 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.473 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 78.5 m-85 -137.2 137.64 39.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 117.486 0.643 . . . . 0.0 111.571 -174.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.676 HD22 HD12 ' A' ' 9' ' ' ILE . 42.0 tp -100.65 108.38 20.24 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.072 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.01 111.35 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.154 0.502 . . . . 0.0 111.293 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.575 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.1 mp -98.06 140.16 32.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.101 176.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LYS . . . . . 0.523 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 39.5 mttm -129.6 133.56 47.23 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . 0.591 ' HB2' ' HB2' ' A' ' 64' ' ' MET . . . -122.04 148.76 52.44 Favored Pre-proline 0 C--N 1.326 -0.44 0 C-N-CA 118.897 -1.121 . . . . 0.0 113.254 -176.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . 0.434 ' HD2' ' CE1' ' A' ' 107' ' ' HIS . 23.1 Cg_exo -65.37 85.01 0.2 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.312 2.008 . . . . 0.0 110.648 168.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.38 -26.66 4.34 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.792 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.591 ' HB2' ' HB2' ' A' ' 61' ' ' ALA . 94.8 mmm -117.47 154.12 31.96 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.411 HD22 ' N ' ' A' ' 65' ' ' LEU . 3.3 mm? -77.12 -144.34 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.575 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 49.2 ptt85 -83.55 149.68 26.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.272 0.558 . . . . 0.0 111.14 176.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.461 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 59.9 tp -121.95 102.79 8.39 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.637 170.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.488 ' OD1' ' HD2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -81.11 100.92 9.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.758 -179.123 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.499 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 64.2 mt -100.3 105.17 34.55 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.927 176.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . 0.559 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 15.7 Cg_exo -68.3 125.4 12.87 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.172 1.915 . . . . 0.0 110.881 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.7 mt -52.22 -48.09 65.32 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.513 0.508 . . . . 0.0 111.979 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -140.97 15.29 2.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.331 0.586 . . . . 0.0 110.682 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 70' ' ' PRO . 15.7 t -99.82 69.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.969 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 mt -107.4 155.02 8.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.094 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -85.97 13.22 7.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.789 0.804 . . . . 0.0 109.813 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -137.63 -167.76 2.19 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.984 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -107.34 152.76 23.72 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -82.02 13.0 3.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.24 0.543 . . . . 0.0 110.76 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 p -95.63 15.22 20.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.409 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.434 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 48.0 t -70.55 98.8 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -97.38 113.94 25.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.89 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -112.11 120.1 40.69 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.701 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -78.85 118.09 20.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.457 0.646 . . . . 0.0 110.541 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.834 ' HE2' HG22 ' A' ' 93' ' ' VAL . 53.7 ttm -98.1 159.89 14.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.313 -176.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LEU . . . . . 0.422 ' HG ' ' HA ' ' A' ' 88' ' ' GLU . 14.2 tp -135.7 87.11 2.29 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.153 0.501 . . . . 0.0 110.278 -175.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.55 HG12 ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -72.3 90.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.261 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.73 -75.18 1.27 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -170.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLU . . . . . 0.422 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 8.8 pt-20 -152.1 18.76 0.67 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.027 0.441 . . . . 0.0 110.242 171.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLN . . . . . 0.683 HE21 HG11 ' A' ' 124' ' ' VAL . 19.2 tt0 -92.03 107.25 19.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 m -80.36 108.61 14.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.099 -175.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.521 HG23 ' HB3' ' A' ' 84' ' ' MET . 5.8 m -123.94 151.65 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.507 -174.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -93.82 112.8 24.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.543 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.834 HG22 ' HE2' ' A' ' 84' ' ' MET . 14.6 m -131.26 154.22 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 0.0 110.527 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . 0.434 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 91.1 t -101.48 135.38 38.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.603 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.452 ' HA ' ' CD2' ' A' ' 115' ' ' LEU . 16.7 t70 -80.39 135.92 36.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -106.55 10.43 31.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.97 0.414 . . . . 0.0 111.703 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.81 136.74 4.21 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.401 -1.381 . . . . 0.0 114.294 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.85 -25.0 67.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.827 -0.687 . . . . 0.0 110.714 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.8 tp -62.31 -45.47 93.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.085 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . 0.496 ' HB1' HD11 ' A' ' 114' ' ' ILE . . . -69.33 -33.54 73.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.177 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ALA . . . . . 0.596 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -59.37 -57.96 10.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.164 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.01 -38.75 87.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.369 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' TRP . . . . . 0.458 ' CH2' ' HB3' ' A' ' 61' ' ' ALA . 62.7 t90 -57.28 -46.01 83.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.949 -178.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.588 HG12 HG21 ' A' ' 29' ' ' VAL . 2.8 tp -83.69 -25.81 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 73.3 m -59.93 -26.85 66.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.171 0.51 . . . . 0.0 109.713 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -88.99 -40.36 13.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.496 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.543 ' HB3' HD11 ' A' ' 104' ' ' ILE . 77.7 t60 -77.41 -53.16 7.99 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.162 -0.336 . . . . 0.0 111.789 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.404 ' N ' ' O ' ' A' ' 104' ' ' ILE . . . -62.55 -40.21 96.11 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.32 -16.61 34.99 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.421 170.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.67 HG22 ' SG ' ' A' ' 112' ' ' CYS . 16.6 m -121.67 160.87 44.66 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.512 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 18.0 Cg_endo -58.36 96.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.81 2.34 . . . . 0.0 112.168 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' CYS . . . . . 0.67 ' SG ' HG22 ' A' ' 110' ' ' VAL . 73.9 m -135.22 173.22 11.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.708 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.596 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 9.5 ptp85 -149.95 140.15 22.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.815 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.526 HG12 HG23 ' A' ' 29' ' ' VAL . 60.8 mt -75.79 120.95 26.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.495 HD11 ' HE3' ' A' ' 84' ' ' MET . 96.5 mt -124.81 151.26 45.42 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.442 0.639 . . . . 0.0 111.097 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -108.58 105.3 14.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.131 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . 0.502 ' HA ' HG12 ' A' ' 93' ' ' VAL . 86.3 t -64.01 118.43 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.392 0.615 . . . . 0.0 110.34 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' HIS . . . . . 0.684 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 7.4 t-160 -69.9 132.3 88.75 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.103 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PRO . . . . . 0.684 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 28.5 Cg_endo -62.5 15.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.748 0 C-N-CA 123.687 2.925 . . . . 0.0 114.259 -176.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.499 ' H ' ' C ' ' A' ' 118' ' ' HIS . 9.9 t70 -60.0 -60.77 3.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.271 0.558 . . . . 0.0 109.515 176.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' MET . . . . . 0.482 ' HG3' HG11 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -99.73 -30.4 12.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.313 173.004 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 69.28 -77.94 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.06 -72.17 0.11 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -170.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.683 HG11 HE21 ' A' ' 89' ' ' GLN . 58.3 t 70.99 -58.29 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.558 0.536 . . . . 0.0 111.924 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . 0.596 ' O ' ' HB2' ' A' ' 126' ' ' TRP . 66.8 ttt180 79.03 -89.35 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.999 1.319 . . . . 0.0 111.745 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' TRP . . . . . 0.605 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 9.5 t90 162.79 142.57 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -174.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 38.0 Cg_endo -59.04 118.4 5.29 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.513 2.809 . . . . 0.0 112.777 -177.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.1 m -102.74 46.38 0.92 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.486 0.66 . . . . 0.0 110.128 -175.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.659 HD21 ' H ' ' A' ' 129' ' ' LEU . 1.6 pt? -74.18 65.06 1.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.869 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 . . . . . 0 C--O 1.247 0.955 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.324 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.755 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -80.69 141.5 34.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.804 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -115.25 85.74 13.26 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.287 -0.165 . . . . 0.0 110.894 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 49.0 Cg_endo -74.45 -35.87 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.885 1.724 . . . . 0.0 111.082 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.772 HD11 HD11 ' A' ' 57' ' ' LEU . 2.4 mt -114.52 145.28 20.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.208 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.88 -70.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 111.941 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.835 ' HG2' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -56.73 -50.09 73.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.457 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.805 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 73.8 m -53.48 -45.57 69.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.303 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.71 -127.52 9.18 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.782 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.755 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -85.13 138.37 32.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.436 0.636 . . . . 0.0 112.506 -169.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.518 HG21 HD13 ' A' ' 52' ' ' LEU . 17.0 m -123.96 123.69 40.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.789 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.07 22.03 2.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.139 0.495 . . . . 0.0 111.495 -175.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -110.83 135.53 51.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.864 0.364 . . . . 0.0 110.15 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.8 t -70.29 -18.95 63.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.3 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.75 -26.86 68.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.618 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -71.23 -20.23 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.859 -176.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.68 -9.53 58.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.724 0.297 . . . . 0.0 111.455 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.2 -1.45 16.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.736 0.303 . . . . 0.0 111.627 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -129.66 12.02 5.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.671 0.272 . . . . 0.0 111.144 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.4 pt20 -68.57 153.67 43.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.133 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.429 ' HG3' ' H ' ' A' ' 26' ' ' ARG . 3.8 tppt? -165.26 179.79 6.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.429 ' H ' ' HG3' ' A' ' 25' ' ' LYS . 73.7 mtt85 -83.26 60.83 5.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.842 0.829 . . . . 0.0 109.291 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.62 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -78.01 147.67 34.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.143 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.617 ' HA ' ' OE2' ' A' ' 11' ' ' GLU . 2.0 pp -176.92 177.42 1.3 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.119 0.485 . . . . 0.0 111.882 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.835 HG23 ' HG2' ' A' ' 11' ' ' GLU . 88.3 t -107.42 146.75 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.43 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.451 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -128.26 145.15 51.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -96.53 168.84 10.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.774 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -46.49 -34.16 4.59 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.735 0.814 . . . . 0.0 113.078 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.84 -4.33 4.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 84' ' ' MET . . . 83.88 3.39 89.32 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.778 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -100.57 152.61 20.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.48 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.678 ' CH2' ' HB ' ' A' ' 124' ' ' VAL . 39.3 m0 -66.71 145.0 56.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 175.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.0 tp -106.61 143.4 34.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -134.41 165.69 24.57 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.006 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.499 ' CD ' ' H ' ' A' ' 39' ' ' ARG . 0.2 OUTLIER -69.03 -32.08 71.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.548 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -67.34 -25.02 65.79 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.93 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -91.19 -52.41 4.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.376 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.18 99.85 17.42 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.564 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.17 -16.92 45.17 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.325 2.683 . . . . 0.0 113.155 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -58.7 -32.42 69.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.213 0.53 . . . . 0.0 111.011 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 48' ' ' VAL . 7.0 mp -72.91 -19.86 61.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.849 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -68.21 -11.36 59.17 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.092 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -95.66 46.0 1.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.531 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.805 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 64.7 t -104.8 135.49 42.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.704 0.288 . . . . 0.0 110.667 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 m -94.74 117.54 30.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.628 HG22 ' HB3' ' A' ' 12' ' ' CYS . 11.2 t -99.2 137.45 26.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.063 -172.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -136.08 141.45 44.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.099 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 20' ' ' ALA . 6.9 mp -123.39 133.84 54.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.895 0.378 . . . . 0.0 110.414 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.428 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 2.6 mmp_? -121.95 169.38 10.87 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 87.5 mtp -67.5 84.15 0.17 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 110.709 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.76 -21.24 9.11 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.923 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -130.21 137.89 50.29 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.616 0.708 . . . . 0.0 112.212 -173.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.772 HD11 HD11 ' A' ' 9' ' ' ILE . 53.4 tp -96.52 107.09 19.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.808 174.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 68' ' ' ASP . 41.6 t -101.02 100.69 10.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.317 0.58 . . . . 0.0 111.055 -173.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.4 mp -86.34 146.05 26.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.37 177.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -137.58 132.61 33.36 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.701 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -115.01 142.24 28.17 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 119.273 -0.971 . . . . 0.0 112.167 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.98 81.23 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.233 1.955 . . . . 0.0 110.5 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.2 -31.83 2.74 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.701 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 13.8 mmt -114.79 153.41 30.42 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.434 HD22 ' H ' ' A' ' 65' ' ' LEU . 2.8 mm? -68.67 -158.64 0.02 OUTLIER 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.508 0.67 . . . . 0.0 111.714 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 13.2 ptm180 -89.4 151.2 22.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.925 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.422 HD21 ' HA ' ' A' ' 100' ' ' ALA . 60.7 tp -137.44 103.94 5.21 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.753 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 2.2 p-10 -99.21 112.75 24.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.649 0.738 . . . . 0.0 111.016 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 96' ' ' GLU . 34.2 mt -110.67 138.83 21.15 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.503 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.29 119.71 7.08 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 121.931 1.754 . . . . 0.0 111.446 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 57' ' ' LEU . 64.3 mt . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 121.206 0.527 . . . . 0.0 111.462 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 41.0 t . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 121.143 0.497 . . . . 0.0 111.392 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -85.39 105.08 15.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -95.39 132.53 40.33 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.827 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -80.19 102.68 9.57 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 2.7 tpt -102.93 159.29 15.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.213 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp -133.01 87.61 2.42 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.632 0.73 . . . . 0.0 109.727 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.601 HG12 ' HD3' ' A' ' 127' ' ' PRO . 5.0 t -83.63 93.55 3.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.388 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.37 -89.43 1.31 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.78 11.81 2.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.05 0.452 . . . . 0.0 110.214 171.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.454 ' HG2' HG13 ' A' ' 91' ' ' VAL . 17.2 tt0 -96.5 112.9 24.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.544 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.7 m -83.23 114.48 21.4 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.156 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.528 HG11 HG22 ' A' ' 124' ' ' VAL . 3.6 m -136.25 147.24 28.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.031 0.443 . . . . 0.0 111.973 -174.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.464 ' H ' ' HG3' ' A' ' 121' ' ' MET . 0.8 OUTLIER -80.07 117.09 20.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.252 177.588 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.521 HG21 HD13 ' A' ' 115' ' ' LEU . 36.0 m -120.23 148.85 23.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 93.5 t -94.94 129.85 44.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.35 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.529 ' OD1' ' HD3' ' A' ' 113' ' ' ARG . 33.3 t70 -82.6 132.33 35.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.303 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HB3' HD13 ' A' ' 69' ' ' ILE . 17.8 mm-40 -82.64 -6.49 59.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.713 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.11 157.01 11.93 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.225 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -53.68 -31.57 48.28 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 122.744 0.418 . . . . 0.0 111.345 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.788 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.4 pt? -62.18 -36.96 83.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.811 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.422 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -76.3 -35.18 58.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.056 0.455 . . . . 0.0 110.221 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -59.96 -57.23 13.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.67 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.71 -42.65 99.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.437 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -54.14 -47.53 71.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.055 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.598 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.1 tp -85.26 -23.91 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.198 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.3 m -64.96 -16.44 63.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.403 -0.81 . . . . 0.0 109.996 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -88.68 -51.09 5.86 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.2 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.598 ' HB3' HD12 ' A' ' 104' ' ' ILE . 57.5 t60 -72.71 -44.48 61.68 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -76.17 -36.64 58.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.24 -32.4 7.52 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.849 171.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.662 HG23 ' SG ' ' A' ' 112' ' ' CYS . 16.1 m -100.43 158.76 31.34 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 25.1 Cg_endo -62.64 90.88 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.649 2.232 . . . . 0.0 112.108 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.662 ' SG ' HG23 ' A' ' 110' ' ' VAL . 76.5 m -135.21 164.73 27.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.277 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 10.9 ptp180 -140.48 143.37 35.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.404 175.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.623 HG12 HG22 ' A' ' 29' ' ' VAL . 37.6 mt -73.27 131.92 34.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.521 HD13 HG21 ' A' ' 93' ' ' VAL . 71.7 mt -134.87 139.54 45.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.176 0.512 . . . . 0.0 110.55 -176.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -108.16 110.78 22.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.273 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 93' ' ' VAL . 58.5 t -63.26 132.94 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.602 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.439 ' CG ' ' HD2' ' A' ' 119' ' ' PRO . 0.5 OUTLIER -86.81 139.45 33.05 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.076 -177.384 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 118' ' ' HIS . 48.9 Cg_endo -68.36 -2.13 8.53 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.303 2.669 . . . . 0.0 114.531 -173.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -71.7 -51.61 22.08 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.21 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.464 ' HG3' ' H ' ' A' ' 92' ' ' ASP . 95.3 mmm -73.52 -44.81 56.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 170.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 67.42 -77.97 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.733 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.88 139.87 30.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.368 0.604 . . . . 0.0 111.544 -172.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.678 ' HB ' ' CH2' ' A' ' 36' ' ' TRP . 52.8 t -133.9 -30.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.902 175.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 78.13 -37.97 0.24 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.558 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 19.7 t90 77.73 138.35 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.601 ' HD3' HG12 ' A' ' 86' ' ' VAL . 21.0 Cg_endo . . . . . 0 C--N 1.351 0.699 0 C-N-CA 123.544 2.829 . . . . 0.0 113.422 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.326 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.51 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.6 m-85 -94.31 134.4 36.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.33 91.75 20.6 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 6.1 Cg_exo -82.11 -55.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.937 2.425 . . . . 0.0 113.413 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.723 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -114.88 132.24 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 123.741 0.651 . . . . 0.0 110.555 -174.446 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.63 -55.14 36.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -170.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.813 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -62.32 -49.22 76.46 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -171.48 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.723 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 9.9 p -74.0 -35.75 64.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.771 0.319 . . . . 0.0 110.693 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.05 -140.52 14.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.807 170.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.75 152.15 23.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.309 0.576 . . . . 0.0 111.64 -172.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.8 m -134.5 134.43 41.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.256 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 p -94.63 66.41 3.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.49 0.662 . . . . 0.0 110.94 176.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -133.58 128.39 35.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.066 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.7 m -56.87 -33.09 66.5 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.65 -16.18 56.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.501 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -65.61 -22.67 66.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.361 . . . . 0.0 111.378 -176.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.61 -25.63 67.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.472 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.91 0.26 48.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.425 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -129.51 20.97 5.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.707 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 5.3 pp0? -91.16 150.79 21.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.191 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -162.51 -179.58 7.04 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.639 ' NH1' ' HA ' ' A' ' 123' ' ' GLU . 50.5 mtt85 -82.82 65.38 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 165.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.569 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 2.0 t90 -88.7 144.98 25.91 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.919 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -177.78 -177.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.552 0.691 . . . . 0.0 112.317 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.592 HG22 HG12 ' A' ' 114' ' ' ILE . 17.6 t -106.04 142.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.009 175.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.72 155.25 39.58 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -99.8 160.44 14.3 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.779 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.545 ' HB2' ' HB2' ' A' ' 111' ' ' PRO . 14.2 t70 -45.7 -34.74 3.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.55 0.74 . . . . 0.0 112.81 -176.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.79 -7.17 3.26 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.59 7.18 72.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.614 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -100.03 140.22 34.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.553 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -61.71 129.02 39.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.6 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.477 HD22 ' SG ' ' A' ' 112' ' ' CYS . 20.9 tp -90.27 144.86 25.45 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -137.13 167.44 21.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.24 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -67.7 -21.09 65.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.93 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -77.37 -26.37 51.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.77 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 37' ' ' LEU . 78.2 mt -90.72 -51.22 5.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.277 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' A' ' 37' ' ' LEU . 74.7 m -122.94 93.83 47.95 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.645 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.68 -30.27 91.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.004 2.469 . . . . 0.0 112.461 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 44' ' ' ARG . 47.7 mtm105 -69.19 -13.38 62.38 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.939 0.399 . . . . 0.0 111.156 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.813 ' HG ' ' HB2' ' A' ' 11' ' ' GLU . 32.5 tp -79.5 -18.86 51.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.57 -17.1 64.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.165 0.507 . . . . 0.0 109.944 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.695 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 57.5 mm-40 -82.95 58.8 4.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.418 177.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.0 t -129.39 139.22 52.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.7 m -105.49 142.28 35.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.67 0.272 . . . . 0.0 110.801 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 12' ' ' CYS . 1.5 t -96.73 143.35 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.867 -174.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 3.8 tp10 -146.56 137.33 24.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 167.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 mp -119.25 125.47 49.21 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.885 0.374 . . . . 0.0 110.279 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 56' ' ' TYR . 34.2 mmt180 -105.31 175.59 5.44 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.2 ttm -68.38 91.85 0.41 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.39 -0.28 65.73 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.136 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.465 ' C ' ' HG ' ' A' ' 71' ' ' LEU . 59.4 m-85 -136.21 148.36 48.06 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 117.59 0.695 . . . . 0.0 112.313 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.499 ' HB2' HD23 ' A' ' 71' ' ' LEU . 42.1 tp -109.32 118.51 36.87 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.128 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 66.8 t -109.05 111.05 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.228 0.537 . . . . 0.0 110.513 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 3.8 mp -97.07 137.19 36.52 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.947 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -129.3 130.39 46.09 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -122.27 134.03 24.64 Favored Pre-proline 0 C--O 1.215 -0.718 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.879 -173.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.695 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 82.5 Cg_exo -46.16 107.08 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.272 1.981 . . . . 0.0 111.178 166.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.17 -10.51 61.75 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.951 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.639 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 76.8 mmm -136.4 156.53 48.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.768 0.794 . . . . 0.0 111.53 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.521 HD22 ' H ' ' A' ' 65' ' ' LEU . 2.6 mm? -67.7 -165.87 0.05 Allowed 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.816 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 33.6 ptt85 -88.33 169.22 12.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.448 173.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.483 ' HG ' HG13 ' A' ' 69' ' ' ILE . 55.3 tp -147.48 111.33 5.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.761 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.22 99.82 12.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 110.587 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.483 HG13 ' HG ' ' A' ' 67' ' ' LEU . 70.0 mt -105.93 138.72 19.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.42 139.19 23.02 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.189 1.926 . . . . 0.0 112.509 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 57' ' ' LEU . 8.7 mt . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.573 0.702 . . . . 0.0 111.428 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.401 HH21 ' CG ' ' A' ' 92' ' ' ASP . 76.0 mtp180 -77.53 99.18 5.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.613 0.72 . . . . 0.0 109.783 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -86.13 126.66 34.38 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.589 -175.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -76.61 112.03 12.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.453 ' HE2' ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -98.94 145.84 26.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.8 -175.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.847 ' HG ' ' HA ' ' A' ' 88' ' ' GLU . 12.9 tp -126.35 79.07 1.82 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.498 0.666 . . . . 0.0 109.501 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.419 HG12 ' HD3' ' A' ' 127' ' ' PRO . 4.6 t -85.92 96.97 5.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.306 -174.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.69 31.95 70.64 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.847 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.9 OUTLIER 69.39 18.19 7.98 Favored 'General case' 0 N--CA 1.46 0.051 0 CA-C-N 114.504 -0.848 . . . . 0.0 111.296 -176.124 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -92.84 107.76 19.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.8 m -78.84 99.88 6.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.909 -172.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 m -132.32 142.57 42.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.713 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.401 ' CG ' HH21 ' A' ' 81' ' ' ARG . 7.1 p-10 -91.78 140.5 29.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.19 0.519 . . . . 0.0 110.721 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.9 m -131.15 153.72 39.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.691 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.2 t -88.87 132.84 32.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.894 0.378 . . . . 0.0 111.221 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.674 ' OD2' ' HD3' ' A' ' 113' ' ' ARG . 26.3 t0 -77.42 127.11 31.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.312 175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.474 ' CD ' ' HZ2' ' A' ' 116' ' ' LYS . 13.5 mm-40 -92.65 -3.15 55.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.315 -175.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.29 129.84 1.34 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.685 -1.245 . . . . 0.0 114.511 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.42 -36.29 71.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.29 0.567 . . . . 0.0 110.144 171.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.86 -35.7 81.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.436 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.496 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -65.54 -37.71 87.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.489 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.69 84.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.73 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.72 83.46 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.993 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.4 ' CZ3' HD13 ' A' ' 104' ' ' ILE . 73.8 t90 -51.48 -44.66 62.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.274 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.587 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.2 tp -86.94 -23.17 6.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.635 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 94.6 p -65.02 -17.99 64.92 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.357 -0.839 . . . . 0.0 109.301 175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HB3' ' SD ' ' A' ' 64' ' ' MET . 33.1 m-80 -81.97 -57.84 3.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.342 170.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.587 ' HB3' HD12 ' A' ' 104' ' ' ILE . 75.5 t60 -69.04 -45.5 70.27 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.12 -42.67 59.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.62 -30.68 8.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.586 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.666 HG23 ' SG ' ' A' ' 112' ' ' CYS . 16.5 m -99.78 163.45 18.41 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 17.8 Cg_endo -60.26 96.71 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.533 2.156 . . . . 0.0 112.155 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.666 ' SG ' HG23 ' A' ' 110' ' ' VAL . 72.1 m -134.05 158.15 44.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.721 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.674 ' HD3' ' OD2' ' A' ' 95' ' ' ASP . 48.9 ttm-85 -143.15 132.83 23.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.138 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.592 HG12 HG22 ' A' ' 29' ' ' VAL . 41.7 mt -80.06 120.91 32.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 95' ' ' ASP . 70.4 mt -131.51 155.96 46.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.747 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.474 ' HZ2' ' CD ' ' A' ' 96' ' ' GLU . 7.2 ttpm? -121.56 138.67 54.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.155 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.13 135.17 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.69 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -73.1 119.54 76.19 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.796 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.07 -24.68 20.44 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.627 2.885 . . . . 0.0 113.704 -173.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.97 -39.79 82.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 110.714 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -117.75 -175.47 2.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.12 -170.62 3.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.137 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.639 ' HA ' ' NH1' ' A' ' 26' ' ' ARG . 8.0 mm-40 65.79 -140.07 0.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.793 0.683 . . . . 0.0 111.142 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.1 t 65.67 100.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -167.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -108.28 27.25 9.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.532 -169.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.696 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 5.2 t90 72.58 151.5 0.14 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -174.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.696 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 10.6 Cg_endo . . . . . 0 C--N 1.352 0.722 0 C-N-CA 123.272 2.648 . . . . 0.0 114.135 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.834 0.349 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.704 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 55.5 m-85 -112.46 141.33 46.34 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.994 -177.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -99.68 97.25 5.49 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.012 0.195 . . . . 0.0 110.7 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.823 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 2.6 Cg_exo -77.07 -54.4 0.06 OUTLIER 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.874 2.383 . . . . 0.0 111.735 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.823 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 4.9 mm -107.22 150.88 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.462 -175.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.74 -54.73 8.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.017 -174.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 1.6 mp0 -56.59 -53.18 60.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.5 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.823 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 25.9 p -70.51 -47.27 61.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.95 -127.79 9.26 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.533 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -89.83 139.3 30.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.3 0.571 . . . . 0.0 112.207 -173.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.517 HG21 HD13 ' A' ' 52' ' ' LEU . 16.9 m -113.5 138.84 49.55 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.94 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -87.41 31.66 0.73 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -119.96 136.35 54.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.085 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.427 ' HA ' ' HE2' ' A' ' 6' ' ' TYR . 20.1 m -65.85 -28.76 69.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.791 0.329 . . . . 0.0 111.618 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -65.32 -23.6 67.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.498 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.823 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -58.47 -30.98 67.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.566 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.11 -24.8 67.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.69 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.19 -14.71 28.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.589 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -112.77 -0.94 14.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.695 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.637 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 3.7 pp0? -67.58 150.8 48.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.568 0.223 . . . . 0.0 110.562 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 24' ' ' GLN . 38.5 mmtm -165.54 -178.7 5.04 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.175 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -81.82 79.13 8.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.896 0.855 . . . . 0.0 109.482 170.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -100.63 147.14 26.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.907 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 pp -173.99 178.88 2.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.63 0.729 . . . . 0.0 112.246 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.862 HG22 HD13 ' A' ' 114' ' ' ILE . 60.3 t -111.5 136.42 47.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.488 175.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.732 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -124.85 144.94 50.04 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -77.6 142.75 38.76 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.755 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -48.02 -25.64 1.48 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.442 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . . . -57.24 -18.38 15.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.651 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.432 ' HA2' ' CE ' ' A' ' 84' ' ' MET . . . 103.61 18.67 13.69 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -176.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -112.87 127.45 56.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.938 -173.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -56.64 123.64 15.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.432 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.649 HD23 HD22 ' A' ' 45' ' ' LEU . 10.5 tp -82.47 154.31 25.18 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -140.88 164.3 30.61 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.498 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -69.06 -24.57 64.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 110.074 176.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.8 -27.66 61.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.879 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.2 mt -87.79 -51.47 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.611 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.6 m -130.25 95.68 26.96 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.64 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.58 -28.87 69.99 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.771 2.314 . . . . 0.0 112.139 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -67.76 -14.11 62.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.233 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.649 HD22 HD23 ' A' ' 37' ' ' LEU . 33.0 tp -74.47 -23.12 58.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.746 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.2 -13.35 61.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.232 0.539 . . . . 0.0 110.384 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -92.68 54.62 2.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.69 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 12' ' ' CYS . 92.0 t -110.88 134.26 53.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.038 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.8 m -100.56 148.77 24.44 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.12 148.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.177 0.513 . . . . 0.0 111.722 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 28.8 tt0 -152.05 139.75 19.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.517 HD13 HG21 ' A' ' 15' ' ' THR . 9.2 mp -106.93 125.39 50.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.682 0.753 . . . . 0.0 111.443 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -112.42 154.4 25.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.38 -1.282 . . . . 0.0 107.671 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' MET . . . . . 0.433 ' O ' ' HG3' ' A' ' 54' ' ' MET . 23.6 ptt? -60.66 100.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.939 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.59 0.07 64.95 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.117 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -143.14 137.62 29.21 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 117.403 0.601 . . . . 0.0 111.536 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.526 ' HB2' HD21 ' A' ' 71' ' ' LEU . 28.1 tp -100.21 114.39 27.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.176 175.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 70.8 t -96.4 96.45 5.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.892 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 8.1 mp -87.53 143.44 27.21 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -140.28 130.95 25.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -115.67 144.96 33.54 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.453 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.95 98.03 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.061 1.841 . . . . 0.0 110.487 170.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.09 -32.2 6.08 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.302 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.639 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 13.1 mmt -116.04 154.64 29.53 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.437 0.637 . . . . 0.0 110.218 -177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.812 ' H ' HD12 ' A' ' 65' ' ' LEU . 2.5 mp -69.71 -154.38 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.755 -171.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 12.4 ptm180 -94.33 145.14 24.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.652 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 53.4 tp -121.67 114.61 21.38 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.234 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.99 102.22 14.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.716 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 70.1 mt -97.8 116.47 65.73 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.739 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.62 119.5 6.62 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.321 2.014 . . . . 0.0 112.168 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 57' ' ' LEU . 96.1 mt . . . . . 0 C--N 1.324 -0.51 0 CA-C-O 121.182 0.515 . . . . 0.0 110.028 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.447 -0.609 0 CA-C-O 121.135 0.493 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.585 ' HG2' HG22 ' A' ' 94' ' ' VAL . 74.1 mtp180 -86.5 112.98 22.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.89 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.526 ' HE2' ' HB2' ' A' ' 95' ' ' ASP . 98.0 m-85 -101.13 133.15 46.11 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.388 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -80.06 98.77 7.38 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -90.17 153.46 20.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.283 -171.536 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.27 86.41 2.45 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.75 0.786 . . . . 0.0 109.449 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.571 HG12 ' HD3' ' A' ' 127' ' ' PRO . 4.0 t -76.57 84.6 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.497 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.73 -78.34 1.67 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -175.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.81 16.08 1.77 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.018 0.437 . . . . 0.0 110.441 174.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.427 ' HG2' HG13 ' A' ' 91' ' ' VAL . 58.4 tt0 -111.26 108.93 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 110.725 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 84' ' ' MET . 7.5 m -80.29 113.97 18.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.494 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.55 HG12 ' HG2' ' A' ' 121' ' ' MET . 5.9 m -134.63 159.33 41.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.336 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.65 113.13 25.32 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 -174.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.48 HG23 HD22 ' A' ' 115' ' ' LEU . 34.9 m -120.03 136.96 55.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.97 177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 81' ' ' ARG . 6.4 t -99.25 129.96 48.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.063 -176.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.526 ' HB2' ' HE2' ' A' ' 82' ' ' TYR . 53.8 t0 -74.48 119.92 19.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.695 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -74.4 -7.83 54.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.982 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.76 146.31 4.45 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.111 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -62.2 -30.45 71.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.22 0.533 . . . . 0.0 110.217 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.7 tp -67.78 -33.94 75.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.913 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.533 ' HB1' HG13 ' A' ' 114' ' ' ILE . . . -71.41 -40.63 70.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.111 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.26 -41.81 94.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.528 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.5 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -62.76 -43.03 99.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.984 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.409 ' HH2' HG13 ' A' ' 48' ' ' VAL . 38.1 t90 -55.66 -39.43 70.9 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.654 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.579 HG22 ' HB2' ' A' ' 112' ' ' CYS . 9.8 mm -89.41 -26.12 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 80.1 p -65.41 -14.96 62.06 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.466 -0.771 . . . . 0.0 109.356 172.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -90.23 -52.76 4.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.466 170.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.449 ' HB3' HD13 ' A' ' 104' ' ' ILE . 82.9 t60 -65.23 -40.69 94.4 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.43 -33.89 14.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.146 0.498 . . . . 0.0 110.142 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.44 -29.6 11.16 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.649 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.514 HG23 ' SG ' ' A' ' 112' ' ' CYS . 24.2 m -106.13 156.65 36.45 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.2 97.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.792 2.328 . . . . 0.0 112.622 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.579 ' HB2' HG22 ' A' ' 104' ' ' ILE . 58.1 m -129.03 147.65 50.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.9 176.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.468 ' HD3' ' CG ' ' A' ' 95' ' ' ASP . 41.6 ttm-85 -126.43 130.76 51.32 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.188 -171.752 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.862 HD13 HG22 ' A' ' 29' ' ' VAL . 25.6 mm -68.37 118.14 11.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 30' ' ' ALA . 18.4 mt -133.1 129.88 38.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.732 0.777 . . . . 0.0 111.896 -173.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB3' ' HZ3' ' A' ' 116' ' ' LYS . 7.9 ttpm? -103.68 120.51 41.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.322 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.3 t -62.75 132.0 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.694 0.283 . . . . 0.0 110.343 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -69.22 139.2 89.76 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -51.02 -15.84 2.19 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.55 2.833 . . . . 0.0 114.219 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -60.09 -34.36 73.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.142 0.496 . . . . 0.0 110.584 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.55 ' HG2' HG12 ' A' ' 91' ' ' VAL . 2.4 mpt? -112.29 124.56 52.73 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.248 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.53 36.46 4.37 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.335 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -140.37 -135.0 0.11 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.73 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 86' ' ' VAL . 4.3 t 67.34 94.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.387 0.613 . . . . 0.0 110.06 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 125' ' ' ARG . 11.5 ttp180 -99.15 20.07 14.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.586 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.572 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 6.3 t90 70.61 151.56 0.14 Allowed Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 5.7 Cg_exo . . . . . 0 C--N 1.359 1.1 0 C-N-CA 123.151 2.568 . . . . 0.0 112.486 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.405 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 120.864 0.364 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.683 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 24.6 m-85 -86.98 133.92 33.54 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 10.3 tt0 -105.66 94.23 8.41 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.888 0.375 . . . . 0.0 111.031 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.81 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 7.0 Cg_endo -87.11 -41.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.283 2.655 . . . . 0.0 112.317 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 3.6 mp -100.97 145.15 11.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.89 -73.03 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -172.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.639 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -58.93 -50.01 75.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.903 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 66.5 m -54.95 -47.33 74.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.965 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.8 -140.87 15.11 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.363 175.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 7' ' ' GLN . . . -94.67 151.91 18.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.459 0.647 . . . . 0.0 112.212 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.499 HG21 HD13 ' A' ' 52' ' ' LEU . 15.2 m -125.42 139.3 53.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.005 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -86.78 23.33 1.73 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.445 ' HG3' HG22 ' A' ' 15' ' ' THR . 9.3 mt-30 -114.83 145.63 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.672 0.272 . . . . 0.0 110.31 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 t -61.97 -35.15 77.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.292 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.506 ' CD ' ' H ' ' A' ' 19' ' ' GLU . 2.1 mp0 -52.76 -34.13 51.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.465 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.81 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -61.5 -27.6 68.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.459 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.55 -2.76 18.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.801 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.43 18.8 4.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.97 14.9 3.07 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.337 0.589 . . . . 0.0 110.44 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -64.12 143.56 57.78 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.095 177.574 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 24' ' ' GLN . 68.5 mmtt -161.88 166.9 25.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -172.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.472 ' CB ' ' HB ' ' A' ' 117' ' ' VAL . 4.8 mpt_? -86.64 82.53 7.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.233 0.54 . . . . 0.0 110.156 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.17 153.0 21.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.123 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.504 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -160.59 164.24 32.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.023 0.439 . . . . 0.0 110.512 -177.101 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.595 HG23 ' HG2' ' A' ' 11' ' ' GLU . 89.4 t -126.48 136.87 59.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.529 ' HB2' ' HE1' ' A' ' 84' ' ' MET . . . -111.97 133.63 54.03 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.602 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -79.48 179.52 7.41 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -46.07 -40.02 10.14 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.27 -5.72 43.75 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.85 11.64 84.37 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.761 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -85.2 144.16 28.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.594 -0.303 . . . . 0.0 110.753 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.654 ' CD1' HG22 ' A' ' 86' ' ' VAL . 2.2 m0 -53.54 122.4 9.69 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 124.14 0.9 . . . . 0.0 111.67 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 tp -104.91 130.97 52.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -122.74 170.19 10.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.083 0.468 . . . . 0.0 111.79 -173.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -71.52 -19.44 62.18 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -70.65 -26.25 63.38 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.5 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.9 mt -94.74 -47.45 6.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.458 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.0 m -124.95 98.53 36.25 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.911 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.15 -31.02 75.45 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.891 2.394 . . . . 0.0 111.677 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -60.52 -30.06 69.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.968 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.639 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 63.2 tp -72.84 -28.09 62.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.261 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -71.39 -12.97 61.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.175 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -85.69 38.97 0.77 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.743 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.903 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 78.4 t -92.77 130.84 41.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.553 0.216 . . . . 0.0 110.473 173.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.675 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . 18.1 m -86.89 117.09 25.39 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.622 HG22 ' HB3' ' A' ' 12' ' ' CYS . 1.4 t -99.0 144.56 11.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.384 -172.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 78.9 tt0 -148.86 144.02 26.64 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 15' ' ' THR . 8.2 mp -123.74 129.75 51.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.015 0.435 . . . . 0.0 109.914 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.416 ' NE ' ' HA ' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -118.83 156.98 28.48 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.81 98.13 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.149 0.5 . . . . 0.0 110.998 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.25 -12.09 44.06 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.391 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -138.65 137.88 37.29 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 117.839 0.82 . . . . 0.0 112.145 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.8 tp -95.87 110.31 22.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 59.7 t -96.48 95.67 4.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.925 -173.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 7.6 mp -88.25 152.01 22.26 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.675 ' HG3' ' HB2' ' A' ' 49' ' ' SER . 11.1 ptpp? -159.89 143.17 14.05 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 172.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.595 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -132.25 147.37 65.45 Favored Pre-proline 0 C--O 1.218 -0.557 0 C-N-CA 118.665 -1.214 . . . . 0.0 113.413 -173.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.71 102.74 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.875 1.717 . . . . 0.0 110.45 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.78 -6.9 33.32 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.278 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.595 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 83.7 mmm -140.61 151.96 45.07 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.336 0.588 . . . . 0.0 110.879 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.405 ' HB3' ' H ' ' A' ' 66' ' ' ARG . 3.6 mm? -69.99 -159.1 0.03 OUTLIER 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.294 0.569 . . . . 0.0 111.18 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 45.4 mtp180 -80.36 149.38 30.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.597 174.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 68.6 tp -121.83 107.99 12.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 171.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -91.66 106.91 18.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.063 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 62.1 mt -115.66 116.65 40.89 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.441 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.45 131.74 48.03 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.636 2.224 . . . . 0.0 111.925 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 111.055 -178.389 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 57.7 t . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.905 0.383 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 81' ' ' ARG . 28.3 mtp180 -88.08 110.97 21.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.266 0.555 . . . . 0.0 109.849 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -101.28 132.35 46.85 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.239 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -78.47 104.7 9.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.246 0.546 . . . . 0.0 110.241 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.529 ' HE1' ' HB2' ' A' ' 30' ' ' ALA . 8.7 tpt -86.18 146.38 26.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.803 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp -125.57 92.24 3.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.854 0.835 . . . . 0.0 110.408 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.654 HG22 ' CD1' ' A' ' 36' ' ' TRP . 3.7 t -79.29 83.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.638 176.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.93 -74.89 1.14 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.19 4.95 1.86 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.265 0.555 . . . . 0.0 109.7 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -91.51 110.04 21.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.14 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 m -84.48 114.83 22.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.123 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.518 HG23 ' HB3' ' A' ' 84' ' ' MET . 2.2 m -134.84 144.54 34.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.921 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.69 119.89 23.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.435 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 117' ' ' VAL . 27.7 m -122.39 153.79 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.747 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.6 t -96.55 128.01 48.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.0 110.66 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.561 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 56.9 t0 -71.78 129.0 37.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.265 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -82.52 -20.05 37.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.863 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.21 156.45 9.68 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.856 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 101' ' ' ALA . 41.6 mt-10 -78.64 -5.82 54.0 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.763 -0.257 . . . . 0.0 111.5 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.724 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.8 pt? -68.38 -38.93 81.84 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 172.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.25 -36.47 63.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.75 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB2' ' HG3' ' A' ' 113' ' ' ARG . . . -59.27 -52.51 65.36 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.31 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.451 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -63.0 -40.03 96.54 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.346 0.593 . . . . 0.0 111.08 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -57.35 -35.71 70.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.538 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.532 HD12 ' HB3' ' A' ' 107' ' ' HIS . 2.3 tp -95.41 -22.65 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.862 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.451 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 86.2 p -66.86 -20.27 65.89 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.251 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -87.9 -46.2 9.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.332 173.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.532 ' HB3' HD12 ' A' ' 104' ' ' ILE . 76.3 t60 -75.17 -48.43 23.67 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.04 -38.15 57.51 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.51 -23.49 35.61 Favored Glycine 0 C--N 1.329 0.161 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.325 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.444 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 27.7 m -103.52 159.32 29.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 O-C-N 122.824 -0.221 . . . . 0.0 110.659 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 37.2 Cg_endo -66.48 90.53 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.466 2.111 . . . . 0.0 111.829 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.448 ' SG ' HG23 ' A' ' 104' ' ' ILE . 2.2 p -134.76 157.18 47.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.969 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.532 ' HG3' ' HB2' ' A' ' 101' ' ' ALA . 21.9 ttm180 -132.55 137.48 47.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.331 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.526 HG13 HG22 ' A' ' 29' ' ' VAL . 2.0 mp -77.16 128.92 37.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.45 ' CD2' ' HA ' ' A' ' 95' ' ' ASP . 80.0 mt -131.8 142.82 49.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.227 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -107.34 120.68 42.82 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 93' ' ' VAL . 60.2 t -65.58 116.34 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.071 0.463 . . . . 0.0 110.051 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.551 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 2.2 t-80 -77.2 133.56 68.37 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 10.8 Cg_endo -57.58 -5.36 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.492 2.794 . . . . 0.0 114.472 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -54.71 -44.47 73.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.458 0.647 . . . . 0.0 109.353 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.1 mmt -93.59 -56.76 2.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.617 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 60.26 -173.38 0.12 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.867 0.729 . . . . 0.0 110.493 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.411 ' CD ' ' H ' ' A' ' 124' ' ' VAL . 1.8 tm-20 57.65 -141.64 0.75 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.61 ' CG1' HG21 ' A' ' 86' ' ' VAL . 48.4 t 71.3 113.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.511 0.672 . . . . 0.0 111.783 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -124.48 150.08 46.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.021 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.485 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 6.7 t90 -45.12 142.17 2.97 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.093 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.589 ' HD3' HG12 ' A' ' 86' ' ' VAL . 3.2 Cg_endo . . . . . 0 C--N 1.355 0.89 0 C-N-CA 123.643 2.895 . . . . 0.0 112.824 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.578 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.626 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 9.6 m-85 -97.76 141.15 31.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.449 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 75.6 mt-30 -105.23 95.93 10.48 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.45 0.167 . . . . 0.0 111.262 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.626 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 11.0 Cg_exo -72.41 -62.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.161 2.574 . . . . 0.0 112.619 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.855 HD11 HD21 ' A' ' 57' ' ' LEU . 8.0 mt -113.81 159.79 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.658 0.599 . . . . 0.0 110.912 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.415 ' H ' HG22 ' A' ' 9' ' ' ILE . . . -71.17 -56.73 5.47 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -66.08 -45.02 82.72 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -171.964 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.803 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 4.7 p -68.48 -42.21 79.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.755 0.312 . . . . 0.0 111.011 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.74 -127.74 9.34 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.362 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.578 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -96.82 145.1 26.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.377 0.608 . . . . 0.0 111.794 -173.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.6 m -137.38 127.79 26.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.691 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.6 m -86.68 83.5 7.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.397 0.618 . . . . 0.0 110.732 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.416 ' HG2' ' H ' ' A' ' 19' ' ' GLU . 9.1 tt0 -147.39 126.63 13.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.059 176.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.8 p -55.76 -28.2 54.78 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -174.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' A' ' 17' ' ' GLN . 0.9 OUTLIER -76.89 -22.37 53.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.717 0.294 . . . . 0.0 111.267 -176.954 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.534 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -65.42 -28.25 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.346 . . . . 0.0 111.556 -176.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . . . -61.67 -22.03 64.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.113 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.92 -23.64 17.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -109.71 4.42 21.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.484 -172.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 5.0 pp0? -78.19 141.62 38.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 64.4 mttm -163.86 -169.75 1.97 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -78.74 72.68 5.27 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.697 0.76 . . . . 0.0 110.372 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.701 ' HB3' HG23 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -101.42 145.15 29.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.418 178.44 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -176.19 179.2 1.29 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.348 0.594 . . . . 0.0 112.265 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 114' ' ' ILE . 16.8 t -110.84 148.07 14.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.199 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.525 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -134.22 156.55 48.18 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -112.46 173.15 6.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.272 0.558 . . . . 0.0 112.143 -171.268 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 111' ' ' PRO . 9.9 p-10 -46.24 -33.62 3.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.264 -1.335 . . . . 0.0 113.669 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.64 2.03 7.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -173.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 84' ' ' MET . . . 80.58 8.68 87.28 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -106.71 152.16 24.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.114 -0.543 . . . . 0.0 110.022 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -64.3 146.72 53.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.293 173.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.446 HD22 ' SG ' ' A' ' 112' ' ' CYS . 20.3 tp -98.65 166.26 11.41 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.406 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . 17.2 t-20 -147.95 158.18 43.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -173.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 43' ' ' PRO . 54.5 mtm180 -73.25 -14.95 61.42 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.97 -18.89 35.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.189 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.406 ' HG ' ' HB3' ' A' ' 38' ' ' ASN . 91.3 mt -92.7 -51.82 4.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.2 m -114.78 94.27 36.84 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.996 173.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 51.7 Cg_exo -54.83 -44.53 48.78 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.723 2.949 . . . . 0.0 113.608 -171.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -77.52 8.38 4.38 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 108' ' ' ALA . 2.4 mp -76.16 -21.65 56.31 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.2 -22.62 61.3 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.983 170.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 52.5 mt-10 -86.06 63.16 7.87 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.225 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 12' ' ' CYS . 73.3 t -123.18 127.93 74.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.136 169.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 60' ' ' LYS . 5.8 t -91.24 140.19 30.03 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 2.7 t -121.39 128.29 75.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.0 111.821 -172.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.589 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 15.4 mt-10 -120.86 129.41 53.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.559 169.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' A' ' 20' ' ' ALA . 5.7 mp -110.57 133.58 53.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.52 0.676 . . . . 0.0 110.013 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.1 ttm105 -135.91 148.14 48.44 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 70.0 mtm -62.98 93.68 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.433 0.635 . . . . 0.0 110.741 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.37 -16.03 11.71 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.938 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -143.28 138.42 29.56 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 117.828 0.814 . . . . 0.0 111.776 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.855 HD21 HD11 ' A' ' 9' ' ' ILE . 39.0 tp -113.1 112.46 23.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.702 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 51' ' ' GLU . 61.0 t -100.68 110.6 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.055 0.455 . . . . 0.0 111.251 -173.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 mp -98.67 132.5 44.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.996 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 66' ' ' ARG . 44.3 mtmt -129.52 136.81 50.31 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -116.45 142.28 29.25 Favored Pre-proline 0 C--O 1.222 -0.372 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.449 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 26.8 Cg_exo -62.89 94.74 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.93 1.753 . . . . 0.0 110.225 168.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.29 -28.33 6.33 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.042 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.604 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 16.7 mmt -122.4 152.65 40.0 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.34 -166.89 0.02 OUTLIER 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.856 0.836 . . . . 0.0 112.561 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.564 ' HB3' ' HG2' ' A' ' 60' ' ' LYS . 12.2 ptt180 -95.71 146.63 24.36 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.45 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 tp -124.54 115.36 20.73 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.793 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.76 109.75 21.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.619 0.723 . . . . 0.0 110.788 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.4 mt -104.73 113.81 64.55 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.361 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.47 123.04 12.7 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.258 1.972 . . . . 0.0 111.957 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 57' ' ' LEU . 95.9 mt . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.631 0.729 . . . . 0.0 109.12 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.636 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 45.1 t . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.539 ' HG2' ' HB2' ' A' ' 92' ' ' ASP . 52.7 ttp180 -88.8 90.68 8.51 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -93.11 130.0 38.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.895 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -79.07 114.91 18.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.843 0.354 . . . . 0.0 110.405 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 2.4 tpt -105.22 154.94 19.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.754 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.25 87.61 2.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.689 0.757 . . . . 0.0 109.559 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 t -81.46 92.88 2.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.736 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.27 -81.24 1.08 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.57 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -140.06 9.48 2.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.793 -0.203 . . . . 0.0 110.788 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -111.48 110.53 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.359 . . . . 0.0 110.506 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 m -84.29 109.61 17.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.224 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 m -131.85 149.21 32.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.806 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.539 ' HB2' ' HG2' ' A' ' 81' ' ' ARG . 7.1 p-10 -87.22 128.71 35.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.442 0.639 . . . . 0.0 111.06 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 115' ' ' LEU . 29.5 m -124.91 153.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.011 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 118' ' ' HIS . 98.8 t -96.33 137.3 24.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.636 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 32.0 t70 -86.8 123.79 32.34 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.448 ' HG3' ' HE1' ' A' ' 27' ' ' TRP . 16.3 mm-40 -83.38 5.73 22.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 -174.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.78 126.65 2.41 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.211 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -67.47 -19.54 65.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.037 0.446 . . . . 0.0 110.244 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.03 -33.47 74.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 173.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.11 79.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.875 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -57.94 -54.26 48.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.5 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.93 87.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -54.32 -46.49 72.86 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.966 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.564 HD12 ' HB3' ' A' ' 107' ' ' HIS . 1.5 tp -84.93 -21.54 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.692 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.4 m -67.12 -15.66 63.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.167 0.508 . . . . 0.0 109.699 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -90.39 -52.02 5.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.276 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.564 ' HB3' HD12 ' A' ' 104' ' ' ILE . 72.5 t60 -67.63 -46.66 71.84 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.02 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.459 ' HB2' HD11 ' A' ' 45' ' ' LEU . . . -82.29 -42.22 19.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.046 0.45 . . . . 0.0 109.807 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.06 -12.36 62.2 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.055 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.544 HG23 ' SG ' ' A' ' 112' ' ' CYS . 15.4 m -112.78 159.42 34.49 Favored Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 122.788 -0.242 . . . . 0.0 110.353 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.435 ' HB2' ' HB3' ' A' ' 32' ' ' ASP . 25.4 Cg_exo -63.18 93.11 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.831 2.354 . . . . 0.0 112.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.544 ' SG ' HG23 ' A' ' 110' ' ' VAL . 68.6 m -134.8 155.86 49.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.955 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 10.5 ptm180 -141.16 146.8 37.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.605 HG12 HG22 ' A' ' 29' ' ' VAL . 35.2 mt -85.15 122.78 38.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.107 -177.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 93' ' ' VAL . 35.8 mt -126.06 152.23 46.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.139 -171.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.612 ' HB3' ' HZ3' ' A' ' 116' ' ' LYS . 7.8 ttpm? -119.09 123.16 43.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.104 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.67 137.55 24.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.764 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.515 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -76.49 134.25 70.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.653 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' A' ' 118' ' ' HIS . 3.7 Cg_exo -74.53 -8.05 20.17 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.231 2.621 . . . . 0.0 113.242 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.79 -52.48 56.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.338 . . . . 0.0 111.077 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -91.98 -45.43 8.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.959 178.052 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.429 ' N ' ' SD ' ' A' ' 121' ' ' MET . . . 58.94 -174.36 0.09 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.078 0.551 . . . . 0.0 112.142 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 49.78 84.03 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 122.096 0.951 . . . . 0.0 112.992 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.7 t -132.19 131.8 60.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.891 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -131.3 133.22 45.15 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.883 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.508 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 8.3 t90 -45.28 140.74 3.78 Favored Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 124.196 0.935 . . . . 0.0 110.772 175.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.508 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 9.5 Cg_endo . . . . . 0 C--N 1.353 0.768 0 C-N-CA 123.607 2.871 . . . . 0.0 112.745 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.621 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 36.5 m-85 -103.25 140.37 37.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.25 95.76 14.06 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.947 0.404 . . . . 0.0 110.048 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.87 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 7.5 Cg_endo -90.06 -35.65 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.449 2.766 . . . . 0.0 113.395 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 2.4 mm -115.93 135.78 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 O-C-N 123.9 0.75 . . . . 0.0 110.231 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.451 ' O ' ' HD2' ' A' ' 39' ' ' ARG . . . -68.22 -56.23 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -70.86 -53.53 14.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.489 -178.109 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.835 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 39.7 m -56.48 -47.59 78.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.146 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.37 -130.39 10.16 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.115 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.73 150.46 21.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.321 0.581 . . . . 0.0 112.034 -172.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.46 HG22 ' H ' ' A' ' 17' ' ' GLN . 10.7 m -121.65 139.09 53.98 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.491 176.19 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m -90.44 8.47 33.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.36 0.6 . . . . 0.0 111.201 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.46 ' H ' HG22 ' A' ' 15' ' ' THR . 1.2 mp0 -95.63 142.19 28.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.779 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.8 m -67.68 -15.95 63.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.081 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HB3' ' HE2' ' A' ' 23' ' ' TYR . 7.2 mm-40 -64.3 -36.1 83.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.288 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.87 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -62.08 -25.01 67.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.768 -171.035 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.03 -23.93 67.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.03 0.443 . . . . 0.0 111.093 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.05 1.04 22.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.685 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.405 ' HE2' ' HB3' ' A' ' 19' ' ' GLU . 35.3 m-85 -126.44 12.4 7.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.723 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 14.0 pt20 -70.26 143.07 52.22 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HG3' ' C ' ' A' ' 24' ' ' GLN . 83.1 mttt -160.67 173.14 15.9 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -172.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -78.73 75.64 5.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.351 0.596 . . . . 0.0 109.742 173.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.44 ' HE1' ' HG3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -92.76 152.9 19.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.178 177.893 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 pp -175.58 177.39 1.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.468 0.651 . . . . 0.0 112.184 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 114' ' ' ILE . 64.6 t -122.0 138.16 53.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -122.81 141.63 51.64 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 122.174 -0.328 . . . . 0.0 110.16 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -88.51 172.78 9.08 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.117 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -47.79 -31.7 5.2 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.677 0.791 . . . . 0.0 112.631 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.93 -14.79 63.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.709 0.29 . . . . 0.0 111.736 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.53 5.85 68.81 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.559 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -94.06 144.97 25.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.562 -176.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.593 ' CH2' ' HB ' ' A' ' 124' ' ' VAL . 31.0 m0 -68.99 125.29 26.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.844 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.447 ' HG ' ' SG ' ' A' ' 42' ' ' CYS . 29.5 tp -96.24 131.67 42.49 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -119.76 157.97 27.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.871 0.367 . . . . 0.0 111.126 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 10' ' ' ALA . 11.4 ptm180 -64.64 -15.41 61.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.46 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.04 -37.66 61.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.487 0.66 . . . . 0.0 109.461 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.4 HD11 ' HZ2' ' A' ' 126' ' ' TRP . 68.3 mt -77.64 -50.4 12.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.885 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.447 ' SG ' ' HG ' ' A' ' 37' ' ' LEU . 13.1 p -116.7 92.98 39.62 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.371 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.58 -25.02 69.68 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.068 2.512 . . . . 0.0 113.214 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -71.36 -17.64 62.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 111.734 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.445 HD13 ' SG ' ' A' ' 42' ' ' CYS . 7.7 mp -72.46 -21.67 61.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.0 0.429 . . . . 0.0 110.599 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.81 -5.18 32.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.514 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 6.7 mm-40 -84.67 3.9 35.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.338 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.835 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 95.3 t -79.77 118.74 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.87 0.367 . . . . 0.0 110.969 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.9 p -87.18 119.12 27.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.687 ' HB ' ' HB3' ' A' ' 12' ' ' CYS . 12.0 p -117.71 128.26 74.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.315 -171.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 35.2 mm-40 -120.87 129.84 53.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.561 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 20' ' ' ALA . 10.1 mp -97.78 125.89 42.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.499 0.666 . . . . 0.0 110.66 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.529 HH21 HG21 ' A' ' 58' ' ' VAL . 28.0 ttm-85 -110.09 164.66 12.41 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.373 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.43 88.9 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.483 0.658 . . . . 0.0 110.257 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.39 -13.7 36.3 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.933 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.75 138.3 48.56 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.621 0.724 . . . . 0.0 112.345 -174.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.411 ' HB2' HD23 ' A' ' 71' ' ' LEU . 61.3 tp -100.59 107.87 19.65 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.695 173.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.529 HG21 HH21 ' A' ' 53' ' ' ARG . 46.2 t -99.56 102.78 13.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.928 0.394 . . . . 0.0 110.685 -175.617 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.671 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 5.8 mp -90.88 140.54 29.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.715 176.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.496 ' HE2' ' HG2' ' A' ' 51' ' ' GLU . 39.6 mtmt -136.44 130.1 32.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.759 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -114.74 153.09 46.88 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 119.211 -0.995 . . . . 0.0 112.829 -176.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.503 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 20.0 Cg_exo -67.14 98.25 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.236 1.957 . . . . 0.0 110.618 170.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.7 -18.31 32.2 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.267 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.759 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 14.3 mmt -121.73 144.84 48.56 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.2 mt -68.15 -149.93 0.01 OUTLIER 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.407 0.622 . . . . 0.0 111.971 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -69.77 170.25 11.36 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.745 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 60.2 tp -151.71 87.72 1.38 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.894 166.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -84.0 104.98 14.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.447 -175.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.0 mt -115.81 136.75 22.93 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.393 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.22 139.72 91.58 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 121.66 1.573 . . . . 0.0 110.613 171.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.411 HD23 ' HB2' ' A' ' 57' ' ' LEU . 69.2 mt . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -175.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 41.1 t . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 120.769 0.319 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.7 104.33 16.34 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.373 0.606 . . . . 0.0 111.139 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.515 ' O ' HG22 ' A' ' 93' ' ' VAL . 39.5 m-85 -94.95 116.4 28.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 173.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLN . . . . . 0.507 ' HG2' HG22 ' A' ' 90' ' ' THR . 31.6 tt0 -80.87 99.28 8.25 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.633 ' O ' ' HA ' ' A' ' 90' ' ' THR . 1.0 OUTLIER -86.96 159.31 19.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.881 -169.739 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.8 tp -117.99 87.36 2.7 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.885 0.85 . . . . 0.0 109.554 -173.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.495 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 2.8 t -78.99 86.84 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.874 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.85 -68.9 2.48 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.592 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -145.41 2.95 0.99 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.777 0.322 . . . . 0.0 110.367 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.462 ' HG2' HG13 ' A' ' 91' ' ' VAL . 20.3 tt0 -109.95 109.61 20.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.925 0.393 . . . . 0.0 111.025 -170.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -85.13 104.83 15.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.655 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.692 HG21 HG21 ' A' ' 124' ' ' VAL . 2.7 m -118.93 144.99 25.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.062 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.09 112.68 16.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.034 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.592 HG21 HD13 ' A' ' 115' ' ' LEU . 16.8 m -120.07 152.47 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.48 176.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -103.22 135.37 41.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.767 0.317 . . . . 0.0 111.176 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.584 ' HA ' HD23 ' A' ' 115' ' ' LEU . 43.5 t0 -83.2 126.13 32.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.44 ' HG3' ' HE1' ' A' ' 27' ' ' TRP . 8.3 mm-40 -81.32 -5.91 58.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.495 -176.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.5 136.92 2.95 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.378 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.47 ' HG2' ' NH1' ' A' ' 113' ' ' ARG . 14.6 mt-10 -69.15 -23.13 63.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.826 0.346 . . . . 0.0 110.573 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -64.56 -30.91 71.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.082 0.467 . . . . 0.0 109.86 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.532 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -74.35 -37.95 63.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.9 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB2' ' HD3' ' A' ' 113' ' ' ARG . . . -59.51 -46.39 88.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.621 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.506 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -66.69 -36.5 82.66 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.351 0.596 . . . . 0.0 111.027 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.415 ' CZ2' ' HB2' ' A' ' 61' ' ' ALA . 76.1 t90 -57.45 -40.27 78.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.311 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.2 tp -93.23 -21.1 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.528 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 90.5 p -66.87 -19.87 65.82 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.488 -0.757 . . . . 0.0 109.237 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -83.65 -48.66 9.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.135 172.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.578 ' HB3' HD12 ' A' ' 104' ' ' ILE . 75.1 t60 -74.28 -51.98 13.66 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 45' ' ' LEU . . . -71.78 -41.39 68.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 109.739 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.13 -22.94 38.03 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.74 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.22 157.03 35.58 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 120.532 0.206 . . . . 0.0 110.671 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.17 92.89 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.464 2.11 . . . . 0.0 111.469 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.432 ' HB2' HG12 ' A' ' 29' ' ' VAL . 5.0 p -134.25 156.5 48.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.015 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.509 ' HD3' ' HB2' ' A' ' 101' ' ' ALA . 7.3 tpp180 -117.77 128.44 54.88 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.172 -175.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 29' ' ' VAL . 54.5 mt -79.1 118.33 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.592 HD13 HG21 ' A' ' 93' ' ' VAL . 23.2 mt -130.46 142.1 50.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.286 0.565 . . . . 0.0 112.061 -168.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.466 ' HB3' ' HZ3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -117.1 117.33 29.33 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.206 175.109 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.91 137.56 23.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.522 -174.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.99 125.69 79.22 Favored Pre-proline 0 C--O 1.234 0.243 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.5 -4.46 6.86 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.377 2.718 . . . . 0.0 114.881 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -51.03 -57.33 8.91 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.347 0.594 . . . . 0.0 110.785 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 18.6 ptp -107.17 -54.19 2.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.077 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 124' ' ' VAL . . . 54.7 -106.85 0.34 Allowed 'General case' 0 CA--C 1.531 0.23 0 O-C-N 123.489 0.493 . . . . 0.0 110.887 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 66.72 -59.13 0.37 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.816 0.846 . . . . 0.0 113.233 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.692 HG21 HG21 ' A' ' 91' ' ' VAL . 3.4 t -54.57 122.69 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 112.504 -168.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -112.41 36.45 3.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.092 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.669 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 11.7 t90 72.35 152.41 0.14 Allowed Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -169.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.669 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 41.8 Cg_exo . . . . . 0 C--N 1.365 1.399 0 C-N-CA 124.523 3.482 . . . . 0.0 114.438 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.688 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.443 -0.791 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.712 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 61.8 m-85 -87.45 117.66 26.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 13' ' ' GLY . 61.8 tt0 -96.39 98.85 4.61 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.266 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.758 ' HA ' ' CB ' ' A' ' 24' ' ' GLN . 21.4 Cg_exo -64.69 -60.59 0.13 Allowed 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 122.67 2.247 . . . . 0.0 110.9 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 27' ' ' TRP . 44.9 mt -114.54 136.01 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.951 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.02 -58.74 5.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.759 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 16.9 mm-40 -70.61 -22.43 62.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.794 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.859 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 73.6 m -73.6 -48.08 35.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.133 0.492 . . . . 0.0 110.087 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . 120.33 -153.72 16.63 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.231 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.688 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -113.33 142.73 45.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.106 0.479 . . . . 0.0 111.909 -172.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.3 m -118.87 137.57 53.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.699 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m -86.49 76.29 9.62 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.144 0.497 . . . . 0.0 110.126 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 19' ' ' GLU . 8.6 tt0 -160.19 120.7 2.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.858 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -68.49 -10.33 54.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.922 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.401 ' H ' ' HG2' ' A' ' 17' ' ' GLN . 22.2 tt0 -68.35 -28.54 67.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.287 0.565 . . . . 0.0 109.72 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -67.94 -24.22 65.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.624 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.84 -15.75 63.19 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.23 -3.84 50.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.631 0.253 . . . . 0.0 111.419 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.426 ' CD2' HD13 ' A' ' 71' ' ' LEU . 74.3 m-85 -130.56 -25.67 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.758 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -66.0 155.35 36.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.989 -177.744 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -172.65 -160.63 0.14 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.219 0.324 . . . . 0.0 110.169 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -74.95 69.06 1.86 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 122.122 0.963 . . . . 0.0 109.729 175.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.677 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 1.3 t90 -100.51 144.84 29.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.452 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -170.31 -173.79 1.55 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.575 0.625 . . . . 0.0 112.243 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.508 HG22 HG12 ' A' ' 114' ' ' ILE . 80.7 t -113.2 144.23 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.758 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.02 150.13 37.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 0.0 111.281 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.49 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 27.5 t30 -98.89 156.81 16.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.137 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -46.13 -37.11 6.53 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.758 0.823 . . . . 0.0 112.683 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.09 -6.97 37.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 111.401 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.63 4.53 63.77 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.582 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -98.44 160.35 14.34 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.443 ' HB2' ' HD1' ' A' ' 126' ' ' TRP . 28.2 m0 -68.07 134.79 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 172.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.627 HD22 ' SG ' ' A' ' 112' ' ' CYS . 28.4 tp -99.19 131.59 45.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.39 152.86 42.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.351 0.596 . . . . 0.0 112.597 -173.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.2 ttm105 -48.8 -32.11 8.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.736 164.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.77 -17.8 64.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.492 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 75.5 mt -105.6 -39.6 6.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.12 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 50.5 t -132.29 101.59 14.71 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.029 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.72 -29.45 59.85 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.653 2.236 . . . . 0.0 112.138 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -59.34 -30.74 68.59 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.398 0.618 . . . . 0.0 110.473 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.759 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 37.3 tp -66.79 -34.03 76.92 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.566 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -73.98 9.21 1.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -98.26 24.26 7.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.844 0.354 . . . . 0.0 111.203 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.859 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 55.4 t -84.79 113.79 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.714 0.292 . . . . 0.0 110.409 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.8 t -77.54 132.06 38.17 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.28 138.25 53.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.559 0.695 . . . . 0.0 112.074 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 35.3 tt0 -140.86 149.12 41.56 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.458 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 20' ' ' ALA . 5.5 mp -128.61 158.03 39.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.687 0.756 . . . . 0.0 112.238 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -158.45 149.06 20.24 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.501 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 tpt -49.26 98.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.516 0.51 . . . . 0.0 110.992 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.51 -31.19 6.07 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.486 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.88 137.76 52.44 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.092 0.946 . . . . 0.0 112.963 -172.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.488 ' HB2' ' CD2' ' A' ' 71' ' ' LEU . 37.9 tp -100.72 108.59 20.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.213 170.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 42.5 t -96.96 99.82 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.977 0.418 . . . . 0.0 110.95 -172.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 8.0 mp -91.86 141.74 28.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.048 175.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -137.44 130.27 30.24 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.637 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -126.0 151.67 71.88 Favored Pre-proline 0 C--O 1.221 -0.41 0 C-N-CA 118.68 -1.208 . . . . 0.0 113.247 -175.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -62.81 107.19 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.986 1.79 . . . . 0.0 110.228 168.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.23 -24.29 25.01 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.169 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.637 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 95.1 mmm -122.39 147.57 46.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 0.0 110.327 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.3 mt -68.34 -144.58 0.01 OUTLIER 'General case' 0 C--O 1.247 0.937 0 CA-C-O 121.548 0.69 . . . . 0.0 110.756 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 5.8 ptt180 -86.75 151.63 23.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.066 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 60.3 tp -124.32 93.53 3.94 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 168.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.59 97.95 10.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.891 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.447 HG13 ' HG ' ' A' ' 67' ' ' LEU . 65.9 mt -100.21 122.52 49.98 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.922 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.94 123.97 15.11 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.006 1.804 . . . . 0.0 110.77 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' CD2' ' HB2' ' A' ' 57' ' ' LEU . 64.7 mt . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.898 0.38 . . . . 0.0 110.707 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 61.2 t . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 120.607 0.241 . . . . 0.0 110.416 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -66.58 112.63 4.24 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.526 ' O ' HG22 ' A' ' 93' ' ' VAL . 3.1 t80 -105.15 107.97 19.24 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -80.11 113.82 18.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.636 ' HA ' ' CE ' ' A' ' 84' ' ' MET . 5.3 mmt -103.68 169.59 8.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.195 -175.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.2 tp -139.38 88.04 2.23 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 t -89.39 103.24 13.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.785 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.61 -77.76 1.4 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -146.27 4.19 0.92 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.51 0.195 . . . . 0.0 110.933 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.602 ' HG2' HG13 ' A' ' 91' ' ' VAL . 57.2 tt0 -105.26 120.48 41.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.849 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 84' ' ' MET . 0.2 OUTLIER -79.93 116.33 20.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.264 174.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.602 HG13 ' HG2' ' A' ' 89' ' ' GLN . 3.6 m -129.74 164.29 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.39 112.69 24.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.754 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 115' ' ' LEU . 7.1 m -125.81 152.13 32.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.7 t -106.21 142.17 19.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 122.237 -0.289 . . . . 0.0 110.743 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.649 ' OD1' ' HD3' ' A' ' 113' ' ' ARG . 26.4 t70 -92.94 125.86 37.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.56 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.98 -14.03 62.21 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.708 0.289 . . . . 0.0 111.652 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 137.46 149.21 5.53 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.999 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -64.68 -13.54 54.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.934 0.397 . . . . 0.0 111.001 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.4 tp -66.04 -43.55 87.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.49 -36.53 76.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.388 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.09 67.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.131 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.438 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -62.95 -39.35 94.37 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.247 0.546 . . . . 0.0 111.103 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.417 ' HH2' HG13 ' A' ' 48' ' ' VAL . 49.8 t90 -57.81 -44.33 86.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.019 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 104' ' ' ILE . 1.6 tp -87.12 -25.17 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.571 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.438 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 16.5 p -68.49 -15.85 63.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.533 -0.729 . . . . 0.0 109.959 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -88.99 -45.25 9.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.448 171.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -74.4 -49.51 22.29 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.64 -40.87 55.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.48 -38.22 3.38 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.614 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.512 HG23 ' SG ' ' A' ' 112' ' ' CYS . 18.7 m -87.64 157.85 51.88 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.84 88.63 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.761 2.307 . . . . 0.0 111.923 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.627 ' SG ' HD22 ' A' ' 37' ' ' LEU . 73.8 m -134.83 168.73 18.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.939 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.649 ' HD3' ' OD1' ' A' ' 95' ' ' ASP . 11.1 ptp180 -149.14 151.23 34.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.606 0.241 . . . . 0.0 110.634 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 29' ' ' VAL . 52.3 mt -82.85 131.88 32.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 95' ' ' ASP . 64.7 mt -138.23 133.34 33.07 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 120.926 0.393 . . . . 0.0 111.214 -174.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -99.89 120.47 39.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.785 173.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.1 t -64.16 133.85 29.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -55.99 126.65 67.08 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.88 -177.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -47.78 -32.49 17.09 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.679 2.919 . . . . 0.0 113.45 -175.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.21 -53.24 58.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.391 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 51.7 ttm -89.78 121.41 31.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.462 0.649 . . . . 0.0 110.636 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -115.4 -35.5 4.6 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.405 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -82.63 103.23 11.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.227 0.537 . . . . 0.0 111.364 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.556 HG13 HG11 ' A' ' 91' ' ' VAL . 51.4 t -130.47 -66.86 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.297 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 68.28 121.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.605 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.47 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 2.9 t90 -58.37 145.62 74.61 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.47 165.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 4.9 Cg_endo . . . . . 0 C--N 1.351 0.688 0 C-N-CA 123.732 2.955 . . . . 0.0 113.386 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.445 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 36.8 m-85 -89.98 138.17 31.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -114.54 93.24 31.71 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 120.735 0.302 . . . . 0.0 110.452 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.585 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 1.1 Cg_endo -84.8 -38.23 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.871 2.38 . . . . 0.0 112.213 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.635 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 0.7 OUTLIER -114.75 147.12 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.381 -176.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.13 -69.22 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.849 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -65.46 -39.9 92.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.283 -176.664 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.851 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 34.2 m -60.55 -47.92 84.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.846 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.55 -130.38 10.03 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.625 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -109.6 147.8 32.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.305 0.574 . . . . 0.0 112.112 -171.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.8 m -139.51 125.66 19.99 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.357 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -86.8 88.87 7.78 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.91 0.862 . . . . 0.0 110.639 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -148.19 135.97 20.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.194 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 p -56.46 -38.03 71.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -74.95 -23.35 58.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.417 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.585 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -62.13 -27.35 68.88 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.47 67.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.86 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.2 3.11 27.48 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -118.31 13.83 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.71 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.572 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -77.07 153.54 34.24 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.08 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -162.95 171.31 16.76 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.5 ' HD2' ' O ' ' A' ' 122' ' ' ALA . 58.6 mtt180 -76.81 76.84 3.42 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 122.145 0.974 . . . . 0.0 109.314 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -91.39 152.3 20.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.351 -1.749 . . . . 0.0 108.913 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 pp 179.49 -176.9 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.184 0.516 . . . . 0.0 111.097 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -118.87 140.73 41.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.573 178.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.31 140.05 50.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 10.1 p30 -95.88 -177.52 4.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.438 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -46.53 -41.44 14.24 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.81 0.694 . . . . 0.0 112.765 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.47 -8.13 48.73 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.09 8.78 87.33 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.704 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -88.63 142.76 27.42 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.461 ' HB2' ' HD1' ' A' ' 126' ' ' TRP . 29.8 m0 -62.36 128.31 35.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.824 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 29' ' ' VAL . 8.5 tp -87.42 131.45 34.31 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -120.64 162.8 19.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.47 -169.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -71.58 -21.55 61.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.258 0.551 . . . . 0.0 109.778 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.9 -27.16 61.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.825 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.9 mt -90.18 -45.39 9.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.525 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.699 ' SG ' ' HG ' ' A' ' 37' ' ' LEU . 1.7 p -130.44 96.83 23.22 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.105 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.27 -37.14 52.55 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.948 2.432 . . . . 0.0 112.859 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -73.24 -6.29 44.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.231 0.539 . . . . 0.0 111.003 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.849 ' HG ' ' HB2' ' A' ' 11' ' ' GLU . 33.8 tp -73.02 -24.23 60.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.919 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -72.19 -6.3 41.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.426 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.74 31.24 0.77 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.484 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.851 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 88.8 t -93.49 127.86 45.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.644 0.259 . . . . 0.0 110.418 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.2 t -86.47 137.54 32.46 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.585 HG22 ' HB3' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -119.41 144.7 27.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.182 0.515 . . . . 0.0 111.239 -173.751 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 35.0 tt0 -148.7 140.36 23.58 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -111.36 125.04 53.44 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.734 0.778 . . . . 0.0 110.578 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.608 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 2.4 tpm_? -105.1 154.89 19.56 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.09 -1.414 . . . . 0.0 107.487 176.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.1 ttt -64.0 89.18 0.05 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.917 0.389 . . . . 0.0 110.544 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.35 -9.44 33.14 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.521 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.608 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 87.5 m-85 -132.24 147.85 52.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.174 0.511 . . . . 0.0 111.235 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.599 ' HB3' HG13 ' A' ' 69' ' ' ILE . 45.8 tp -104.83 111.93 24.85 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 61.5 t -100.28 101.64 12.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.011 0.434 . . . . 0.0 110.778 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 11.1 mp -90.64 145.19 25.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.431 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -137.34 129.23 28.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.615 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -120.54 144.75 39.21 Favored Pre-proline 0 C--O 1.219 -0.514 0 C-N-CA 118.946 -1.102 . . . . 0.0 113.35 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -63.35 97.32 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.743 1.628 . . . . 0.0 109.758 166.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.94 -33.98 3.88 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.768 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.615 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 91.7 mmm -122.19 149.6 43.41 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.446 HD22 ' H ' ' A' ' 65' ' ' LEU . 2.6 mm? -70.91 -144.59 0.01 OUTLIER 'General case' 0 C--O 1.246 0.873 0 CA-C-O 120.895 0.379 . . . . 0.0 110.635 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 92.2 mtt180 -79.06 155.93 28.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.107 0.479 . . . . 0.0 110.563 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 59.9 tp -127.39 103.46 7.38 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -88.76 101.77 14.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.588 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.599 HG13 ' HB3' ' A' ' 57' ' ' LEU . 8.5 pt -124.43 119.25 26.14 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.444 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.15 144.64 89.8 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.354 2.036 . . . . 0.0 111.33 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -167.27 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 120.834 0.349 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -104.31 111.17 23.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.217 0.532 . . . . 0.0 110.306 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 93' ' ' VAL . 33.0 m-85 -102.89 135.06 45.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.379 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -88.32 128.1 35.49 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.286 0.565 . . . . 0.0 110.76 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.675 ' HE2' HD12 ' A' ' 115' ' ' LEU . 52.4 mtt -95.69 171.83 8.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.3 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.5 tp -139.96 87.26 2.15 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.435 0.636 . . . . 0.0 109.636 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.402 HG12 ' HD3' ' A' ' 127' ' ' PRO . 3.2 t -97.85 96.28 5.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.046 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 60.63 48.06 88.09 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.719 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 74.71 7.88 4.35 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.543 0.737 . . . . 0.0 111.708 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLN . . . . . 0.56 ' HG2' HG13 ' A' ' 91' ' ' VAL . 9.8 tt0 -96.02 99.01 10.82 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 84' ' ' MET . 30.3 m -77.14 105.97 8.56 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.314 0.578 . . . . 0.0 110.402 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.56 HG13 ' HG2' ' A' ' 89' ' ' GLN . 3.6 m -122.74 162.16 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.106 -175.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.633 ' O ' ' HB2' ' A' ' 118' ' ' HIS . 8.8 t70 -108.11 127.13 53.53 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 117' ' ' VAL . 23.1 m -132.74 154.11 39.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.921 0.391 . . . . 0.0 111.307 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 63.6 t -91.02 135.01 27.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.734 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.542 ' HA ' ' CD2' ' A' ' 115' ' ' LEU . 18.2 t70 -88.43 133.28 34.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.799 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -80.52 -2.84 47.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.247 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.91 141.59 5.57 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.0 -13.8 62.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.881 0.341 . . . . 0.0 111.078 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.1 pt? -69.7 -32.94 71.81 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 171.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.55 -33.23 58.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.787 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -57.36 -55.22 37.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.275 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.07 99.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.805 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' TRP . . . . . 0.429 ' CZ3' HD13 ' A' ' 104' ' ' ILE . 84.4 t90 -49.25 -47.68 46.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.725 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.542 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.3 tp -87.27 -22.51 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.122 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 64.5 m -66.44 -13.03 60.19 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.642 -0.661 . . . . 0.0 109.512 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -89.81 -49.93 6.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.602 173.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.542 ' HB3' HD12 ' A' ' 104' ' ' ILE . 78.1 t60 -76.18 -46.0 30.56 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.33 -36.78 71.69 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.72 -31.12 8.95 Favored Glycine 0 N--CA 1.454 -0.16 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.203 170.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.645 HG23 ' SG ' ' A' ' 112' ' ' CYS . 31.2 m -103.83 157.18 34.47 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.5 99.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.715 2.277 . . . . 0.0 112.265 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.645 ' SG ' HG23 ' A' ' 110' ' ' VAL . 57.2 m -134.56 -176.41 4.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.958 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 7.7 ptp180 -166.2 142.88 5.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.302 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.442 HG12 ' CG1' ' A' ' 29' ' ' VAL . 62.3 mt -79.44 123.03 35.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.675 HD12 ' HE2' ' A' ' 84' ' ' MET . 43.3 mt -134.83 150.29 50.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.004 -173.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -117.2 139.64 50.53 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.916 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.584 ' HA ' HG12 ' A' ' 93' ' ' VAL . 33.1 t -66.0 142.08 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.421 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.633 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 0.2 OUTLIER -61.74 142.32 94.7 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.537 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.27 -19.02 65.33 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.717 2.278 . . . . 0.0 111.773 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.1 -10.56 54.95 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.985 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.42 ' SD ' ' HB ' ' A' ' 91' ' ' VAL . 11.4 ptp -144.72 -44.24 0.24 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -176.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . 68.55 -64.45 0.31 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 172.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 125' ' ' ARG . 35.5 tt0 -70.47 -76.24 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -168.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.502 HG22 HG11 ' A' ' 91' ' ' VAL . 58.8 t 67.43 -77.33 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 122.758 0.423 . . . . 0.0 111.658 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.537 ' HG3' ' HG2' ' A' ' 123' ' ' GLU . 36.9 mtm180 81.96 131.89 0.05 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.26 1.024 . . . . 0.0 113.647 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.5 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 5.1 t90 -56.71 150.06 38.59 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.522 170.102 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.5 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 2.9 Cg_endo . . . . . 0 C--N 1.354 0.833 0 C-N-CA 123.106 2.537 . . . . 0.0 112.391 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.455 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.172 0.51 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.718 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 62.4 m-85 -91.54 142.5 27.58 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.476 -176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.25 85.57 0.9 Allowed Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.907 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 3.3 Cg_exo -81.39 -59.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.726 2.284 . . . . 0.0 112.147 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 0.4 OUTLIER -99.71 138.7 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.582 -179.296 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.69 -56.41 20.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -170.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.877 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -77.81 -41.53 36.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.735 -176.429 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.846 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 78.1 m -52.37 -45.97 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.742 0.651 . . . . 0.0 111.898 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.545 ' HA2' HH12 ' A' ' 39' ' ' ARG . . . 108.5 -151.49 17.04 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.007 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.455 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -84.7 138.31 32.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.272 0.558 . . . . 0.0 111.525 -174.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.49 HG21 HD13 ' A' ' 52' ' ' LEU . 16.1 m -118.56 132.33 56.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.61 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -91.89 14.96 14.1 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.427 ' H ' HG22 ' A' ' 15' ' ' THR . 0.9 OUTLIER -101.55 139.05 37.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.814 0.34 . . . . 0.0 110.375 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 p -61.96 -36.3 81.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.65 -21.25 66.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.622 0.249 . . . . 0.0 111.632 -176.046 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.907 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -61.83 -27.28 68.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.649 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 -27.73 69.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.552 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.98 -13.83 26.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.375 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -113.57 6.66 17.11 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.747 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.619 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 16.1 pt20 -67.29 140.95 57.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 171.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -166.05 -179.29 5.09 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.905 -174.624 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -77.92 77.92 4.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.5 0.667 . . . . 0.0 110.715 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.429 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -102.03 162.53 12.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.992 177.557 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -179.49 178.52 0.67 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.271 0.558 . . . . 0.0 111.25 172.125 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 114' ' ' ILE . 60.4 t -112.69 146.34 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.028 173.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.632 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -126.9 147.03 50.09 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.283 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.518 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 5.7 p-10 -86.79 -179.58 6.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.045 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -46.03 -36.13 5.42 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.18 0.992 . . . . 0.0 113.367 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.479 ' H ' ' ND2' ' A' ' 31' ' ' ASN . . . -79.3 -0.32 31.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.93 45.53 63.11 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.535 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.468 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 25.1 tt0 -121.66 141.47 51.11 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.33 -177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.727 ' CZ2' HG21 ' A' ' 124' ' ' VAL . 5.6 m95 -57.51 125.01 20.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.126 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.524 ' HG ' ' SG ' ' A' ' 42' ' ' CYS . 9.9 tp -113.49 132.18 55.77 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.57 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 22.4 p-10 -130.4 -177.04 4.16 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.965 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.545 HH12 ' HA2' ' A' ' 13' ' ' GLY . 10.0 mmm-85 -64.68 -15.14 60.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.575 -176.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.428 ' HB2' HD21 ' A' ' 38' ' ' ASN . 11.7 m-20 -93.33 -29.73 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.757 0.313 . . . . 0.0 110.884 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.57 ' HG ' ' OD1' ' A' ' 38' ' ' ASN . 86.8 mt -89.04 -42.71 11.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.672 ' HB2' HD13 ' A' ' 45' ' ' LEU . 24.2 p -123.85 91.53 49.54 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.609 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.4 -39.86 0.51 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.007 2.471 . . . . 0.0 113.776 -174.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.741 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 47.5 mtm-85 -67.12 -11.82 58.27 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.338 0.59 . . . . 0.0 111.745 -172.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.877 ' HB3' ' HB2' ' A' ' 11' ' ' GLU . 11.0 mp -68.59 -19.21 64.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.139 0.495 . . . . 0.0 110.402 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -67.8 -9.64 46.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.757 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.741 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 10.9 pt-20 -98.59 29.05 3.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.787 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.846 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 98.5 t -81.12 138.11 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.662 0.268 . . . . 0.0 110.556 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 t -92.24 134.54 34.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 12' ' ' CYS . 4.2 t -120.25 128.17 75.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.938 0.399 . . . . 0.0 111.598 -172.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.48 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 9.4 tp10 -123.61 143.61 50.12 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.184 172.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.49 HD13 HG21 ' A' ' 15' ' ' THR . 6.9 mp -124.75 125.82 44.67 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.546 0.689 . . . . 0.0 110.963 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.592 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 19.7 tpp180 -109.29 154.45 22.46 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 66.1 mtt -62.03 89.59 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 110.41 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.57 -7.45 26.25 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.932 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.592 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 97.9 m-85 -138.01 137.75 38.19 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.414 0.607 . . . . 0.0 111.606 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.0 tp -102.17 107.83 19.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.138 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 43.0 t -101.67 102.58 13.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.022 0.439 . . . . 0.0 111.031 -173.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.64 147.71 25.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.27 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -144.47 133.21 22.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.633 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -112.35 147.73 37.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.133 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -65.43 93.33 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.273 1.982 . . . . 0.0 110.67 172.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.93 -24.48 10.1 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.44 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.633 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 13.0 mmt -120.07 157.36 29.11 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.07 -163.13 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.315 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -90.31 165.84 13.66 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.518 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.7 tp -143.51 93.68 2.51 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.967 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -88.01 114.15 24.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.526 0.679 . . . . 0.0 110.248 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.552 HD13 ' HG2' ' A' ' 96' ' ' GLU . 55.0 mt -111.65 118.9 46.05 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.396 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.72 127.91 28.13 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.252 1.968 . . . . 0.0 111.296 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 120.98 0.419 . . . . 0.0 110.589 -178.994 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 48.5 t . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.668 0.27 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ARG . . . . . 0.709 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -97.17 97.59 9.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.797 0.808 . . . . 0.0 109.124 170.162 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -76.98 121.57 23.68 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.334 -174.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -68.91 105.24 2.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.251 0.548 . . . . 0.0 110.058 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.486 ' HE1' HD13 ' A' ' 115' ' ' LEU . 23.4 tpp -93.17 150.73 20.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.816 -175.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.445 ' N ' ' HG3' ' A' ' 84' ' ' MET . 42.3 tp -125.9 89.2 2.98 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.695 0.759 . . . . 0.0 109.241 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.777 HG21 ' HB ' ' A' ' 124' ' ' VAL . 2.1 t -80.94 87.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.099 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.31 -86.83 1.01 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.63 16.33 2.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.062 0.458 . . . . 0.0 110.763 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -102.15 119.27 38.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 110.538 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.1 m -92.98 109.5 20.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.078 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.609 HG21 HG12 ' A' ' 124' ' ' VAL . 3.9 m -142.58 139.44 28.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.605 -177.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.709 ' HB2' ' HB2' ' A' ' 81' ' ' ARG . 5.3 p-10 -83.3 141.73 31.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.163 0.506 . . . . 0.0 110.334 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.58 HG23 HD22 ' A' ' 115' ' ' LEU . 18.6 m -128.94 152.71 37.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.571 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.0 t -81.4 123.62 38.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.949 0.404 . . . . 0.0 111.46 -174.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.762 ' HA ' HD23 ' A' ' 115' ' ' LEU . 59.3 t0 -87.07 129.26 34.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.79 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.552 ' HG2' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -75.73 -6.55 51.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.215 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.59 158.47 10.37 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.546 173.022 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.76 -11.14 60.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 0.0 110.373 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.3 mt -65.5 -41.59 93.04 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.97 -34.42 68.95 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.046 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.65 -50.22 74.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.514 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.412 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -62.17 -44.65 96.14 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.99 0.424 . . . . 0.0 110.698 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 49.0 t90 -53.85 -44.51 70.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.39 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.617 HD12 ' HB3' ' A' ' 107' ' ' HIS . 2.1 tp -92.84 -21.01 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.987 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 40.5 p -68.3 -13.41 62.24 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.578 174.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -85.43 -45.62 11.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.362 170.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.617 ' HB3' HD12 ' A' ' 104' ' ' ILE . 84.4 t60 -79.68 -45.45 18.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.934 0.397 . . . . 0.0 111.692 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.87 43.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.87 -3.83 84.82 Favored Glycine 0 C--N 1.325 -0.049 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.841 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.534 HG23 ' SG ' ' A' ' 112' ' ' CYS . 13.7 m -120.47 159.61 47.31 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -67.88 87.57 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.772 2.315 . . . . 0.0 112.083 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.534 ' SG ' HG23 ' A' ' 110' ' ' VAL . 75.1 m -134.52 154.53 51.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.128 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -135.37 151.98 51.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.549 HG12 HG22 ' A' ' 29' ' ' VAL . 55.4 mt -83.11 119.79 33.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.03 0.443 . . . . 0.0 109.947 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 95' ' ' ASP . 52.3 mt -122.1 133.97 54.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.74 -173.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 27' ' ' TRP . 6.5 ttpm? -107.05 128.4 54.33 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.347 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.2 t -71.21 119.17 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.184 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -61.97 124.96 84.03 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.195 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.76 35.52 0.22 Allowed 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.723 2.948 . . . . 0.0 114.143 -172.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -118.76 -32.01 4.65 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 26.3 mmt -77.49 -57.97 3.53 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.476 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 68.21 -66.99 0.21 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.084 0.865 . . . . 0.0 112.417 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.44 113.5 22.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.681 0.753 . . . . 0.0 111.288 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.777 ' HB ' HG21 ' A' ' 86' ' ' VAL . 12.3 m -115.62 -22.48 4.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.807 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 60.94 66.05 0.94 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.487 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.493 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 46.6 t90 -47.71 138.97 9.12 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 170.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.493 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 9.0 Cg_endo . . . . . 0 C--N 1.35 0.658 0 C-N-CA 123.987 3.125 . . . . 0.0 113.769 -173.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.729 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -96.04 140.42 30.8 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.479 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.4 mp0 -100.4 97.46 6.46 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.538 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.592 ' HA ' ' CB ' ' A' ' 24' ' ' GLN . 38.5 Cg_endo -70.18 -59.81 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.825 1.684 . . . . 0.0 110.103 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.637 HD11 HD21 ' A' ' 57' ' ' LEU . 18.4 mt -103.76 146.48 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.633 173.479 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.24 -55.05 15.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . 0.742 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 1.4 mp0 -60.21 -42.58 95.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.689 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.832 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 52.7 m -60.84 -44.74 96.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.447 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.04 -134.25 11.78 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.003 174.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.729 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -84.81 121.68 28.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.586 0.708 . . . . 0.0 112.331 -170.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.483 HG21 HD13 ' A' ' 52' ' ' LEU . 8.6 m -123.02 119.13 29.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.764 173.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 5' ' ' ALA . 9.8 t -85.85 -6.6 59.06 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.169 -170.263 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -60.74 122.38 14.63 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 t -61.45 -25.88 67.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.794 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -59.36 -30.52 68.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.835 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.41 -30.04 70.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.278 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 -17.03 64.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.936 0.398 . . . . 0.0 111.566 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.99 -22.1 15.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.233 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -105.54 -11.3 16.44 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.974 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.592 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 27.7 pt20 -64.16 155.8 30.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.137 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 51.1 mmtt -162.91 179.73 7.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.225 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.464 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.5 OUTLIER -71.13 76.21 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.166 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TRP . . . . . 0.565 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -95.06 147.75 23.08 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.359 -176.597 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.724 ' HA ' ' OE2' ' A' ' 11' ' ' GLU . 2.2 pp -176.83 166.58 2.54 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.395 0.616 . . . . 0.0 112.578 174.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.597 HG21 HG12 ' A' ' 104' ' ' ILE . 56.1 t -98.28 129.59 48.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.782 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.11 133.69 53.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.582 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . 0.46 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 20.9 t-20 -77.59 154.45 32.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -47.18 -30.1 2.71 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.86 -23.4 60.78 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.054 0.454 . . . . 0.0 111.543 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 5.72 55.13 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.19 149.16 21.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 111.025 -174.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.461 ' CD1' HG13 ' A' ' 86' ' ' VAL . 12.0 m0 -70.79 122.27 19.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.945 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.45 HD13 ' HB2' ' A' ' 31' ' ' ASN . 4.4 tp -82.49 133.91 35.21 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.473 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 1.8 t-20 -119.93 161.96 19.99 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.432 -170.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.472 ' HG3' ' HB2' ' A' ' 46' ' ' ALA . 24.7 ttm180 -65.55 -26.33 67.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.655 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -92.92 -11.33 33.67 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.492 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.473 ' HB2' ' H ' ' A' ' 38' ' ' ASN . 80.2 mt -82.64 -50.57 8.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.1 m -131.33 100.24 16.92 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.485 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -59.39 -36.39 94.12 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.987 2.458 . . . . 0.0 112.66 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -61.94 -21.63 64.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.057 0.456 . . . . 0.0 111.264 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.742 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 37.1 tp -68.54 -29.88 68.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.524 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.703 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -87.64 10.35 18.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.595 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -96.62 18.96 13.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.679 0.276 . . . . 0.0 111.299 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.832 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 56.8 t -75.84 127.46 37.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.83 0.348 . . . . 0.0 110.699 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 14.0 m -85.87 122.15 29.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.697 HG22 ' HB3' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -101.12 140.62 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.02 0.438 . . . . 0.0 111.263 -172.821 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -145.77 129.93 17.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.468 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.483 HD13 HG21 ' A' ' 15' ' ' THR . 10.9 mp -107.63 125.05 50.87 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.558 0.694 . . . . 0.0 110.677 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 36.3 ttm180 -105.29 150.85 24.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.0 ttt -65.35 97.2 0.27 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.695 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.8 33.45 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.95 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.497 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 78.5 m-85 -137.2 137.64 39.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 117.486 0.643 . . . . 0.0 111.571 -174.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.637 HD21 HD11 ' A' ' 9' ' ' ILE . 42.0 tp -100.65 108.38 20.24 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.072 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.01 111.35 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.154 0.502 . . . . 0.0 111.293 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.1 mp -98.06 140.16 32.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.101 176.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 39.5 mttm -129.6 133.56 47.23 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ALA . . . . . 0.806 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -122.04 148.76 52.44 Favored Pre-proline 0 C--N 1.326 -0.44 0 C-N-CA 118.897 -1.121 . . . . 0.0 113.254 -176.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PRO . . . . . 0.44 ' HD2' ' CE1' ' A' ' 107' ' ' HIS . 23.1 Cg_exo -65.37 85.01 0.2 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.312 2.008 . . . . 0.0 110.648 168.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.38 -26.66 4.34 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.792 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.806 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 94.8 mmm -117.47 154.12 31.96 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.3 mm? -77.12 -144.34 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 49.2 ptt85 -83.55 149.68 26.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.272 0.558 . . . . 0.0 111.14 176.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 59.9 tp -121.95 102.79 8.39 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.637 170.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.488 ' OD1' ' HD2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -81.11 100.92 9.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.758 -179.123 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 64.2 mt -100.3 105.17 34.55 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.927 176.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 68' ' ' ASP . 15.7 Cg_exo -68.3 125.4 12.87 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.172 1.915 . . . . 0.0 110.881 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 N--CA 1.465 0.295 0 O-C-N 123.513 0.508 . . . . 0.0 111.979 -172.901 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 48.0 t . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -97.38 113.94 25.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.89 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 93' ' ' VAL . 6.3 t80 -112.11 120.1 40.69 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.701 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -78.85 118.09 20.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.457 0.646 . . . . 0.0 110.541 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.579 ' HE3' HG11 ' A' ' 93' ' ' VAL . 53.7 ttm -98.1 159.89 14.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.313 -176.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 88' ' ' GLU . 14.2 tp -135.7 87.11 2.29 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.153 0.501 . . . . 0.0 110.278 -175.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.681 HG12 ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -72.3 90.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.261 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.73 -75.18 1.27 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -170.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 8.8 pt-20 -152.1 18.76 0.67 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.027 0.441 . . . . 0.0 110.242 171.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -92.03 107.25 19.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 m -80.36 108.61 14.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.099 -175.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 84' ' ' MET . 5.8 m -123.94 151.65 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.507 -174.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -93.82 112.8 24.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.543 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.579 HG11 ' HE3' ' A' ' 84' ' ' MET . 14.6 m -131.26 154.22 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 0.0 110.527 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 91.1 t -101.48 135.38 38.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.603 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.471 ' HA ' ' CD2' ' A' ' 115' ' ' LEU . 16.7 t70 -80.39 135.92 36.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -106.55 10.43 31.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.97 0.414 . . . . 0.0 111.703 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.81 136.74 4.21 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.401 -1.381 . . . . 0.0 114.294 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.85 -25.0 67.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.827 -0.687 . . . . 0.0 110.714 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.8 tp -62.31 -45.47 93.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.085 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ALA . . . . . 0.511 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -69.33 -33.54 73.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.177 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -59.37 -57.96 10.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.164 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.01 -38.75 87.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.369 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -57.28 -46.01 83.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.949 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.597 HG12 HG21 ' A' ' 29' ' ' VAL . 2.8 tp -83.69 -25.81 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 73.3 m -59.93 -26.85 66.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.171 0.51 . . . . 0.0 109.713 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -88.99 -40.36 13.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.496 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.571 ' HB3' HD12 ' A' ' 104' ' ' ILE . 77.7 t60 -77.41 -53.16 7.99 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.162 -0.336 . . . . 0.0 111.789 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -62.55 -40.21 96.11 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.32 -16.61 34.99 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.421 170.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.679 HG23 ' SG ' ' A' ' 112' ' ' CYS . 16.6 m -121.67 160.87 44.66 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 18.0 Cg_endo -58.36 96.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.81 2.34 . . . . 0.0 112.168 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' CYS . . . . . 0.679 ' SG ' HG23 ' A' ' 110' ' ' VAL . 73.9 m -135.22 173.22 11.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.708 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 9.5 ptp85 -149.95 140.15 22.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.815 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 29' ' ' VAL . 60.8 mt -75.79 120.95 26.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.471 ' CD2' ' HA ' ' A' ' 95' ' ' ASP . 96.5 mt -124.81 151.26 45.42 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.442 0.639 . . . . 0.0 111.097 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -108.58 105.3 14.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.131 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 93' ' ' VAL . 86.3 t -64.01 118.43 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.392 0.615 . . . . 0.0 110.34 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' HIS . . . . . 0.685 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 7.4 t-160 -69.9 132.3 88.75 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.103 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PRO . . . . . 0.685 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 28.5 Cg_endo -62.5 15.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.748 0 C-N-CA 123.687 2.925 . . . . 0.0 114.259 -176.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 118' ' ' HIS . 9.9 t70 -60.0 -60.77 3.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.271 0.558 . . . . 0.0 109.515 176.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' MET . . . . . 0.493 ' HG3' HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -99.73 -30.4 12.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.313 173.004 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 69.28 -77.94 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.06 -72.17 0.11 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -170.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.524 ' CG1' HG21 ' A' ' 86' ' ' VAL . 58.3 t 70.99 -58.29 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.558 0.536 . . . . 0.0 111.924 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . 0.609 ' O ' ' HB2' ' A' ' 126' ' ' TRP . 66.8 ttt180 79.03 -89.35 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.999 1.319 . . . . 0.0 111.745 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' TRP . . . . . 0.609 ' HB2' ' O ' ' A' ' 125' ' ' ARG . 9.5 t90 162.79 142.57 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -174.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.681 ' HD3' HG12 ' A' ' 86' ' ' VAL . 38.0 Cg_endo . . . . . 0 C--N 1.351 0.659 0 C-N-CA 123.513 2.809 . . . . 0.0 112.777 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.5 m -69.46 162.92 26.45 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.2 m -60.43 -52.11 66.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m 59.38 21.62 9.97 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.842 0.83 . . . . 0.0 111.551 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.755 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -99.66 95.6 7.07 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.8 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -80.69 141.5 34.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.804 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -115.25 85.74 13.26 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.287 -0.165 . . . . 0.0 110.894 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 49.0 Cg_endo -74.45 -35.87 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.885 1.724 . . . . 0.0 111.082 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.772 HD11 HD11 ' A' ' 57' ' ' LEU . 2.4 mt -114.52 145.28 20.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.208 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.88 -70.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 111.941 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.835 ' HG2' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -56.73 -50.09 73.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.457 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.805 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 73.8 m -53.48 -45.57 69.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.303 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.71 -127.52 9.18 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.782 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.755 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -85.13 138.37 32.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.436 0.636 . . . . 0.0 112.506 -169.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.518 HG21 HD13 ' A' ' 52' ' ' LEU . 17.0 m -123.96 123.69 40.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.789 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.07 22.03 2.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.139 0.495 . . . . 0.0 111.495 -175.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -110.83 135.53 51.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.864 0.364 . . . . 0.0 110.15 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.8 t -70.29 -18.95 63.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.3 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.75 -26.86 68.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.618 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -71.23 -20.23 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.859 -176.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.68 -9.53 58.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.724 0.297 . . . . 0.0 111.455 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.2 -1.45 16.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.736 0.303 . . . . 0.0 111.627 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -129.66 12.02 5.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.671 0.272 . . . . 0.0 111.144 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.4 pt20 -68.57 153.67 43.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.133 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.429 ' HG3' ' H ' ' A' ' 26' ' ' ARG . 3.8 tppt? -165.26 179.79 6.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.429 ' H ' ' HG3' ' A' ' 25' ' ' LYS . 73.7 mtt85 -83.26 60.83 5.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.842 0.829 . . . . 0.0 109.291 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.62 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -78.01 147.67 34.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.143 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.617 ' HA ' ' OE2' ' A' ' 11' ' ' GLU . 2.0 pp -176.92 177.42 1.3 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.119 0.485 . . . . 0.0 111.882 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.835 HG23 ' HG2' ' A' ' 11' ' ' GLU . 88.3 t -107.42 146.75 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.43 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -128.26 145.15 51.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.9 p30 -96.53 168.84 10.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.774 -174.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -46.49 -34.16 4.59 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.735 0.814 . . . . 0.0 113.078 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.84 -4.33 4.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 84' ' ' MET . . . 83.88 3.39 89.32 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.778 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -100.57 152.61 20.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.48 -175.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.678 ' CH2' ' HB ' ' A' ' 124' ' ' VAL . 39.3 m0 -66.71 145.0 56.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 175.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.0 tp -106.61 143.4 34.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -134.41 165.69 24.57 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.006 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.499 ' CD ' ' H ' ' A' ' 39' ' ' ARG . 0.2 OUTLIER -69.03 -32.08 71.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.548 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -67.34 -25.02 65.79 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.93 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -91.19 -52.41 4.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.376 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.18 99.85 17.42 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.564 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.17 -16.92 45.17 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.325 2.683 . . . . 0.0 113.155 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -58.7 -32.42 69.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.213 0.53 . . . . 0.0 111.011 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 48' ' ' VAL . 7.0 mp -72.91 -19.86 61.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.849 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -68.21 -11.36 59.17 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.092 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -95.66 46.0 1.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.531 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.805 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 64.7 t -104.8 135.49 42.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.704 0.288 . . . . 0.0 110.667 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 m -94.74 117.54 30.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.628 HG22 ' HB3' ' A' ' 12' ' ' CYS . 11.2 t -99.2 137.45 26.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.063 -172.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -136.08 141.45 44.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.099 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 20' ' ' ALA . 6.9 mp -123.39 133.84 54.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.895 0.378 . . . . 0.0 110.414 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.428 ' HA ' ' HE ' ' A' ' 53' ' ' ARG . 2.6 mmp_? -121.95 169.38 10.87 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 87.5 mtp -67.5 84.15 0.17 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 110.709 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.76 -21.24 9.11 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.923 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -130.21 137.89 50.29 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.616 0.708 . . . . 0.0 112.212 -173.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.772 HD11 HD11 ' A' ' 9' ' ' ILE . 53.4 tp -96.52 107.09 19.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.808 174.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 68' ' ' ASP . 41.6 t -101.02 100.69 10.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.317 0.58 . . . . 0.0 111.055 -173.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.4 mp -86.34 146.05 26.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.37 177.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -137.58 132.61 33.36 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.701 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -115.01 142.24 28.17 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 119.273 -0.971 . . . . 0.0 112.167 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.98 81.23 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.233 1.955 . . . . 0.0 110.5 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.2 -31.83 2.74 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.701 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 13.8 mmt -114.79 153.41 30.42 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.434 HD22 ' H ' ' A' ' 65' ' ' LEU . 2.8 mm? -68.67 -158.64 0.02 OUTLIER 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.508 0.67 . . . . 0.0 111.714 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 13.2 ptm180 -89.4 151.2 22.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.925 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.422 HD21 ' HA ' ' A' ' 100' ' ' ALA . 60.7 tp -137.44 103.94 5.21 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.753 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 2.2 p-10 -99.21 112.75 24.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.649 0.738 . . . . 0.0 111.016 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 96' ' ' GLU . 34.2 mt -110.67 138.83 21.15 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.503 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.29 119.71 7.08 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 121.931 1.754 . . . . 0.0 111.446 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 57' ' ' LEU . 64.3 mt -54.21 -74.22 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.206 0.527 . . . . 0.0 111.462 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -150.73 28.84 0.69 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 30.8 m -87.56 22.73 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.506 -175.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.7 mm -112.59 137.49 45.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -144.79 23.82 1.55 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.36 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -109.38 -160.53 0.72 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.515 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -103.34 -4.67 23.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.728 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.63 -0.52 23.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.34 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 m -66.3 104.49 1.21 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 41.0 t -68.35 99.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.392 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -85.39 105.08 15.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -95.39 132.53 40.33 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.827 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -80.19 102.68 9.57 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 2.7 tpt -102.93 159.29 15.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.213 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp -133.01 87.61 2.42 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.632 0.73 . . . . 0.0 109.727 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.601 HG12 ' HD3' ' A' ' 127' ' ' PRO . 5.0 t -83.63 93.55 3.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.388 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.37 -89.43 1.31 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.78 11.81 2.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.05 0.452 . . . . 0.0 110.214 171.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.454 ' HG2' HG13 ' A' ' 91' ' ' VAL . 17.2 tt0 -96.5 112.9 24.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.544 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.7 m -83.23 114.48 21.4 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.156 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.528 HG11 HG22 ' A' ' 124' ' ' VAL . 3.6 m -136.25 147.24 28.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.031 0.443 . . . . 0.0 111.973 -174.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.464 ' H ' ' HG3' ' A' ' 121' ' ' MET . 0.8 OUTLIER -80.07 117.09 20.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.252 177.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.521 HG21 HD13 ' A' ' 115' ' ' LEU . 36.0 m -120.23 148.85 23.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 93.5 t -94.94 129.85 44.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.35 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.529 ' OD1' ' HD3' ' A' ' 113' ' ' ARG . 33.3 t70 -82.6 132.33 35.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.303 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HB3' HD13 ' A' ' 69' ' ' ILE . 17.8 mm-40 -82.64 -6.49 59.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.713 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.11 157.01 11.93 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.225 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -53.68 -31.57 48.28 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 122.744 0.418 . . . . 0.0 111.345 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.788 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.4 pt? -62.18 -36.96 83.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.811 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.422 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -76.3 -35.18 58.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.056 0.455 . . . . 0.0 110.221 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -59.96 -57.23 13.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.67 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.71 -42.65 99.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.437 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -54.14 -47.53 71.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.055 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.598 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.1 tp -85.26 -23.91 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.198 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.3 m -64.96 -16.44 63.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.403 -0.81 . . . . 0.0 109.996 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -88.68 -51.09 5.86 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.2 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.598 ' HB3' HD12 ' A' ' 104' ' ' ILE . 57.5 t60 -72.71 -44.48 61.68 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -76.17 -36.64 58.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.24 -32.4 7.52 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.849 171.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.662 HG23 ' SG ' ' A' ' 112' ' ' CYS . 16.1 m -100.43 158.76 31.34 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 25.1 Cg_endo -62.64 90.88 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.649 2.232 . . . . 0.0 112.108 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.662 ' SG ' HG23 ' A' ' 110' ' ' VAL . 76.5 m -135.21 164.73 27.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.277 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 10.9 ptp180 -140.48 143.37 35.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.404 175.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.623 HG12 HG22 ' A' ' 29' ' ' VAL . 37.6 mt -73.27 131.92 34.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.521 HD13 HG21 ' A' ' 93' ' ' VAL . 71.7 mt -134.87 139.54 45.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.176 0.512 . . . . 0.0 110.55 -176.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -108.16 110.78 22.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.273 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 93' ' ' VAL . 58.5 t -63.26 132.94 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.602 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.439 ' CG ' ' HD2' ' A' ' 119' ' ' PRO . 0.5 OUTLIER -86.81 139.45 33.05 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.076 -177.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 118' ' ' HIS . 48.9 Cg_endo -68.36 -2.13 8.53 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.303 2.669 . . . . 0.0 114.531 -173.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -71.7 -51.61 22.08 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.21 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.464 ' HG3' ' H ' ' A' ' 92' ' ' ASP . 95.3 mmm -73.52 -44.81 56.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 170.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 67.42 -77.97 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.733 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.88 139.87 30.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.368 0.604 . . . . 0.0 111.544 -172.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.678 ' HB ' ' CH2' ' A' ' 36' ' ' TRP . 52.8 t -133.9 -30.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.902 175.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 78.13 -37.97 0.24 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.558 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 19.7 t90 77.73 138.35 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.601 ' HD3' HG12 ' A' ' 86' ' ' VAL . 21.0 Cg_endo -54.59 119.15 5.95 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.544 2.829 . . . . 0.0 113.422 -175.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 m -79.01 24.12 0.33 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.018 0.437 . . . . 0.0 110.106 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 127' ' ' PRO . 74.5 mt 58.05 33.8 23.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.474 -173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--O 1.248 0.992 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.18 -177.314 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptp . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.4 p -131.55 -38.21 1.18 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.219 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 t -145.65 0.58 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.815 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m 63.84 30.22 14.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.758 0.789 . . . . 0.0 111.199 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.85 144.75 34.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.631 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.51 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.6 m-85 -94.31 134.4 36.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.33 91.75 20.6 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 6.1 Cg_exo -82.11 -55.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.937 2.425 . . . . 0.0 113.413 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.723 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -114.88 132.24 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 123.741 0.651 . . . . 0.0 110.555 -174.446 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.63 -55.14 36.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -170.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.813 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -62.32 -49.22 76.46 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -171.48 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.723 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 9.9 p -74.0 -35.75 64.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.771 0.319 . . . . 0.0 110.693 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.05 -140.52 14.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.807 170.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.75 152.15 23.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.309 0.576 . . . . 0.0 111.64 -172.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.8 m -134.5 134.43 41.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.256 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 p -94.63 66.41 3.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.49 0.662 . . . . 0.0 110.94 176.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -133.58 128.39 35.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.066 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.7 m -56.87 -33.09 66.5 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.65 -16.18 56.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.501 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -65.61 -22.67 66.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.361 . . . . 0.0 111.378 -176.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.61 -25.63 67.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.472 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.91 0.26 48.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.425 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -129.51 20.97 5.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.707 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 5.3 pp0? -91.16 150.79 21.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.191 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -162.51 -179.58 7.04 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.639 ' NH1' ' HA ' ' A' ' 123' ' ' GLU . 50.5 mtt85 -82.82 65.38 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 165.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.569 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 2.0 t90 -88.7 144.98 25.91 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.919 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -177.78 -177.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.552 0.691 . . . . 0.0 112.317 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.592 HG22 HG12 ' A' ' 114' ' ' ILE . 17.6 t -106.04 142.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.009 175.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.72 155.25 39.58 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.4 p30 -99.8 160.44 14.3 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.779 -179.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.545 ' HB2' ' HB2' ' A' ' 111' ' ' PRO . 14.2 t70 -45.7 -34.74 3.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.55 0.74 . . . . 0.0 112.81 -176.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.79 -7.17 3.26 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.59 7.18 72.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.614 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -100.03 140.22 34.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.553 -175.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -61.71 129.02 39.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.6 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.477 HD22 ' SG ' ' A' ' 112' ' ' CYS . 20.9 tp -90.27 144.86 25.45 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -137.13 167.44 21.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.24 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -67.7 -21.09 65.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.93 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -77.37 -26.37 51.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.77 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 37' ' ' LEU . 78.2 mt -90.72 -51.22 5.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.277 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' A' ' 37' ' ' LEU . 74.7 m -122.94 93.83 47.95 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.645 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.68 -30.27 91.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.004 2.469 . . . . 0.0 112.461 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 44' ' ' ARG . 47.7 mtm105 -69.19 -13.38 62.38 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.939 0.399 . . . . 0.0 111.156 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.813 ' HG ' ' HB2' ' A' ' 11' ' ' GLU . 32.5 tp -79.5 -18.86 51.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.57 -17.1 64.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.165 0.507 . . . . 0.0 109.944 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.695 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 57.5 mm-40 -82.95 58.8 4.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.418 177.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.0 t -129.39 139.22 52.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.7 m -105.49 142.28 35.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.67 0.272 . . . . 0.0 110.801 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 12' ' ' CYS . 1.5 t -96.73 143.35 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.867 -174.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 3.8 tp10 -146.56 137.33 24.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 167.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 mp -119.25 125.47 49.21 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.885 0.374 . . . . 0.0 110.279 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 56' ' ' TYR . 34.2 mmt180 -105.31 175.59 5.44 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.2 ttm -68.38 91.85 0.41 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.39 -0.28 65.73 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.136 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.465 ' C ' ' HG ' ' A' ' 71' ' ' LEU . 59.4 m-85 -136.21 148.36 48.06 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 117.59 0.695 . . . . 0.0 112.313 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.499 ' HB2' HD23 ' A' ' 71' ' ' LEU . 42.1 tp -109.32 118.51 36.87 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.128 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 66.8 t -109.05 111.05 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.228 0.537 . . . . 0.0 110.513 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 3.8 mp -97.07 137.19 36.52 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.947 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -129.3 130.39 46.09 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -122.27 134.03 24.64 Favored Pre-proline 0 C--O 1.215 -0.718 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.879 -173.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.695 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 82.5 Cg_exo -46.16 107.08 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.272 1.981 . . . . 0.0 111.178 166.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.17 -10.51 61.75 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.951 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.639 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 76.8 mmm -136.4 156.53 48.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.768 0.794 . . . . 0.0 111.53 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.521 HD22 ' H ' ' A' ' 65' ' ' LEU . 2.6 mm? -67.7 -165.87 0.05 Allowed 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.816 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 33.6 ptt85 -88.33 169.22 12.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.448 173.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.483 ' HG ' HG13 ' A' ' 69' ' ' ILE . 55.3 tp -147.48 111.33 5.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.761 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.22 99.82 12.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 110.587 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.483 HG13 ' HG ' ' A' ' 67' ' ' LEU . 70.0 mt -105.93 138.72 19.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.42 139.19 23.02 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.189 1.926 . . . . 0.0 112.509 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 57' ' ' LEU . 8.7 mt -71.16 94.0 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.573 0.702 . . . . 0.0 111.428 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.4 t70 75.29 88.55 0.09 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.844 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.8 121.92 15.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.8 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.575 HG12 ' H ' ' A' ' 75' ' ' GLU . 13.3 tt -82.37 -174.74 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.289 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.575 ' H ' HG12 ' A' ' 74' ' ' ILE . 6.4 mm-40 -73.53 29.72 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 123.932 0.893 . . . . 0.0 111.328 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 74' ' ' ILE . 8.8 t70 -62.64 152.99 33.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.115 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.49 -25.22 67.9 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.033 -171.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.434 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . 0.8 OUTLIER -77.21 -22.79 51.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.497 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.436 ' HB2' HG13 ' A' ' 94' ' ' VAL . 85.2 p -67.29 139.75 57.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.952 0.406 . . . . 0.0 110.008 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.41 112.83 32.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.525 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.401 HH21 ' CG ' ' A' ' 92' ' ' ASP . 76.0 mtp180 -77.53 99.18 5.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.613 0.72 . . . . 0.0 109.783 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -86.13 126.66 34.38 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.589 -175.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 88.7 mm-40 -76.61 112.03 12.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.453 ' HE2' ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -98.94 145.84 26.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.8 -175.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.847 ' HG ' ' HA ' ' A' ' 88' ' ' GLU . 12.9 tp -126.35 79.07 1.82 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.498 0.666 . . . . 0.0 109.501 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.419 HG12 ' HD3' ' A' ' 127' ' ' PRO . 4.6 t -85.92 96.97 5.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.306 -174.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.69 31.95 70.64 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.847 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.9 OUTLIER 69.39 18.19 7.98 Favored 'General case' 0 N--CA 1.46 0.051 0 CA-C-N 114.504 -0.848 . . . . 0.0 111.296 -176.124 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -92.84 107.76 19.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.8 m -78.84 99.88 6.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.909 -172.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 m -132.32 142.57 42.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.713 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.401 ' CG ' HH21 ' A' ' 81' ' ' ARG . 7.1 p-10 -91.78 140.5 29.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.19 0.519 . . . . 0.0 110.721 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.9 m -131.15 153.72 39.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.691 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.436 HG13 ' HB2' ' A' ' 79' ' ' SER . 93.2 t -88.87 132.84 32.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.894 0.378 . . . . 0.0 111.221 -176.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.674 ' OD2' ' HD3' ' A' ' 113' ' ' ARG . 26.3 t0 -77.42 127.11 31.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.312 175.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.485 ' CD ' ' HZ2' ' A' ' 116' ' ' LYS . 13.5 mm-40 -92.65 -3.15 55.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.315 -175.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.29 129.84 1.34 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.685 -1.245 . . . . 0.0 114.511 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.42 -36.29 71.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.29 0.567 . . . . 0.0 110.144 171.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.86 -35.7 81.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.436 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.496 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -65.54 -37.71 87.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.489 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.69 84.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.73 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.72 83.46 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.993 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.4 ' CZ3' HD13 ' A' ' 104' ' ' ILE . 73.8 t90 -51.48 -44.66 62.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.274 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.587 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.2 tp -86.94 -23.17 6.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.635 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 94.6 p -65.02 -17.99 64.92 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.357 -0.839 . . . . 0.0 109.301 175.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HB3' ' SD ' ' A' ' 64' ' ' MET . 33.1 m-80 -81.97 -57.84 3.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.342 170.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.587 ' HB3' HD12 ' A' ' 104' ' ' ILE . 75.5 t60 -69.04 -45.5 70.27 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.12 -42.67 59.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.62 -30.68 8.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.586 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.666 HG23 ' SG ' ' A' ' 112' ' ' CYS . 16.5 m -99.78 163.45 18.41 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 17.8 Cg_endo -60.26 96.71 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.533 2.156 . . . . 0.0 112.155 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.666 ' SG ' HG23 ' A' ' 110' ' ' VAL . 72.1 m -134.05 158.15 44.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.721 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.674 ' HD3' ' OD2' ' A' ' 95' ' ' ASP . 48.9 ttm-85 -143.15 132.83 23.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.138 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.592 HG12 HG22 ' A' ' 29' ' ' VAL . 41.7 mt -80.06 120.91 32.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 95' ' ' ASP . 70.4 mt -131.51 155.96 46.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.747 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.485 ' HZ2' ' CD ' ' A' ' 96' ' ' GLU . 7.2 ttpm? -121.56 138.67 54.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.155 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.13 135.17 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.69 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -73.1 119.54 76.19 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.796 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.07 -24.68 20.44 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.627 2.885 . . . . 0.0 113.704 -173.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.97 -39.79 82.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 110.714 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -117.75 -175.47 2.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.12 -170.62 3.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.137 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.639 ' HA ' ' NH1' ' A' ' 26' ' ' ARG . 8.0 mm-40 65.79 -140.07 0.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.793 0.683 . . . . 0.0 111.142 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.1 t 65.67 100.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -167.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -108.28 27.25 9.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.532 -169.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.696 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 5.2 t90 72.58 151.5 0.14 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -174.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.696 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 10.6 Cg_endo -51.83 -17.76 5.65 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.272 2.648 . . . . 0.0 114.135 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.8 m 57.51 46.28 18.16 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.185 0.517 . . . . 0.0 110.558 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.4 mt 64.64 79.78 0.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.232 -178.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.249 1.068 0 O-C-N 124.418 1.074 . . . . 0.0 113.254 175.658 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m 62.57 -158.72 0.32 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.473 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.9 p -59.1 -27.49 65.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.734 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m 64.42 25.48 13.37 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.81 0.814 . . . . 0.0 109.871 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -103.77 132.93 49.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.206 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.704 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 55.5 m-85 -112.46 141.33 46.34 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.994 -177.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -99.68 97.25 5.49 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.012 0.195 . . . . 0.0 110.7 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.823 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 2.6 Cg_exo -77.07 -54.4 0.06 OUTLIER 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.874 2.383 . . . . 0.0 111.735 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.823 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 4.9 mm -107.22 150.88 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.462 -175.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.74 -54.73 8.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.017 -174.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 1.6 mp0 -56.59 -53.18 60.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.5 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.823 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 25.9 p -70.51 -47.27 61.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.95 -127.79 9.26 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.533 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -89.83 139.3 30.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.3 0.571 . . . . 0.0 112.207 -173.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.517 HG21 HD13 ' A' ' 52' ' ' LEU . 16.9 m -113.5 138.84 49.55 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.94 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -87.41 31.66 0.73 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -119.96 136.35 54.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.085 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.427 ' HA ' ' HE2' ' A' ' 6' ' ' TYR . 20.1 m -65.85 -28.76 69.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.791 0.329 . . . . 0.0 111.618 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -65.32 -23.6 67.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.498 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.823 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -58.47 -30.98 67.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.566 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.11 -24.8 67.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.69 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.19 -14.71 28.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.589 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -112.77 -0.94 14.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.695 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.637 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 3.7 pp0? -67.58 150.8 48.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.568 0.223 . . . . 0.0 110.562 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 24' ' ' GLN . 38.5 mmtm -165.54 -178.7 5.04 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.175 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -81.82 79.13 8.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.896 0.855 . . . . 0.0 109.482 170.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -100.63 147.14 26.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.907 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 pp -173.99 178.88 2.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.63 0.729 . . . . 0.0 112.246 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.862 HG22 HD13 ' A' ' 114' ' ' ILE . 60.3 t -111.5 136.42 47.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.488 175.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.732 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -124.85 144.94 50.04 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -77.6 142.75 38.76 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.755 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -48.02 -25.64 1.48 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.442 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . . . -57.24 -18.38 15.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.651 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.432 ' HA2' ' CE ' ' A' ' 84' ' ' MET . . . 103.61 18.67 13.69 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -176.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -112.87 127.45 56.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.938 -173.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -56.64 123.64 15.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.432 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.649 HD23 HD22 ' A' ' 45' ' ' LEU . 10.5 tp -82.47 154.31 25.18 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -140.88 164.3 30.61 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.498 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -69.06 -24.57 64.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 110.074 176.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.8 -27.66 61.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.879 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.2 mt -87.79 -51.47 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.611 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.6 m -130.25 95.68 26.96 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.64 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.58 -28.87 69.99 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.771 2.314 . . . . 0.0 112.139 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -67.76 -14.11 62.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.233 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.649 HD22 HD23 ' A' ' 37' ' ' LEU . 33.0 tp -74.47 -23.12 58.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.746 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.2 -13.35 61.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.232 0.539 . . . . 0.0 110.384 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -92.68 54.62 2.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.69 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 12' ' ' CYS . 92.0 t -110.88 134.26 53.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.038 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.8 m -100.56 148.77 24.44 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.12 148.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.177 0.513 . . . . 0.0 111.722 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 28.8 tt0 -152.05 139.75 19.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.517 HD13 HG21 ' A' ' 15' ' ' THR . 9.2 mp -106.93 125.39 50.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.682 0.753 . . . . 0.0 111.443 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -112.42 154.4 25.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.38 -1.282 . . . . 0.0 107.671 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' MET . . . . . 0.433 ' O ' ' HG3' ' A' ' 54' ' ' MET . 23.6 ptt? -60.66 100.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.939 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.59 0.07 64.95 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.117 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -143.14 137.62 29.21 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 117.403 0.601 . . . . 0.0 111.536 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.526 ' HB2' HD21 ' A' ' 71' ' ' LEU . 28.1 tp -100.21 114.39 27.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.176 175.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 70.8 t -96.4 96.45 5.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.892 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 8.1 mp -87.53 143.44 27.21 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -140.28 130.95 25.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -115.67 144.96 33.54 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.453 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.95 98.03 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.061 1.841 . . . . 0.0 110.487 170.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.09 -32.2 6.08 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.302 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.639 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 13.1 mmt -116.04 154.64 29.53 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.437 0.637 . . . . 0.0 110.218 -177.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.812 ' H ' HD12 ' A' ' 65' ' ' LEU . 2.5 mp -69.71 -154.38 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.755 -171.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 12.4 ptm180 -94.33 145.14 24.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.652 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 53.4 tp -121.67 114.61 21.38 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.234 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.99 102.22 14.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.716 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 70.1 mt -97.8 116.47 65.73 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.739 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.62 119.5 6.62 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.321 2.014 . . . . 0.0 112.168 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 57' ' ' LEU . 96.1 mt -82.49 -24.91 33.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.182 0.515 . . . . 0.0 110.028 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -120.34 109.94 15.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.138 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.78 132.39 68.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.699 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.526 HG23 ' H ' ' A' ' 75' ' ' GLU . 1.4 tp -86.15 -85.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.033 175.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.526 ' H ' HG23 ' A' ' 74' ' ' ILE . 10.7 pt-20 -116.9 24.09 11.47 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.714 0.768 . . . . 0.0 110.208 171.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.23 -7.84 54.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.837 170.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -85.93 65.87 9.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.91 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.48 13.3 16.07 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 168.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.709 ' HB3' ' O ' ' A' ' 95' ' ' ASP . 1.4 m -50.98 132.72 27.39 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.47 177.227 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.5 t -79.59 118.69 27.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.95 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.585 ' HG2' HG22 ' A' ' 94' ' ' VAL . 74.1 mtp180 -86.5 112.98 22.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.89 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.526 ' HE2' ' HB2' ' A' ' 95' ' ' ASP . 98.0 m-85 -101.13 133.15 46.11 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.388 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -80.06 98.77 7.38 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -90.17 153.46 20.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.283 -171.536 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.27 86.41 2.45 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.75 0.786 . . . . 0.0 109.449 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.571 HG12 ' HD3' ' A' ' 127' ' ' PRO . 4.0 t -76.57 84.6 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.497 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.73 -78.34 1.67 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -175.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.81 16.08 1.77 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.018 0.437 . . . . 0.0 110.441 174.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.427 ' HG2' HG13 ' A' ' 91' ' ' VAL . 58.4 tt0 -111.26 108.93 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 110.725 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 84' ' ' MET . 7.5 m -80.29 113.97 18.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.494 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.55 HG12 ' HG2' ' A' ' 121' ' ' MET . 5.9 m -134.63 159.33 41.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.336 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.65 113.13 25.32 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 -174.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.48 HG23 HD22 ' A' ' 115' ' ' LEU . 34.9 m -120.03 136.96 55.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.97 177.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 81' ' ' ARG . 6.4 t -99.25 129.96 48.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.063 -176.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.709 ' O ' ' HB3' ' A' ' 79' ' ' SER . 53.8 t0 -74.48 119.92 19.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.695 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -74.4 -7.83 54.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.982 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.76 146.31 4.45 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.111 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -62.2 -30.45 71.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.22 0.533 . . . . 0.0 110.217 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.7 tp -67.78 -33.94 75.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.913 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.533 ' HB1' HG13 ' A' ' 114' ' ' ILE . . . -71.41 -40.63 70.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.111 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.26 -41.81 94.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.528 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.5 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -62.76 -43.03 99.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.984 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.409 ' HH2' HG13 ' A' ' 48' ' ' VAL . 38.1 t90 -55.66 -39.43 70.9 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.654 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.579 HG22 ' HB2' ' A' ' 112' ' ' CYS . 9.8 mm -89.41 -26.12 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 80.1 p -65.41 -14.96 62.06 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.466 -0.771 . . . . 0.0 109.356 172.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -90.23 -52.76 4.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.466 170.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.449 ' HB3' HD13 ' A' ' 104' ' ' ILE . 82.9 t60 -65.23 -40.69 94.4 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.43 -33.89 14.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.146 0.498 . . . . 0.0 110.142 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.44 -29.6 11.16 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.649 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.514 HG23 ' SG ' ' A' ' 112' ' ' CYS . 24.2 m -106.13 156.65 36.45 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.2 97.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.792 2.328 . . . . 0.0 112.622 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.579 ' HB2' HG22 ' A' ' 104' ' ' ILE . 58.1 m -129.03 147.65 50.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.9 176.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.468 ' HD3' ' CG ' ' A' ' 95' ' ' ASP . 41.6 ttm-85 -126.43 130.76 51.32 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.188 -171.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.862 HD13 HG22 ' A' ' 29' ' ' VAL . 25.6 mm -68.37 118.14 11.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 30' ' ' ALA . 18.4 mt -133.1 129.88 38.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.732 0.777 . . . . 0.0 111.896 -173.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HB3' ' HZ3' ' A' ' 116' ' ' LYS . 7.9 ttpm? -103.68 120.51 41.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.322 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.3 t -62.75 132.0 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.694 0.283 . . . . 0.0 110.343 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -69.22 139.2 89.76 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -51.02 -15.84 2.19 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.55 2.833 . . . . 0.0 114.219 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -60.09 -34.36 73.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.142 0.496 . . . . 0.0 110.584 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.55 ' HG2' HG12 ' A' ' 91' ' ' VAL . 2.4 mpt? -112.29 124.56 52.73 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.248 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.53 36.46 4.37 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.335 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -140.37 -135.0 0.11 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.73 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 86' ' ' VAL . 4.3 t 67.34 94.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.387 0.613 . . . . 0.0 110.06 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 125' ' ' ARG . 11.5 ttp180 -99.15 20.07 14.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.586 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.572 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 6.3 t90 70.61 151.56 0.14 Allowed Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 5.7 Cg_exo -37.02 120.5 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.151 2.568 . . . . 0.0 112.486 177.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.1 m -96.07 40.35 1.12 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.804 -170.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 129' ' ' LEU . 1.3 pt? -59.97 116.35 4.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.016 174.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.184 -175.924 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.952 0.406 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.576 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 42.2 p -127.56 172.32 10.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.059 -177.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.2 t -153.57 140.51 19.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.185 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 t 40.34 -137.61 0.12 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.138 0.899 . . . . 0.0 112.135 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.405 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -56.71 114.98 2.29 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.864 0.364 . . . . 0.0 110.859 174.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.683 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 24.6 m-85 -86.98 133.92 33.54 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 10.3 tt0 -105.66 94.23 8.41 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.888 0.375 . . . . 0.0 111.031 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.81 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 7.0 Cg_endo -87.11 -41.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.283 2.655 . . . . 0.0 112.317 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 3.6 mp -100.97 145.15 11.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.89 -73.03 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -172.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.639 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -58.93 -50.01 75.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.903 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 66.5 m -54.95 -47.33 74.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.965 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.8 -140.87 15.11 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.363 175.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 7' ' ' GLN . . . -94.67 151.91 18.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.459 0.647 . . . . 0.0 112.212 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.499 HG21 HD13 ' A' ' 52' ' ' LEU . 15.2 m -125.42 139.3 53.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.005 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -86.78 23.33 1.73 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.445 ' HG3' HG22 ' A' ' 15' ' ' THR . 9.3 mt-30 -114.83 145.63 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.672 0.272 . . . . 0.0 110.31 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 t -61.97 -35.15 77.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.292 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.506 ' CD ' ' H ' ' A' ' 19' ' ' GLU . 2.1 mp0 -52.76 -34.13 51.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.465 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.81 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -61.5 -27.6 68.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.459 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.55 -2.76 18.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.801 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.43 18.8 4.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.97 14.9 3.07 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.337 0.589 . . . . 0.0 110.44 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -64.12 143.56 57.78 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.095 177.574 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 24' ' ' GLN . 68.5 mmtt -161.88 166.9 25.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -172.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.472 ' CB ' ' HB ' ' A' ' 117' ' ' VAL . 4.8 mpt_? -86.64 82.53 7.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.233 0.54 . . . . 0.0 110.156 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.17 153.0 21.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.123 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.504 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -160.59 164.24 32.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.023 0.439 . . . . 0.0 110.512 -177.101 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.595 HG23 ' HG2' ' A' ' 11' ' ' GLU . 89.4 t -126.48 136.87 59.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.529 ' HB2' ' HE1' ' A' ' 84' ' ' MET . . . -111.97 133.63 54.03 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.602 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -79.48 179.52 7.41 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 172.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -46.07 -40.02 10.14 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.27 -5.72 43.75 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.85 11.64 84.37 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.761 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 26.0 tt0 -85.2 144.16 28.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.594 -0.303 . . . . 0.0 110.753 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.654 ' CD1' HG22 ' A' ' 86' ' ' VAL . 2.2 m0 -53.54 122.4 9.69 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 124.14 0.9 . . . . 0.0 111.67 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 tp -104.91 130.97 52.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -122.74 170.19 10.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.083 0.468 . . . . 0.0 111.79 -173.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -71.52 -19.44 62.18 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -70.65 -26.25 63.38 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.5 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.9 mt -94.74 -47.45 6.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.458 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.0 m -124.95 98.53 36.25 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.911 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.15 -31.02 75.45 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.891 2.394 . . . . 0.0 111.677 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -60.52 -30.06 69.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.968 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.639 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 63.2 tp -72.84 -28.09 62.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.261 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -71.39 -12.97 61.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.175 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -85.69 38.97 0.77 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.743 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.903 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 78.4 t -92.77 130.84 41.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.553 0.216 . . . . 0.0 110.473 173.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.675 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . 18.1 m -86.89 117.09 25.39 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.622 HG22 ' HB3' ' A' ' 12' ' ' CYS . 1.4 t -99.0 144.56 11.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.384 -172.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 78.9 tt0 -148.86 144.02 26.64 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 15' ' ' THR . 8.2 mp -123.74 129.75 51.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.015 0.435 . . . . 0.0 109.914 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.416 ' NE ' ' HA ' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -118.83 156.98 28.48 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.81 98.13 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.149 0.5 . . . . 0.0 110.998 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.25 -12.09 44.06 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.391 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -138.65 137.88 37.29 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 117.839 0.82 . . . . 0.0 112.145 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.8 tp -95.87 110.31 22.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 59.7 t -96.48 95.67 4.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.925 -173.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 7.6 mp -88.25 152.01 22.26 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.675 ' HG3' ' HB2' ' A' ' 49' ' ' SER . 11.1 ptpp? -159.89 143.17 14.05 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 172.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.595 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -132.25 147.37 65.45 Favored Pre-proline 0 C--O 1.218 -0.557 0 C-N-CA 118.665 -1.214 . . . . 0.0 113.413 -173.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.71 102.74 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.875 1.717 . . . . 0.0 110.45 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.78 -6.9 33.32 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.278 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.595 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 83.7 mmm -140.61 151.96 45.07 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.336 0.588 . . . . 0.0 110.879 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.405 ' HB3' ' H ' ' A' ' 66' ' ' ARG . 3.6 mm? -69.99 -159.1 0.03 OUTLIER 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.294 0.569 . . . . 0.0 111.18 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 45.4 mtp180 -80.36 149.38 30.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.597 174.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 68.6 tp -121.83 107.99 12.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 171.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -91.66 106.91 18.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.063 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 62.1 mt -115.66 116.65 40.89 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.441 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.45 131.74 48.03 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.636 2.224 . . . . 0.0 111.925 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt -69.31 -34.88 75.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 111.055 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.41 99.95 11.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.066 0.46 . . . . 0.0 110.637 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.3 t -102.63 125.81 56.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.601 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.449 HG12 ' N ' ' A' ' 75' ' ' GLU . 15.7 tt -81.22 162.78 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.036 0.445 . . . . 0.0 110.778 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.449 ' N ' HG12 ' A' ' 74' ' ' ILE . 45.6 mt-10 -124.67 50.73 1.69 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.367 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -87.07 -89.44 0.12 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.734 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -138.57 -22.29 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.162 0.506 . . . . 0.0 111.206 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -75.35 -3.16 31.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.27 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.4 p -72.95 95.88 2.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.359 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 57.7 t -71.38 113.23 7.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.663 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 81' ' ' ARG . 28.3 mtp180 -88.08 110.97 21.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.266 0.555 . . . . 0.0 109.849 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -101.28 132.35 46.85 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.239 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -78.47 104.7 9.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.246 0.546 . . . . 0.0 110.241 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.529 ' HE1' ' HB2' ' A' ' 30' ' ' ALA . 8.7 tpt -86.18 146.38 26.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.803 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp -125.57 92.24 3.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.854 0.835 . . . . 0.0 110.408 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.654 HG22 ' CD1' ' A' ' 36' ' ' TRP . 3.7 t -79.29 83.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.638 176.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.93 -74.89 1.14 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.19 4.95 1.86 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.265 0.555 . . . . 0.0 109.7 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -91.51 110.04 21.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.14 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 m -84.48 114.83 22.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.123 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.518 HG23 ' HB3' ' A' ' 84' ' ' MET . 2.2 m -134.84 144.54 34.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.921 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.69 119.89 23.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.435 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 117' ' ' VAL . 27.7 m -122.39 153.79 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.747 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.6 t -96.55 128.01 48.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.0 110.66 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.561 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 56.9 t0 -71.78 129.0 37.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.265 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -82.52 -20.05 37.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.863 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.21 156.45 9.68 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.856 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 101' ' ' ALA . 41.6 mt-10 -78.64 -5.82 54.0 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.763 -0.257 . . . . 0.0 111.5 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.724 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.8 pt? -68.38 -38.93 81.84 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 172.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.25 -36.47 63.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.75 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB2' ' HG3' ' A' ' 113' ' ' ARG . . . -59.27 -52.51 65.36 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.31 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.451 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -63.0 -40.03 96.54 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.346 0.593 . . . . 0.0 111.08 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -57.35 -35.71 70.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.538 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.532 HD12 ' HB3' ' A' ' 107' ' ' HIS . 2.3 tp -95.41 -22.65 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.862 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.451 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 86.2 p -66.86 -20.27 65.89 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.251 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -87.9 -46.2 9.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.332 173.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.532 ' HB3' HD12 ' A' ' 104' ' ' ILE . 76.3 t60 -75.17 -48.43 23.67 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.04 -38.15 57.51 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.51 -23.49 35.61 Favored Glycine 0 C--N 1.329 0.161 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.325 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.444 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 27.7 m -103.52 159.32 29.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 O-C-N 122.824 -0.221 . . . . 0.0 110.659 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 37.2 Cg_endo -66.48 90.53 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.466 2.111 . . . . 0.0 111.829 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.448 ' SG ' HG23 ' A' ' 104' ' ' ILE . 2.2 p -134.76 157.18 47.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.969 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.532 ' HG3' ' HB2' ' A' ' 101' ' ' ALA . 21.9 ttm180 -132.55 137.48 47.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.331 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.526 HG13 HG22 ' A' ' 29' ' ' VAL . 2.0 mp -77.16 128.92 37.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.45 ' CD2' ' HA ' ' A' ' 95' ' ' ASP . 80.0 mt -131.8 142.82 49.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.227 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -107.34 120.68 42.82 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 93' ' ' VAL . 60.2 t -65.58 116.34 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.071 0.463 . . . . 0.0 110.051 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.551 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 2.2 t-80 -77.2 133.56 68.37 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 10.8 Cg_endo -57.58 -5.36 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.492 2.794 . . . . 0.0 114.472 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -54.71 -44.47 73.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.458 0.647 . . . . 0.0 109.353 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.1 mmt -93.59 -56.76 2.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.617 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 60.26 -173.38 0.12 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.867 0.729 . . . . 0.0 110.493 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.411 ' CD ' ' H ' ' A' ' 124' ' ' VAL . 1.8 tm-20 57.65 -141.64 0.75 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.61 ' CG1' HG21 ' A' ' 86' ' ' VAL . 48.4 t 71.3 113.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.511 0.672 . . . . 0.0 111.783 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -124.48 150.08 46.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.021 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.485 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 6.7 t90 -45.12 142.17 2.97 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.093 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.589 ' HD3' HG12 ' A' ' 86' ' ' VAL . 3.2 Cg_endo -41.67 122.27 1.89 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 123.643 2.895 . . . . 0.0 112.824 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 130' ' ' GLU . 17.7 m -94.02 43.79 1.11 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.144 -173.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 129' ' ' LEU . 1.3 pt? -77.39 23.92 0.2 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.97 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 128' ' ' SER . 7.9 pt-20 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.738 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.045 0.45 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -73.62 102.75 3.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.106 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 t -65.69 117.78 8.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.79 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.3 m 61.26 32.13 19.37 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.257 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.578 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -98.55 119.96 38.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.54 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.626 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 9.6 m-85 -97.76 141.15 31.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.449 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 75.6 mt-30 -105.23 95.93 10.48 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.45 0.167 . . . . 0.0 111.262 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.626 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 11.0 Cg_exo -72.41 -62.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.161 2.574 . . . . 0.0 112.619 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.855 HD11 HD21 ' A' ' 57' ' ' LEU . 8.0 mt -113.81 159.79 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.658 0.599 . . . . 0.0 110.912 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' H ' HG22 ' A' ' 9' ' ' ILE . . . -71.17 -56.73 5.47 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -66.08 -45.02 82.72 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -171.964 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.803 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 4.7 p -68.48 -42.21 79.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.755 0.312 . . . . 0.0 111.011 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.74 -127.74 9.34 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.362 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.578 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -96.82 145.1 26.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.377 0.608 . . . . 0.0 111.794 -173.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.6 m -137.38 127.79 26.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.691 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.6 m -86.68 83.5 7.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.397 0.618 . . . . 0.0 110.732 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.416 ' HG2' ' H ' ' A' ' 19' ' ' GLU . 9.1 tt0 -147.39 126.63 13.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.059 176.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.8 p -55.76 -28.2 54.78 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -174.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' A' ' 17' ' ' GLN . 0.9 OUTLIER -76.89 -22.37 53.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.717 0.294 . . . . 0.0 111.267 -176.954 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.534 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -65.42 -28.25 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.346 . . . . 0.0 111.556 -176.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . . . -61.67 -22.03 64.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.113 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.92 -23.64 17.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -109.71 4.42 21.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.484 -172.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 5.0 pp0? -78.19 141.62 38.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 64.4 mttm -163.86 -169.75 1.97 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -78.74 72.68 5.27 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.697 0.76 . . . . 0.0 110.372 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.701 ' HB3' HG23 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -101.42 145.15 29.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.418 178.44 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -176.19 179.2 1.29 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.348 0.594 . . . . 0.0 112.265 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 114' ' ' ILE . 16.8 t -110.84 148.07 14.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.199 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.525 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -134.22 156.55 48.18 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 p30 -112.46 173.15 6.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.272 0.558 . . . . 0.0 112.143 -171.268 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 111' ' ' PRO . 9.9 p-10 -46.24 -33.62 3.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.264 -1.335 . . . . 0.0 113.669 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -72.64 2.03 7.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -173.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 84' ' ' MET . . . 80.58 8.68 87.28 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -106.71 152.16 24.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.114 -0.543 . . . . 0.0 110.022 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -64.3 146.72 53.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.293 173.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.446 HD22 ' SG ' ' A' ' 112' ' ' CYS . 20.3 tp -98.65 166.26 11.41 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.406 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . 17.2 t-20 -147.95 158.18 43.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -173.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 43' ' ' PRO . 54.5 mtm180 -73.25 -14.95 61.42 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.97 -18.89 35.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.189 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.406 ' HG ' ' HB3' ' A' ' 38' ' ' ASN . 91.3 mt -92.7 -51.82 4.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.2 m -114.78 94.27 36.84 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.996 173.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 51.7 Cg_exo -54.83 -44.53 48.78 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.723 2.949 . . . . 0.0 113.608 -171.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -77.52 8.38 4.38 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 108' ' ' ALA . 2.4 mp -76.16 -21.65 56.31 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.2 -22.62 61.3 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.983 170.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 52.5 mt-10 -86.06 63.16 7.87 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.225 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 12' ' ' CYS . 73.3 t -123.18 127.93 74.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.136 169.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 60' ' ' LYS . 5.8 t -91.24 140.19 30.03 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 2.7 t -121.39 128.29 75.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.0 111.821 -172.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.589 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 15.4 mt-10 -120.86 129.41 53.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.559 169.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' A' ' 20' ' ' ALA . 5.7 mp -110.57 133.58 53.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.52 0.676 . . . . 0.0 110.013 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.1 ttm105 -135.91 148.14 48.44 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 70.0 mtm -62.98 93.68 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.433 0.635 . . . . 0.0 110.741 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.37 -16.03 11.71 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.938 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -143.28 138.42 29.56 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 117.828 0.814 . . . . 0.0 111.776 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.855 HD21 HD11 ' A' ' 9' ' ' ILE . 39.0 tp -113.1 112.46 23.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.702 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 51' ' ' GLU . 61.0 t -100.68 110.6 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.055 0.455 . . . . 0.0 111.251 -173.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 mp -98.67 132.5 44.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.996 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 66' ' ' ARG . 44.3 mtmt -129.52 136.81 50.31 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -116.45 142.28 29.25 Favored Pre-proline 0 C--O 1.222 -0.372 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.449 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 26.8 Cg_exo -62.89 94.74 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.93 1.753 . . . . 0.0 110.225 168.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.29 -28.33 6.33 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.042 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.604 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 16.7 mmt -122.4 152.65 40.0 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.34 -166.89 0.02 OUTLIER 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.856 0.836 . . . . 0.0 112.561 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.564 ' HB3' ' HG2' ' A' ' 60' ' ' LYS . 12.2 ptt180 -95.71 146.63 24.36 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.45 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 tp -124.54 115.36 20.73 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.793 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.76 109.75 21.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.619 0.723 . . . . 0.0 110.788 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.4 mt -104.73 113.81 64.55 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.361 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.47 123.04 12.7 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.258 1.972 . . . . 0.0 111.957 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 57' ' ' LEU . 95.9 mt -66.04 -28.48 68.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.631 0.729 . . . . 0.0 109.12 176.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -85.01 90.55 7.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.199 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.93 143.97 10.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.048 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.2 mt -81.63 148.04 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -138.67 61.0 1.59 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.177 0.513 . . . . 0.0 110.171 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -146.03 -59.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.313 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -109.21 -62.61 1.46 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.666 0.269 . . . . 0.0 111.577 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -83.05 32.99 0.44 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.957 0.884 . . . . 0.0 110.358 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.3 t -107.94 97.34 7.06 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.636 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 45.1 t -71.88 99.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.92 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.539 ' HG2' ' HB2' ' A' ' 92' ' ' ASP . 52.7 ttp180 -88.8 90.68 8.51 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -93.11 130.0 38.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.895 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -79.07 114.91 18.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.843 0.354 . . . . 0.0 110.405 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 2.4 tpt -105.22 154.94 19.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.754 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.25 87.61 2.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.689 0.757 . . . . 0.0 109.559 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 t -81.46 92.88 2.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.736 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.27 -81.24 1.08 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.57 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -140.06 9.48 2.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.793 -0.203 . . . . 0.0 110.788 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -111.48 110.53 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.359 . . . . 0.0 110.506 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 m -84.29 109.61 17.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.224 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 m -131.85 149.21 32.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.806 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.539 ' HB2' ' HG2' ' A' ' 81' ' ' ARG . 7.1 p-10 -87.22 128.71 35.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.442 0.639 . . . . 0.0 111.06 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 115' ' ' LEU . 29.5 m -124.91 153.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.011 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 118' ' ' HIS . 98.8 t -96.33 137.3 24.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.636 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 32.0 t70 -86.8 123.79 32.34 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.448 ' HG3' ' HE1' ' A' ' 27' ' ' TRP . 16.3 mm-40 -83.38 5.73 22.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 -174.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.78 126.65 2.41 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.211 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -67.47 -19.54 65.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.037 0.446 . . . . 0.0 110.244 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.03 -33.47 74.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 173.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.11 79.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.875 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -57.94 -54.26 48.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.5 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.93 87.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -54.32 -46.49 72.86 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.966 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.564 HD12 ' HB3' ' A' ' 107' ' ' HIS . 1.5 tp -84.93 -21.54 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.692 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.4 m -67.12 -15.66 63.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.167 0.508 . . . . 0.0 109.699 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -90.39 -52.02 5.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.276 171.492 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.564 ' HB3' HD12 ' A' ' 104' ' ' ILE . 72.5 t60 -67.63 -46.66 71.84 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.02 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.459 ' HB2' HD11 ' A' ' 45' ' ' LEU . . . -82.29 -42.22 19.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.046 0.45 . . . . 0.0 109.807 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.06 -12.36 62.2 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.055 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.544 HG23 ' SG ' ' A' ' 112' ' ' CYS . 15.4 m -112.78 159.42 34.49 Favored Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 122.788 -0.242 . . . . 0.0 110.353 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.435 ' HB2' ' HB3' ' A' ' 32' ' ' ASP . 25.4 Cg_exo -63.18 93.11 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.831 2.354 . . . . 0.0 112.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.544 ' SG ' HG23 ' A' ' 110' ' ' VAL . 68.6 m -134.8 155.86 49.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.955 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 10.5 ptm180 -141.16 146.8 37.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.605 HG12 HG22 ' A' ' 29' ' ' VAL . 35.2 mt -85.15 122.78 38.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.107 -177.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 93' ' ' VAL . 35.8 mt -126.06 152.23 46.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.139 -171.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.612 ' HB3' ' HZ3' ' A' ' 116' ' ' LYS . 7.8 ttpm? -119.09 123.16 43.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.104 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.67 137.55 24.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.764 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.515 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -76.49 134.25 70.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.653 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' A' ' 118' ' ' HIS . 3.7 Cg_exo -74.53 -8.05 20.17 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.231 2.621 . . . . 0.0 113.242 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.79 -52.48 56.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.338 . . . . 0.0 111.077 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -91.98 -45.43 8.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.959 178.052 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.429 ' N ' ' SD ' ' A' ' 121' ' ' MET . . . 58.94 -174.36 0.09 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.078 0.551 . . . . 0.0 112.142 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 49.78 84.03 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 122.096 0.951 . . . . 0.0 112.992 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.7 t -132.19 131.8 60.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.891 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -131.3 133.22 45.15 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.883 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.508 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 8.3 t90 -45.28 140.74 3.78 Favored Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 124.196 0.935 . . . . 0.0 110.772 175.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.621 ' HB2' HD23 ' A' ' 129' ' ' LEU . 9.5 Cg_endo -47.73 115.42 1.43 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.607 2.871 . . . . 0.0 112.745 -176.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.4 m -85.7 37.84 0.72 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.383 0.611 . . . . 0.0 110.724 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.621 HD23 ' HB2' ' A' ' 127' ' ' PRO . 3.2 pp -77.33 171.99 14.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.178 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.4 -0.81 . . . . 0.0 109.789 177.857 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -73.41 107.97 6.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.99 0.424 . . . . 0.0 111.61 -176.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.669 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -155.68 -83.55 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.042 175.389 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.669 ' HB ' ' O ' ' A' ' 3' ' ' THR . 6.9 t 147.97 146.29 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.438 1.095 . . . . 0.0 110.522 172.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -167.21 122.59 1.08 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.077 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.621 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 36.5 m-85 -103.25 140.37 37.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.25 95.76 14.06 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.947 0.404 . . . . 0.0 110.048 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.87 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 7.5 Cg_endo -90.06 -35.65 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.449 2.766 . . . . 0.0 113.395 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 2.4 mm -115.93 135.78 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 O-C-N 123.9 0.75 . . . . 0.0 110.231 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.451 ' O ' ' HD2' ' A' ' 39' ' ' ARG . . . -68.22 -56.23 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.618 ' CD ' ' H ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -70.86 -53.53 14.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.489 -178.109 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.835 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 39.7 m -56.48 -47.59 78.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.146 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.37 -130.39 10.16 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.115 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.73 150.46 21.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.321 0.581 . . . . 0.0 112.034 -172.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.46 HG22 ' H ' ' A' ' 17' ' ' GLN . 10.7 m -121.65 139.09 53.98 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.491 176.19 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m -90.44 8.47 33.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.36 0.6 . . . . 0.0 111.201 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.46 ' H ' HG22 ' A' ' 15' ' ' THR . 1.2 mp0 -95.63 142.19 28.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.779 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.8 m -67.68 -15.95 63.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.081 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HB3' ' HE2' ' A' ' 23' ' ' TYR . 7.2 mm-40 -64.3 -36.1 83.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.288 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.87 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -62.08 -25.01 67.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.768 -171.035 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.03 -23.93 67.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.03 0.443 . . . . 0.0 111.093 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.05 1.04 22.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.685 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.405 ' HE2' ' HB3' ' A' ' 19' ' ' GLU . 35.3 m-85 -126.44 12.4 7.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.723 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 14.0 pt20 -70.26 143.07 52.22 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HG3' ' C ' ' A' ' 24' ' ' GLN . 83.1 mttt -160.67 173.14 15.9 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -172.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -78.73 75.64 5.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.351 0.596 . . . . 0.0 109.742 173.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.44 ' HE1' ' HG3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -92.76 152.9 19.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.178 177.893 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 pp -175.58 177.39 1.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.468 0.651 . . . . 0.0 112.184 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 114' ' ' ILE . 64.6 t -122.0 138.16 53.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -122.81 141.63 51.64 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 122.174 -0.328 . . . . 0.0 110.16 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -88.51 172.78 9.08 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.117 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -47.79 -31.7 5.2 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.677 0.791 . . . . 0.0 112.631 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.93 -14.79 63.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.709 0.29 . . . . 0.0 111.736 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.53 5.85 68.81 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.559 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -94.06 144.97 25.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.562 -176.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.593 ' CH2' ' HB ' ' A' ' 124' ' ' VAL . 31.0 m0 -68.99 125.29 26.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.844 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.447 ' HG ' ' SG ' ' A' ' 42' ' ' CYS . 29.5 tp -96.24 131.67 42.49 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -119.76 157.97 27.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.871 0.367 . . . . 0.0 111.126 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 10' ' ' ALA . 11.4 ptm180 -64.64 -15.41 61.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.46 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.04 -37.66 61.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.487 0.66 . . . . 0.0 109.461 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.4 HD11 ' HZ2' ' A' ' 126' ' ' TRP . 68.3 mt -77.64 -50.4 12.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.885 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.447 ' SG ' ' HG ' ' A' ' 37' ' ' LEU . 13.1 p -116.7 92.98 39.62 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.371 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.58 -25.02 69.68 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.068 2.512 . . . . 0.0 113.214 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -71.36 -17.64 62.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 111.734 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.445 HD13 ' SG ' ' A' ' 42' ' ' CYS . 7.7 mp -72.46 -21.67 61.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.0 0.429 . . . . 0.0 110.599 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.81 -5.18 32.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.514 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 6.7 mm-40 -84.67 3.9 35.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.338 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.835 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 95.3 t -79.77 118.74 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.87 0.367 . . . . 0.0 110.969 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.9 p -87.18 119.12 27.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.687 ' HB ' ' HB3' ' A' ' 12' ' ' CYS . 12.0 p -117.71 128.26 74.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.315 -171.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 35.2 mm-40 -120.87 129.84 53.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.561 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 20' ' ' ALA . 10.1 mp -97.78 125.89 42.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.499 0.666 . . . . 0.0 110.66 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.529 HH21 HG21 ' A' ' 58' ' ' VAL . 28.0 ttm-85 -110.09 164.66 12.41 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.373 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.43 88.9 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.483 0.658 . . . . 0.0 110.257 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.39 -13.7 36.3 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.933 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.75 138.3 48.56 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.621 0.724 . . . . 0.0 112.345 -174.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.411 ' HB2' HD23 ' A' ' 71' ' ' LEU . 61.3 tp -100.59 107.87 19.65 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.695 173.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.529 HG21 HH21 ' A' ' 53' ' ' ARG . 46.2 t -99.56 102.78 13.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.928 0.394 . . . . 0.0 110.685 -175.617 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.671 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 5.8 mp -90.88 140.54 29.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.715 176.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.496 ' HE2' ' HG2' ' A' ' 51' ' ' GLU . 39.6 mtmt -136.44 130.1 32.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.759 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -114.74 153.09 46.88 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 119.211 -0.995 . . . . 0.0 112.829 -176.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.503 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 20.0 Cg_exo -67.14 98.25 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.236 1.957 . . . . 0.0 110.618 170.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.7 -18.31 32.2 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.267 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.759 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 14.3 mmt -121.73 144.84 48.56 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.2 mt -68.15 -149.93 0.01 OUTLIER 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.407 0.622 . . . . 0.0 111.971 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -69.77 170.25 11.36 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.745 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 60.2 tp -151.71 87.72 1.38 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.894 166.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -84.0 104.98 14.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.447 -175.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.0 mt -115.81 136.75 22.93 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.393 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.22 139.72 91.58 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 121.66 1.573 . . . . 0.0 110.613 171.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.411 HD23 ' HB2' ' A' ' 57' ' ' LEU . 69.2 mt -52.69 -33.41 47.37 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -140.02 110.17 6.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.4 t -59.21 123.1 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 77' ' ' ASP . 24.2 mm -57.45 145.75 7.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.911 0.386 . . . . 0.0 110.409 -176.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -74.94 -2.28 26.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.765 0.793 . . . . 0.0 110.924 -170.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -129.07 -0.01 5.23 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.097 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.611 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 25.1 t70 -85.09 -67.9 0.77 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -160.23 44.34 0.21 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.518 0.675 . . . . 0.0 109.44 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.3 t -77.06 92.44 3.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.926 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 41.1 t -85.81 122.23 38.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.502 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.7 104.33 16.34 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.373 0.606 . . . . 0.0 111.139 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.515 ' O ' HG22 ' A' ' 93' ' ' VAL . 39.5 m-85 -94.95 116.4 28.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 173.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLN . . . . . 0.507 ' HG2' HG22 ' A' ' 90' ' ' THR . 31.6 tt0 -80.87 99.28 8.25 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.633 ' O ' ' HA ' ' A' ' 90' ' ' THR . 1.0 OUTLIER -86.96 159.31 19.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.881 -169.739 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.8 tp -117.99 87.36 2.7 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.885 0.85 . . . . 0.0 109.554 -173.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.495 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 2.8 t -78.99 86.84 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.874 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.85 -68.9 2.48 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.592 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -145.41 2.95 0.99 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.777 0.322 . . . . 0.0 110.367 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.462 ' HG2' HG13 ' A' ' 91' ' ' VAL . 20.3 tt0 -109.95 109.61 20.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.925 0.393 . . . . 0.0 111.025 -170.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -85.13 104.83 15.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.655 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.692 HG21 HG21 ' A' ' 124' ' ' VAL . 2.7 m -118.93 144.99 25.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.062 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.09 112.68 16.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.034 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.592 HG21 HD13 ' A' ' 115' ' ' LEU . 16.8 m -120.07 152.47 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.48 176.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -103.22 135.37 41.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.767 0.317 . . . . 0.0 111.176 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.584 ' HA ' HD23 ' A' ' 115' ' ' LEU . 43.5 t0 -83.2 126.13 32.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' HG3' ' HE1' ' A' ' 27' ' ' TRP . 8.3 mm-40 -81.32 -5.91 58.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.495 -176.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.5 136.92 2.95 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.378 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.47 ' HG2' ' NH1' ' A' ' 113' ' ' ARG . 14.6 mt-10 -69.15 -23.13 63.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.826 0.346 . . . . 0.0 110.573 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -64.56 -30.91 71.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.082 0.467 . . . . 0.0 109.86 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.532 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -74.35 -37.95 63.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.9 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB2' ' HD3' ' A' ' 113' ' ' ARG . . . -59.51 -46.39 88.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.621 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.506 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -66.69 -36.5 82.66 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.351 0.596 . . . . 0.0 111.027 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.415 ' CZ2' ' HB2' ' A' ' 61' ' ' ALA . 76.1 t90 -57.45 -40.27 78.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.311 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.2 tp -93.23 -21.1 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.528 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 90.5 p -66.87 -19.87 65.82 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.488 -0.757 . . . . 0.0 109.237 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -83.65 -48.66 9.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.135 172.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.578 ' HB3' HD12 ' A' ' 104' ' ' ILE . 75.1 t60 -74.28 -51.98 13.66 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 45' ' ' LEU . . . -71.78 -41.39 68.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 109.739 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.13 -22.94 38.03 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.74 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.22 157.03 35.58 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 120.532 0.206 . . . . 0.0 110.671 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.17 92.89 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.464 2.11 . . . . 0.0 111.469 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.432 ' HB2' HG12 ' A' ' 29' ' ' VAL . 5.0 p -134.25 156.5 48.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.015 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.509 ' HD3' ' HB2' ' A' ' 101' ' ' ALA . 7.3 tpp180 -117.77 128.44 54.88 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.172 -175.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 29' ' ' VAL . 54.5 mt -79.1 118.33 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.592 HD13 HG21 ' A' ' 93' ' ' VAL . 23.2 mt -130.46 142.1 50.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.286 0.565 . . . . 0.0 112.061 -168.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.466 ' HB3' ' HZ3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -117.1 117.33 29.33 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.206 175.109 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.91 137.56 23.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.522 -174.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.99 125.69 79.22 Favored Pre-proline 0 C--O 1.234 0.243 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.5 -4.46 6.86 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.377 2.718 . . . . 0.0 114.881 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -51.03 -57.33 8.91 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.347 0.594 . . . . 0.0 110.785 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 18.6 ptp -107.17 -54.19 2.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.077 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 124' ' ' VAL . . . 54.7 -106.85 0.34 Allowed 'General case' 0 CA--C 1.531 0.23 0 O-C-N 123.489 0.493 . . . . 0.0 110.887 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 66.72 -59.13 0.37 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.816 0.846 . . . . 0.0 113.233 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.692 HG21 HG21 ' A' ' 91' ' ' VAL . 3.4 t -54.57 122.69 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 112.504 -168.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -112.41 36.45 3.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.092 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.679 ' HB3' ' HG ' ' A' ' 129' ' ' LEU . 11.7 t90 72.35 152.41 0.14 Allowed Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -169.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.669 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 41.8 Cg_exo -25.86 -54.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 124.523 3.482 . . . . 0.0 114.438 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.3 p -171.84 82.69 0.07 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.479 0.657 . . . . 0.0 110.931 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.679 ' HG ' ' HB3' ' A' ' 126' ' ' TRP . 70.3 mt -81.13 120.06 24.37 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.391 170.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.663 -176.388 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 120.763 0.316 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 t -147.6 169.76 18.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.78 0.324 . . . . 0.0 110.499 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.2 t -113.23 164.67 13.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.199 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.4 m 64.59 23.33 12.83 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 122.211 1.005 . . . . 0.0 109.878 -176.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.688 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -103.09 111.65 24.1 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.869 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.712 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 61.8 m-85 -87.45 117.66 26.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 13' ' ' GLY . 61.8 tt0 -96.39 98.85 4.61 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.266 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.758 ' HA ' ' CB ' ' A' ' 24' ' ' GLN . 21.4 Cg_exo -64.69 -60.59 0.13 Allowed 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 122.67 2.247 . . . . 0.0 110.9 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 27' ' ' TRP . 44.9 mt -114.54 136.01 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.951 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.02 -58.74 5.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.759 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 16.9 mm-40 -70.61 -22.43 62.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.794 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.859 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 73.6 m -73.6 -48.08 35.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.133 0.492 . . . . 0.0 110.087 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . 120.33 -153.72 16.63 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.231 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.688 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -113.33 142.73 45.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.106 0.479 . . . . 0.0 111.909 -172.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.3 m -118.87 137.57 53.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.699 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m -86.49 76.29 9.62 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.144 0.497 . . . . 0.0 110.126 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 19' ' ' GLU . 8.6 tt0 -160.19 120.7 2.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.858 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -68.49 -10.33 54.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.922 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.401 ' H ' ' HG2' ' A' ' 17' ' ' GLN . 22.2 tt0 -68.35 -28.54 67.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.287 0.565 . . . . 0.0 109.72 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -67.94 -24.22 65.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.624 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.84 -15.75 63.19 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.23 -3.84 50.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.631 0.253 . . . . 0.0 111.419 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.426 ' CD2' HD13 ' A' ' 71' ' ' LEU . 74.3 m-85 -130.56 -25.67 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.758 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -66.0 155.35 36.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.989 -177.744 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -172.65 -160.63 0.14 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.219 0.324 . . . . 0.0 110.169 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -74.95 69.06 1.86 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 122.122 0.963 . . . . 0.0 109.729 175.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.677 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 1.3 t90 -100.51 144.84 29.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.452 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -170.31 -173.79 1.55 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.575 0.625 . . . . 0.0 112.243 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.508 HG22 HG12 ' A' ' 114' ' ' ILE . 80.7 t -113.2 144.23 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.758 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.02 150.13 37.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 0.0 111.281 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.49 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 27.5 t30 -98.89 156.81 16.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.137 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -46.13 -37.11 6.53 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.758 0.823 . . . . 0.0 112.683 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.09 -6.97 37.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 111.401 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.63 4.53 63.77 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.582 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -98.44 160.35 14.34 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.443 ' HB2' ' HD1' ' A' ' 126' ' ' TRP . 28.2 m0 -68.07 134.79 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 172.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.627 HD22 ' SG ' ' A' ' 112' ' ' CYS . 28.4 tp -99.19 131.59 45.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.39 152.86 42.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.351 0.596 . . . . 0.0 112.597 -173.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.2 ttm105 -48.8 -32.11 8.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.736 164.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.77 -17.8 64.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.492 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 75.5 mt -105.6 -39.6 6.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.12 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 50.5 t -132.29 101.59 14.71 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.029 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.72 -29.45 59.85 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.653 2.236 . . . . 0.0 112.138 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -59.34 -30.74 68.59 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.398 0.618 . . . . 0.0 110.473 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.759 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 37.3 tp -66.79 -34.03 76.92 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.566 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -73.98 9.21 1.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -98.26 24.26 7.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.844 0.354 . . . . 0.0 111.203 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.859 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 55.4 t -84.79 113.79 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.714 0.292 . . . . 0.0 110.409 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.8 t -77.54 132.06 38.17 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.28 138.25 53.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.559 0.695 . . . . 0.0 112.074 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 35.3 tt0 -140.86 149.12 41.56 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.458 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 20' ' ' ALA . 5.5 mp -128.61 158.03 39.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.687 0.756 . . . . 0.0 112.238 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -158.45 149.06 20.24 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.501 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 tpt -49.26 98.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.516 0.51 . . . . 0.0 110.992 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.51 -31.19 6.07 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.486 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.88 137.76 52.44 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.092 0.946 . . . . 0.0 112.963 -172.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.488 ' HB2' ' CD2' ' A' ' 71' ' ' LEU . 37.9 tp -100.72 108.59 20.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.213 170.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 42.5 t -96.96 99.82 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.977 0.418 . . . . 0.0 110.95 -172.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 8.0 mp -91.86 141.74 28.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.048 175.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -137.44 130.27 30.24 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.637 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -126.0 151.67 71.88 Favored Pre-proline 0 C--O 1.221 -0.41 0 C-N-CA 118.68 -1.208 . . . . 0.0 113.247 -175.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -62.81 107.19 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.986 1.79 . . . . 0.0 110.228 168.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.23 -24.29 25.01 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.169 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.637 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 95.1 mmm -122.39 147.57 46.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 0.0 110.327 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.3 mt -68.34 -144.58 0.01 OUTLIER 'General case' 0 C--O 1.247 0.937 0 CA-C-O 121.548 0.69 . . . . 0.0 110.756 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 5.8 ptt180 -86.75 151.63 23.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.066 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 60.3 tp -124.32 93.53 3.94 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 168.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.59 97.95 10.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.891 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.447 HG13 ' HG ' ' A' ' 67' ' ' LEU . 65.9 mt -100.21 122.52 49.98 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.922 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.94 123.97 15.11 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.006 1.804 . . . . 0.0 110.77 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' CD2' ' HB2' ' A' ' 57' ' ' LEU . 64.7 mt -67.72 -42.14 82.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.898 0.38 . . . . 0.0 110.707 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -92.39 64.3 4.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.699 0.762 . . . . 0.0 110.898 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.33 130.53 29.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.718 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' A' ' 77' ' ' ASP . 7.6 mt -67.59 136.28 26.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -91.81 12.71 20.55 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.695 0.759 . . . . 0.0 110.368 -169.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -129.15 -8.72 4.8 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.773 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.648 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 38.3 t70 -81.36 -85.32 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.378 -170.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.11 34.34 5.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.169 0.509 . . . . 0.0 109.954 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.7 p -72.31 77.63 1.0 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.281 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 61.2 t -66.92 108.2 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.416 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -66.58 112.63 4.24 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.526 ' O ' HG22 ' A' ' 93' ' ' VAL . 3.1 t80 -105.15 107.97 19.24 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -80.11 113.82 18.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.636 ' HA ' ' CE ' ' A' ' 84' ' ' MET . 5.3 mmt -103.68 169.59 8.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.195 -175.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.2 tp -139.38 88.04 2.23 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 t -89.39 103.24 13.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.785 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.61 -77.76 1.4 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -146.27 4.19 0.92 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.51 0.195 . . . . 0.0 110.933 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.602 ' HG2' HG13 ' A' ' 91' ' ' VAL . 57.2 tt0 -105.26 120.48 41.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.849 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 84' ' ' MET . 0.2 OUTLIER -79.93 116.33 20.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.264 174.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.602 HG13 ' HG2' ' A' ' 89' ' ' GLN . 3.6 m -129.74 164.29 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.39 112.69 24.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.754 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 115' ' ' LEU . 7.1 m -125.81 152.13 32.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.7 t -106.21 142.17 19.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 122.237 -0.289 . . . . 0.0 110.743 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.649 ' OD1' ' HD3' ' A' ' 113' ' ' ARG . 26.4 t70 -92.94 125.86 37.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.56 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.98 -14.03 62.21 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.708 0.289 . . . . 0.0 111.652 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 137.46 149.21 5.53 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.999 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -64.68 -13.54 54.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.934 0.397 . . . . 0.0 111.001 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.4 tp -66.04 -43.55 87.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.49 -36.53 76.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.388 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.09 67.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.131 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.438 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -62.95 -39.35 94.37 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.247 0.546 . . . . 0.0 111.103 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.417 ' HH2' HG13 ' A' ' 48' ' ' VAL . 49.8 t90 -57.81 -44.33 86.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.019 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 104' ' ' ILE . 1.6 tp -87.12 -25.17 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.571 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.438 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 16.5 p -68.49 -15.85 63.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.533 -0.729 . . . . 0.0 109.959 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -88.99 -45.25 9.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.448 171.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -74.4 -49.51 22.29 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.64 -40.87 55.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.48 -38.22 3.38 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.614 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.512 HG23 ' SG ' ' A' ' 112' ' ' CYS . 18.7 m -87.64 157.85 51.88 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.84 88.63 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.761 2.307 . . . . 0.0 111.923 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.627 ' SG ' HD22 ' A' ' 37' ' ' LEU . 73.8 m -134.83 168.73 18.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.939 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.649 ' HD3' ' OD1' ' A' ' 95' ' ' ASP . 11.1 ptp180 -149.14 151.23 34.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.606 0.241 . . . . 0.0 110.634 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 29' ' ' VAL . 52.3 mt -82.85 131.88 32.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 95' ' ' ASP . 64.7 mt -138.23 133.34 33.07 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 120.926 0.393 . . . . 0.0 111.214 -174.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -99.89 120.47 39.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.785 173.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.1 t -64.16 133.85 29.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.554 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 5.0 t-160 -55.99 126.65 67.08 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.88 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.554 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 6.1 Cg_endo -47.78 -32.49 17.09 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.679 2.919 . . . . 0.0 113.45 -175.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.21 -53.24 58.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.391 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 51.7 ttm -89.78 121.41 31.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.462 0.649 . . . . 0.0 110.636 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -115.4 -35.5 4.6 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.405 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -82.63 103.23 11.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.227 0.537 . . . . 0.0 111.364 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.556 HG13 HG11 ' A' ' 91' ' ' VAL . 51.4 t -130.47 -66.86 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.297 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 68.28 121.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.605 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.616 ' HE3' ' H ' ' A' ' 128' ' ' SER . 2.9 t90 -58.37 145.62 74.61 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.47 165.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 4.9 Cg_endo -45.37 -32.33 7.57 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.732 2.955 . . . . 0.0 113.386 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' SER . . . . . 0.616 ' H ' ' HE3' ' A' ' 126' ' ' TRP . 20.3 m 61.88 27.63 16.83 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.99 0.516 . . . . 0.0 111.537 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 79.9 mt 62.94 91.86 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.141 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.248 0.979 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.111 -178.934 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.5 m -90.86 98.38 11.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.102 0.477 . . . . 0.0 109.811 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.4 t -89.41 -20.06 24.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.763 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.1 m 64.29 92.03 0.07 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.592 0.71 . . . . 0.0 111.705 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -115.95 125.93 53.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.754 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.445 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 36.8 m-85 -89.98 138.17 31.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -114.54 93.24 31.71 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 120.735 0.302 . . . . 0.0 110.452 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.585 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 1.1 Cg_endo -84.8 -38.23 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.871 2.38 . . . . 0.0 112.213 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.635 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 0.7 OUTLIER -114.75 147.12 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.381 -176.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.13 -69.22 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.849 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -65.46 -39.9 92.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.283 -176.664 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.851 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 34.2 m -60.55 -47.92 84.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.846 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.55 -130.38 10.03 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.625 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -109.6 147.8 32.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.305 0.574 . . . . 0.0 112.112 -171.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.8 m -139.51 125.66 19.99 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.357 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -86.8 88.87 7.78 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.91 0.862 . . . . 0.0 110.639 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -148.19 135.97 20.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.194 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 p -56.46 -38.03 71.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -74.95 -23.35 58.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.417 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.585 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -62.13 -27.35 68.88 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.47 67.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.86 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.2 3.11 27.48 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -118.31 13.83 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.71 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.572 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -77.07 153.54 34.24 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.08 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -162.95 171.31 16.76 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.5 ' HD2' ' O ' ' A' ' 122' ' ' ALA . 58.6 mtt180 -76.81 76.84 3.42 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 122.145 0.974 . . . . 0.0 109.314 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -91.39 152.3 20.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.351 -1.749 . . . . 0.0 108.913 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 pp 179.49 -176.9 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.184 0.516 . . . . 0.0 111.097 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -118.87 140.73 41.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.573 178.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.31 140.05 50.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 10.1 p30 -95.88 -177.52 4.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.438 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -46.53 -41.44 14.24 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.81 0.694 . . . . 0.0 112.765 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.47 -8.13 48.73 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.09 8.78 87.33 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.704 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -88.63 142.76 27.42 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.461 ' HB2' ' HD1' ' A' ' 126' ' ' TRP . 29.8 m0 -62.36 128.31 35.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.824 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 29' ' ' VAL . 8.5 tp -87.42 131.45 34.31 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -120.64 162.8 19.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.47 -169.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -71.58 -21.55 61.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.258 0.551 . . . . 0.0 109.778 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.9 -27.16 61.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.825 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.9 mt -90.18 -45.39 9.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.525 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.699 ' SG ' ' HG ' ' A' ' 37' ' ' LEU . 1.7 p -130.44 96.83 23.22 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.105 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.27 -37.14 52.55 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.948 2.432 . . . . 0.0 112.859 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -73.24 -6.29 44.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.231 0.539 . . . . 0.0 111.003 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.849 ' HG ' ' HB2' ' A' ' 11' ' ' GLU . 33.8 tp -73.02 -24.23 60.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.919 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -72.19 -6.3 41.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.426 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.74 31.24 0.77 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.484 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.851 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 88.8 t -93.49 127.86 45.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.644 0.259 . . . . 0.0 110.418 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.2 t -86.47 137.54 32.46 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.585 HG22 ' HB3' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -119.41 144.7 27.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.182 0.515 . . . . 0.0 111.239 -173.751 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 35.0 tt0 -148.7 140.36 23.58 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -111.36 125.04 53.44 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.734 0.778 . . . . 0.0 110.578 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.608 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 2.4 tpm_? -105.1 154.89 19.56 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.09 -1.414 . . . . 0.0 107.487 176.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.1 ttt -64.0 89.18 0.05 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.917 0.389 . . . . 0.0 110.544 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.35 -9.44 33.14 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.521 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.608 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 87.5 m-85 -132.24 147.85 52.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.174 0.511 . . . . 0.0 111.235 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.599 ' HB3' HG13 ' A' ' 69' ' ' ILE . 45.8 tp -104.83 111.93 24.85 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 61.5 t -100.28 101.64 12.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.011 0.434 . . . . 0.0 110.778 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 11.1 mp -90.64 145.19 25.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.431 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -137.34 129.23 28.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.615 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -120.54 144.75 39.21 Favored Pre-proline 0 C--O 1.219 -0.514 0 C-N-CA 118.946 -1.102 . . . . 0.0 113.35 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -63.35 97.32 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.743 1.628 . . . . 0.0 109.758 166.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.94 -33.98 3.88 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.768 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.615 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 91.7 mmm -122.19 149.6 43.41 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.446 HD22 ' H ' ' A' ' 65' ' ' LEU . 2.6 mm? -70.91 -144.59 0.01 OUTLIER 'General case' 0 C--O 1.246 0.873 0 CA-C-O 120.895 0.379 . . . . 0.0 110.635 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 92.2 mtt180 -79.06 155.93 28.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.107 0.479 . . . . 0.0 110.563 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 59.9 tp -127.39 103.46 7.38 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -88.76 101.77 14.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.588 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.599 HG13 ' HB3' ' A' ' 57' ' ' LEU . 8.5 pt -124.43 119.25 26.14 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.444 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HB2' ' O ' ' A' ' 73' ' ' VAL . 39.5 Cg_exo -57.15 144.64 89.8 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.354 2.036 . . . . 0.0 111.33 176.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.0 mt -50.33 -69.22 0.12 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -167.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -88.94 -48.07 7.7 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.813 -171.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.538 ' O ' ' HB2' ' A' ' 70' ' ' PRO . 25.7 m -140.54 155.91 23.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.661 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.515 HG13 ' N ' ' A' ' 75' ' ' GLU . 7.4 tp -70.45 162.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 173.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.515 ' N ' HG13 ' A' ' 74' ' ' ILE . 26.7 mt-10 -82.28 23.8 0.72 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.34 0.59 . . . . 0.0 111.323 -175.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -132.51 156.63 46.45 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -84.62 -2.0 56.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.791 0.805 . . . . 0.0 109.885 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -88.35 29.51 0.97 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.902 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 m -60.89 102.82 0.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t -70.19 130.83 34.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.585 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -104.31 111.17 23.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.217 0.532 . . . . 0.0 110.306 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 93' ' ' VAL . 33.0 m-85 -102.89 135.06 45.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.379 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -88.32 128.1 35.49 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.286 0.565 . . . . 0.0 110.76 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.675 ' HE2' HD12 ' A' ' 115' ' ' LEU . 52.4 mtt -95.69 171.83 8.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.3 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.5 tp -139.96 87.26 2.15 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.435 0.636 . . . . 0.0 109.636 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.402 HG12 ' HD3' ' A' ' 127' ' ' PRO . 3.2 t -97.85 96.28 5.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.046 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 60.63 48.06 88.09 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.719 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 74.71 7.88 4.35 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.543 0.737 . . . . 0.0 111.708 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLN . . . . . 0.56 ' HG2' HG13 ' A' ' 91' ' ' VAL . 9.8 tt0 -96.02 99.01 10.82 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 84' ' ' MET . 30.3 m -77.14 105.97 8.56 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.314 0.578 . . . . 0.0 110.402 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.56 HG13 ' HG2' ' A' ' 89' ' ' GLN . 3.6 m -122.74 162.16 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.106 -175.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.633 ' O ' ' HB2' ' A' ' 118' ' ' HIS . 8.8 t70 -108.11 127.13 53.53 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 117' ' ' VAL . 23.1 m -132.74 154.11 39.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.921 0.391 . . . . 0.0 111.307 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 63.6 t -91.02 135.01 27.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.734 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.542 ' HA ' ' CD2' ' A' ' 115' ' ' LEU . 18.2 t70 -88.43 133.28 34.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.799 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -80.52 -2.84 47.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.247 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.91 141.59 5.57 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.0 -13.8 62.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.881 0.341 . . . . 0.0 111.078 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.1 pt? -69.7 -32.94 71.81 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 171.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.55 -33.23 58.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.787 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -57.36 -55.22 37.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.275 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.07 99.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.805 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' TRP . . . . . 0.429 ' CZ3' HD13 ' A' ' 104' ' ' ILE . 84.4 t90 -49.25 -47.68 46.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.725 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.542 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.3 tp -87.27 -22.51 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.122 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 64.5 m -66.44 -13.03 60.19 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.642 -0.661 . . . . 0.0 109.512 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -89.81 -49.93 6.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.602 173.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.542 ' HB3' HD12 ' A' ' 104' ' ' ILE . 78.1 t60 -76.18 -46.0 30.56 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.33 -36.78 71.69 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.72 -31.12 8.95 Favored Glycine 0 N--CA 1.454 -0.16 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.203 170.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.645 HG23 ' SG ' ' A' ' 112' ' ' CYS . 31.2 m -103.83 157.18 34.47 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.5 99.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.715 2.277 . . . . 0.0 112.265 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.645 ' SG ' HG23 ' A' ' 110' ' ' VAL . 57.2 m -134.56 -176.41 4.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.958 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 7.7 ptp180 -166.2 142.88 5.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.302 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.442 HG12 ' CG1' ' A' ' 29' ' ' VAL . 62.3 mt -79.44 123.03 35.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.675 HD12 ' HE2' ' A' ' 84' ' ' MET . 43.3 mt -134.83 150.29 50.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.004 -173.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -117.2 139.64 50.53 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.916 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.584 ' HA ' HG12 ' A' ' 93' ' ' VAL . 33.1 t -66.0 142.08 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.421 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.633 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 0.2 OUTLIER -61.74 142.32 94.7 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.537 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.27 -19.02 65.33 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.717 2.278 . . . . 0.0 111.773 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.1 -10.56 54.95 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.985 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.42 ' SD ' ' HB ' ' A' ' 91' ' ' VAL . 11.4 ptp -144.72 -44.24 0.24 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -176.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . 68.55 -64.45 0.31 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 172.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 125' ' ' ARG . 35.5 tt0 -70.47 -76.24 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -168.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.502 HG22 HG11 ' A' ' 91' ' ' VAL . 58.8 t 67.43 -77.33 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 122.758 0.423 . . . . 0.0 111.658 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.537 ' HG3' ' HG2' ' A' ' 123' ' ' GLU . 36.9 mtm180 81.96 131.89 0.05 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.26 1.024 . . . . 0.0 113.647 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.5 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 5.1 t90 -56.71 150.06 38.59 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.522 170.102 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.5 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 2.9 Cg_endo -44.14 120.29 2.44 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.106 2.537 . . . . 0.0 112.391 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.6 m -99.91 51.02 0.91 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.73 -173.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 129' ' ' LEU . 1.9 pt? -65.39 -0.11 1.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.032 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 C--N 1.312 -1.06 0 CA-C-O 118.334 -0.841 . . . . 0.0 109.141 175.735 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tmm? . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 m -129.11 122.59 30.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.863 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.7 m -89.01 -76.51 0.4 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 42.0 42.59 2.4 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.455 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -104.17 109.6 21.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.789 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.718 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 62.4 m-85 -91.54 142.5 27.58 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.476 -176.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.25 85.57 0.9 Allowed Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.907 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 3.3 Cg_exo -81.39 -59.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.726 2.284 . . . . 0.0 112.147 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 0.4 OUTLIER -99.71 138.7 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.582 -179.296 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.69 -56.41 20.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -170.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.877 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -77.81 -41.53 36.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.735 -176.429 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.846 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 78.1 m -52.37 -45.97 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.742 0.651 . . . . 0.0 111.898 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.545 ' HA2' HH12 ' A' ' 39' ' ' ARG . . . 108.5 -151.49 17.04 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.007 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.455 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -84.7 138.31 32.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.272 0.558 . . . . 0.0 111.525 -174.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.49 HG21 HD13 ' A' ' 52' ' ' LEU . 16.1 m -118.56 132.33 56.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.61 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -91.89 14.96 14.1 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.427 ' H ' HG22 ' A' ' 15' ' ' THR . 0.9 OUTLIER -101.55 139.05 37.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.814 0.34 . . . . 0.0 110.375 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 p -61.96 -36.3 81.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.65 -21.25 66.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.622 0.249 . . . . 0.0 111.632 -176.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.907 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -61.83 -27.28 68.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.649 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 -27.73 69.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.552 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.98 -13.83 26.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.375 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -113.57 6.66 17.11 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.747 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.619 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 16.1 pt20 -67.29 140.95 57.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 171.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -166.05 -179.29 5.09 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.905 -174.624 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -77.92 77.92 4.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.5 0.667 . . . . 0.0 110.715 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.429 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -102.03 162.53 12.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.992 177.557 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -179.49 178.52 0.67 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.271 0.558 . . . . 0.0 111.25 172.125 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 114' ' ' ILE . 60.4 t -112.69 146.34 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.028 173.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.632 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -126.9 147.03 50.09 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.283 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.518 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 5.7 p-10 -86.79 -179.58 6.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.045 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -46.03 -36.13 5.42 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.18 0.992 . . . . 0.0 113.367 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.479 ' H ' ' ND2' ' A' ' 31' ' ' ASN . . . -79.3 -0.32 31.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.93 45.53 63.11 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.535 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.468 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 25.1 tt0 -121.66 141.47 51.11 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.33 -177.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.727 ' CZ2' HG21 ' A' ' 124' ' ' VAL . 5.6 m95 -57.51 125.01 20.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.126 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.524 ' HG ' ' SG ' ' A' ' 42' ' ' CYS . 9.9 tp -113.49 132.18 55.77 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.57 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 22.4 p-10 -130.4 -177.04 4.16 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.545 HH12 ' HA2' ' A' ' 13' ' ' GLY . 10.0 mmm-85 -64.68 -15.14 60.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.575 -176.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' HB2' HD21 ' A' ' 38' ' ' ASN . 11.7 m-20 -93.33 -29.73 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.757 0.313 . . . . 0.0 110.884 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.57 ' HG ' ' OD1' ' A' ' 38' ' ' ASN . 86.8 mt -89.04 -42.71 11.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.672 ' HB2' HD13 ' A' ' 45' ' ' LEU . 24.2 p -123.85 91.53 49.54 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.609 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.4 -39.86 0.51 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.007 2.471 . . . . 0.0 113.776 -174.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.741 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 47.5 mtm-85 -67.12 -11.82 58.27 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.338 0.59 . . . . 0.0 111.745 -172.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.877 ' HB3' ' HB2' ' A' ' 11' ' ' GLU . 11.0 mp -68.59 -19.21 64.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.139 0.495 . . . . 0.0 110.402 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -67.8 -9.64 46.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.757 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.741 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 10.9 pt-20 -98.59 29.05 3.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.787 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.846 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 98.5 t -81.12 138.11 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.662 0.268 . . . . 0.0 110.556 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 t -92.24 134.54 34.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 12' ' ' CYS . 4.2 t -120.25 128.17 75.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.938 0.399 . . . . 0.0 111.598 -172.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.48 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 9.4 tp10 -123.61 143.61 50.12 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.184 172.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.49 HD13 HG21 ' A' ' 15' ' ' THR . 6.9 mp -124.75 125.82 44.67 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.546 0.689 . . . . 0.0 110.963 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.592 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 19.7 tpp180 -109.29 154.45 22.46 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 66.1 mtt -62.03 89.59 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 110.41 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.57 -7.45 26.25 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.932 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.592 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 97.9 m-85 -138.01 137.75 38.19 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.414 0.607 . . . . 0.0 111.606 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.0 tp -102.17 107.83 19.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.138 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 43.0 t -101.67 102.58 13.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.022 0.439 . . . . 0.0 111.031 -173.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.64 147.71 25.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.27 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -144.47 133.21 22.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.633 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -112.35 147.73 37.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.133 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -65.43 93.33 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.273 1.982 . . . . 0.0 110.67 172.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.93 -24.48 10.1 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.44 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.633 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 13.0 mmt -120.07 157.36 29.11 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.07 -163.13 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.315 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -90.31 165.84 13.66 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.518 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.7 tp -143.51 93.68 2.51 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.967 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -88.01 114.15 24.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.526 0.679 . . . . 0.0 110.248 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.552 HD13 ' HG2' ' A' ' 96' ' ' GLU . 55.0 mt -111.65 118.9 46.05 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.396 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.72 127.91 28.13 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.252 1.968 . . . . 0.0 111.296 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.73 -27.55 69.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.98 0.419 . . . . 0.0 110.589 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -106.47 103.12 12.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.216 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 t -84.67 162.05 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.189 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.3 mt -60.98 152.42 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.01 0.433 . . . . 0.0 111.499 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -96.49 23.0 7.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.759 0.79 . . . . 0.0 110.854 -173.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -125.47 -176.45 3.6 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.328 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -74.69 2.7 9.33 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.674 0.274 . . . . 0.0 111.387 -174.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -60.6 -40.86 93.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 168.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.2 t -81.06 82.54 6.98 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 171.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 48.5 t -60.21 130.6 24.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.484 -174.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ARG . . . . . 0.709 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -97.17 97.59 9.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.797 0.808 . . . . 0.0 109.124 170.162 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -76.98 121.57 23.68 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.334 -174.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -68.91 105.24 2.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.251 0.548 . . . . 0.0 110.058 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.486 ' HE1' HD13 ' A' ' 115' ' ' LEU . 23.4 tpp -93.17 150.73 20.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.816 -175.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.445 ' N ' ' HG3' ' A' ' 84' ' ' MET . 42.3 tp -125.9 89.2 2.98 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.695 0.759 . . . . 0.0 109.241 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.777 HG21 ' HB ' ' A' ' 124' ' ' VAL . 2.1 t -80.94 87.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.099 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.31 -86.83 1.01 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.63 16.33 2.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.062 0.458 . . . . 0.0 110.763 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -102.15 119.27 38.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 110.538 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.1 m -92.98 109.5 20.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.078 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.609 HG21 HG12 ' A' ' 124' ' ' VAL . 3.9 m -142.58 139.44 28.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.605 -177.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.709 ' HB2' ' HB2' ' A' ' 81' ' ' ARG . 5.3 p-10 -83.3 141.73 31.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.163 0.506 . . . . 0.0 110.334 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.58 HG23 HD22 ' A' ' 115' ' ' LEU . 18.6 m -128.94 152.71 37.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.571 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.0 t -81.4 123.62 38.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.949 0.404 . . . . 0.0 111.46 -174.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.762 ' HA ' HD23 ' A' ' 115' ' ' LEU . 59.3 t0 -87.07 129.26 34.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.79 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.552 ' HG2' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -75.73 -6.55 51.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.215 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.59 158.47 10.37 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.546 173.022 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.76 -11.14 60.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 0.0 110.373 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.3 mt -65.5 -41.59 93.04 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.97 -34.42 68.95 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.046 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.65 -50.22 74.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.514 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.412 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -62.17 -44.65 96.14 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.99 0.424 . . . . 0.0 110.698 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 49.0 t90 -53.85 -44.51 70.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.39 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.617 HD12 ' HB3' ' A' ' 107' ' ' HIS . 2.1 tp -92.84 -21.01 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.987 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 40.5 p -68.3 -13.41 62.24 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.578 174.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -85.43 -45.62 11.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.362 170.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.617 ' HB3' HD12 ' A' ' 104' ' ' ILE . 84.4 t60 -79.68 -45.45 18.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.934 0.397 . . . . 0.0 111.692 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.87 43.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.87 -3.83 84.82 Favored Glycine 0 C--N 1.325 -0.049 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.841 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.534 HG23 ' SG ' ' A' ' 112' ' ' CYS . 13.7 m -120.47 159.61 47.31 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -67.88 87.57 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.772 2.315 . . . . 0.0 112.083 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.534 ' SG ' HG23 ' A' ' 110' ' ' VAL . 75.1 m -134.52 154.53 51.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.128 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -135.37 151.98 51.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.549 HG12 HG22 ' A' ' 29' ' ' VAL . 55.4 mt -83.11 119.79 33.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.03 0.443 . . . . 0.0 109.947 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 95' ' ' ASP . 52.3 mt -122.1 133.97 54.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.74 -173.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 27' ' ' TRP . 6.5 ttpm? -107.05 128.4 54.33 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.347 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.2 t -71.21 119.17 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.184 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -61.97 124.96 84.03 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.195 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.76 35.52 0.22 Allowed 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.723 2.948 . . . . 0.0 114.143 -172.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -118.76 -32.01 4.65 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 26.3 mmt -77.49 -57.97 3.53 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.476 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 68.21 -66.99 0.21 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.084 0.865 . . . . 0.0 112.417 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.44 113.5 22.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.681 0.753 . . . . 0.0 111.288 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.777 ' HB ' HG21 ' A' ' 86' ' ' VAL . 12.3 m -115.62 -22.48 4.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.807 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 60.94 66.05 0.94 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.487 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.493 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 46.6 t90 -47.71 138.97 9.12 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 170.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.493 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 9.0 Cg_endo -44.52 127.92 7.98 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.987 3.125 . . . . 0.0 113.769 -173.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.1 m -82.61 12.95 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.232 0.539 . . . . 0.0 110.592 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.3 mt 56.27 26.13 10.12 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.28 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.638 -179.171 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.792 0.329 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 t -93.42 88.22 5.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.022 0.439 . . . . 0.0 111.047 -175.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.7 p -147.55 0.77 0.69 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.937 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 4' ' ' THR . 12.0 m 64.44 15.86 9.83 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.522 1.153 . . . . 0.0 109.479 -169.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.729 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -127.79 113.2 15.65 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.869 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -96.04 140.42 30.8 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.479 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 28.4 mp0 -100.4 97.46 6.46 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.538 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.592 ' HA ' ' CB ' ' A' ' 24' ' ' GLN . 38.5 Cg_endo -70.18 -59.81 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.825 1.684 . . . . 0.0 110.103 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.637 HD11 HD21 ' A' ' 57' ' ' LEU . 18.4 mt -103.76 146.48 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.633 173.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.24 -55.05 15.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.742 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 1.4 mp0 -60.21 -42.58 95.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.689 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.832 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 52.7 m -60.84 -44.74 96.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.447 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.04 -134.25 11.78 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.003 174.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.729 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -84.81 121.68 28.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.586 0.708 . . . . 0.0 112.331 -170.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.483 HG21 HD13 ' A' ' 52' ' ' LEU . 8.6 m -123.02 119.13 29.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.764 173.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 5' ' ' ALA . 9.8 t -85.85 -6.6 59.06 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.169 -170.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -60.74 122.38 14.63 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 t -61.45 -25.88 67.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.794 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -59.36 -30.52 68.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.835 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.41 -30.04 70.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.278 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 -17.03 64.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.936 0.398 . . . . 0.0 111.566 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.99 -22.1 15.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.233 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -105.54 -11.3 16.44 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.974 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.592 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 27.7 pt20 -64.16 155.8 30.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.137 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 51.1 mmtt -162.91 179.73 7.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.225 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.464 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.5 OUTLIER -71.13 76.21 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.166 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TRP . . . . . 0.565 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -95.06 147.75 23.08 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.359 -176.597 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.724 ' HA ' ' OE2' ' A' ' 11' ' ' GLU . 2.2 pp -176.83 166.58 2.54 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.395 0.616 . . . . 0.0 112.578 174.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.597 HG21 HG12 ' A' ' 104' ' ' ILE . 56.1 t -98.28 129.59 48.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.782 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.11 133.69 53.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.582 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.46 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 20.9 t-20 -77.59 154.45 32.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -47.18 -30.1 2.71 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -58.86 -23.4 60.78 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.054 0.454 . . . . 0.0 111.543 176.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 5.72 55.13 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -174.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.19 149.16 21.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 111.025 -174.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.461 ' CD1' HG13 ' A' ' 86' ' ' VAL . 12.0 m0 -70.79 122.27 19.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.945 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.45 HD13 ' HB2' ' A' ' 31' ' ' ASN . 4.4 tp -82.49 133.91 35.21 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.473 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 1.8 t-20 -119.93 161.96 19.99 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.432 -170.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.472 ' HG3' ' HB2' ' A' ' 46' ' ' ALA . 24.7 ttm180 -65.55 -26.33 67.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.655 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -92.92 -11.33 33.67 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.492 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.473 ' HB2' ' H ' ' A' ' 38' ' ' ASN . 80.2 mt -82.64 -50.57 8.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.1 m -131.33 100.24 16.92 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.485 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -59.39 -36.39 94.12 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.987 2.458 . . . . 0.0 112.66 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -61.94 -21.63 64.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.057 0.456 . . . . 0.0 111.264 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.742 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 37.1 tp -68.54 -29.88 68.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.524 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.703 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -87.64 10.35 18.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.595 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -96.62 18.96 13.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.679 0.276 . . . . 0.0 111.299 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.832 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 56.8 t -75.84 127.46 37.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.83 0.348 . . . . 0.0 110.699 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 14.0 m -85.87 122.15 29.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.697 HG22 ' HB3' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -101.12 140.62 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.02 0.438 . . . . 0.0 111.263 -172.821 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -145.77 129.93 17.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.468 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.483 HD13 HG21 ' A' ' 15' ' ' THR . 10.9 mp -107.63 125.05 50.87 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.558 0.694 . . . . 0.0 110.677 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 36.3 ttm180 -105.29 150.85 24.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.0 ttt -65.35 97.2 0.27 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.695 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.8 33.45 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.95 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.497 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 78.5 m-85 -137.2 137.64 39.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 117.486 0.643 . . . . 0.0 111.571 -174.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.637 HD21 HD11 ' A' ' 9' ' ' ILE . 42.0 tp -100.65 108.38 20.24 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.072 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.01 111.35 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.154 0.502 . . . . 0.0 111.293 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.1 mp -98.06 140.16 32.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.101 176.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 39.5 mttm -129.6 133.56 47.23 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ALA . . . . . 0.806 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -122.04 148.76 52.44 Favored Pre-proline 0 C--N 1.326 -0.44 0 C-N-CA 118.897 -1.121 . . . . 0.0 113.254 -176.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PRO . . . . . 0.44 ' HD2' ' CE1' ' A' ' 107' ' ' HIS . 23.1 Cg_exo -65.37 85.01 0.2 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.312 2.008 . . . . 0.0 110.648 168.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.38 -26.66 4.34 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.792 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.806 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 94.8 mmm -117.47 154.12 31.96 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.3 mm? -77.12 -144.34 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 49.2 ptt85 -83.55 149.68 26.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.272 0.558 . . . . 0.0 111.14 176.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 59.9 tp -121.95 102.79 8.39 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.637 170.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.488 ' OD1' ' HD2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -81.11 100.92 9.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.758 -179.123 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 64.2 mt -100.3 105.17 34.55 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.927 176.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.6 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 15.7 Cg_exo -68.3 125.4 12.87 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.172 1.915 . . . . 0.0 110.881 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.7 mt -52.22 -48.09 65.32 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.513 0.508 . . . . 0.0 111.979 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -140.97 15.29 2.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.331 0.586 . . . . 0.0 110.682 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 70' ' ' PRO . 15.7 t -99.82 69.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.969 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 mt -107.4 155.02 8.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.094 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -85.97 13.22 7.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.789 0.804 . . . . 0.0 109.813 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -137.63 -167.76 2.19 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.984 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -107.34 152.76 23.72 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -82.02 13.0 3.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.24 0.543 . . . . 0.0 110.76 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 p -95.63 15.22 20.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.409 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 48.0 t -70.55 98.8 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -97.38 113.94 25.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.89 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 93' ' ' VAL . 6.3 t80 -112.11 120.1 40.69 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.701 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -78.85 118.09 20.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.457 0.646 . . . . 0.0 110.541 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.579 ' HE3' HG11 ' A' ' 93' ' ' VAL . 53.7 ttm -98.1 159.89 14.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.313 -176.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 88' ' ' GLU . 14.2 tp -135.7 87.11 2.29 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.153 0.501 . . . . 0.0 110.278 -175.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.681 HG12 ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -72.3 90.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.261 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.73 -75.18 1.27 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -170.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 8.8 pt-20 -152.1 18.76 0.67 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.027 0.441 . . . . 0.0 110.242 171.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -92.03 107.25 19.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 m -80.36 108.61 14.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.099 -175.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 84' ' ' MET . 5.8 m -123.94 151.65 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.507 -174.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -93.82 112.8 24.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.543 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.579 HG11 ' HE3' ' A' ' 84' ' ' MET . 14.6 m -131.26 154.22 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 0.0 110.527 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 91.1 t -101.48 135.38 38.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.603 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.471 ' HA ' ' CD2' ' A' ' 115' ' ' LEU . 16.7 t70 -80.39 135.92 36.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -106.55 10.43 31.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.97 0.414 . . . . 0.0 111.703 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.81 136.74 4.21 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.401 -1.381 . . . . 0.0 114.294 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.85 -25.0 67.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.827 -0.687 . . . . 0.0 110.714 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.8 tp -62.31 -45.47 93.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.085 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ALA . . . . . 0.511 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -69.33 -33.54 73.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.177 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -59.37 -57.96 10.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.164 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.01 -38.75 87.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.369 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -57.28 -46.01 83.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.949 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.597 HG12 HG21 ' A' ' 29' ' ' VAL . 2.8 tp -83.69 -25.81 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 73.3 m -59.93 -26.85 66.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.171 0.51 . . . . 0.0 109.713 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -88.99 -40.36 13.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.496 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.571 ' HB3' HD12 ' A' ' 104' ' ' ILE . 77.7 t60 -77.41 -53.16 7.99 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.162 -0.336 . . . . 0.0 111.789 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -62.55 -40.21 96.11 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.32 -16.61 34.99 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.421 170.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.679 HG23 ' SG ' ' A' ' 112' ' ' CYS . 16.6 m -121.67 160.87 44.66 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 18.0 Cg_endo -58.36 96.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.81 2.34 . . . . 0.0 112.168 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' CYS . . . . . 0.679 ' SG ' HG23 ' A' ' 110' ' ' VAL . 73.9 m -135.22 173.22 11.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.708 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 9.5 ptp85 -149.95 140.15 22.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.815 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 29' ' ' VAL . 60.8 mt -75.79 120.95 26.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.471 ' CD2' ' HA ' ' A' ' 95' ' ' ASP . 96.5 mt -124.81 151.26 45.42 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.442 0.639 . . . . 0.0 111.097 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -108.58 105.3 14.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.131 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 93' ' ' VAL . 86.3 t -64.01 118.43 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.392 0.615 . . . . 0.0 110.34 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' HIS . . . . . 0.685 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 7.4 t-160 -69.9 132.3 88.75 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.103 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PRO . . . . . 0.685 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 28.5 Cg_endo -62.5 15.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.748 0 C-N-CA 123.687 2.925 . . . . 0.0 114.259 -176.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 118' ' ' HIS . 9.9 t70 -60.0 -60.77 3.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.271 0.558 . . . . 0.0 109.515 176.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' MET . . . . . 0.493 ' HG3' HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -99.73 -30.4 12.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.313 173.004 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 69.28 -77.94 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.06 -72.17 0.11 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -170.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.524 ' CG1' HG21 ' A' ' 86' ' ' VAL . 58.3 t 70.99 -58.29 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.558 0.536 . . . . 0.0 111.924 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . 0.609 ' O ' ' HB2' ' A' ' 126' ' ' TRP . 66.8 ttt180 79.03 -89.35 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.999 1.319 . . . . 0.0 111.745 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' TRP . . . . . 0.609 ' HB2' ' O ' ' A' ' 125' ' ' ARG . 9.5 t90 162.79 142.57 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -174.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.681 ' HD3' HG12 ' A' ' 86' ' ' VAL . 38.0 Cg_endo -59.04 118.4 5.29 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.513 2.809 . . . . 0.0 112.777 -177.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.1 m -102.74 46.38 0.92 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.486 0.66 . . . . 0.0 110.128 -175.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.728 HD23 ' H ' ' A' ' 129' ' ' LEU . 1.6 pt? -74.18 65.06 1.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.869 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 . . . . . 0 C--O 1.247 0.955 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.324 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.755 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.448 -0.527 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -80.69 141.5 34.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.804 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -115.25 85.74 13.26 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.287 -0.165 . . . . 0.0 110.894 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 49.0 Cg_endo -74.45 -35.87 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.885 1.724 . . . . 0.0 111.082 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.772 HD11 HD11 ' A' ' 57' ' ' LEU . 2.4 mt -114.52 145.28 20.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.208 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.88 -70.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 111.941 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.835 ' HG2' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -56.73 -50.09 73.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.457 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.805 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 73.8 m -53.48 -45.57 69.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.303 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.71 -127.52 9.18 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.782 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.755 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -85.13 138.37 32.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.436 0.636 . . . . 0.0 112.506 -169.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.518 HG21 HD13 ' A' ' 52' ' ' LEU . 17.0 m -123.96 123.69 40.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.789 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.07 22.03 2.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.139 0.495 . . . . 0.0 111.495 -175.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -110.83 135.53 51.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.864 0.364 . . . . 0.0 110.15 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.8 t -70.29 -18.95 63.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.3 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.75 -26.86 68.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.618 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -71.23 -20.23 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.859 -176.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.68 -9.53 58.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.724 0.297 . . . . 0.0 111.455 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.2 -1.45 16.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.736 0.303 . . . . 0.0 111.627 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -129.66 12.02 5.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.671 0.272 . . . . 0.0 111.144 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.4 pt20 -68.57 153.67 43.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.133 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.429 ' HG3' ' H ' ' A' ' 26' ' ' ARG . 3.8 tppt? -165.26 179.79 6.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.429 ' H ' ' HG3' ' A' ' 25' ' ' LYS . 73.7 mtt85 -83.26 60.83 5.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.842 0.829 . . . . 0.0 109.291 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.62 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -78.01 147.67 34.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.143 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.617 ' HA ' ' OE2' ' A' ' 11' ' ' GLU . 2.0 pp -176.92 177.42 1.3 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.119 0.485 . . . . 0.0 111.882 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.835 HG23 ' HG2' ' A' ' 11' ' ' GLU . 88.3 t -107.42 146.75 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.43 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.451 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -128.26 145.15 51.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.586 HD21 ' HB3' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -96.53 168.84 10.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.774 -174.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -46.49 -34.16 4.59 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.735 0.814 . . . . 0.0 113.078 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.84 -4.33 4.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 84' ' ' MET . . . 83.88 3.39 89.32 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.778 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.586 ' HB3' HD21 ' A' ' 31' ' ' ASN . 26.0 tt0 -100.57 152.61 20.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.48 -175.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.678 ' CH2' ' HB ' ' A' ' 124' ' ' VAL . 39.3 m0 -66.71 145.0 56.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 175.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.0 tp -106.61 143.4 34.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -134.41 165.69 24.57 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.006 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.499 ' H ' ' CD ' ' A' ' 39' ' ' ARG . 0.2 OUTLIER -69.03 -32.08 71.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -67.34 -25.02 65.79 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.93 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -91.19 -52.41 4.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.376 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.18 99.85 17.42 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.564 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.17 -16.92 45.17 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.325 2.683 . . . . 0.0 113.155 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -58.7 -32.42 69.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.213 0.53 . . . . 0.0 111.011 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 48' ' ' VAL . 7.0 mp -72.91 -19.86 61.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.849 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -68.21 -11.36 59.17 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.092 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -95.66 46.0 1.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.531 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.805 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 64.7 t -104.8 135.49 42.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.704 0.288 . . . . 0.0 110.667 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 m -94.74 117.54 30.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.628 HG22 ' HB3' ' A' ' 12' ' ' CYS . 11.2 t -99.2 137.45 26.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.063 -172.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -136.08 141.45 44.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.099 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 20' ' ' ALA . 6.9 mp -123.39 133.84 54.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.895 0.378 . . . . 0.0 110.414 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.428 ' HE ' ' HA ' ' A' ' 53' ' ' ARG . 2.6 mmp_? -121.95 169.38 10.87 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 87.5 mtp -67.5 84.15 0.17 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 110.709 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.76 -21.24 9.11 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.923 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -130.21 137.89 50.29 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.616 0.708 . . . . 0.0 112.212 -173.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.772 HD11 HD11 ' A' ' 9' ' ' ILE . 53.4 tp -96.52 107.09 19.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.808 174.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 68' ' ' ASP . 41.6 t -101.02 100.69 10.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.317 0.58 . . . . 0.0 111.055 -173.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.4 mp -86.34 146.05 26.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.37 177.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -137.58 132.61 33.36 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.701 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -115.01 142.24 28.17 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 119.273 -0.971 . . . . 0.0 112.167 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.98 81.23 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.233 1.955 . . . . 0.0 110.5 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.2 -31.83 2.74 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.701 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 13.8 mmt -114.79 153.41 30.42 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.434 ' H ' HD22 ' A' ' 65' ' ' LEU . 2.8 mm? -68.67 -158.64 0.02 OUTLIER 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.508 0.67 . . . . 0.0 111.714 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 13.2 ptm180 -89.4 151.2 22.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.925 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.422 HD21 ' HA ' ' A' ' 100' ' ' ALA . 60.7 tp -137.44 103.94 5.21 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.753 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 2.2 p-10 -99.21 112.75 24.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.649 0.738 . . . . 0.0 111.016 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 96' ' ' GLU . 34.2 mt -110.67 138.83 21.15 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.503 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.29 119.71 7.08 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 121.931 1.754 . . . . 0.0 111.446 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 57' ' ' LEU . 64.3 mt . . . . . 0 N--CA 1.467 0.413 0 CA-C-O 121.206 0.527 . . . . 0.0 111.462 -177.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 41.0 t . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 121.143 0.497 . . . . 0.0 111.392 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -85.39 105.08 15.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -95.39 132.53 40.33 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.827 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -80.19 102.68 9.57 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 2.7 tpt -102.93 159.29 15.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.213 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp -133.01 87.61 2.42 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.632 0.73 . . . . 0.0 109.727 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.601 HG12 ' HD3' ' A' ' 127' ' ' PRO . 5.0 t -83.63 93.55 3.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.388 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.37 -89.43 1.31 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.78 11.81 2.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.05 0.452 . . . . 0.0 110.214 171.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.543 HE21 HG13 ' A' ' 124' ' ' VAL . 15.3 tt0 -96.5 112.9 24.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.544 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.7 m -83.23 114.48 21.4 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.156 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.528 HG11 HG22 ' A' ' 124' ' ' VAL . 3.6 m -136.25 147.24 28.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.031 0.443 . . . . 0.0 111.973 -174.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.464 ' H ' ' HG3' ' A' ' 121' ' ' MET . 0.8 OUTLIER -80.07 117.09 20.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.252 177.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.521 HG21 HD13 ' A' ' 115' ' ' LEU . 36.0 m -120.23 148.85 23.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 93.5 t -94.94 129.85 44.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.35 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.529 ' OD1' ' HD3' ' A' ' 113' ' ' ARG . 33.3 t70 -82.6 132.33 35.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.303 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HB3' HD13 ' A' ' 69' ' ' ILE . 17.8 mm-40 -82.64 -6.49 59.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.713 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.11 157.01 11.93 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.225 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -53.68 -31.57 48.28 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 122.744 0.418 . . . . 0.0 111.345 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.788 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.4 pt? -62.18 -36.96 83.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.811 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.422 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -76.3 -35.18 58.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.056 0.455 . . . . 0.0 110.221 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -59.96 -57.23 13.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.67 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.71 -42.65 99.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.437 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -54.14 -47.53 71.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.055 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.598 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.1 tp -85.26 -23.91 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.198 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.3 m -64.96 -16.44 63.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.403 -0.81 . . . . 0.0 109.996 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -88.68 -51.09 5.86 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.2 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.598 ' HB3' HD12 ' A' ' 104' ' ' ILE . 57.5 t60 -72.71 -44.48 61.68 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -76.17 -36.64 58.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.24 -32.4 7.52 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.849 171.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.662 HG23 ' SG ' ' A' ' 112' ' ' CYS . 16.1 m -100.43 158.76 31.34 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 25.1 Cg_endo -62.64 90.88 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.649 2.232 . . . . 0.0 112.108 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.662 ' SG ' HG23 ' A' ' 110' ' ' VAL . 76.5 m -135.21 164.73 27.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.277 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 10.9 ptp180 -140.48 143.37 35.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.404 175.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.623 HG12 HG22 ' A' ' 29' ' ' VAL . 37.6 mt -73.27 131.92 34.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.521 HD13 HG21 ' A' ' 93' ' ' VAL . 71.7 mt -134.87 139.54 45.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.176 0.512 . . . . 0.0 110.55 -176.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -108.16 110.78 22.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.273 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 93' ' ' VAL . 58.5 t -63.26 132.94 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.602 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.439 ' CG ' ' HD2' ' A' ' 119' ' ' PRO . 0.5 OUTLIER -86.81 139.45 33.05 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.076 -177.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 118' ' ' HIS . 48.9 Cg_endo -68.36 -2.13 8.53 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.303 2.669 . . . . 0.0 114.531 -173.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -71.7 -51.61 22.08 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.21 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.464 ' HG3' ' H ' ' A' ' 92' ' ' ASP . 95.3 mmm -73.52 -44.81 56.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 170.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 67.42 -77.97 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.733 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.88 139.87 30.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.368 0.604 . . . . 0.0 111.544 -172.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.678 ' HB ' ' CH2' ' A' ' 36' ' ' TRP . 52.8 t -133.9 -30.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.902 175.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 78.13 -37.97 0.24 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.558 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 19.7 t90 77.73 138.35 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.601 ' HD3' HG12 ' A' ' 86' ' ' VAL . 21.0 Cg_endo . . . . . 0 C--N 1.351 0.699 0 C-N-CA 123.544 2.829 . . . . 0.0 113.422 -175.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.326 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.51 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.6 m-85 -94.31 134.4 36.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.33 91.75 20.6 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 6.1 Cg_exo -82.11 -55.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.937 2.425 . . . . 0.0 113.413 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.723 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -114.88 132.24 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 123.741 0.651 . . . . 0.0 110.555 -174.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.63 -55.14 36.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -170.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.813 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -62.32 -49.22 76.46 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -171.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.723 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 9.9 p -74.0 -35.75 64.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.771 0.319 . . . . 0.0 110.693 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.05 -140.52 14.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.807 170.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.75 152.15 23.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.309 0.576 . . . . 0.0 111.64 -172.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.8 m -134.5 134.43 41.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.256 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 p -94.63 66.41 3.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.49 0.662 . . . . 0.0 110.94 176.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -133.58 128.39 35.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.066 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.7 m -56.87 -33.09 66.5 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.65 -16.18 56.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.501 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -65.61 -22.67 66.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.361 . . . . 0.0 111.378 -176.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.61 -25.63 67.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.472 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.91 0.26 48.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.425 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -129.51 20.97 5.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.707 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 5.3 pp0? -91.16 150.79 21.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.191 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -162.51 -179.58 7.04 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.639 ' NH1' ' HA ' ' A' ' 123' ' ' GLU . 50.5 mtt85 -82.82 65.38 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 165.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.569 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 2.0 t90 -88.7 144.98 25.91 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.919 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -177.78 -177.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.552 0.691 . . . . 0.0 112.317 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.592 HG22 HG12 ' A' ' 114' ' ' ILE . 17.6 t -106.04 142.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.009 175.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.72 155.25 39.58 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.854 HD21 ' HB3' ' A' ' 35' ' ' GLN . 0.3 OUTLIER -99.8 160.44 14.3 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.779 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.545 ' HB2' ' HB2' ' A' ' 111' ' ' PRO . 14.2 t70 -45.7 -34.74 3.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.55 0.74 . . . . 0.0 112.81 -176.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.79 -7.17 3.26 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.59 7.18 72.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.614 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.854 ' HB3' HD21 ' A' ' 31' ' ' ASN . 22.6 tt0 -100.03 140.22 34.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.553 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -61.71 129.02 39.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.6 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.477 HD22 ' SG ' ' A' ' 112' ' ' CYS . 20.9 tp -90.27 144.86 25.45 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -137.13 167.44 21.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.24 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -67.7 -21.09 65.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.93 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -77.37 -26.37 51.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.77 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 37' ' ' LEU . 78.2 mt -90.72 -51.22 5.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.277 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' A' ' 37' ' ' LEU . 74.7 m -122.94 93.83 47.95 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.645 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.68 -30.27 91.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.004 2.469 . . . . 0.0 112.461 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 44' ' ' ARG . 47.7 mtm105 -69.19 -13.38 62.38 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.939 0.399 . . . . 0.0 111.156 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.813 ' HG ' ' HB2' ' A' ' 11' ' ' GLU . 32.5 tp -79.5 -18.86 51.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.57 -17.1 64.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.165 0.507 . . . . 0.0 109.944 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.695 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 57.5 mm-40 -82.95 58.8 4.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.418 177.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.0 t -129.39 139.22 52.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.7 m -105.49 142.28 35.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.67 0.272 . . . . 0.0 110.801 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 12' ' ' CYS . 1.5 t -96.73 143.35 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.867 -174.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 3.8 tp10 -146.56 137.33 24.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 167.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 mp -119.25 125.47 49.21 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.885 0.374 . . . . 0.0 110.279 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 56' ' ' TYR . 34.2 mmt180 -105.31 175.59 5.44 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.2 ttm -68.38 91.85 0.41 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.39 -0.28 65.73 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.136 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.465 ' C ' ' HG ' ' A' ' 71' ' ' LEU . 59.4 m-85 -136.21 148.36 48.06 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 117.59 0.695 . . . . 0.0 112.313 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.499 ' HB2' HD23 ' A' ' 71' ' ' LEU . 42.1 tp -109.32 118.51 36.87 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.128 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 66.8 t -109.05 111.05 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.228 0.537 . . . . 0.0 110.513 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 3.8 mp -97.07 137.19 36.52 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.947 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -129.3 130.39 46.09 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -122.27 134.03 24.64 Favored Pre-proline 0 C--O 1.215 -0.718 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.879 -173.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.695 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 82.5 Cg_exo -46.16 107.08 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.272 1.981 . . . . 0.0 111.178 166.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.17 -10.51 61.75 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.951 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.639 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 76.8 mmm -136.4 156.53 48.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.768 0.794 . . . . 0.0 111.53 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.521 ' H ' HD22 ' A' ' 65' ' ' LEU . 2.6 mm? -67.7 -165.87 0.05 Allowed 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.816 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 33.6 ptt85 -88.33 169.22 12.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.448 173.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.483 ' HG ' HG13 ' A' ' 69' ' ' ILE . 55.3 tp -147.48 111.33 5.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.761 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.22 99.82 12.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 110.587 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.483 HG13 ' HG ' ' A' ' 67' ' ' LEU . 70.0 mt -105.93 138.72 19.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.42 139.19 23.02 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.189 1.926 . . . . 0.0 112.509 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 57' ' ' LEU . 8.7 mt . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.573 0.702 . . . . 0.0 111.428 178.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.5 t . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 110.525 -0.176 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.401 HH21 ' CG ' ' A' ' 92' ' ' ASP . 76.0 mtp180 -77.53 99.18 5.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.613 0.72 . . . . 0.0 109.783 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -86.13 126.66 34.38 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.589 -175.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -76.61 112.03 12.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.453 ' HE2' ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -98.94 145.84 26.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.8 -175.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.847 ' HG ' ' HA ' ' A' ' 88' ' ' GLU . 12.9 tp -126.35 79.07 1.82 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.498 0.666 . . . . 0.0 109.501 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.419 HG12 ' HD3' ' A' ' 127' ' ' PRO . 4.6 t -85.92 96.97 5.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.306 -174.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.69 31.95 70.64 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.847 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.9 OUTLIER 69.39 18.19 7.98 Favored 'General case' 0 N--CA 1.46 0.051 0 CA-C-N 114.504 -0.848 . . . . 0.0 111.296 -176.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -92.84 107.76 19.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.8 m -78.84 99.88 6.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.909 -172.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 m -132.32 142.57 42.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.713 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.401 ' CG ' HH21 ' A' ' 81' ' ' ARG . 7.1 p-10 -91.78 140.5 29.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.19 0.519 . . . . 0.0 110.721 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.9 m -131.15 153.72 39.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.691 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 93.2 t -88.87 132.84 32.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.894 0.378 . . . . 0.0 111.221 -176.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.674 ' OD2' ' HD3' ' A' ' 113' ' ' ARG . 26.3 t0 -77.42 127.11 31.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.312 175.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.474 ' CD ' ' HZ2' ' A' ' 116' ' ' LYS . 13.5 mm-40 -92.65 -3.15 55.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.315 -175.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.29 129.84 1.34 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.685 -1.245 . . . . 0.0 114.511 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.42 -36.29 71.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.29 0.567 . . . . 0.0 110.144 171.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.86 -35.7 81.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.436 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.496 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -65.54 -37.71 87.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.489 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.69 84.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.73 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.72 83.46 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.993 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.4 ' CZ3' HD13 ' A' ' 104' ' ' ILE . 73.8 t90 -51.48 -44.66 62.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.274 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.587 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.2 tp -86.94 -23.17 6.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.635 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 94.6 p -65.02 -17.99 64.92 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.357 -0.839 . . . . 0.0 109.301 175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HB3' ' SD ' ' A' ' 64' ' ' MET . 33.1 m-80 -81.97 -57.84 3.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.342 170.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.587 ' HB3' HD12 ' A' ' 104' ' ' ILE . 75.5 t60 -69.04 -45.5 70.27 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.12 -42.67 59.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.62 -30.68 8.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.586 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.666 HG23 ' SG ' ' A' ' 112' ' ' CYS . 16.5 m -99.78 163.45 18.41 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 17.8 Cg_endo -60.26 96.71 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.533 2.156 . . . . 0.0 112.155 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.666 ' SG ' HG23 ' A' ' 110' ' ' VAL . 72.1 m -134.05 158.15 44.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.721 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.674 ' HD3' ' OD2' ' A' ' 95' ' ' ASP . 48.9 ttm-85 -143.15 132.83 23.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.138 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.592 HG12 HG22 ' A' ' 29' ' ' VAL . 41.7 mt -80.06 120.91 32.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 95' ' ' ASP . 70.4 mt -131.51 155.96 46.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.747 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.474 ' HZ2' ' CD ' ' A' ' 96' ' ' GLU . 7.2 ttpm? -121.56 138.67 54.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.155 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.13 135.17 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.69 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -73.1 119.54 76.19 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.796 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.07 -24.68 20.44 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.627 2.885 . . . . 0.0 113.704 -173.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.97 -39.79 82.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 110.714 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -117.75 -175.47 2.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.12 -170.62 3.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.137 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.639 ' HA ' ' NH1' ' A' ' 26' ' ' ARG . 8.0 mm-40 65.79 -140.07 0.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.793 0.683 . . . . 0.0 111.142 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.1 t 65.67 100.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -167.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -108.28 27.25 9.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.532 -169.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.696 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 5.2 t90 72.58 151.5 0.14 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -174.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.696 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 10.6 Cg_endo . . . . . 0 C--N 1.352 0.722 0 C-N-CA 123.272 2.648 . . . . 0.0 114.135 -179.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.452 -0.327 0 CA-C-O 120.834 0.349 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.704 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 55.5 m-85 -112.46 141.33 46.34 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.994 -177.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -99.68 97.25 5.49 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.012 0.195 . . . . 0.0 110.7 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.823 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 2.6 Cg_exo -77.07 -54.4 0.06 OUTLIER 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.874 2.383 . . . . 0.0 111.735 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.823 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 4.9 mm -107.22 150.88 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.462 -175.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.74 -54.73 8.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.017 -174.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 1.6 mp0 -56.59 -53.18 60.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.5 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.823 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 25.9 p -70.51 -47.27 61.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.95 -127.79 9.26 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.533 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -89.83 139.3 30.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.3 0.571 . . . . 0.0 112.207 -173.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.517 HG21 HD13 ' A' ' 52' ' ' LEU . 16.9 m -113.5 138.84 49.55 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.94 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -87.41 31.66 0.73 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -119.96 136.35 54.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.085 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.427 ' HA ' ' HE2' ' A' ' 6' ' ' TYR . 20.1 m -65.85 -28.76 69.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.791 0.329 . . . . 0.0 111.618 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -65.32 -23.6 67.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.498 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.823 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -58.47 -30.98 67.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.566 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.11 -24.8 67.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.69 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.19 -14.71 28.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.589 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -112.77 -0.94 14.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.695 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.637 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 3.7 pp0? -67.58 150.8 48.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.568 0.223 . . . . 0.0 110.562 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 24' ' ' GLN . 38.5 mmtm -165.54 -178.7 5.04 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.175 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -81.82 79.13 8.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.896 0.855 . . . . 0.0 109.482 170.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -100.63 147.14 26.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.907 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 pp -173.99 178.88 2.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.63 0.729 . . . . 0.0 112.246 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.862 HG22 HD13 ' A' ' 114' ' ' ILE . 60.3 t -111.5 136.42 47.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.488 175.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.732 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -124.85 144.94 50.04 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -77.6 142.75 38.76 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -48.02 -25.64 1.48 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.442 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . . . -57.24 -18.38 15.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.651 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.432 ' HA2' ' CE ' ' A' ' 84' ' ' MET . . . 103.61 18.67 13.69 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -176.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -112.87 127.45 56.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.938 -173.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -56.64 123.64 15.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.432 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.649 HD23 HD22 ' A' ' 45' ' ' LEU . 10.5 tp -82.47 154.31 25.18 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -140.88 164.3 30.61 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.498 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -69.06 -24.57 64.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 110.074 176.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.8 -27.66 61.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.879 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.2 mt -87.79 -51.47 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.611 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.6 m -130.25 95.68 26.96 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.64 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.58 -28.87 69.99 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.771 2.314 . . . . 0.0 112.139 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -67.76 -14.11 62.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.233 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.649 HD22 HD23 ' A' ' 37' ' ' LEU . 33.0 tp -74.47 -23.12 58.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.746 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.2 -13.35 61.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.232 0.539 . . . . 0.0 110.384 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -92.68 54.62 2.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.69 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 12' ' ' CYS . 92.0 t -110.88 134.26 53.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.038 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.8 m -100.56 148.77 24.44 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.12 148.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.177 0.513 . . . . 0.0 111.722 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 28.8 tt0 -152.05 139.75 19.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.517 HD13 HG21 ' A' ' 15' ' ' THR . 9.2 mp -106.93 125.39 50.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.682 0.753 . . . . 0.0 111.443 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -112.42 154.4 25.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.38 -1.282 . . . . 0.0 107.671 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . 0.433 ' O ' ' HG3' ' A' ' 54' ' ' MET . 23.6 ptt? -60.66 100.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.939 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.59 0.07 64.95 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.117 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -143.14 137.62 29.21 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 117.403 0.601 . . . . 0.0 111.536 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.526 ' HB2' HD21 ' A' ' 71' ' ' LEU . 28.1 tp -100.21 114.39 27.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.176 175.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 70.8 t -96.4 96.45 5.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.892 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 8.1 mp -87.53 143.44 27.21 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -140.28 130.95 25.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -115.67 144.96 33.54 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.453 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.95 98.03 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.061 1.841 . . . . 0.0 110.487 170.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.09 -32.2 6.08 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.302 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.639 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 13.1 mmt -116.04 154.64 29.53 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.437 0.637 . . . . 0.0 110.218 -177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.812 ' H ' HD12 ' A' ' 65' ' ' LEU . 2.5 mp -69.71 -154.38 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.755 -171.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 12.4 ptm180 -94.33 145.14 24.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.652 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 53.4 tp -121.67 114.61 21.38 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.234 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.99 102.22 14.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.716 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 70.1 mt -97.8 116.47 65.73 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.739 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.62 119.5 6.62 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.321 2.014 . . . . 0.0 112.168 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 57' ' ' LEU . 96.1 mt . . . . . 0 C--N 1.324 -0.51 0 CA-C-O 121.182 0.515 . . . . 0.0 110.028 179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.447 -0.609 0 CA-C-O 121.135 0.493 . . . . 0.0 110.95 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.585 ' HG2' HG22 ' A' ' 94' ' ' VAL . 74.1 mtp180 -86.5 112.98 22.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.89 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.526 ' HE2' ' HB2' ' A' ' 95' ' ' ASP . 98.0 m-85 -101.13 133.15 46.11 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.388 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -80.06 98.77 7.38 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -90.17 153.46 20.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.283 -171.536 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.27 86.41 2.45 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.75 0.786 . . . . 0.0 109.449 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.571 HG12 ' HD3' ' A' ' 127' ' ' PRO . 4.0 t -76.57 84.6 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.497 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.73 -78.34 1.67 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -175.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.81 16.08 1.77 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.018 0.437 . . . . 0.0 110.441 174.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.427 ' HG2' HG13 ' A' ' 91' ' ' VAL . 10.0 tt0 -111.26 108.93 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 110.725 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 84' ' ' MET . 7.5 m -80.29 113.97 18.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.494 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.55 HG12 ' HG2' ' A' ' 121' ' ' MET . 5.9 m -134.63 159.33 41.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.336 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.65 113.13 25.32 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 -174.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.48 HG23 HD22 ' A' ' 115' ' ' LEU . 34.9 m -120.03 136.96 55.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.97 177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 81' ' ' ARG . 6.4 t -99.25 129.96 48.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.063 -176.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.526 ' HB2' ' HE2' ' A' ' 82' ' ' TYR . 53.8 t0 -74.48 119.92 19.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.695 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -74.4 -7.83 54.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.982 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.76 146.31 4.45 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.111 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -62.2 -30.45 71.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.22 0.533 . . . . 0.0 110.217 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.7 tp -67.78 -33.94 75.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.913 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.533 ' HB1' HG13 ' A' ' 114' ' ' ILE . . . -71.41 -40.63 70.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.111 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.26 -41.81 94.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.528 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.5 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -62.76 -43.03 99.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.984 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.409 ' HH2' HG13 ' A' ' 48' ' ' VAL . 38.1 t90 -55.66 -39.43 70.9 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.654 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.579 HG22 ' HB2' ' A' ' 112' ' ' CYS . 9.8 mm -89.41 -26.12 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 80.1 p -65.41 -14.96 62.06 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.466 -0.771 . . . . 0.0 109.356 172.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -90.23 -52.76 4.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.466 170.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.449 ' HB3' HD13 ' A' ' 104' ' ' ILE . 82.9 t60 -65.23 -40.69 94.4 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.43 -33.89 14.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.146 0.498 . . . . 0.0 110.142 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.44 -29.6 11.16 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.649 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.514 HG23 ' SG ' ' A' ' 112' ' ' CYS . 24.2 m -106.13 156.65 36.45 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.2 97.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.792 2.328 . . . . 0.0 112.622 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.579 ' HB2' HG22 ' A' ' 104' ' ' ILE . 58.1 m -129.03 147.65 50.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.9 176.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.468 ' HD3' ' CG ' ' A' ' 95' ' ' ASP . 41.6 ttm-85 -126.43 130.76 51.32 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.188 -171.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.862 HD13 HG22 ' A' ' 29' ' ' VAL . 25.6 mm -68.37 118.14 11.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 30' ' ' ALA . 18.4 mt -133.1 129.88 38.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.732 0.777 . . . . 0.0 111.896 -173.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HZ3' ' HB3' ' A' ' 116' ' ' LYS . 7.9 ttpm? -103.68 120.51 41.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.322 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.3 t -62.75 132.0 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.694 0.283 . . . . 0.0 110.343 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -69.22 139.2 89.76 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -51.02 -15.84 2.19 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.55 2.833 . . . . 0.0 114.219 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -60.09 -34.36 73.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.142 0.496 . . . . 0.0 110.584 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.55 ' HG2' HG12 ' A' ' 91' ' ' VAL . 2.4 mpt? -112.29 124.56 52.73 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.248 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.53 36.46 4.37 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.335 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -140.37 -135.0 0.11 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.73 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 86' ' ' VAL . 4.3 t 67.34 94.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.387 0.613 . . . . 0.0 110.06 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 125' ' ' ARG . 11.5 ttp180 -99.15 20.07 14.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.586 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.572 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 6.3 t90 70.61 151.56 0.14 Allowed Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 5.7 Cg_exo . . . . . 0 C--N 1.359 1.1 0 C-N-CA 123.151 2.568 . . . . 0.0 112.486 177.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.405 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 120.864 0.364 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.683 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 24.6 m-85 -86.98 133.92 33.54 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 10.3 tt0 -105.66 94.23 8.41 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.888 0.375 . . . . 0.0 111.031 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.81 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 7.0 Cg_endo -87.11 -41.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.283 2.655 . . . . 0.0 112.317 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 3.6 mp -100.97 145.15 11.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.89 -73.03 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -172.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.639 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -58.93 -50.01 75.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.903 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 66.5 m -54.95 -47.33 74.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.965 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.8 -140.87 15.11 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.363 175.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 7' ' ' GLN . . . -94.67 151.91 18.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.459 0.647 . . . . 0.0 112.212 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.499 HG21 HD13 ' A' ' 52' ' ' LEU . 15.2 m -125.42 139.3 53.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.005 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -86.78 23.33 1.73 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.445 ' HG3' HG22 ' A' ' 15' ' ' THR . 9.3 mt-30 -114.83 145.63 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.672 0.272 . . . . 0.0 110.31 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 t -61.97 -35.15 77.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.292 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.506 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 2.1 mp0 -52.76 -34.13 51.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.465 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.81 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -61.5 -27.6 68.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.459 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.55 -2.76 18.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.801 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.43 18.8 4.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.97 14.9 3.07 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.337 0.589 . . . . 0.0 110.44 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -64.12 143.56 57.78 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.095 177.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 24' ' ' GLN . 68.5 mmtt -161.88 166.9 25.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -172.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.472 ' CB ' ' HB ' ' A' ' 117' ' ' VAL . 4.8 mpt_? -86.64 82.53 7.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.233 0.54 . . . . 0.0 110.156 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.17 153.0 21.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.123 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.504 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -160.59 164.24 32.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.023 0.439 . . . . 0.0 110.512 -177.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.595 HG23 ' HG2' ' A' ' 11' ' ' GLU . 89.4 t -126.48 136.87 59.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.529 ' HB2' ' HE1' ' A' ' 84' ' ' MET . . . -111.97 133.63 54.03 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.602 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.71 HD21 ' HB3' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -79.48 179.52 7.41 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 172.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -46.07 -40.02 10.14 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.27 -5.72 43.75 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.85 11.64 84.37 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.761 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.71 ' HB3' HD21 ' A' ' 31' ' ' ASN . 26.0 tt0 -85.2 144.16 28.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.594 -0.303 . . . . 0.0 110.753 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.654 ' CD1' HG22 ' A' ' 86' ' ' VAL . 2.2 m0 -53.54 122.4 9.69 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 124.14 0.9 . . . . 0.0 111.67 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 tp -104.91 130.97 52.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -122.74 170.19 10.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.083 0.468 . . . . 0.0 111.79 -173.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -71.52 -19.44 62.18 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -70.65 -26.25 63.38 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.5 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.9 mt -94.74 -47.45 6.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.458 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.0 m -124.95 98.53 36.25 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.911 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.15 -31.02 75.45 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.891 2.394 . . . . 0.0 111.677 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -60.52 -30.06 69.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.968 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.639 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 63.2 tp -72.84 -28.09 62.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.261 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -71.39 -12.97 61.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.175 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -85.69 38.97 0.77 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.743 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.903 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 78.4 t -92.77 130.84 41.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.553 0.216 . . . . 0.0 110.473 173.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.675 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . 18.1 m -86.89 117.09 25.39 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.622 HG22 ' HB3' ' A' ' 12' ' ' CYS . 1.4 t -99.0 144.56 11.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.384 -172.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 78.9 tt0 -148.86 144.02 26.64 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 15' ' ' THR . 8.2 mp -123.74 129.75 51.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.015 0.435 . . . . 0.0 109.914 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.416 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -118.83 156.98 28.48 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.81 98.13 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.149 0.5 . . . . 0.0 110.998 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.25 -12.09 44.06 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.391 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -138.65 137.88 37.29 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 117.839 0.82 . . . . 0.0 112.145 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.8 tp -95.87 110.31 22.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 59.7 t -96.48 95.67 4.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.925 -173.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 7.6 mp -88.25 152.01 22.26 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.675 ' HG3' ' HB2' ' A' ' 49' ' ' SER . 11.1 ptpp? -159.89 143.17 14.05 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 172.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.595 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -132.25 147.37 65.45 Favored Pre-proline 0 C--O 1.218 -0.557 0 C-N-CA 118.665 -1.214 . . . . 0.0 113.413 -173.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.71 102.74 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.875 1.717 . . . . 0.0 110.45 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.78 -6.9 33.32 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.278 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.595 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 83.7 mmm -140.61 151.96 45.07 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.336 0.588 . . . . 0.0 110.879 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.405 ' HB3' ' H ' ' A' ' 66' ' ' ARG . 3.6 mm? -69.99 -159.1 0.03 OUTLIER 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.294 0.569 . . . . 0.0 111.18 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 45.4 mtp180 -80.36 149.38 30.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.597 174.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 68.6 tp -121.83 107.99 12.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 171.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -91.66 106.91 18.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.063 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 62.1 mt -115.66 116.65 40.89 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.441 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.45 131.74 48.03 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.636 2.224 . . . . 0.0 111.925 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt . . . . . 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 111.055 -178.389 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 57.7 t . . . . . 0 N--CA 1.456 -0.164 0 CA-C-O 120.905 0.383 . . . . 0.0 110.663 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.423 ' HD2' HH11 ' A' ' 81' ' ' ARG . 28.3 mtp180 -88.08 110.97 21.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.266 0.555 . . . . 0.0 109.849 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -101.28 132.35 46.85 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.239 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -78.47 104.7 9.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.246 0.546 . . . . 0.0 110.241 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.529 ' HE1' ' HB2' ' A' ' 30' ' ' ALA . 8.7 tpt -86.18 146.38 26.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.803 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp -125.57 92.24 3.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.854 0.835 . . . . 0.0 110.408 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.654 HG22 ' CD1' ' A' ' 36' ' ' TRP . 3.7 t -79.29 83.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.638 176.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.93 -74.89 1.14 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.19 4.95 1.86 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.265 0.555 . . . . 0.0 109.7 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -91.51 110.04 21.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.14 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 m -84.48 114.83 22.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.123 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.518 HG23 ' HB3' ' A' ' 84' ' ' MET . 2.2 m -134.84 144.54 34.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.921 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.69 119.89 23.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.435 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 117' ' ' VAL . 27.7 m -122.39 153.79 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.747 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.6 t -96.55 128.01 48.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.0 110.66 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.561 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 56.9 t0 -71.78 129.0 37.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.265 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -82.52 -20.05 37.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.863 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.21 156.45 9.68 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.856 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 101' ' ' ALA . 41.6 mt-10 -78.64 -5.82 54.0 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.763 -0.257 . . . . 0.0 111.5 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.724 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.8 pt? -68.38 -38.93 81.84 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 172.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.25 -36.47 63.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.75 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB2' ' HG3' ' A' ' 113' ' ' ARG . . . -59.27 -52.51 65.36 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.31 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.451 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -63.0 -40.03 96.54 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.346 0.593 . . . . 0.0 111.08 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -57.35 -35.71 70.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.538 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.532 HD12 ' HB3' ' A' ' 107' ' ' HIS . 2.3 tp -95.41 -22.65 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.862 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.451 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 86.2 p -66.86 -20.27 65.89 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.251 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -87.9 -46.2 9.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.332 173.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.532 ' HB3' HD12 ' A' ' 104' ' ' ILE . 76.3 t60 -75.17 -48.43 23.67 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.04 -38.15 57.51 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.51 -23.49 35.61 Favored Glycine 0 C--N 1.329 0.161 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.325 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.444 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 27.7 m -103.52 159.32 29.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 O-C-N 122.824 -0.221 . . . . 0.0 110.659 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 37.2 Cg_endo -66.48 90.53 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.466 2.111 . . . . 0.0 111.829 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.448 ' SG ' HG23 ' A' ' 104' ' ' ILE . 2.2 p -134.76 157.18 47.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.969 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.532 ' HG3' ' HB2' ' A' ' 101' ' ' ALA . 21.9 ttm180 -132.55 137.48 47.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.331 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.526 HG13 HG22 ' A' ' 29' ' ' VAL . 2.0 mp -77.16 128.92 37.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.45 ' CD2' ' HA ' ' A' ' 95' ' ' ASP . 80.0 mt -131.8 142.82 49.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.227 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -107.34 120.68 42.82 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 93' ' ' VAL . 60.2 t -65.58 116.34 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.071 0.463 . . . . 0.0 110.051 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.551 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 2.2 t-80 -77.2 133.56 68.37 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 10.8 Cg_endo -57.58 -5.36 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.492 2.794 . . . . 0.0 114.472 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -54.71 -44.47 73.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.458 0.647 . . . . 0.0 109.353 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.1 mmt -93.59 -56.76 2.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.617 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 60.26 -173.38 0.12 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.867 0.729 . . . . 0.0 110.493 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.411 ' CD ' ' H ' ' A' ' 124' ' ' VAL . 1.8 tm-20 57.65 -141.64 0.75 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.61 ' CG1' HG21 ' A' ' 86' ' ' VAL . 48.4 t 71.3 113.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.511 0.672 . . . . 0.0 111.783 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -124.48 150.08 46.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.021 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.485 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 6.7 t90 -45.12 142.17 2.97 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.093 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.589 ' HD3' HG12 ' A' ' 86' ' ' VAL . 3.2 Cg_endo . . . . . 0 C--N 1.355 0.89 0 C-N-CA 123.643 2.895 . . . . 0.0 112.824 -176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.578 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.453 -0.281 0 CA-C-O 120.847 0.356 . . . . 0.0 110.54 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.626 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 9.6 m-85 -97.76 141.15 31.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.449 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 75.6 mt-30 -105.23 95.93 10.48 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.45 0.167 . . . . 0.0 111.262 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.626 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 11.0 Cg_exo -72.41 -62.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.161 2.574 . . . . 0.0 112.619 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.855 HD11 HD21 ' A' ' 57' ' ' LEU . 8.0 mt -113.81 159.79 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.658 0.599 . . . . 0.0 110.912 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.415 ' H ' HG22 ' A' ' 9' ' ' ILE . . . -71.17 -56.73 5.47 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -66.08 -45.02 82.72 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -171.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.803 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 4.7 p -68.48 -42.21 79.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.755 0.312 . . . . 0.0 111.011 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.74 -127.74 9.34 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.362 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.578 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -96.82 145.1 26.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.377 0.608 . . . . 0.0 111.794 -173.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.6 m -137.38 127.79 26.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.691 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.6 m -86.68 83.5 7.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.397 0.618 . . . . 0.0 110.732 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.416 ' HG2' ' H ' ' A' ' 19' ' ' GLU . 9.1 tt0 -147.39 126.63 13.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.059 176.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.8 p -55.76 -28.2 54.78 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -174.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' A' ' 17' ' ' GLN . 0.9 OUTLIER -76.89 -22.37 53.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.717 0.294 . . . . 0.0 111.267 -176.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.534 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -65.42 -28.25 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.346 . . . . 0.0 111.556 -176.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . . . -61.67 -22.03 64.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.113 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.92 -23.64 17.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -109.71 4.42 21.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.484 -172.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.19 141.62 38.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 64.4 mttm -163.86 -169.75 1.97 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -78.74 72.68 5.27 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.697 0.76 . . . . 0.0 110.372 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.701 ' HB3' HG23 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -101.42 145.15 29.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.418 178.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -176.19 179.2 1.29 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.348 0.594 . . . . 0.0 112.265 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 114' ' ' ILE . 16.8 t -110.84 148.07 14.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.199 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.525 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -134.22 156.55 48.18 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.589 ' ND2' ' H ' ' A' ' 33' ' ' ALA . 2.6 p-10 -112.46 173.15 6.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.272 0.558 . . . . 0.0 112.143 -171.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 111' ' ' PRO . 9.9 p-10 -46.24 -33.62 3.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.264 -1.335 . . . . 0.0 113.669 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.589 ' H ' ' ND2' ' A' ' 31' ' ' ASN . . . -72.64 2.03 7.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 84' ' ' MET . . . 80.58 8.68 87.28 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -106.71 152.16 24.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.114 -0.543 . . . . 0.0 110.022 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -64.3 146.72 53.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.293 173.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.446 HD22 ' SG ' ' A' ' 112' ' ' CYS . 20.3 tp -98.65 166.26 11.41 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.406 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . 17.2 t-20 -147.95 158.18 43.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -173.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 43' ' ' PRO . 54.5 mtm180 -73.25 -14.95 61.42 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.97 -18.89 35.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.189 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.406 ' HG ' ' HB3' ' A' ' 38' ' ' ASN . 91.3 mt -92.7 -51.82 4.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.2 m -114.78 94.27 36.84 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.996 173.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 51.7 Cg_exo -54.83 -44.53 48.78 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.723 2.949 . . . . 0.0 113.608 -171.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -77.52 8.38 4.38 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 108' ' ' ALA . 2.4 mp -76.16 -21.65 56.31 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.2 -22.62 61.3 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.983 170.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 52.5 mt-10 -86.06 63.16 7.87 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.225 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 12' ' ' CYS . 73.3 t -123.18 127.93 74.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.136 169.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 60' ' ' LYS . 5.8 t -91.24 140.19 30.03 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 2.7 t -121.39 128.29 75.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.0 111.821 -172.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.589 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 15.4 mt-10 -120.86 129.41 53.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.559 169.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' A' ' 20' ' ' ALA . 5.7 mp -110.57 133.58 53.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.52 0.676 . . . . 0.0 110.013 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.1 ttm105 -135.91 148.14 48.44 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 70.0 mtm -62.98 93.68 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.433 0.635 . . . . 0.0 110.741 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.37 -16.03 11.71 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.938 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -143.28 138.42 29.56 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 117.828 0.814 . . . . 0.0 111.776 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.855 HD21 HD11 ' A' ' 9' ' ' ILE . 39.0 tp -113.1 112.46 23.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.702 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 51' ' ' GLU . 61.0 t -100.68 110.6 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.055 0.455 . . . . 0.0 111.251 -173.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 mp -98.67 132.5 44.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.996 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 66' ' ' ARG . 44.3 mtmt -129.52 136.81 50.31 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -116.45 142.28 29.25 Favored Pre-proline 0 C--O 1.222 -0.372 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.449 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 26.8 Cg_exo -62.89 94.74 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.93 1.753 . . . . 0.0 110.225 168.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.29 -28.33 6.33 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.042 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.604 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 16.7 mmt -122.4 152.65 40.0 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.34 -166.89 0.02 OUTLIER 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.856 0.836 . . . . 0.0 112.561 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.564 ' HB3' ' HG2' ' A' ' 60' ' ' LYS . 12.2 ptt180 -95.71 146.63 24.36 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.45 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 tp -124.54 115.36 20.73 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.793 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.76 109.75 21.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.619 0.723 . . . . 0.0 110.788 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.4 mt -104.73 113.81 64.55 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.361 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.47 123.04 12.7 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.258 1.972 . . . . 0.0 111.957 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 57' ' ' LEU . 95.9 mt . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 121.631 0.729 . . . . 0.0 109.12 176.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.636 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 45.1 t . . . . . 0 N--CA 1.452 -0.368 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.539 ' HG2' ' HB2' ' A' ' 92' ' ' ASP . 52.7 ttp180 -88.8 90.68 8.51 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -93.11 130.0 38.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.895 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -79.07 114.91 18.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.843 0.354 . . . . 0.0 110.405 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 2.4 tpt -105.22 154.94 19.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.754 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.25 87.61 2.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.689 0.757 . . . . 0.0 109.559 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 t -81.46 92.88 2.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.736 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.27 -81.24 1.08 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.57 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -140.06 9.48 2.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.793 -0.203 . . . . 0.0 110.788 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -111.48 110.53 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.359 . . . . 0.0 110.506 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 m -84.29 109.61 17.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.224 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 m -131.85 149.21 32.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.806 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.539 ' HB2' ' HG2' ' A' ' 81' ' ' ARG . 7.1 p-10 -87.22 128.71 35.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.442 0.639 . . . . 0.0 111.06 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 115' ' ' LEU . 29.5 m -124.91 153.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.011 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 118' ' ' HIS . 98.8 t -96.33 137.3 24.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.636 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 32.0 t70 -86.8 123.79 32.34 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.448 ' HG3' ' HE1' ' A' ' 27' ' ' TRP . 16.3 mm-40 -83.38 5.73 22.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 -174.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.78 126.65 2.41 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.211 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -67.47 -19.54 65.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.037 0.446 . . . . 0.0 110.244 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.03 -33.47 74.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 173.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.11 79.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.875 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -57.94 -54.26 48.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.5 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.93 87.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -54.32 -46.49 72.86 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.966 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.564 HD12 ' HB3' ' A' ' 107' ' ' HIS . 1.5 tp -84.93 -21.54 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.692 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.4 m -67.12 -15.66 63.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.167 0.508 . . . . 0.0 109.699 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.39 -52.02 5.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.276 171.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.564 ' HB3' HD12 ' A' ' 104' ' ' ILE . 72.5 t60 -67.63 -46.66 71.84 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.02 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.459 ' HB2' HD11 ' A' ' 45' ' ' LEU . . . -82.29 -42.22 19.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.046 0.45 . . . . 0.0 109.807 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.06 -12.36 62.2 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.055 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.544 HG23 ' SG ' ' A' ' 112' ' ' CYS . 15.4 m -112.78 159.42 34.49 Favored Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 122.788 -0.242 . . . . 0.0 110.353 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.435 ' HB2' ' HB3' ' A' ' 32' ' ' ASP . 25.4 Cg_exo -63.18 93.11 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.831 2.354 . . . . 0.0 112.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.544 ' SG ' HG23 ' A' ' 110' ' ' VAL . 68.6 m -134.8 155.86 49.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.955 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 10.5 ptm180 -141.16 146.8 37.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.605 HG12 HG22 ' A' ' 29' ' ' VAL . 35.2 mt -85.15 122.78 38.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.107 -177.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 93' ' ' VAL . 35.8 mt -126.06 152.23 46.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.139 -171.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.612 ' HZ3' ' HB3' ' A' ' 116' ' ' LYS . 7.8 ttpm? -119.09 123.16 43.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.104 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.67 137.55 24.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.764 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.515 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -76.49 134.25 70.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.653 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' A' ' 118' ' ' HIS . 3.7 Cg_exo -74.53 -8.05 20.17 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.231 2.621 . . . . 0.0 113.242 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.79 -52.48 56.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.338 . . . . 0.0 111.077 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -91.98 -45.43 8.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.959 178.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.429 ' N ' ' SD ' ' A' ' 121' ' ' MET . . . 58.94 -174.36 0.09 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.078 0.551 . . . . 0.0 112.142 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 49.78 84.03 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 122.096 0.951 . . . . 0.0 112.992 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.7 t -132.19 131.8 60.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.891 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -131.3 133.22 45.15 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.883 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.508 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 8.3 t90 -45.28 140.74 3.78 Favored Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 124.196 0.935 . . . . 0.0 110.772 175.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.508 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 9.5 Cg_endo . . . . . 0 C--N 1.353 0.768 0 C-N-CA 123.607 2.871 . . . . 0.0 112.745 -176.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.137 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.621 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 36.5 m-85 -103.25 140.37 37.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.25 95.76 14.06 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.947 0.404 . . . . 0.0 110.048 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.87 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 7.5 Cg_endo -90.06 -35.65 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.449 2.766 . . . . 0.0 113.395 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 2.4 mm -115.93 135.78 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 O-C-N 123.9 0.75 . . . . 0.0 110.231 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.451 ' O ' ' HD2' ' A' ' 39' ' ' ARG . . . -68.22 -56.23 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.618 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -70.86 -53.53 14.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.489 -178.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.835 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 39.7 m -56.48 -47.59 78.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.146 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.37 -130.39 10.16 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.115 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.73 150.46 21.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.321 0.581 . . . . 0.0 112.034 -172.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.46 HG22 ' H ' ' A' ' 17' ' ' GLN . 10.7 m -121.65 139.09 53.98 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.491 176.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m -90.44 8.47 33.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.36 0.6 . . . . 0.0 111.201 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.46 ' H ' HG22 ' A' ' 15' ' ' THR . 1.2 mp0 -95.63 142.19 28.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.779 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.8 m -67.68 -15.95 63.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.081 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HB3' ' HE2' ' A' ' 23' ' ' TYR . 7.2 mm-40 -64.3 -36.1 83.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.288 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.87 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -62.08 -25.01 67.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.768 -171.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.03 -23.93 67.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.03 0.443 . . . . 0.0 111.093 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.05 1.04 22.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.685 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.405 ' HE2' ' HB3' ' A' ' 19' ' ' GLU . 35.3 m-85 -126.44 12.4 7.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.723 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 14.0 pt20 -70.26 143.07 52.22 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HG3' ' C ' ' A' ' 24' ' ' GLN . 83.1 mttt -160.67 173.14 15.9 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -172.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -78.73 75.64 5.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.351 0.596 . . . . 0.0 109.742 173.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.44 ' HE1' ' HG3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -92.76 152.9 19.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.178 177.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 pp -175.58 177.39 1.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.468 0.651 . . . . 0.0 112.184 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 114' ' ' ILE . 64.6 t -122.0 138.16 53.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -122.81 141.63 51.64 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 122.174 -0.328 . . . . 0.0 110.16 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -88.51 172.78 9.08 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.117 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -47.79 -31.7 5.2 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.677 0.791 . . . . 0.0 112.631 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.93 -14.79 63.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.709 0.29 . . . . 0.0 111.736 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.53 5.85 68.81 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.559 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -94.06 144.97 25.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.562 -176.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.593 ' CH2' ' HB ' ' A' ' 124' ' ' VAL . 31.0 m0 -68.99 125.29 26.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.844 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.447 ' HG ' ' SG ' ' A' ' 42' ' ' CYS . 29.5 tp -96.24 131.67 42.49 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -119.76 157.97 27.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.871 0.367 . . . . 0.0 111.126 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 10' ' ' ALA . 11.4 ptm180 -64.64 -15.41 61.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.46 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.04 -37.66 61.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.487 0.66 . . . . 0.0 109.461 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.4 HD11 ' HZ2' ' A' ' 126' ' ' TRP . 68.3 mt -77.64 -50.4 12.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.885 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.447 ' SG ' ' HG ' ' A' ' 37' ' ' LEU . 13.1 p -116.7 92.98 39.62 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.371 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.58 -25.02 69.68 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.068 2.512 . . . . 0.0 113.214 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -71.36 -17.64 62.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 111.734 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.445 HD13 ' SG ' ' A' ' 42' ' ' CYS . 7.7 mp -72.46 -21.67 61.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.0 0.429 . . . . 0.0 110.599 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.81 -5.18 32.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.514 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 6.7 mm-40 -84.67 3.9 35.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.338 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.835 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 95.3 t -79.77 118.74 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.87 0.367 . . . . 0.0 110.969 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.9 p -87.18 119.12 27.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.687 ' HB ' ' HB3' ' A' ' 12' ' ' CYS . 12.0 p -117.71 128.26 74.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.315 -171.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 35.2 mm-40 -120.87 129.84 53.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.561 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 20' ' ' ALA . 10.1 mp -97.78 125.89 42.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.499 0.666 . . . . 0.0 110.66 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.529 HH21 HG21 ' A' ' 58' ' ' VAL . 28.0 ttm-85 -110.09 164.66 12.41 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.373 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.43 88.9 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.483 0.658 . . . . 0.0 110.257 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.39 -13.7 36.3 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.933 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.75 138.3 48.56 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.621 0.724 . . . . 0.0 112.345 -174.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.411 ' HB2' HD23 ' A' ' 71' ' ' LEU . 61.3 tp -100.59 107.87 19.65 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.695 173.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.529 HG21 HH21 ' A' ' 53' ' ' ARG . 46.2 t -99.56 102.78 13.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.928 0.394 . . . . 0.0 110.685 -175.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.671 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 5.8 mp -90.88 140.54 29.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.715 176.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.496 ' HE2' ' HG2' ' A' ' 51' ' ' GLU . 39.6 mtmt -136.44 130.1 32.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.759 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -114.74 153.09 46.88 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 119.211 -0.995 . . . . 0.0 112.829 -176.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.503 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 20.0 Cg_exo -67.14 98.25 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.236 1.957 . . . . 0.0 110.618 170.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.7 -18.31 32.2 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.267 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.759 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 14.3 mmt -121.73 144.84 48.56 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.2 mt -68.15 -149.93 0.01 OUTLIER 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.407 0.622 . . . . 0.0 111.971 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -69.77 170.25 11.36 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.745 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 60.2 tp -151.71 87.72 1.38 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.894 166.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -84.0 104.98 14.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.447 -175.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.0 mt -115.81 136.75 22.93 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.393 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.22 139.72 91.58 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 121.66 1.573 . . . . 0.0 110.613 171.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.411 HD23 ' HB2' ' A' ' 57' ' ' LEU . 69.2 mt . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -175.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 41.1 t . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 120.769 0.319 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.7 104.33 16.34 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.373 0.606 . . . . 0.0 111.139 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.515 ' O ' HG22 ' A' ' 93' ' ' VAL . 39.5 m-85 -94.95 116.4 28.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 173.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . 0.507 ' HG2' HG22 ' A' ' 90' ' ' THR . 31.6 tt0 -80.87 99.28 8.25 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.633 ' O ' ' HA ' ' A' ' 90' ' ' THR . 1.0 OUTLIER -86.96 159.31 19.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.881 -169.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.8 tp -117.99 87.36 2.7 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.885 0.85 . . . . 0.0 109.554 -173.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.495 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 2.8 t -78.99 86.84 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.874 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.85 -68.9 2.48 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.592 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -145.41 2.95 0.99 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.777 0.322 . . . . 0.0 110.367 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.642 HE21 HG22 ' A' ' 124' ' ' VAL . 15.8 tt0 -109.95 109.61 20.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.925 0.393 . . . . 0.0 111.025 -170.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -85.13 104.83 15.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.655 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.692 HG21 HG21 ' A' ' 124' ' ' VAL . 2.7 m -118.93 144.99 25.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.062 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.09 112.68 16.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.034 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.592 HG21 HD13 ' A' ' 115' ' ' LEU . 16.8 m -120.07 152.47 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.48 176.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -103.22 135.37 41.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.767 0.317 . . . . 0.0 111.176 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.584 ' HA ' HD23 ' A' ' 115' ' ' LEU . 43.5 t0 -83.2 126.13 32.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.44 ' HG3' ' HE1' ' A' ' 27' ' ' TRP . 8.3 mm-40 -81.32 -5.91 58.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.495 -176.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.5 136.92 2.95 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.378 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.47 ' HG2' ' NH1' ' A' ' 113' ' ' ARG . 14.6 mt-10 -69.15 -23.13 63.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.826 0.346 . . . . 0.0 110.573 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -64.56 -30.91 71.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.082 0.467 . . . . 0.0 109.86 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.532 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -74.35 -37.95 63.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.9 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB2' ' HD3' ' A' ' 113' ' ' ARG . . . -59.51 -46.39 88.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.621 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.506 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -66.69 -36.5 82.66 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.351 0.596 . . . . 0.0 111.027 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.415 ' CZ2' ' HB2' ' A' ' 61' ' ' ALA . 76.1 t90 -57.45 -40.27 78.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.311 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.2 tp -93.23 -21.1 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.528 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 90.5 p -66.87 -19.87 65.82 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.488 -0.757 . . . . 0.0 109.237 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -83.65 -48.66 9.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.135 172.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.578 ' HB3' HD12 ' A' ' 104' ' ' ILE . 75.1 t60 -74.28 -51.98 13.66 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 45' ' ' LEU . . . -71.78 -41.39 68.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 109.739 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.13 -22.94 38.03 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.74 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.22 157.03 35.58 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 120.532 0.206 . . . . 0.0 110.671 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.17 92.89 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.464 2.11 . . . . 0.0 111.469 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.432 ' HB2' HG12 ' A' ' 29' ' ' VAL . 5.0 p -134.25 156.5 48.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.015 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.509 ' HD3' ' HB2' ' A' ' 101' ' ' ALA . 7.3 tpp180 -117.77 128.44 54.88 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.172 -175.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 29' ' ' VAL . 54.5 mt -79.1 118.33 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.592 HD13 HG21 ' A' ' 93' ' ' VAL . 23.2 mt -130.46 142.1 50.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.286 0.565 . . . . 0.0 112.061 -168.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.466 ' HZ3' ' HB3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -117.1 117.33 29.33 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.206 175.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.91 137.56 23.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.522 -174.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.99 125.69 79.22 Favored Pre-proline 0 C--O 1.234 0.243 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.5 -4.46 6.86 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.377 2.718 . . . . 0.0 114.881 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -51.03 -57.33 8.91 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.347 0.594 . . . . 0.0 110.785 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 18.6 ptp -107.17 -54.19 2.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.077 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 124' ' ' VAL . . . 54.7 -106.85 0.34 Allowed 'General case' 0 CA--C 1.531 0.23 0 O-C-N 123.489 0.493 . . . . 0.0 110.887 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 66.72 -59.13 0.37 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.816 0.846 . . . . 0.0 113.233 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.692 HG21 HG21 ' A' ' 91' ' ' VAL . 3.4 t -54.57 122.69 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 112.504 -168.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -112.41 36.45 3.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.092 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.669 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 11.7 t90 72.35 152.41 0.14 Allowed Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -169.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.669 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 41.8 Cg_exo . . . . . 0 C--N 1.365 1.399 0 C-N-CA 124.523 3.482 . . . . 0.0 114.438 -179.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.688 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.443 -0.791 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.712 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 61.8 m-85 -87.45 117.66 26.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 13' ' ' GLY . 10.3 tt0 -96.39 98.85 4.61 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.266 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.758 ' HA ' ' CB ' ' A' ' 24' ' ' GLN . 21.4 Cg_exo -64.69 -60.59 0.13 Allowed 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 122.67 2.247 . . . . 0.0 110.9 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 27' ' ' TRP . 44.9 mt -114.54 136.01 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.951 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.02 -58.74 5.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.759 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 16.9 mm-40 -70.61 -22.43 62.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.794 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.859 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 73.6 m -73.6 -48.08 35.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.133 0.492 . . . . 0.0 110.087 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . 120.33 -153.72 16.63 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.231 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.688 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -113.33 142.73 45.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.106 0.479 . . . . 0.0 111.909 -172.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.3 m -118.87 137.57 53.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.699 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m -86.49 76.29 9.62 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.144 0.497 . . . . 0.0 110.126 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 19' ' ' GLU . 8.6 tt0 -160.19 120.7 2.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.858 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -68.49 -10.33 54.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.922 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.401 ' H ' ' HG2' ' A' ' 17' ' ' GLN . 22.2 tt0 -68.35 -28.54 67.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.287 0.565 . . . . 0.0 109.72 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -67.94 -24.22 65.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.624 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.84 -15.75 63.19 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.23 -3.84 50.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.631 0.253 . . . . 0.0 111.419 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.426 ' CD2' HD13 ' A' ' 71' ' ' LEU . 74.3 m-85 -130.56 -25.67 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.758 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -66.0 155.35 36.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.989 -177.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -172.65 -160.63 0.14 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.219 0.324 . . . . 0.0 110.169 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -74.95 69.06 1.86 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 122.122 0.963 . . . . 0.0 109.729 175.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.677 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 1.3 t90 -100.51 144.84 29.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.452 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -170.31 -173.79 1.55 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.575 0.625 . . . . 0.0 112.243 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.508 HG22 HG12 ' A' ' 114' ' ' ILE . 80.7 t -113.2 144.23 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.758 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.02 150.13 37.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 0.0 111.281 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.49 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 27.5 t30 -98.89 156.81 16.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.137 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -46.13 -37.11 6.53 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.758 0.823 . . . . 0.0 112.683 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.09 -6.97 37.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 111.401 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.63 4.53 63.77 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.582 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -98.44 160.35 14.34 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.443 ' HB2' ' HD1' ' A' ' 126' ' ' TRP . 28.2 m0 -68.07 134.79 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 172.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.627 HD22 ' SG ' ' A' ' 112' ' ' CYS . 28.4 tp -99.19 131.59 45.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.39 152.86 42.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.351 0.596 . . . . 0.0 112.597 -173.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.2 ttm105 -48.8 -32.11 8.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.736 164.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.77 -17.8 64.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.492 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 75.5 mt -105.6 -39.6 6.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.12 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 50.5 t -132.29 101.59 14.71 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.029 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.72 -29.45 59.85 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.653 2.236 . . . . 0.0 112.138 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -59.34 -30.74 68.59 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.398 0.618 . . . . 0.0 110.473 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.759 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 37.3 tp -66.79 -34.03 76.92 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.566 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -73.98 9.21 1.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -98.26 24.26 7.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.844 0.354 . . . . 0.0 111.203 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.859 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 55.4 t -84.79 113.79 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.714 0.292 . . . . 0.0 110.409 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.8 t -77.54 132.06 38.17 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.28 138.25 53.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.559 0.695 . . . . 0.0 112.074 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 35.3 tt0 -140.86 149.12 41.56 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.458 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 20' ' ' ALA . 5.5 mp -128.61 158.03 39.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.687 0.756 . . . . 0.0 112.238 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -158.45 149.06 20.24 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.501 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 tpt -49.26 98.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.516 0.51 . . . . 0.0 110.992 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.51 -31.19 6.07 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.486 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.88 137.76 52.44 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.092 0.946 . . . . 0.0 112.963 -172.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.488 ' HB2' ' CD2' ' A' ' 71' ' ' LEU . 37.9 tp -100.72 108.59 20.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.213 170.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 42.5 t -96.96 99.82 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.977 0.418 . . . . 0.0 110.95 -172.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 8.0 mp -91.86 141.74 28.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.048 175.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -137.44 130.27 30.24 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.637 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -126.0 151.67 71.88 Favored Pre-proline 0 C--O 1.221 -0.41 0 C-N-CA 118.68 -1.208 . . . . 0.0 113.247 -175.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -62.81 107.19 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.986 1.79 . . . . 0.0 110.228 168.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.23 -24.29 25.01 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.169 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.637 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 95.1 mmm -122.39 147.57 46.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 0.0 110.327 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.3 mt -68.34 -144.58 0.01 OUTLIER 'General case' 0 C--O 1.247 0.937 0 CA-C-O 121.548 0.69 . . . . 0.0 110.756 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 5.8 ptt180 -86.75 151.63 23.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.066 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 60.3 tp -124.32 93.53 3.94 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 168.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.59 97.95 10.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.891 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.447 HG13 ' HG ' ' A' ' 67' ' ' LEU . 65.9 mt -100.21 122.52 49.98 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.922 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.94 123.97 15.11 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.006 1.804 . . . . 0.0 110.77 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.488 ' CD2' ' HB2' ' A' ' 57' ' ' LEU . 64.7 mt . . . . . 0 C--N 1.323 -0.551 0 CA-C-O 120.898 0.38 . . . . 0.0 110.707 -178.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 61.2 t . . . . . 0 N--CA 1.45 -0.455 0 CA-C-O 120.607 0.241 . . . . 0.0 110.416 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -66.58 112.63 4.24 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.526 ' O ' HG22 ' A' ' 93' ' ' VAL . 3.1 t80 -105.15 107.97 19.24 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -80.11 113.82 18.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.636 ' CE ' ' HA ' ' A' ' 84' ' ' MET . 5.3 mmt -103.68 169.59 8.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.195 -175.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.2 tp -139.38 88.04 2.23 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 t -89.39 103.24 13.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.785 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.61 -77.76 1.4 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -146.27 4.19 0.92 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.51 0.195 . . . . 0.0 110.933 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.602 ' HG2' HG13 ' A' ' 91' ' ' VAL . 10.2 tt0 -105.26 120.48 41.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.849 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 84' ' ' MET . 0.2 OUTLIER -79.93 116.33 20.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.264 174.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.602 HG13 ' HG2' ' A' ' 89' ' ' GLN . 3.6 m -129.74 164.29 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.39 112.69 24.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.754 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 115' ' ' LEU . 7.1 m -125.81 152.13 32.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.7 t -106.21 142.17 19.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 122.237 -0.289 . . . . 0.0 110.743 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.649 ' OD1' ' HD3' ' A' ' 113' ' ' ARG . 26.4 t70 -92.94 125.86 37.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.56 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.98 -14.03 62.21 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.708 0.289 . . . . 0.0 111.652 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 137.46 149.21 5.53 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.999 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -64.68 -13.54 54.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.934 0.397 . . . . 0.0 111.001 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.4 tp -66.04 -43.55 87.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.49 -36.53 76.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.388 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.09 67.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.131 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.438 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -62.95 -39.35 94.37 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.247 0.546 . . . . 0.0 111.103 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.417 ' HH2' HG13 ' A' ' 48' ' ' VAL . 49.8 t90 -57.81 -44.33 86.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.019 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 104' ' ' ILE . 1.6 tp -87.12 -25.17 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.571 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.438 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 16.5 p -68.49 -15.85 63.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.533 -0.729 . . . . 0.0 109.959 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -88.99 -45.25 9.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.448 171.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -74.4 -49.51 22.29 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.64 -40.87 55.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.48 -38.22 3.38 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.614 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.512 HG23 ' SG ' ' A' ' 112' ' ' CYS . 18.7 m -87.64 157.85 51.88 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.84 88.63 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.761 2.307 . . . . 0.0 111.923 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.627 ' SG ' HD22 ' A' ' 37' ' ' LEU . 73.8 m -134.83 168.73 18.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.939 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.649 ' HD3' ' OD1' ' A' ' 95' ' ' ASP . 11.1 ptp180 -149.14 151.23 34.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.606 0.241 . . . . 0.0 110.634 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 29' ' ' VAL . 52.3 mt -82.85 131.88 32.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 95' ' ' ASP . 64.7 mt -138.23 133.34 33.07 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 120.926 0.393 . . . . 0.0 111.214 -174.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -99.89 120.47 39.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.785 173.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.1 t -64.16 133.85 29.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.554 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 5.0 t-160 -55.99 126.65 67.08 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.88 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.554 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 6.1 Cg_endo -47.78 -32.49 17.09 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.679 2.919 . . . . 0.0 113.45 -175.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.21 -53.24 58.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.391 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 51.7 ttm -89.78 121.41 31.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.462 0.649 . . . . 0.0 110.636 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -115.4 -35.5 4.6 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.405 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -82.63 103.23 11.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.227 0.537 . . . . 0.0 111.364 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.556 HG13 HG11 ' A' ' 91' ' ' VAL . 51.4 t -130.47 -66.86 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.297 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 68.28 121.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.605 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.47 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 2.9 t90 -58.37 145.62 74.61 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.47 165.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 4.9 Cg_endo . . . . . 0 C--N 1.351 0.688 0 C-N-CA 123.732 2.955 . . . . 0.0 113.386 -178.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.445 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 36.8 m-85 -89.98 138.17 31.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -114.54 93.24 31.71 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 120.735 0.302 . . . . 0.0 110.452 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.585 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 1.1 Cg_endo -84.8 -38.23 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.871 2.38 . . . . 0.0 112.213 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.635 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 0.7 OUTLIER -114.75 147.12 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.381 -176.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.13 -69.22 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.849 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -65.46 -39.9 92.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.283 -176.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.851 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 34.2 m -60.55 -47.92 84.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.846 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.55 -130.38 10.03 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.625 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -109.6 147.8 32.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.305 0.574 . . . . 0.0 112.112 -171.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.8 m -139.51 125.66 19.99 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.357 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -86.8 88.87 7.78 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.91 0.862 . . . . 0.0 110.639 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -148.19 135.97 20.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.194 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 p -56.46 -38.03 71.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -74.95 -23.35 58.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.417 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.585 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -62.13 -27.35 68.88 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.47 67.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.86 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.2 3.11 27.48 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -118.31 13.83 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.71 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.572 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -77.07 153.54 34.24 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -162.95 171.31 16.76 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.5 ' HD2' ' O ' ' A' ' 122' ' ' ALA . 58.6 mtt180 -76.81 76.84 3.42 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 122.145 0.974 . . . . 0.0 109.314 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -91.39 152.3 20.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.351 -1.749 . . . . 0.0 108.913 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 pp 179.49 -176.9 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.184 0.516 . . . . 0.0 111.097 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -118.87 140.73 41.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.573 178.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.31 140.05 50.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 10.1 p30 -95.88 -177.52 4.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.438 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -46.53 -41.44 14.24 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.81 0.694 . . . . 0.0 112.765 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.47 -8.13 48.73 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.09 8.78 87.33 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.704 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -88.63 142.76 27.42 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.461 ' HB2' ' HD1' ' A' ' 126' ' ' TRP . 29.8 m0 -62.36 128.31 35.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.824 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 29' ' ' VAL . 8.5 tp -87.42 131.45 34.31 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -120.64 162.8 19.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.47 -169.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -71.58 -21.55 61.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.258 0.551 . . . . 0.0 109.778 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.9 -27.16 61.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.825 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.9 mt -90.18 -45.39 9.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.525 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.699 ' SG ' ' HG ' ' A' ' 37' ' ' LEU . 1.7 p -130.44 96.83 23.22 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.105 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.27 -37.14 52.55 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.948 2.432 . . . . 0.0 112.859 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -73.24 -6.29 44.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.231 0.539 . . . . 0.0 111.003 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.849 ' HG ' ' HB2' ' A' ' 11' ' ' GLU . 33.8 tp -73.02 -24.23 60.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.919 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -72.19 -6.3 41.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.426 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.74 31.24 0.77 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.484 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.851 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 88.8 t -93.49 127.86 45.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.644 0.259 . . . . 0.0 110.418 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.2 t -86.47 137.54 32.46 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.585 HG22 ' HB3' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -119.41 144.7 27.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.182 0.515 . . . . 0.0 111.239 -173.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 35.0 tt0 -148.7 140.36 23.58 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -111.36 125.04 53.44 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.734 0.778 . . . . 0.0 110.578 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.608 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 2.4 tpm_? -105.1 154.89 19.56 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.09 -1.414 . . . . 0.0 107.487 176.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.1 ttt -64.0 89.18 0.05 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.917 0.389 . . . . 0.0 110.544 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.35 -9.44 33.14 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.521 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.608 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 87.5 m-85 -132.24 147.85 52.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.174 0.511 . . . . 0.0 111.235 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.599 ' HB3' HG13 ' A' ' 69' ' ' ILE . 45.8 tp -104.83 111.93 24.85 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 61.5 t -100.28 101.64 12.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.011 0.434 . . . . 0.0 110.778 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 11.1 mp -90.64 145.19 25.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.431 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -137.34 129.23 28.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.615 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -120.54 144.75 39.21 Favored Pre-proline 0 C--O 1.219 -0.514 0 C-N-CA 118.946 -1.102 . . . . 0.0 113.35 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -63.35 97.32 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.743 1.628 . . . . 0.0 109.758 166.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.94 -33.98 3.88 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.768 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.615 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 91.7 mmm -122.19 149.6 43.41 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.446 ' H ' HD22 ' A' ' 65' ' ' LEU . 2.6 mm? -70.91 -144.59 0.01 OUTLIER 'General case' 0 C--O 1.246 0.873 0 CA-C-O 120.895 0.379 . . . . 0.0 110.635 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 92.2 mtt180 -79.06 155.93 28.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.107 0.479 . . . . 0.0 110.563 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 59.9 tp -127.39 103.46 7.38 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -88.76 101.77 14.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.588 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.599 HG13 ' HB3' ' A' ' 57' ' ' LEU . 8.5 pt -124.43 119.25 26.14 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.444 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.15 144.64 89.8 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.354 2.036 . . . . 0.0 111.33 176.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.466 0.364 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -167.27 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t . . . . . 0 N--CA 1.451 -0.392 0 CA-C-O 120.834 0.349 . . . . 0.0 110.585 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -104.31 111.17 23.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.217 0.532 . . . . 0.0 110.306 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 93' ' ' VAL . 33.0 m-85 -102.89 135.06 45.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.379 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -88.32 128.1 35.49 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.286 0.565 . . . . 0.0 110.76 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.675 ' HE2' HD12 ' A' ' 115' ' ' LEU . 52.4 mtt -95.69 171.83 8.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.3 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.5 tp -139.96 87.26 2.15 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.435 0.636 . . . . 0.0 109.636 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.402 HG12 ' HD3' ' A' ' 127' ' ' PRO . 3.2 t -97.85 96.28 5.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.046 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 60.63 48.06 88.09 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.719 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 74.71 7.88 4.35 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.543 0.737 . . . . 0.0 111.708 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.56 ' HG2' HG13 ' A' ' 91' ' ' VAL . 9.8 tt0 -96.02 99.01 10.82 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 84' ' ' MET . 30.3 m -77.14 105.97 8.56 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.314 0.578 . . . . 0.0 110.402 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.56 HG13 ' HG2' ' A' ' 89' ' ' GLN . 3.6 m -122.74 162.16 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.106 -175.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.633 ' O ' ' HB2' ' A' ' 118' ' ' HIS . 8.8 t70 -108.11 127.13 53.53 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 117' ' ' VAL . 23.1 m -132.74 154.11 39.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.921 0.391 . . . . 0.0 111.307 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 63.6 t -91.02 135.01 27.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.734 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.542 ' HA ' ' CD2' ' A' ' 115' ' ' LEU . 18.2 t70 -88.43 133.28 34.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.799 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -80.52 -2.84 47.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.247 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.91 141.59 5.57 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.0 -13.8 62.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.881 0.341 . . . . 0.0 111.078 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.1 pt? -69.7 -32.94 71.81 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 171.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.55 -33.23 58.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.787 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -57.36 -55.22 37.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.275 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.07 99.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.805 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . 0.429 ' CZ3' HD13 ' A' ' 104' ' ' ILE . 84.4 t90 -49.25 -47.68 46.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.725 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.542 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.3 tp -87.27 -22.51 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.122 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 64.5 m -66.44 -13.03 60.19 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.642 -0.661 . . . . 0.0 109.512 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -89.81 -49.93 6.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.602 173.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.542 ' HB3' HD12 ' A' ' 104' ' ' ILE . 78.1 t60 -76.18 -46.0 30.56 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.33 -36.78 71.69 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.72 -31.12 8.95 Favored Glycine 0 N--CA 1.454 -0.16 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.203 170.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.645 HG23 ' SG ' ' A' ' 112' ' ' CYS . 31.2 m -103.83 157.18 34.47 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.5 99.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.715 2.277 . . . . 0.0 112.265 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.645 ' SG ' HG23 ' A' ' 110' ' ' VAL . 57.2 m -134.56 -176.41 4.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.958 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 7.7 ptp180 -166.2 142.88 5.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.302 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.442 HG12 ' CG1' ' A' ' 29' ' ' VAL . 62.3 mt -79.44 123.03 35.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.675 HD12 ' HE2' ' A' ' 84' ' ' MET . 43.3 mt -134.83 150.29 50.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.004 -173.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -117.2 139.64 50.53 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.916 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.584 ' HA ' HG12 ' A' ' 93' ' ' VAL . 33.1 t -66.0 142.08 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.421 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.633 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 0.2 OUTLIER -61.74 142.32 94.7 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.537 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.27 -19.02 65.33 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.717 2.278 . . . . 0.0 111.773 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.1 -10.56 54.95 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.985 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.42 ' SD ' ' HB ' ' A' ' 91' ' ' VAL . 11.4 ptp -144.72 -44.24 0.24 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -176.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . 68.55 -64.45 0.31 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 172.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 125' ' ' ARG . 35.5 tt0 -70.47 -76.24 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -168.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.502 HG22 HG11 ' A' ' 91' ' ' VAL . 58.8 t 67.43 -77.33 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 122.758 0.423 . . . . 0.0 111.658 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.537 ' HG3' ' HG2' ' A' ' 123' ' ' GLU . 36.9 mtm180 81.96 131.89 0.05 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.26 1.024 . . . . 0.0 113.647 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.5 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 5.1 t90 -56.71 150.06 38.59 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.522 170.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.5 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 2.9 Cg_endo . . . . . 0 C--N 1.354 0.833 0 C-N-CA 123.106 2.537 . . . . 0.0 112.391 177.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.455 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 121.172 0.51 . . . . 0.0 109.789 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.718 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 62.4 m-85 -91.54 142.5 27.58 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.476 -176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.25 85.57 0.9 Allowed Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.907 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 3.3 Cg_exo -81.39 -59.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.726 2.284 . . . . 0.0 112.147 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 0.4 OUTLIER -99.71 138.7 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.582 -179.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.69 -56.41 20.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -170.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.877 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -77.81 -41.53 36.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.735 -176.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.846 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 78.1 m -52.37 -45.97 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.742 0.651 . . . . 0.0 111.898 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.545 ' HA2' HH12 ' A' ' 39' ' ' ARG . . . 108.5 -151.49 17.04 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.007 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.455 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -84.7 138.31 32.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.272 0.558 . . . . 0.0 111.525 -174.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.49 HG21 HD13 ' A' ' 52' ' ' LEU . 16.1 m -118.56 132.33 56.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.61 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -91.89 14.96 14.1 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.427 ' H ' HG22 ' A' ' 15' ' ' THR . 0.9 OUTLIER -101.55 139.05 37.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.814 0.34 . . . . 0.0 110.375 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 p -61.96 -36.3 81.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.65 -21.25 66.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.622 0.249 . . . . 0.0 111.632 -176.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.907 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -61.83 -27.28 68.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.649 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 -27.73 69.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.552 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.98 -13.83 26.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.375 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -113.57 6.66 17.11 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.747 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.619 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 16.1 pt20 -67.29 140.95 57.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 171.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -166.05 -179.29 5.09 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.905 -174.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -77.92 77.92 4.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.5 0.667 . . . . 0.0 110.715 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.429 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -102.03 162.53 12.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.992 177.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -179.49 178.52 0.67 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.271 0.558 . . . . 0.0 111.25 172.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 114' ' ' ILE . 60.4 t -112.69 146.34 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.028 173.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.632 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -126.9 147.03 50.09 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.283 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.518 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 5.7 p-10 -86.79 -179.58 6.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.045 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -46.03 -36.13 5.42 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.18 0.992 . . . . 0.0 113.367 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.479 ' H ' ' ND2' ' A' ' 31' ' ' ASN . . . -79.3 -0.32 31.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.93 45.53 63.11 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.535 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.468 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 25.1 tt0 -121.66 141.47 51.11 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.33 -177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.727 ' CZ2' HG21 ' A' ' 124' ' ' VAL . 5.6 m95 -57.51 125.01 20.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.126 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.524 ' HG ' ' SG ' ' A' ' 42' ' ' CYS . 9.9 tp -113.49 132.18 55.77 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.57 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 22.4 p-10 -130.4 -177.04 4.16 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.545 HH12 ' HA2' ' A' ' 13' ' ' GLY . 10.0 mmm-85 -64.68 -15.14 60.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.575 -176.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.428 ' HB2' HD21 ' A' ' 38' ' ' ASN . 11.7 m-20 -93.33 -29.73 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.757 0.313 . . . . 0.0 110.884 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.57 ' HG ' ' OD1' ' A' ' 38' ' ' ASN . 86.8 mt -89.04 -42.71 11.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.672 ' HB2' HD13 ' A' ' 45' ' ' LEU . 24.2 p -123.85 91.53 49.54 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.609 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.4 -39.86 0.51 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.007 2.471 . . . . 0.0 113.776 -174.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.741 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 47.5 mtm-85 -67.12 -11.82 58.27 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.338 0.59 . . . . 0.0 111.745 -172.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.877 ' HB3' ' HB2' ' A' ' 11' ' ' GLU . 11.0 mp -68.59 -19.21 64.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.139 0.495 . . . . 0.0 110.402 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -67.8 -9.64 46.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.757 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.741 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 10.9 pt-20 -98.59 29.05 3.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.787 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.846 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 98.5 t -81.12 138.11 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.662 0.268 . . . . 0.0 110.556 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 t -92.24 134.54 34.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 12' ' ' CYS . 4.2 t -120.25 128.17 75.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.938 0.399 . . . . 0.0 111.598 -172.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.48 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 9.4 tp10 -123.61 143.61 50.12 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.184 172.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.49 HD13 HG21 ' A' ' 15' ' ' THR . 6.9 mp -124.75 125.82 44.67 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.546 0.689 . . . . 0.0 110.963 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.592 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 19.7 tpp180 -109.29 154.45 22.46 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 66.1 mtt -62.03 89.59 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 110.41 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.57 -7.45 26.25 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.932 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.592 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 97.9 m-85 -138.01 137.75 38.19 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.414 0.607 . . . . 0.0 111.606 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.0 tp -102.17 107.83 19.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.138 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 43.0 t -101.67 102.58 13.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.022 0.439 . . . . 0.0 111.031 -173.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.64 147.71 25.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.27 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -144.47 133.21 22.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.633 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -112.35 147.73 37.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.133 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -65.43 93.33 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.273 1.982 . . . . 0.0 110.67 172.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.93 -24.48 10.1 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.44 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.633 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 13.0 mmt -120.07 157.36 29.11 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.07 -163.13 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.315 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -90.31 165.84 13.66 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.518 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.7 tp -143.51 93.68 2.51 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.967 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -88.01 114.15 24.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.526 0.679 . . . . 0.0 110.248 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.552 HD13 ' HG2' ' A' ' 96' ' ' GLU . 55.0 mt -111.65 118.9 46.05 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.396 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.72 127.91 28.13 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.252 1.968 . . . . 0.0 111.296 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.5 mt . . . . . 0 C--N 1.327 -0.398 0 CA-C-O 120.98 0.419 . . . . 0.0 110.589 -178.994 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 48.5 t . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.668 0.27 . . . . 0.0 111.484 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . 0.709 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -97.17 97.59 9.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.797 0.808 . . . . 0.0 109.124 170.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -76.98 121.57 23.68 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.334 -174.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -68.91 105.24 2.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.251 0.548 . . . . 0.0 110.058 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.486 ' HE1' HD13 ' A' ' 115' ' ' LEU . 23.4 tpp -93.17 150.73 20.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.816 -175.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.445 ' N ' ' HG3' ' A' ' 84' ' ' MET . 42.3 tp -125.9 89.2 2.98 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.695 0.759 . . . . 0.0 109.241 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.777 HG21 ' HB ' ' A' ' 124' ' ' VAL . 2.1 t -80.94 87.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.099 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.31 -86.83 1.01 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.63 16.33 2.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.062 0.458 . . . . 0.0 110.763 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -102.15 119.27 38.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 110.538 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.1 m -92.98 109.5 20.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.078 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.609 HG21 HG12 ' A' ' 124' ' ' VAL . 3.9 m -142.58 139.44 28.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.605 -177.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.709 ' HB2' ' HB2' ' A' ' 81' ' ' ARG . 5.3 p-10 -83.3 141.73 31.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.163 0.506 . . . . 0.0 110.334 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.58 HG23 HD22 ' A' ' 115' ' ' LEU . 18.6 m -128.94 152.71 37.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.571 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.0 t -81.4 123.62 38.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.949 0.404 . . . . 0.0 111.46 -174.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.762 ' HA ' HD23 ' A' ' 115' ' ' LEU . 59.3 t0 -87.07 129.26 34.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.79 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.552 ' HG2' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -75.73 -6.55 51.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.215 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.59 158.47 10.37 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.546 173.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.76 -11.14 60.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 0.0 110.373 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.3 mt -65.5 -41.59 93.04 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.97 -34.42 68.95 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.046 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.65 -50.22 74.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.514 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.412 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -62.17 -44.65 96.14 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.99 0.424 . . . . 0.0 110.698 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 49.0 t90 -53.85 -44.51 70.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.39 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.617 HD12 ' HB3' ' A' ' 107' ' ' HIS . 2.1 tp -92.84 -21.01 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.987 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 40.5 p -68.3 -13.41 62.24 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.578 174.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -85.43 -45.62 11.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.362 170.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.617 ' HB3' HD12 ' A' ' 104' ' ' ILE . 84.4 t60 -79.68 -45.45 18.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.934 0.397 . . . . 0.0 111.692 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.87 43.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.87 -3.83 84.82 Favored Glycine 0 C--N 1.325 -0.049 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.841 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.534 HG23 ' SG ' ' A' ' 112' ' ' CYS . 13.7 m -120.47 159.61 47.31 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -67.88 87.57 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.772 2.315 . . . . 0.0 112.083 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.534 ' SG ' HG23 ' A' ' 110' ' ' VAL . 75.1 m -134.52 154.53 51.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.128 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -135.37 151.98 51.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.549 HG12 HG22 ' A' ' 29' ' ' VAL . 55.4 mt -83.11 119.79 33.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.03 0.443 . . . . 0.0 109.947 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 95' ' ' ASP . 52.3 mt -122.1 133.97 54.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.74 -173.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 27' ' ' TRP . 6.5 ttpm? -107.05 128.4 54.33 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.347 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.2 t -71.21 119.17 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.184 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -61.97 124.96 84.03 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.195 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.76 35.52 0.22 Allowed 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.723 2.948 . . . . 0.0 114.143 -172.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -118.76 -32.01 4.65 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 26.3 mmt -77.49 -57.97 3.53 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.476 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 68.21 -66.99 0.21 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.084 0.865 . . . . 0.0 112.417 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.44 113.5 22.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.681 0.753 . . . . 0.0 111.288 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.777 ' HB ' HG21 ' A' ' 86' ' ' VAL . 12.3 m -115.62 -22.48 4.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.807 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 60.94 66.05 0.94 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.487 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.493 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 46.6 t90 -47.71 138.97 9.12 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 170.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.493 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 9.0 Cg_endo . . . . . 0 C--N 1.35 0.658 0 C-N-CA 123.987 3.125 . . . . 0.0 113.769 -173.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.729 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . . . . . . 0 N--CA 1.445 -0.68 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -96.04 140.42 30.8 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.479 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -100.4 97.46 6.46 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.538 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.592 ' HA ' ' CB ' ' A' ' 24' ' ' GLN . 38.5 Cg_endo -70.18 -59.81 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.825 1.684 . . . . 0.0 110.103 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.637 HD11 HD21 ' A' ' 57' ' ' LEU . 18.4 mt -103.76 146.48 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.633 173.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.24 -55.05 15.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . 0.742 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 1.4 mp0 -60.21 -42.58 95.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.689 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.832 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 52.7 m -60.84 -44.74 96.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.447 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.04 -134.25 11.78 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.003 174.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.729 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -84.81 121.68 28.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.586 0.708 . . . . 0.0 112.331 -170.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.483 HG21 HD13 ' A' ' 52' ' ' LEU . 8.6 m -123.02 119.13 29.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.764 173.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 5' ' ' ALA . 9.8 t -85.85 -6.6 59.06 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.169 -170.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -60.74 122.38 14.63 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 t -61.45 -25.88 67.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.794 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -59.36 -30.52 68.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.835 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.41 -30.04 70.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.278 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 -17.03 64.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.936 0.398 . . . . 0.0 111.566 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.99 -22.1 15.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.233 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -105.54 -11.3 16.44 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.974 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.592 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 3.4 pt20 -64.16 155.8 30.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.137 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 51.1 mmtt -162.91 179.73 7.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.225 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.464 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.5 OUTLIER -71.13 76.21 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TRP . . . . . 0.565 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -95.06 147.75 23.08 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.359 -176.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.724 ' HA ' ' OE2' ' A' ' 11' ' ' GLU . 2.2 pp -176.83 166.58 2.54 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.395 0.616 . . . . 0.0 112.578 174.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.597 HG21 HG12 ' A' ' 104' ' ' ILE . 56.1 t -98.28 129.59 48.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.782 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.11 133.69 53.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.582 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . 0.46 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 12.0 t30 -77.59 154.45 32.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -47.18 -30.1 2.71 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.452 ' H ' ' ND2' ' A' ' 31' ' ' ASN . . . -58.86 -23.4 60.78 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.054 0.454 . . . . 0.0 111.543 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 5.72 55.13 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.19 149.16 21.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 111.025 -174.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.461 ' CD1' HG13 ' A' ' 86' ' ' VAL . 12.0 m0 -70.79 122.27 19.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.945 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.45 HD13 ' HB2' ' A' ' 31' ' ' ASN . 4.4 tp -82.49 133.91 35.21 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.473 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 1.8 t-20 -119.93 161.96 19.99 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.432 -170.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.472 ' HG3' ' HB2' ' A' ' 46' ' ' ALA . 24.7 ttm180 -65.55 -26.33 67.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.655 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -92.92 -11.33 33.67 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.492 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.473 ' HB2' ' H ' ' A' ' 38' ' ' ASN . 80.2 mt -82.64 -50.57 8.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.1 m -131.33 100.24 16.92 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.485 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -59.39 -36.39 94.12 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.987 2.458 . . . . 0.0 112.66 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -61.94 -21.63 64.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.057 0.456 . . . . 0.0 111.264 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.742 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 37.1 tp -68.54 -29.88 68.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.524 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.703 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -87.64 10.35 18.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.595 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -96.62 18.96 13.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.679 0.276 . . . . 0.0 111.299 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.832 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 56.8 t -75.84 127.46 37.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.83 0.348 . . . . 0.0 110.699 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 14.0 m -85.87 122.15 29.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.697 HG22 ' HB3' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -101.12 140.62 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.02 0.438 . . . . 0.0 111.263 -172.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -145.77 129.93 17.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.468 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.483 HD13 HG21 ' A' ' 15' ' ' THR . 10.9 mp -107.63 125.05 50.87 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.558 0.694 . . . . 0.0 110.677 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 36.3 ttm180 -105.29 150.85 24.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.0 ttt -65.35 97.2 0.27 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.695 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.8 33.45 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.95 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.497 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 78.5 m-85 -137.2 137.64 39.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 117.486 0.643 . . . . 0.0 111.571 -174.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.637 HD21 HD11 ' A' ' 9' ' ' ILE . 42.0 tp -100.65 108.38 20.24 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.072 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.01 111.35 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.154 0.502 . . . . 0.0 111.293 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.1 mp -98.06 140.16 32.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.101 176.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 39.5 mttm -129.6 133.56 47.23 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . 0.806 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -122.04 148.76 52.44 Favored Pre-proline 0 C--N 1.326 -0.44 0 C-N-CA 118.897 -1.121 . . . . 0.0 113.254 -176.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . 0.44 ' HD2' ' CE1' ' A' ' 107' ' ' HIS . 23.1 Cg_exo -65.37 85.01 0.2 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.312 2.008 . . . . 0.0 110.648 168.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.38 -26.66 4.34 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.792 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.806 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 94.8 mmm -117.47 154.12 31.96 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.3 mm? -77.12 -144.34 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 49.2 ptt85 -83.55 149.68 26.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.272 0.558 . . . . 0.0 111.14 176.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 59.9 tp -121.95 102.79 8.39 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.637 170.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.488 ' OD1' ' HD2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -81.11 100.92 9.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.758 -179.123 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 64.2 mt -100.3 105.17 34.55 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.927 176.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 68' ' ' ASP . 15.7 Cg_exo -68.3 125.4 12.87 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.172 1.915 . . . . 0.0 110.881 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.7 mt . . . . . 0 N--CA 1.465 0.295 0 O-C-N 123.513 0.508 . . . . 0.0 111.979 -172.901 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 48.0 t . . . . . 0 CA--C 1.521 -0.14 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -97.38 113.94 25.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.89 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 93' ' ' VAL . 6.3 t80 -112.11 120.1 40.69 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.701 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -78.85 118.09 20.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.457 0.646 . . . . 0.0 110.541 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.579 ' HE3' HG11 ' A' ' 93' ' ' VAL . 53.7 ttm -98.1 159.89 14.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.313 -176.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 88' ' ' GLU . 14.2 tp -135.7 87.11 2.29 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.153 0.501 . . . . 0.0 110.278 -175.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.681 HG12 ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -72.3 90.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.261 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.73 -75.18 1.27 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -170.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 8.8 pt-20 -152.1 18.76 0.67 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.027 0.441 . . . . 0.0 110.242 171.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLN . . . . . 0.739 HE21 HG13 ' A' ' 124' ' ' VAL . 19.2 tt0 -92.03 107.25 19.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 m -80.36 108.61 14.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.099 -175.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 84' ' ' MET . 5.8 m -123.94 151.65 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.507 -174.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -93.82 112.8 24.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.543 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.579 HG11 ' HE3' ' A' ' 84' ' ' MET . 14.6 m -131.26 154.22 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 0.0 110.527 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 91.1 t -101.48 135.38 38.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.603 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.471 ' HA ' ' CD2' ' A' ' 115' ' ' LEU . 16.7 t70 -80.39 135.92 36.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -106.55 10.43 31.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.97 0.414 . . . . 0.0 111.703 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.81 136.74 4.21 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.401 -1.381 . . . . 0.0 114.294 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.85 -25.0 67.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.827 -0.687 . . . . 0.0 110.714 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.8 tp -62.31 -45.47 93.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.085 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ALA . . . . . 0.511 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -69.33 -33.54 73.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.177 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -59.37 -57.96 10.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.164 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.01 -38.75 87.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.369 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -57.28 -46.01 83.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.949 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.597 HG12 HG21 ' A' ' 29' ' ' VAL . 2.8 tp -83.69 -25.81 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 73.3 m -59.93 -26.85 66.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.171 0.51 . . . . 0.0 109.713 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -88.99 -40.36 13.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.496 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.571 ' HB3' HD12 ' A' ' 104' ' ' ILE . 77.7 t60 -77.41 -53.16 7.99 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.162 -0.336 . . . . 0.0 111.789 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -62.55 -40.21 96.11 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.32 -16.61 34.99 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.421 170.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.679 HG23 ' SG ' ' A' ' 112' ' ' CYS . 16.6 m -121.67 160.87 44.66 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 18.0 Cg_endo -58.36 96.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.81 2.34 . . . . 0.0 112.168 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' CYS . . . . . 0.679 ' SG ' HG23 ' A' ' 110' ' ' VAL . 73.9 m -135.22 173.22 11.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.708 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 9.5 ptp85 -149.95 140.15 22.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.815 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 29' ' ' VAL . 60.8 mt -75.79 120.95 26.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.471 ' CD2' ' HA ' ' A' ' 95' ' ' ASP . 96.5 mt -124.81 151.26 45.42 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.442 0.639 . . . . 0.0 111.097 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -108.58 105.3 14.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.131 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 93' ' ' VAL . 86.3 t -64.01 118.43 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.392 0.615 . . . . 0.0 110.34 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' HIS . . . . . 0.685 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 7.4 t-160 -69.9 132.3 88.75 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.103 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PRO . . . . . 0.685 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 28.5 Cg_endo -62.5 15.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.748 0 C-N-CA 123.687 2.925 . . . . 0.0 114.259 -176.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 118' ' ' HIS . 9.9 t70 -60.0 -60.77 3.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.271 0.558 . . . . 0.0 109.515 176.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' MET . . . . . 0.493 ' HG3' HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -99.73 -30.4 12.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.313 173.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 69.28 -77.94 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.06 -72.17 0.11 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -170.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.739 HG13 HE21 ' A' ' 89' ' ' GLN . 58.3 t 70.99 -58.29 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.558 0.536 . . . . 0.0 111.924 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . 0.609 ' O ' ' HB2' ' A' ' 126' ' ' TRP . 66.8 ttt180 79.03 -89.35 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.999 1.319 . . . . 0.0 111.745 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' TRP . . . . . 0.609 ' HB2' ' O ' ' A' ' 125' ' ' ARG . 9.5 t90 162.79 142.57 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -174.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.681 ' HD3' HG12 ' A' ' 86' ' ' VAL . 38.0 Cg_endo . . . . . 0 C--N 1.351 0.659 0 C-N-CA 123.513 2.809 . . . . 0.0 112.777 -177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 43.5 m -69.46 162.92 26.45 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 175.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 20.2 m -60.43 -52.11 66.63 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.2 m 59.38 21.62 9.97 Favored 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 121.842 0.83 . . . . 0.0 111.551 172.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.755 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -99.66 95.6 7.07 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.8 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -80.69 141.5 34.82 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.758 -0.655 . . . . 0.0 109.804 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -115.25 85.74 13.26 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 121.287 -0.165 . . . . 0.0 110.894 -178.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.571 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 49.0 Cg_endo -74.45 -35.87 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 121.885 1.724 . . . . 0.0 111.082 174.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.772 HD11 HD11 ' A' ' 57' ' ' LEU . 2.4 mt -114.52 145.28 20.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-N 114.941 -1.027 . . . . 0.0 110.208 -177.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -73.88 -70.95 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.869 0.366 . . . . 0.0 111.941 -174.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.835 ' HG2' HG23 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -56.73 -50.09 73.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.457 -178.094 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.805 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 73.8 m -53.48 -45.57 69.67 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.028 -0.987 . . . . 0.0 111.303 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.71 -127.52 9.18 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.021 -1.085 . . . . 0.0 113.782 170.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.755 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -85.13 138.37 32.44 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.436 0.636 . . . . 0.0 112.506 -169.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.518 HG21 HD13 ' A' ' 52' ' ' LEU . 17.0 m -123.96 123.69 40.94 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.789 174.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -87.07 22.03 2.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.139 0.495 . . . . 0.0 111.495 -175.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 20.0 mt-30 -110.83 135.53 51.24 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.864 0.364 . . . . 0.0 110.15 178.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.8 t -70.29 -18.95 63.12 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.3 -177.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -63.75 -26.86 68.83 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.618 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.617 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -71.23 -20.23 62.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.859 -176.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.68 -9.53 58.4 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.724 0.297 . . . . 0.0 111.455 -177.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -111.2 -1.45 16.13 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.736 0.303 . . . . 0.0 111.627 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -129.66 12.02 5.79 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.671 0.272 . . . . 0.0 111.144 -176.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.571 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 6.4 pt20 -68.57 153.67 43.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.133 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.429 ' HG3' ' H ' ' A' ' 26' ' ' ARG . 3.8 tppt? -165.26 179.79 6.05 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 -178.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.429 ' H ' ' HG3' ' A' ' 25' ' ' LYS . 73.7 mtt85 -83.26 60.83 5.78 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.842 0.829 . . . . 0.0 109.291 172.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.62 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -78.01 147.67 34.72 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.246 -1.343 . . . . 0.0 109.143 178.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.617 ' HA ' ' OE2' ' A' ' 11' ' ' GLU . 2.0 pp -176.92 177.42 1.3 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 121.119 0.485 . . . . 0.0 111.882 178.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.835 HG23 ' HG2' ' A' ' 11' ' ' GLU . 88.3 t -107.42 146.75 13.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.43 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -128.26 145.15 51.13 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 110.165 -0.309 . . . . 0.0 110.165 176.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.586 HD21 ' HB3' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -96.53 168.84 10.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.774 -174.32 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -46.49 -34.16 4.59 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.735 0.814 . . . . 0.0 113.078 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.84 -4.33 4.3 Favored 'General case' 0 N--CA 1.467 0.376 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -179.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 84' ' ' MET . . . 83.88 3.39 89.32 Favored Glycine 0 N--CA 1.453 -0.216 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.778 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.586 ' HB3' HD21 ' A' ' 31' ' ' ASN . 26.0 tt0 -100.57 152.61 20.22 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.161 -0.519 . . . . 0.0 110.48 -175.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.678 ' CH2' ' HB ' ' A' ' 124' ' ' VAL . 39.3 m0 -66.71 145.0 56.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.917 175.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 21.0 tp -106.61 143.4 34.77 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 177.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -134.41 165.69 24.57 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 121.077 -0.249 . . . . 0.0 111.006 -171.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.499 ' H ' ' CD ' ' A' ' 39' ' ' ARG . 0.2 OUTLIER -69.03 -32.08 71.33 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -67.34 -25.02 65.79 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.93 178.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 61.9 mt -91.19 -52.41 4.83 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.312 -0.858 . . . . 0.0 109.376 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 79.4 m -131.18 99.85 17.42 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.564 177.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -68.17 -16.92 45.17 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 123.325 2.683 . . . . 0.0 113.155 -176.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -58.7 -32.42 69.14 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.213 0.53 . . . . 0.0 111.011 -177.708 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.585 ' O ' HG23 ' A' ' 48' ' ' VAL . 7.0 mp -72.91 -19.86 61.18 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.849 -175.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -68.21 -11.36 59.17 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.092 179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -95.66 46.0 1.09 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.531 -178.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.805 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 64.7 t -104.8 135.49 42.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.704 0.288 . . . . 0.0 110.667 176.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 40.4 m -94.74 117.54 30.29 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 175.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.628 HG22 ' HB3' ' A' ' 12' ' ' CYS . 11.2 t -99.2 137.45 26.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.25 -0.432 . . . . 0.0 112.063 -172.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -136.08 141.45 44.24 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.596 -0.729 . . . . 0.0 109.099 172.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.617 HD22 ' HA ' ' A' ' 20' ' ' ALA . 6.9 mp -123.39 133.84 54.05 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.895 0.378 . . . . 0.0 110.414 178.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.428 ' HE ' ' HA ' ' A' ' 53' ' ' ARG . 2.6 mmp_? -121.95 169.38 10.87 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 175.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 87.5 mtp -67.5 84.15 0.17 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.199 0.523 . . . . 0.0 110.709 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.76 -21.24 9.11 Favored Glycine 0 N--CA 1.44 -1.043 0 CA-C-N 115.515 -0.766 . . . . 0.0 112.923 178.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -130.21 137.89 50.29 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 117.616 0.708 . . . . 0.0 112.212 -173.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.772 HD11 HD11 ' A' ' 9' ' ' ILE . 53.4 tp -96.52 107.09 19.44 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.632 -1.167 . . . . 0.0 108.808 174.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.43 HG22 ' HB3' ' A' ' 68' ' ' ASP . 41.6 t -101.02 100.69 10.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-O 121.317 0.58 . . . . 0.0 111.055 -173.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.434 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.4 mp -86.34 146.05 26.64 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.37 177.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -137.58 132.61 33.36 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 175.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.701 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -115.01 142.24 28.17 Favored Pre-proline 0 C--N 1.327 -0.405 0 C-N-CA 119.273 -0.971 . . . . 0.0 112.167 -178.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -66.98 81.23 0.35 Allowed 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.233 1.955 . . . . 0.0 110.5 173.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 134.2 -31.83 2.74 Favored Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 111.416 -0.673 . . . . 0.0 111.416 -175.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.701 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 13.8 mmt -114.79 153.41 30.42 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.434 ' H ' HD22 ' A' ' 65' ' ' LEU . 2.8 mm? -68.67 -158.64 0.02 OUTLIER 'General case' 0 C--O 1.245 0.853 0 CA-C-O 121.508 0.67 . . . . 0.0 111.714 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.434 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 13.2 ptm180 -89.4 151.2 22.17 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.925 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.422 HD21 ' HA ' ' A' ' 100' ' ' ALA . 60.7 tp -137.44 103.94 5.21 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.753 177.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.484 ' HA ' ' O ' ' A' ' 57' ' ' LEU . 2.2 p-10 -99.21 112.75 24.83 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.649 0.738 . . . . 0.0 111.016 179.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.49 HD13 ' HB3' ' A' ' 96' ' ' GLU . 34.2 mt -110.67 138.83 21.15 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.503 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -56.29 119.71 7.08 Favored 'Trans proline' 0 CA--C 1.529 0.257 0 C-N-CA 121.931 1.754 . . . . 0.0 111.446 174.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.512 HD23 ' HB2' ' A' ' 57' ' ' LEU . 64.3 mt -54.21 -74.22 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.206 0.527 . . . . 0.0 111.462 -177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -150.73 28.84 0.69 Allowed 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 30.8 m -87.56 22.73 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 115.01 -0.996 . . . . 0.0 111.506 -175.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 23.7 mm -112.59 137.49 45.25 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 174.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -144.79 23.82 1.55 Allowed 'General case' 0 C--N 1.303 -1.443 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.36 -173.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -109.38 -160.53 0.72 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.772 -1.104 . . . . 0.0 109.515 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -103.34 -4.67 23.88 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.728 -179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -76.63 -0.52 23.72 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.34 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.4 m -66.3 104.49 1.21 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 41.0 t -68.35 99.74 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.392 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 18.6 mtp180 -85.39 105.08 15.77 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 11.5 t80 -95.39 132.53 40.33 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.827 -175.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -80.19 102.68 9.57 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 178.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.433 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 2.7 tpt -102.93 159.29 15.63 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.213 -176.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp -133.01 87.61 2.42 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-O 121.632 0.73 . . . . 0.0 109.727 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.601 HG12 ' HD3' ' A' ' 127' ' ' PRO . 5.0 t -83.63 93.55 3.14 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.103 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.388 -177.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 80.37 -89.43 1.31 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 110.589 -1.004 . . . . 0.0 110.589 -173.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.78 11.81 2.68 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.05 0.452 . . . . 0.0 110.214 171.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.543 HE21 HG13 ' A' ' 124' ' ' VAL . 15.3 tt0 -96.5 112.9 24.47 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.544 -177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 26.7 m -83.23 114.48 21.4 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.156 179.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.528 HG11 HG22 ' A' ' 124' ' ' VAL . 3.6 m -136.25 147.24 28.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-O 121.031 0.443 . . . . 0.0 111.973 -174.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.464 ' H ' ' HG3' ' A' ' 121' ' ' MET . 0.8 OUTLIER -80.07 117.09 20.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.252 177.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.521 HG21 HD13 ' A' ' 115' ' ' LEU . 36.0 m -120.23 148.85 23.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.181 -0.674 . . . . 0.0 109.181 173.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 93.5 t -94.94 129.85 44.53 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.795 0 C-N-CA 120.562 -0.455 . . . . 0.0 110.35 179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.529 ' OD1' ' HD3' ' A' ' 113' ' ' ARG . 33.3 t70 -82.6 132.33 35.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.303 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.49 ' HB3' HD13 ' A' ' 69' ' ' ILE . 17.8 mm-40 -82.64 -6.49 59.39 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.713 -177.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 114.11 157.01 11.93 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.812 -0.708 . . . . 0.0 113.225 176.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -53.68 -31.57 48.28 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 122.744 0.418 . . . . 0.0 111.345 176.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.788 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.4 pt? -62.18 -36.96 83.47 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.811 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.422 ' HA ' HD21 ' A' ' 67' ' ' LEU . . . -76.3 -35.18 58.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.056 0.455 . . . . 0.0 110.221 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.563 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -59.96 -57.23 13.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.67 177.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.71 -42.65 99.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.437 -178.045 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 76.3 t90 -54.14 -47.53 71.8 Favored 'General case' 0 C--O 1.236 0.369 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.055 -178.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.598 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.1 tp -85.26 -23.91 7.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 119.893 -0.723 . . . . 0.0 111.198 -178.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 66.3 m -64.96 -16.44 63.37 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.403 -0.81 . . . . 0.0 109.996 174.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -88.68 -51.09 5.86 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.2 172.096 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.598 ' HB3' HD12 ' A' ' 104' ' ' ILE . 57.5 t60 -72.71 -44.48 61.68 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 111.698 0.258 . . . . 0.0 111.698 -178.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.45 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -76.17 -36.64 58.61 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 176.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 101.24 -32.4 7.52 Favored Glycine 0 N--CA 1.452 -0.273 0 CA-C-N 115.365 -0.834 . . . . 0.0 112.849 171.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.662 HG23 ' SG ' ' A' ' 112' ' ' CYS . 16.1 m -100.43 158.76 31.34 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 110.414 -0.217 . . . . 0.0 110.414 -177.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.44 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 25.1 Cg_endo -62.64 90.88 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.649 2.232 . . . . 0.0 112.108 -179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.662 ' SG ' HG23 ' A' ' 110' ' ' VAL . 76.5 m -135.21 164.73 27.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.277 -179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.563 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 10.9 ptp180 -140.48 143.37 35.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.439 -0.346 . . . . 0.0 110.404 175.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.623 HG12 HG22 ' A' ' 29' ' ' VAL . 37.6 mt -73.27 131.92 34.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 176.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.521 HD13 HG21 ' A' ' 93' ' ' VAL . 71.7 mt -134.87 139.54 45.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.176 0.512 . . . . 0.0 110.55 -176.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? -108.16 110.78 22.51 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.273 179.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.411 HG22 HG12 ' A' ' 93' ' ' VAL . 58.5 t -63.26 132.94 29.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.602 179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.439 ' CG ' ' HD2' ' A' ' 119' ' ' PRO . 0.5 OUTLIER -86.81 139.45 33.05 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.076 -177.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.439 ' HD2' ' CG ' ' A' ' 118' ' ' HIS . 48.9 Cg_endo -68.36 -2.13 8.53 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 123.303 2.669 . . . . 0.0 114.531 -173.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -71.7 -51.61 22.08 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.21 175.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.464 ' HG3' ' H ' ' A' ' 92' ' ' ASP . 95.3 mmm -73.52 -44.81 56.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 170.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 67.42 -77.97 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.135 0 CA-C-N 114.784 -1.098 . . . . 0.0 112.733 174.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -91.88 139.87 30.24 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.368 0.604 . . . . 0.0 111.544 -172.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.678 ' HB ' ' CH2' ' A' ' 36' ' ' TRP . 52.8 t -133.9 -30.14 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.902 175.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 78.6 ttt180 78.13 -37.97 0.24 Allowed 'General case' 0 N--CA 1.473 0.677 0 N-CA-C 113.271 0.841 . . . . 0.0 113.271 170.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.558 ' CD1' ' HB2' ' A' ' 36' ' ' TRP . 19.7 t90 77.73 138.35 0.06 OUTLIER Pre-proline 0 N--CA 1.473 0.687 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -173.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.601 ' HD3' HG12 ' A' ' 86' ' ' VAL . 21.0 Cg_endo -54.59 119.15 5.95 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.544 2.829 . . . . 0.0 113.422 -175.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 2.2 m -79.01 24.12 0.33 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.018 0.437 . . . . 0.0 110.106 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.449 ' H ' ' C ' ' A' ' 127' ' ' PRO . 74.5 mt 58.05 33.8 23.56 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.474 -173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 . . . . . 0 C--O 1.248 0.992 0 CA-C-N 114.81 -1.086 . . . . 0.0 110.18 -177.314 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.5 ptp . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.4 p -131.55 -38.21 1.18 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.219 178.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.4 t -145.65 0.58 0.88 Allowed 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.861 -0.336 . . . . 0.0 111.815 -179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.7 m 63.84 30.22 14.5 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-O 121.758 0.789 . . . . 0.0 111.199 177.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -78.85 144.75 34.7 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.631 176.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.51 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 53.6 m-85 -94.31 134.4 36.84 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 -176.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -113.33 91.75 20.6 Favored Pre-proline 0 C--N 1.319 -0.726 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 -176.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.582 ' HA ' ' HA ' ' A' ' 24' ' ' GLN . 6.1 Cg_exo -82.11 -55.55 0.03 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.937 2.425 . . . . 0.0 113.413 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.723 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -114.88 132.24 64.7 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.335 0 O-C-N 123.741 0.651 . . . . 0.0 110.555 -174.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.63 -55.14 36.91 Favored 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 -170.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.813 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -62.32 -49.22 76.46 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 111.568 0.21 . . . . 0.0 111.568 -171.48 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.723 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 9.9 p -74.0 -35.75 64.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.771 0.319 . . . . 0.0 110.693 -179.517 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 101.05 -140.52 14.92 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.845 -0.693 . . . . 0.0 113.807 170.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -84.75 152.15 23.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.309 0.576 . . . . 0.0 111.64 -172.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 14.8 m -134.5 134.43 41.47 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.256 -178.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.4 p -94.63 66.41 3.22 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 121.49 0.662 . . . . 0.0 110.94 176.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -133.58 128.39 35.1 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.49 -0.777 . . . . 0.0 109.066 177.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 17.7 m -56.87 -33.09 66.5 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -174.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -79.65 -16.18 56.24 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.501 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -65.61 -22.67 66.69 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.859 0.361 . . . . 0.0 111.378 -176.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.61 -25.63 67.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.472 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -96.91 0.26 48.76 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.425 -177.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -129.51 20.97 5.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.707 -178.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 5.3 pp0? -91.16 150.79 21.23 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.191 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.5 mmtm -162.51 -179.58 7.04 Favored 'General case' 0 CA--C 1.517 -0.313 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.639 ' NH1' ' HA ' ' A' ' 123' ' ' GLU . 50.5 mtt85 -82.82 65.38 7.91 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 165.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.569 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 2.0 t90 -88.7 144.98 25.91 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 113.582 -1.645 . . . . 0.0 107.919 -178.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.4 pp -177.78 -177.27 0.63 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.552 0.691 . . . . 0.0 112.317 -175.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.592 HG22 HG12 ' A' ' 114' ' ' ILE . 17.6 t -106.04 142.46 18.98 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.957 -1.019 . . . . 0.0 109.009 175.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -124.72 155.25 39.58 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 109.826 -0.435 . . . . 0.0 109.826 176.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.854 HD21 ' HB3' ' A' ' 35' ' ' GLN . 0.3 OUTLIER -99.8 160.44 14.3 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 120.759 -0.376 . . . . 0.0 110.779 -179.193 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.545 ' HB2' ' HB2' ' A' ' 111' ' ' PRO . 14.2 t70 -45.7 -34.74 3.74 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.55 0.74 . . . . 0.0 112.81 -176.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -61.79 -7.17 3.26 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.59 7.18 72.24 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.614 -178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.854 ' HB3' HD21 ' A' ' 31' ' ' ASN . 22.6 tt0 -100.03 140.22 34.57 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.428 -0.386 . . . . 0.0 110.553 -175.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 23.5 m0 -61.71 129.02 39.04 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.6 174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.477 HD22 ' SG ' ' A' ' 112' ' ' CYS . 20.9 tp -90.27 144.86 25.45 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 177.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -137.13 167.44 21.54 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.501 -0.48 . . . . 0.0 111.24 -171.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -67.7 -21.09 65.33 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.93 174.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -77.37 -26.37 51.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.77 178.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.417 HD12 ' HA ' ' A' ' 37' ' ' LEU . 78.2 mt -90.72 -51.22 5.49 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.277 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.409 ' SG ' HD11 ' A' ' 37' ' ' LEU . 74.7 m -122.94 93.83 47.95 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.645 178.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -59.68 -30.27 91.77 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 123.004 2.469 . . . . 0.0 112.461 177.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.407 HH11 ' HD2' ' A' ' 44' ' ' ARG . 47.7 mtm105 -69.19 -13.38 62.38 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.939 0.399 . . . . 0.0 111.156 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.813 ' HG ' ' HB2' ' A' ' 11' ' ' GLU . 32.5 tp -79.5 -18.86 51.04 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.009 -0.367 . . . . 0.0 110.009 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -67.57 -17.1 64.51 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.165 0.507 . . . . 0.0 109.944 170.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.695 ' O ' ' HD2' ' A' ' 62' ' ' PRO . 57.5 mm-40 -82.95 58.8 4.55 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.418 177.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 50.0 t -129.39 139.22 52.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 168.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.7 m -105.49 142.28 35.51 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.67 0.272 . . . . 0.0 110.801 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.668 HG22 ' HB2' ' A' ' 12' ' ' CYS . 1.5 t -96.73 143.35 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.867 -174.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.547 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 3.8 tp10 -146.56 137.33 24.05 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 167.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.4 mp -119.25 125.47 49.21 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 120.885 0.374 . . . . 0.0 110.279 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' HB2' ' HB2' ' A' ' 56' ' ' TYR . 34.2 mmt180 -105.31 175.59 5.44 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 177.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 53.2 ttm -68.38 91.85 0.41 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 176.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.39 -0.28 65.73 Favored Glycine 0 N--CA 1.447 -0.578 0 CA-C-N 115.787 -0.642 . . . . 0.0 113.136 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.465 ' C ' ' HG ' ' A' ' 71' ' ' LEU . 59.4 m-85 -136.21 148.36 48.06 Favored 'General case' 0 C--O 1.225 -0.213 0 CA-C-N 117.59 0.695 . . . . 0.0 112.313 -177.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.499 ' HB2' HD23 ' A' ' 71' ' ' LEU . 42.1 tp -109.32 118.51 36.87 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.128 176.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.547 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 66.8 t -109.05 111.05 34.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.228 0.537 . . . . 0.0 110.513 -178.098 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.497 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 3.8 mp -97.07 137.19 36.52 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.947 176.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -129.3 130.39 46.09 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -179.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -122.27 134.03 24.64 Favored Pre-proline 0 C--O 1.215 -0.718 0 C-N-CA 118.544 -1.262 . . . . 0.0 112.879 -173.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.695 ' HD2' ' O ' ' A' ' 47' ' ' GLU . 82.5 Cg_exo -46.16 107.08 0.11 Allowed 'Trans proline' 0 N--CA 1.459 -0.552 0 C-N-CA 122.272 1.981 . . . . 0.0 111.178 166.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.17 -10.51 61.75 Favored Glycine 0 N--CA 1.449 -0.485 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.951 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.639 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 76.8 mmm -136.4 156.53 48.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.768 0.794 . . . . 0.0 111.53 -178.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.521 ' H ' HD22 ' A' ' 65' ' ' LEU . 2.6 mm? -67.7 -165.87 0.05 Allowed 'General case' 0 C--O 1.245 0.817 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.816 -174.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 33.6 ptt85 -88.33 169.22 12.02 Favored 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.448 173.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.483 ' HG ' HG13 ' A' ' 69' ' ' ILE . 55.3 tp -147.48 111.33 5.06 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.761 -178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -92.22 99.82 12.54 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.887 0.375 . . . . 0.0 110.587 -177.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.483 HG13 ' HG ' ' A' ' 67' ' ' LEU . 70.0 mt -105.93 138.72 19.73 Favored Pre-proline 0 C--N 1.321 -0.66 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -48.42 139.19 23.02 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.189 1.926 . . . . 0.0 112.509 171.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.499 HD23 ' HB2' ' A' ' 57' ' ' LEU . 8.7 mt -71.16 94.0 1.11 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.573 0.702 . . . . 0.0 111.428 178.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.4 t70 75.29 88.55 0.09 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 113.546 -1.661 . . . . 0.0 109.844 173.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 73.0 t -65.8 121.92 15.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.8 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.575 HG12 ' H ' ' A' ' 75' ' ' GLU . 13.3 tt -82.37 -174.74 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.298 -0.864 . . . . 0.0 110.289 -177.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.575 ' H ' HG12 ' A' ' 74' ' ' ILE . 6.4 mm-40 -73.53 29.72 0.07 Allowed 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 123.932 0.893 . . . . 0.0 111.328 -178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 74' ' ' ILE . 8.8 t70 -62.64 152.99 33.68 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.115 179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -64.49 -25.22 67.9 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.033 -171.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.434 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . 0.8 OUTLIER -77.21 -22.79 51.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.584 -0.28 . . . . 0.0 111.497 -179.012 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.436 ' HB2' HG13 ' A' ' 94' ' ' VAL . 85.2 p -67.29 139.75 57.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.952 0.406 . . . . 0.0 110.008 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.5 t -99.41 112.83 32.76 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.525 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.401 HH21 ' CG ' ' A' ' 92' ' ' ASP . 76.0 mtp180 -77.53 99.18 5.61 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.613 0.72 . . . . 0.0 109.783 176.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -86.13 126.66 34.38 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 114.657 -1.156 . . . . 0.0 109.589 -175.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -76.61 112.03 12.73 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 178.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.453 ' HE2' ' HA ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -98.94 145.84 26.62 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.8 -175.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.847 ' HG ' ' HA ' ' A' ' 88' ' ' GLU . 12.9 tp -126.35 79.07 1.82 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.498 0.666 . . . . 0.0 109.501 -179.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.419 HG12 ' HD3' ' A' ' 127' ' ' PRO . 4.6 t -85.92 96.97 5.47 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.593 -0.73 . . . . 0.0 110.306 -174.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 69.69 31.95 70.64 Favored Glycine 0 N--CA 1.45 -0.419 0 N-CA-C 110.321 -1.111 . . . . 0.0 110.321 -175.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.847 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 0.9 OUTLIER 69.39 18.19 7.98 Favored 'General case' 0 N--CA 1.46 0.051 0 CA-C-N 114.504 -0.848 . . . . 0.0 111.296 -176.124 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 25.5 tt0 -92.84 107.76 19.47 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 10.8 m -78.84 99.88 6.93 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.909 -172.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 8.2 m -132.32 142.57 42.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.713 176.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.401 ' CG ' HH21 ' A' ' 81' ' ' ARG . 7.1 p-10 -91.78 140.5 29.64 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.19 0.519 . . . . 0.0 110.721 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 20.9 m -131.15 153.72 39.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.691 179.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.436 HG13 ' HB2' ' A' ' 79' ' ' SER . 93.2 t -88.87 132.84 32.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 120.894 0.378 . . . . 0.0 111.221 -176.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.674 ' OD2' ' HD3' ' A' ' 113' ' ' ARG . 26.3 t0 -77.42 127.11 31.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.312 175.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.485 ' CD ' ' HZ2' ' A' ' 116' ' ' LYS . 13.5 mm-40 -92.65 -3.15 55.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.762 -0.199 . . . . 0.0 111.315 -175.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 154.29 129.84 1.34 Allowed Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 119.685 -1.245 . . . . 0.0 114.511 177.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -57.42 -36.29 71.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.29 0.567 . . . . 0.0 110.144 171.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 56.0 tp -63.86 -35.7 81.5 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.436 177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.496 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -65.54 -37.71 87.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.489 179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -61.39 -47.69 84.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.73 176.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.93 -46.72 83.46 Favored 'General case' 0 C--O 1.239 0.526 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.993 179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.4 ' CZ3' HD13 ' A' ' 104' ' ' ILE . 73.8 t90 -51.48 -44.66 62.53 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.274 -179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.587 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.2 tp -86.94 -23.17 6.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.635 -177.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 94.6 p -65.02 -17.99 64.92 Favored 'General case' 0 C--N 1.329 -0.297 0 O-C-N 121.357 -0.839 . . . . 0.0 109.301 175.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . 0.413 ' HB3' ' SD ' ' A' ' 64' ' ' MET . 33.1 m-80 -81.97 -57.84 3.24 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.342 170.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.587 ' HB3' HD12 ' A' ' 104' ' ' ILE . 75.5 t60 -69.04 -45.5 70.27 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 -177.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -74.12 -42.67 59.68 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 176.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 96.62 -30.68 8.45 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.621 -0.8 . . . . 0.0 112.586 174.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.666 HG23 ' SG ' ' A' ' 112' ' ' CYS . 16.5 m -99.78 163.45 18.41 Favored Pre-proline 0 C--N 1.319 -0.728 0 N-CA-C 110.033 -0.358 . . . . 0.0 110.033 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 17.8 Cg_endo -60.26 96.71 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 122.533 2.156 . . . . 0.0 112.155 179.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.666 ' SG ' HG23 ' A' ' 110' ' ' VAL . 72.1 m -134.05 158.15 44.29 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.721 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.674 ' HD3' ' OD2' ' A' ' 95' ' ' ASP . 48.9 ttm-85 -143.15 132.83 23.79 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.138 -176.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.592 HG12 HG22 ' A' ' 29' ' ' VAL . 41.7 mt -80.06 120.91 32.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 178.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 95' ' ' ASP . 70.4 mt -131.51 155.96 46.52 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.747 -174.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.485 ' HZ2' ' CD ' ' A' ' 96' ' ' GLU . 7.2 ttpm? -121.56 138.67 54.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.155 177.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 7.7 p -52.13 135.17 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.69 176.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -73.1 119.54 76.19 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.796 -177.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -52.07 -24.68 20.44 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.627 2.885 . . . . 0.0 113.704 -173.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.97 -39.79 82.79 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.161 0.505 . . . . 0.0 110.714 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 3.0 ppp? -117.75 -175.47 2.84 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.124 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -157.12 -170.62 3.33 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.137 -179.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.639 ' HA ' ' NH1' ' A' ' 26' ' ' ARG . 8.0 mm-40 65.79 -140.07 0.19 Allowed 'General case' 0 C--N 1.327 -0.409 0 O-C-N 123.793 0.683 . . . . 0.0 111.142 -179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 29.1 t 65.67 100.63 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.225 -0.229 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 -167.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -108.28 27.25 9.51 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.532 -169.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.696 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 5.2 t90 72.58 151.5 0.14 Allowed Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -174.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.696 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 10.6 Cg_endo -51.83 -17.76 5.65 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.272 2.648 . . . . 0.0 114.135 -179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 50.8 m 57.51 46.28 18.16 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.185 0.517 . . . . 0.0 110.558 -179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 97.4 mt 64.64 79.78 0.25 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 114.881 -1.054 . . . . 0.0 111.232 -178.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 . . . . . 0 C--O 1.249 1.068 0 O-C-N 124.418 1.074 . . . . 0.0 113.254 175.658 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.483 1.216 0 N-CA-C 110.355 -0.239 . . . . 0.0 110.355 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 50.9 m 62.57 -158.72 0.32 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.473 176.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 55.9 p -59.1 -27.49 65.62 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.734 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 3.6 m 64.42 25.48 13.37 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 121.81 0.814 . . . . 0.0 109.871 -176.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -103.77 132.93 49.56 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.16 -0.927 . . . . 0.0 110.206 178.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.704 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 55.5 m-85 -112.46 141.33 46.34 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.994 -177.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.2 mp0 -99.68 97.25 5.49 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 123.012 0.195 . . . . 0.0 110.7 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.823 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 2.6 Cg_exo -77.07 -54.4 0.06 OUTLIER 'Trans proline' 0 C--O 1.239 0.563 0 C-N-CA 122.874 2.383 . . . . 0.0 111.735 175.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.823 ' HB ' ' SG ' ' A' ' 12' ' ' CYS . 4.9 mm -107.22 150.88 9.41 Favored 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 115.01 -0.995 . . . . 0.0 110.462 -175.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.74 -54.73 8.15 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.017 -174.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.479 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 1.6 mp0 -56.59 -53.18 60.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.5 -175.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.823 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 25.9 p -70.51 -47.27 61.25 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.296 -176.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 103.95 -127.79 9.26 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.533 -179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.424 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -89.83 139.3 30.72 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.3 0.571 . . . . 0.0 112.207 -173.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.517 HG21 HD13 ' A' ' 52' ' ' LEU . 16.9 m -113.5 138.84 49.55 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.94 175.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 p -87.41 31.66 0.73 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -177.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -119.96 136.35 54.56 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.085 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.427 ' HA ' ' HE2' ' A' ' 6' ' ' TYR . 20.1 m -65.85 -28.76 69.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.791 0.329 . . . . 0.0 111.618 -176.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.8 mp0 -65.32 -23.6 67.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.498 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.823 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -58.47 -30.98 67.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.566 -175.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.11 -24.8 67.83 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.69 -178.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -92.19 -14.71 28.63 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.589 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -112.77 -0.94 14.82 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.817 -0.353 . . . . 0.0 111.695 -176.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.637 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 3.7 pp0? -67.58 150.8 48.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.568 0.223 . . . . 0.0 110.562 178.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HG2' ' O ' ' A' ' 24' ' ' GLN . 38.5 mmtm -165.54 -178.7 5.04 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.175 -177.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 51.7 mtt180 -81.82 79.13 8.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.896 0.855 . . . . 0.0 109.482 170.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -100.63 147.14 26.3 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 114.115 -1.402 . . . . 0.0 108.907 -178.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.1 pp -173.99 178.88 2.06 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 121.63 0.729 . . . . 0.0 112.246 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.862 HG22 HD13 ' A' ' 114' ' ' ILE . 60.3 t -111.5 136.42 47.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.488 175.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.732 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -124.85 144.94 50.04 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 173.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.539 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 0.0 OUTLIER -77.6 142.75 38.76 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -177.755 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -48.02 -25.64 1.48 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -170.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.442 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . . . -57.24 -18.38 15.86 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 111.651 178.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.432 ' HA2' ' CE ' ' A' ' 84' ' ' MET . . . 103.61 18.67 13.69 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 110.746 -0.941 . . . . 0.0 110.746 -176.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -112.87 127.45 56.19 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.383 -0.408 . . . . 0.0 110.938 -173.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 4.4 m0 -56.64 123.64 15.58 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.627 -0.26 . . . . 0.0 110.432 174.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.649 HD23 HD22 ' A' ' 45' ' ' LEU . 10.5 tp -82.47 154.31 25.18 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -140.88 164.3 30.61 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.498 -173.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 72.5 mtt180 -69.06 -24.57 64.18 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 110.074 176.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -73.8 -27.66 61.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.879 175.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 77.2 mt -87.79 -51.47 5.84 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.611 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.6 m -130.25 95.68 26.96 Favored Pre-proline 0 C--N 1.324 -0.521 0 CA-C-N 115.443 -0.798 . . . . 0.0 110.64 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.58 -28.87 69.99 Favored 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.771 2.314 . . . . 0.0 112.139 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 75.5 mtt85 -67.76 -14.11 62.68 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.233 -177.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.649 HD22 HD23 ' A' ' 37' ' ' LEU . 33.0 tp -74.47 -23.12 58.84 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.746 -178.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -73.2 -13.35 61.14 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.232 0.539 . . . . 0.0 110.384 175.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -92.68 54.62 2.28 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.69 179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.442 ' O ' ' HA ' ' A' ' 12' ' ' CYS . 92.0 t -110.88 134.26 53.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.038 171.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.8 m -100.56 148.77 24.44 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 14.3 p -138.12 148.16 25.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-O 121.177 0.513 . . . . 0.0 111.722 -169.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.522 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 28.8 tt0 -152.05 139.75 19.82 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.517 HD13 HG21 ' A' ' 15' ' ' THR . 9.2 mp -106.93 125.39 50.95 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.682 0.753 . . . . 0.0 111.443 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -112.42 154.4 25.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 114.38 -1.282 . . . . 0.0 107.671 174.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . 0.433 ' O ' ' HG3' ' A' ' 54' ' ' MET . 23.6 ptt? -60.66 100.11 0.1 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.666 0.746 . . . . 0.0 110.939 -177.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 94.59 0.07 64.95 Favored Glycine 0 N--CA 1.445 -0.714 0 CA-C-N 115.518 -0.765 . . . . 0.0 113.117 178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -143.14 137.62 29.21 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 117.403 0.601 . . . . 0.0 111.536 -177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.526 ' HB2' HD21 ' A' ' 71' ' ' LEU . 28.1 tp -100.21 114.39 27.78 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.176 175.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.522 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 70.8 t -96.4 96.45 5.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.66 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.892 -175.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 8.1 mp -87.53 143.44 27.21 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 175.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 49.4 mtmt -140.28 130.95 25.69 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.639 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -115.67 144.96 33.54 Favored Pre-proline 0 C--N 1.327 -0.402 0 C-N-CA 119.452 -0.899 . . . . 0.0 112.453 -175.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -60.95 98.03 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.061 1.841 . . . . 0.0 110.487 170.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 114.09 -32.2 6.08 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.302 -177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.639 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 13.1 mmt -116.04 154.64 29.53 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.437 0.637 . . . . 0.0 110.218 -177.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.812 ' H ' HD12 ' A' ' 65' ' ' LEU . 2.5 mp -69.71 -154.38 0.02 OUTLIER 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.153 -0.93 . . . . 0.0 111.755 -171.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.505 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 12.4 ptm180 -94.33 145.14 24.96 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.278 -0.874 . . . . 0.0 110.652 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.508 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 53.4 tp -121.67 114.61 21.38 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.234 176.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -94.99 102.22 14.02 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.716 -176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.463 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 70.1 mt -97.8 116.47 65.73 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.739 177.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -62.62 119.5 6.62 Favored 'Trans proline' 0 N--CA 1.463 -0.322 0 C-N-CA 122.321 2.014 . . . . 0.0 112.168 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.526 HD21 ' HB2' ' A' ' 57' ' ' LEU . 96.1 mt -82.49 -24.91 33.94 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.182 0.515 . . . . 0.0 110.028 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -120.34 109.94 15.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.138 178.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 11.4 m -127.78 132.39 68.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.699 178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.526 HG23 ' H ' ' A' ' 75' ' ' GLU . 1.4 tp -86.15 -85.48 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.033 175.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.526 ' H ' HG23 ' A' ' 74' ' ' ILE . 10.7 pt-20 -116.9 24.09 11.47 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-O 121.714 0.768 . . . . 0.0 110.208 171.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -74.23 -7.84 54.1 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.761 -1.108 . . . . 0.0 108.837 170.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -85.93 65.87 9.33 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.91 -174.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -90.48 13.3 16.07 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 168.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.709 ' HB3' ' O ' ' A' ' 95' ' ' ASP . 1.4 m -50.98 132.72 27.39 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 113.737 -1.574 . . . . 0.0 110.47 177.227 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 14.5 t -79.59 118.69 27.54 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.95 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.585 ' HG2' HG22 ' A' ' 94' ' ' VAL . 74.1 mtp180 -86.5 112.98 22.05 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.89 178.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.526 ' HE2' ' HB2' ' A' ' 95' ' ' ASP . 98.0 m-85 -101.13 133.15 46.11 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.388 -178.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -80.06 98.77 7.38 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 170.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.519 ' O ' ' HA ' ' A' ' 90' ' ' THR . 0.0 OUTLIER -90.17 153.46 20.5 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.283 -171.536 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.8 tp -115.27 86.41 2.45 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-O 121.75 0.786 . . . . 0.0 109.449 -176.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.571 HG12 ' HD3' ' A' ' 127' ' ' PRO . 4.0 t -76.57 84.6 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 CA-C-N 114.898 -1.046 . . . . 0.0 109.497 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 78.73 -78.34 1.67 Allowed Glycine 0 N--CA 1.449 -0.496 0 N-CA-C 110.969 -0.853 . . . . 0.0 110.969 -175.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -143.81 16.08 1.77 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.018 0.437 . . . . 0.0 110.441 174.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.427 ' HG2' HG13 ' A' ' 91' ' ' VAL . 10.0 tt0 -111.26 108.93 18.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.858 0.361 . . . . 0.0 110.725 -177.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 84' ' ' MET . 7.5 m -80.29 113.97 18.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.74 -0.663 . . . . 0.0 110.494 179.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.55 HG12 ' HG2' ' A' ' 121' ' ' MET . 5.9 m -134.63 159.33 41.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.336 -177.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -91.65 113.13 25.32 Favored 'General case' 0 C--O 1.235 0.318 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.883 -174.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.48 HG23 HD22 ' A' ' 115' ' ' LEU . 34.9 m -120.03 136.96 55.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.289 -0.414 . . . . 0.0 109.97 177.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.585 HG22 ' HG2' ' A' ' 81' ' ' ARG . 6.4 t -99.25 129.96 48.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.565 -0.289 . . . . 0.0 111.063 -176.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.709 ' O ' ' HB3' ' A' ' 79' ' ' SER . 53.8 t0 -74.48 119.92 19.33 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.042 -0.526 . . . . 0.0 109.695 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -74.4 -7.83 54.23 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.982 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.76 146.31 4.45 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.414 -0.898 . . . . 0.0 113.111 175.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -62.2 -30.45 71.09 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.22 0.533 . . . . 0.0 110.217 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.7 tp -67.78 -33.94 75.82 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.913 177.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.533 ' HB1' HG13 ' A' ' 114' ' ' ILE . . . -71.41 -40.63 70.34 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.111 178.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -60.26 -41.81 94.04 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.528 175.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.5 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -62.76 -43.03 99.87 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.984 177.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.409 ' HH2' HG13 ' A' ' 48' ' ' VAL . 38.1 t90 -55.66 -39.43 70.9 Favored 'General case' 0 C--O 1.236 0.346 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.654 179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.579 HG22 ' HB2' ' A' ' 112' ' ' CYS . 9.8 mm -89.41 -26.12 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.5 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 80.1 p -65.41 -14.96 62.06 Favored 'General case' 0 C--N 1.327 -0.396 0 O-C-N 121.466 -0.771 . . . . 0.0 109.356 172.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 94.3 m-20 -90.23 -52.76 4.77 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.466 170.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.449 ' HB3' HD13 ' A' ' 104' ' ' ILE . 82.9 t60 -65.23 -40.69 94.4 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 112.114 0.413 . . . . 0.0 112.114 -175.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -92.43 -33.89 14.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.146 0.498 . . . . 0.0 110.142 177.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 98.44 -29.6 11.16 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.649 174.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.514 HG23 ' SG ' ' A' ' 112' ' ' CYS . 24.2 m -106.13 156.65 36.45 Favored Pre-proline 0 C--N 1.321 -0.672 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -55.2 97.91 0.06 OUTLIER 'Trans proline' 0 C--N 1.347 0.454 0 C-N-CA 122.792 2.328 . . . . 0.0 112.622 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.579 ' HB2' HG22 ' A' ' 104' ' ' ILE . 58.1 m -129.03 147.65 50.91 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.383 -0.826 . . . . 0.0 108.9 176.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.468 ' HD3' ' CG ' ' A' ' 95' ' ' ASP . 41.6 ttm-85 -126.43 130.76 51.32 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 116.677 -0.238 . . . . 0.0 111.188 -171.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.862 HD13 HG22 ' A' ' 29' ' ' VAL . 25.6 mm -68.37 118.14 11.79 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.14 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.732 HD12 ' HB3' ' A' ' 30' ' ' ALA . 18.4 mt -133.1 129.88 38.54 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.732 0.777 . . . . 0.0 111.896 -173.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.447 ' HZ3' ' HB3' ' A' ' 116' ' ' LYS . 7.9 ttpm? -103.68 120.51 41.08 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.322 176.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 37.3 t -62.75 132.0 28.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.694 0.283 . . . . 0.0 110.343 -178.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -69.22 139.2 89.76 Favored Pre-proline 0 C--N 1.328 -0.364 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_exo -51.02 -15.84 2.19 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.55 2.833 . . . . 0.0 114.219 -177.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -60.09 -34.36 73.35 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.142 0.496 . . . . 0.0 110.584 175.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.55 ' HG2' HG12 ' A' ' 91' ' ' VAL . 2.4 mpt? -112.29 124.56 52.73 Favored 'General case' 0 N--CA 1.445 -0.686 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.248 178.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -127.53 36.46 4.37 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.335 178.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 tt0 -140.37 -135.0 0.11 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.913 -1.04 . . . . 0.0 108.73 -177.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 86' ' ' VAL . 4.3 t 67.34 94.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 121.387 0.613 . . . . 0.0 110.06 -178.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 125' ' ' ARG . 11.5 ttp180 -99.15 20.07 14.12 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.586 -175.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.572 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 6.3 t90 70.61 151.56 0.14 Allowed Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 -176.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.572 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 5.7 Cg_exo -37.02 120.5 0.29 Allowed 'Trans proline' 0 C--N 1.359 1.1 0 C-N-CA 123.151 2.568 . . . . 0.0 112.486 177.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 20.1 m -96.07 40.35 1.12 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.804 -170.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.624 HD23 ' H ' ' A' ' 129' ' ' LEU . 1.3 pt? -59.97 116.35 4.08 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.016 174.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.256 -0.878 . . . . 0.0 111.184 -175.924 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.952 0.406 . . . . 0.0 110.38 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.576 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . 42.2 p -127.56 172.32 10.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.059 -177.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 15.2 t -153.57 140.51 19.22 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.185 -179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.1 t 40.34 -137.61 0.12 Allowed 'General case' 0 N--CA 1.471 0.604 0 O-C-N 124.138 0.899 . . . . 0.0 112.135 175.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.405 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -56.71 114.98 2.29 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 120.864 0.364 . . . . 0.0 110.859 174.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.683 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 24.6 m-85 -86.98 133.92 33.54 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -176.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.525 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 10.3 tt0 -105.66 94.23 8.41 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-O 120.888 0.375 . . . . 0.0 111.031 -176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.81 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 7.0 Cg_endo -87.11 -41.75 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 123.283 2.655 . . . . 0.0 112.317 178.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.646 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 3.6 mp -100.97 145.15 11.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.89 -73.03 0.22 Allowed 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 -172.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.639 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -58.93 -50.01 75.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.758 -179.058 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.903 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 66.5 m -54.95 -47.33 74.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.965 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 100.8 -140.87 15.11 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 120.327 -0.94 . . . . 0.0 113.363 175.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 7' ' ' GLN . . . -94.67 151.91 18.91 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.459 0.647 . . . . 0.0 112.212 -171.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.499 HG21 HD13 ' A' ' 52' ' ' LEU . 15.2 m -125.42 139.3 53.77 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.005 177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 p -86.78 23.33 1.73 Allowed 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.445 ' HG3' HG22 ' A' ' 15' ' ' THR . 9.3 mt-30 -114.83 145.63 41.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.672 0.272 . . . . 0.0 110.31 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 15.7 t -61.97 -35.15 77.61 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.292 -174.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.506 ' H ' ' CD ' ' A' ' 19' ' ' GLU . 2.1 mp0 -52.76 -34.13 51.68 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.465 -178.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.81 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -61.5 -27.6 68.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.459 -174.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -71.55 -2.76 18.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.801 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -131.43 18.8 4.81 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 179.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -136.97 14.9 3.07 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.337 0.589 . . . . 0.0 110.44 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.505 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER -64.12 143.56 57.78 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-N 114.993 -1.003 . . . . 0.0 110.095 177.574 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.403 ' HG2' ' O ' ' A' ' 24' ' ' GLN . 68.5 mmtt -161.88 166.9 25.63 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 -172.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.472 ' CB ' ' HB ' ' A' ' 117' ' ' VAL . 4.8 mpt_? -86.64 82.53 7.86 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.233 0.54 . . . . 0.0 110.156 178.194 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -87.17 153.0 21.85 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.123 176.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.504 HD13 ' H ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -160.59 164.24 32.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.023 0.439 . . . . 0.0 110.512 -177.101 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.595 HG23 ' HG2' ' A' ' 11' ' ' GLU . 89.4 t -126.48 136.87 59.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 108.817 -0.808 . . . . 0.0 108.817 173.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.529 ' HB2' ' HE1' ' A' ' 84' ' ' MET . . . -111.97 133.63 54.03 Favored 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.602 178.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.71 HD21 ' HB3' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -79.48 179.52 7.41 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 172.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -46.07 -40.02 10.14 Favored 'General case' 0 N--CA 1.471 0.596 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -176.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -74.27 -5.72 43.75 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 113.042 0.756 . . . . 0.0 113.042 -176.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 79.85 11.64 84.37 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.761 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.71 ' HB3' HD21 ' A' ' 31' ' ' ASN . 26.0 tt0 -85.2 144.16 28.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.594 -0.303 . . . . 0.0 110.753 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.654 ' CD1' HG22 ' A' ' 86' ' ' VAL . 2.2 m0 -53.54 122.4 9.69 Favored 'General case' 0 C--O 1.235 0.298 0 O-C-N 124.14 0.9 . . . . 0.0 111.67 176.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 tp -104.91 130.97 52.96 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -122.74 170.19 10.31 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.083 0.468 . . . . 0.0 111.79 -173.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.5 mtp180 -71.52 -19.44 62.18 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 174.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -70.65 -26.25 63.38 Favored 'General case' 0 CA--C 1.522 -0.122 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.5 177.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 83.9 mt -94.74 -47.45 6.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.384 -0.826 . . . . 0.0 110.458 -177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 72.0 m -124.95 98.53 36.25 Favored Pre-proline 0 C--N 1.323 -0.587 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.911 -179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_exo -63.15 -31.02 75.45 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.891 2.394 . . . . 0.0 111.677 178.753 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 69.3 mtt180 -60.52 -30.06 69.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.968 177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.639 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 63.2 tp -72.84 -28.09 62.32 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.261 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -71.39 -12.97 61.69 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.175 176.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -85.69 38.97 0.77 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.743 -177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.903 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 78.4 t -92.77 130.84 41.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-O 120.553 0.216 . . . . 0.0 110.473 173.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.675 ' HB2' ' HG3' ' A' ' 60' ' ' LYS . 18.1 m -86.89 117.09 25.39 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 175.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.622 HG22 ' HB3' ' A' ' 12' ' ' CYS . 1.4 t -99.0 144.56 11.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.384 -172.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.594 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 78.9 tt0 -148.86 144.02 26.64 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 174.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.499 HD13 HG21 ' A' ' 15' ' ' THR . 8.2 mp -123.74 129.75 51.55 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 121.015 0.435 . . . . 0.0 109.914 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.416 ' HA ' ' NE ' ' A' ' 53' ' ' ARG . 0.3 OUTLIER -118.83 156.98 28.48 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 175.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -59.81 98.13 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.149 0.5 . . . . 0.0 110.998 178.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.25 -12.09 44.06 Favored Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 115.651 -0.704 . . . . 0.0 113.391 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -138.65 137.88 37.29 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 117.839 0.82 . . . . 0.0 112.145 -173.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 46.8 tp -95.87 110.31 22.51 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.594 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 59.7 t -96.48 95.67 4.93 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.925 -173.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.425 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 7.6 mp -88.25 152.01 22.26 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 174.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.675 ' HG3' ' HB2' ' A' ' 49' ' ' SER . 11.1 ptpp? -159.89 143.17 14.05 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 172.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.595 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -132.25 147.37 65.45 Favored Pre-proline 0 C--O 1.218 -0.557 0 C-N-CA 118.665 -1.214 . . . . 0.0 113.413 -173.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -57.71 102.74 0.13 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 121.875 1.717 . . . . 0.0 110.45 168.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.78 -6.9 33.32 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.278 -177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.595 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 83.7 mmm -140.61 151.96 45.07 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-O 121.336 0.588 . . . . 0.0 110.879 178.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.405 ' HB3' ' H ' ' A' ' 66' ' ' ARG . 3.6 mm? -69.99 -159.1 0.03 OUTLIER 'General case' 0 C--O 1.247 0.952 0 CA-C-O 121.294 0.569 . . . . 0.0 111.18 -179.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 45.4 mtp180 -80.36 149.38 30.26 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.597 174.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 68.6 tp -121.83 107.99 12.95 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 171.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -91.66 106.91 18.83 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.063 -174.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 62.1 mt -115.66 116.65 40.89 Favored Pre-proline 0 C--N 1.325 -0.462 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.441 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.45 131.74 48.03 Favored 'Trans proline' 0 CA--C 1.529 0.245 0 C-N-CA 122.636 2.224 . . . . 0.0 111.925 175.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 69.5 mt -69.31 -34.88 75.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 0.0 111.055 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -85.41 99.95 11.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.066 0.46 . . . . 0.0 110.637 179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 53.3 t -102.63 125.81 56.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.835 -0.621 . . . . 0.0 109.601 177.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.449 HG12 ' N ' ' A' ' 75' ' ' GLU . 15.7 tt -81.22 162.78 3.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.036 0.445 . . . . 0.0 110.778 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.449 ' N ' HG12 ' A' ' 74' ' ' ILE . 45.6 mt-10 -124.67 50.73 1.69 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.367 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -87.07 -89.44 0.12 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.734 -176.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -138.57 -22.29 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.162 0.506 . . . . 0.0 111.206 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -75.35 -3.16 31.95 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.27 -179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 47.4 p -72.95 95.88 2.04 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.359 176.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.561 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 57.7 t -71.38 113.23 7.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.663 -179.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.423 ' HD2' HH11 ' A' ' 81' ' ' ARG . 28.3 mtp180 -88.08 110.97 21.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.266 0.555 . . . . 0.0 109.849 176.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 27.2 t80 -101.28 132.35 46.85 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.239 -178.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 79.7 mm-40 -78.47 104.7 9.24 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.246 0.546 . . . . 0.0 110.241 177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.529 ' HE1' ' HB2' ' A' ' 30' ' ' ALA . 8.7 tpt -86.18 146.38 26.59 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.161 -0.927 . . . . 0.0 108.803 -176.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 27.4 tp -125.57 92.24 3.57 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-O 121.854 0.835 . . . . 0.0 110.408 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.654 HG22 ' CD1' ' A' ' 36' ' ' TRP . 3.7 t -79.29 83.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.014 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.638 176.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 73.93 -74.89 1.14 Allowed Glycine 0 N--CA 1.449 -0.488 0 N-CA-C 111.044 -0.822 . . . . 0.0 111.044 -175.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -141.19 4.95 1.86 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.265 0.555 . . . . 0.0 109.7 175.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -91.51 110.04 21.34 Favored 'General case' 0 N--CA 1.453 -0.316 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.14 -176.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 15.5 m -84.48 114.83 22.22 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.123 179.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.518 HG23 ' HB3' ' A' ' 84' ' ' MET . 2.2 m -134.84 144.54 34.39 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.666 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.921 -177.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -80.69 119.89 23.89 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.435 -176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 117' ' ' VAL . 27.7 m -122.39 153.79 27.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.747 175.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.6 t -96.55 128.01 48.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 120.739 0.304 . . . . 0.0 110.66 179.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.561 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 56.9 t0 -71.78 129.0 37.57 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.265 178.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -82.52 -20.05 37.49 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.863 -178.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 122.21 156.45 9.68 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.856 178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.465 ' HA ' ' HB3' ' A' ' 101' ' ' ALA . 41.6 mt-10 -78.64 -5.82 54.0 Favored 'General case' 0 C--N 1.328 -0.35 0 O-C-N 122.763 -0.257 . . . . 0.0 111.5 -177.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.724 HD23 ' H ' ' A' ' 99' ' ' LEU . 1.8 pt? -68.38 -38.93 81.84 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 172.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -74.25 -36.47 63.86 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.75 175.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.532 ' HB2' ' HG3' ' A' ' 113' ' ' ARG . . . -59.27 -52.51 65.36 Favored 'General case' 0 C--O 1.222 -0.356 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.31 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.451 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -63.0 -40.03 96.54 Favored 'General case' 0 C--O 1.238 0.482 0 CA-C-O 121.346 0.593 . . . . 0.0 111.08 -179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 82.2 t90 -57.35 -35.71 70.26 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.538 177.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.532 HD12 ' HB3' ' A' ' 107' ' ' HIS . 2.3 tp -95.41 -22.65 5.23 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.862 -178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.451 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 86.2 p -66.86 -20.27 65.89 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.433 -0.792 . . . . 0.0 109.251 175.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -87.9 -46.2 9.6 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.332 173.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.532 ' HB3' HD12 ' A' ' 104' ' ' ILE . 76.3 t60 -75.17 -48.43 23.67 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -178.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -76.04 -38.15 57.51 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 177.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.51 -23.49 35.61 Favored Glycine 0 C--N 1.329 0.161 0 CA-C-N 115.667 -0.697 . . . . 0.0 113.325 172.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.444 ' HB ' ' HD2' ' A' ' 111' ' ' PRO . 27.7 m -103.52 159.32 29.67 Favored Pre-proline 0 C--N 1.322 -0.601 0 O-C-N 122.824 -0.221 . . . . 0.0 110.659 -179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.444 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 37.2 Cg_endo -66.48 90.53 0.28 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 122.466 2.111 . . . . 0.0 111.829 176.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.448 ' SG ' HG23 ' A' ' 104' ' ' ILE . 2.2 p -134.76 157.18 47.39 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.969 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.532 ' HG3' ' HB2' ' A' ' 101' ' ' ALA . 21.9 ttm180 -132.55 137.48 47.14 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.331 -176.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.526 HG13 HG22 ' A' ' 29' ' ' VAL . 2.0 mp -77.16 128.92 37.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.45 ' CD2' ' HA ' ' A' ' 95' ' ' ASP . 80.0 mt -131.8 142.82 49.84 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.227 -177.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 8.9 ttmm -107.34 120.68 42.82 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 93' ' ' VAL . 60.2 t -65.58 116.34 4.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.071 0.463 . . . . 0.0 110.051 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.551 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 2.2 t-80 -77.2 133.56 68.37 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -176.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.551 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 10.8 Cg_endo -57.58 -5.36 1.69 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 123.492 2.794 . . . . 0.0 114.472 -176.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 77.9 m-20 -54.71 -44.47 73.5 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.458 0.647 . . . . 0.0 109.353 172.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 25.1 mmt -93.59 -56.76 2.8 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.617 -179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 60.26 -173.38 0.12 Allowed 'General case' 0 N--CA 1.465 0.311 0 O-C-N 123.867 0.729 . . . . 0.0 110.493 -174.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.411 ' CD ' ' H ' ' A' ' 124' ' ' VAL . 1.8 tm-20 57.65 -141.64 0.75 Allowed 'General case' 0 CA--C 1.534 0.365 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.61 ' CG1' HG21 ' A' ' 86' ' ' VAL . 48.4 t 71.3 113.68 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.511 0.672 . . . . 0.0 111.783 176.181 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 75.0 mtm180 -124.48 150.08 46.14 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.021 174.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.485 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 6.7 t90 -45.12 142.17 2.97 Favored Pre-proline 0 C--O 1.234 0.282 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.093 172.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.589 ' HD3' HG12 ' A' ' 86' ' ' VAL . 3.2 Cg_endo -41.67 122.27 1.89 Allowed 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 123.643 2.895 . . . . 0.0 112.824 -176.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 130' ' ' GLU . 17.7 m -94.02 43.79 1.11 Allowed 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.144 -173.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.593 HD23 ' H ' ' A' ' 129' ' ' LEU . 1.3 pt? -77.39 23.92 0.2 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.97 177.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.42 ' H ' ' C ' ' A' ' 128' ' ' SER . 7.9 pt-20 . . . . . 0 C--O 1.248 1.021 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.738 -176.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.1 mtt . . . . . 0 N--CA 1.48 1.026 0 CA-C-O 121.045 0.45 . . . . 0.0 110.285 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.2 m -73.62 102.75 3.99 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.106 178.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.8 t -65.69 117.78 8.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.79 -174.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.3 m 61.26 32.13 19.37 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.257 175.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.578 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -98.55 119.96 38.16 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.54 177.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.626 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 9.6 m-85 -97.76 141.15 31.12 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.449 -178.443 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.45 ' O ' ' HB2' ' A' ' 24' ' ' GLN . 75.6 mt-30 -105.23 95.93 10.48 Favored Pre-proline 0 C--N 1.324 -0.525 0 CA-C-O 120.45 0.167 . . . . 0.0 111.262 -177.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.626 ' HD3' ' O ' ' A' ' 6' ' ' TYR . 11.0 Cg_exo -72.41 -62.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.161 2.574 . . . . 0.0 112.619 177.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.855 HD11 HD21 ' A' ' 57' ' ' LEU . 8.0 mt -113.81 159.79 13.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 O-C-N 123.658 0.599 . . . . 0.0 110.912 -178.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.415 ' H ' HG22 ' A' ' 9' ' ' ILE . . . -71.17 -56.73 5.47 Favored 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 114.007 1.114 . . . . 0.0 114.007 -171.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.1 OUTLIER -66.08 -45.02 82.72 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -171.964 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.803 ' SG ' ' HB ' ' A' ' 9' ' ' ILE . 4.7 p -68.48 -42.21 79.02 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.755 0.312 . . . . 0.0 111.011 178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 98.74 -127.74 9.34 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.377 -0.916 . . . . 0.0 113.362 173.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.578 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -96.82 145.1 26.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.377 0.608 . . . . 0.0 111.794 -173.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.6 m -137.38 127.79 26.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.691 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 19.6 m -86.68 83.5 7.58 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.397 0.618 . . . . 0.0 110.732 -178.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.416 ' HG2' ' H ' ' A' ' 19' ' ' GLU . 9.1 tt0 -147.39 126.63 13.02 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.059 176.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 11.8 p -55.76 -28.2 54.78 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -174.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.416 ' H ' ' HG2' ' A' ' 17' ' ' GLN . 0.9 OUTLIER -76.89 -22.37 53.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.717 0.294 . . . . 0.0 111.267 -176.954 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.534 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -65.42 -28.25 69.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.828 0.346 . . . . 0.0 111.556 -176.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.404 ' HB2' ' CD1' ' A' ' 6' ' ' TYR . . . -61.67 -22.03 64.95 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.113 -176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.92 -23.64 17.34 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -176.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -109.71 4.42 21.89 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.793 -0.363 . . . . 0.0 111.484 -172.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.595 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -78.19 141.62 38.51 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.484 ' HG3' ' O ' ' A' ' 24' ' ' GLN . 64.4 mttm -163.86 -169.75 1.97 Allowed 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 -174.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 77.0 mtt85 -78.74 72.68 5.27 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-O 121.697 0.76 . . . . 0.0 110.372 175.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.701 ' HB3' HG23 ' A' ' 9' ' ' ILE . 1.0 OUTLIER -101.42 145.15 29.33 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.371 -1.286 . . . . 0.0 108.418 178.44 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -176.19 179.2 1.29 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.348 0.594 . . . . 0.0 112.265 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.605 HG22 HG12 ' A' ' 114' ' ' ILE . 16.8 t -110.84 148.07 14.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.199 177.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.525 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -134.22 156.55 48.18 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.973 -0.38 . . . . 0.0 109.973 177.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.589 ' ND2' ' H ' ' A' ' 33' ' ' ALA . 2.6 p-10 -112.46 173.15 6.51 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.272 0.558 . . . . 0.0 112.143 -171.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 111' ' ' PRO . 9.9 p-10 -46.24 -33.62 3.83 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 114.264 -1.335 . . . . 0.0 113.669 -177.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.589 ' H ' ' ND2' ' A' ' 31' ' ' ASN . . . -72.64 2.03 7.24 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.408 0.521 . . . . 0.0 112.408 -173.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.405 ' O ' ' HG3' ' A' ' 84' ' ' MET . . . 80.58 8.68 87.28 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.118 -0.793 . . . . 0.0 111.118 -178.153 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 20.7 tt0 -106.71 152.16 24.17 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.114 -0.543 . . . . 0.0 110.022 -175.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 32.3 m0 -64.3 146.72 53.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.293 173.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.446 HD22 ' SG ' ' A' ' 112' ' ' CYS . 20.3 tp -98.65 166.26 11.41 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 178.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.406 ' HB3' ' HG ' ' A' ' 41' ' ' LEU . 17.2 t-20 -147.95 158.18 43.91 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 -173.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 43' ' ' PRO . 54.5 mtm180 -73.25 -14.95 61.42 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 174.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -83.97 -18.89 35.73 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.681 -0.69 . . . . 0.0 110.189 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.406 ' HG ' ' HB3' ' A' ' 38' ' ' ASN . 91.3 mt -92.7 -51.82 4.92 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 175.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 77.2 m -114.78 94.27 36.84 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.12 -0.946 . . . . 0.0 108.996 173.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 39' ' ' ARG . 51.7 Cg_exo -54.83 -44.53 48.78 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.723 2.949 . . . . 0.0 113.608 -171.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 67.0 mtp180 -77.52 8.38 4.38 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -172.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.459 HD11 ' HB2' ' A' ' 108' ' ' ALA . 2.4 mp -76.16 -21.65 56.31 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.913 -0.403 . . . . 0.0 109.913 173.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.2 -22.62 61.3 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.569 -0.741 . . . . 0.0 109.983 170.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.527 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 52.5 mt-10 -86.06 63.16 7.87 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.225 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 12' ' ' CYS . 73.3 t -123.18 127.93 74.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.695 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.136 169.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.5 ' HB3' ' HB2' ' A' ' 60' ' ' LYS . 5.8 t -91.24 140.19 30.03 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 177.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.465 ' CG2' ' HB2' ' A' ' 12' ' ' CYS . 2.7 t -121.39 128.29 75.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.0 111.821 -172.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.589 ' HB2' ' HB ' ' A' ' 58' ' ' VAL . 15.4 mt-10 -120.86 129.41 53.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.657 -0.701 . . . . 0.0 109.559 169.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.534 HD22 ' HA ' ' A' ' 20' ' ' ALA . 5.7 mp -110.57 133.58 53.18 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.52 0.676 . . . . 0.0 110.013 176.16 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 39.1 ttm105 -135.91 148.14 48.44 Favored 'General case' 0 C--N 1.31 -1.124 0 N-CA-C 107.27 -1.382 . . . . 0.0 107.27 178.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 70.0 mtm -62.98 93.68 0.06 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.433 0.635 . . . . 0.0 110.741 -175.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 118.37 -16.03 11.71 Favored Glycine 0 N--CA 1.441 -1.021 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.938 -179.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 79.0 m-85 -143.28 138.42 29.56 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 117.828 0.814 . . . . 0.0 111.776 -174.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.855 HD21 HD11 ' A' ' 9' ' ' ILE . 39.0 tp -113.1 112.46 23.86 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.702 178.511 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.589 ' HB ' ' HB2' ' A' ' 51' ' ' GLU . 61.0 t -100.68 110.6 28.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-O 121.055 0.455 . . . . 0.0 111.251 -173.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 9.6 mp -98.67 132.5 44.01 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.996 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.564 ' HG2' ' HB3' ' A' ' 66' ' ' ARG . 44.3 mtmt -129.52 136.81 50.31 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -177.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.604 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -116.45 142.28 29.25 Favored Pre-proline 0 C--O 1.222 -0.372 0 C-N-CA 119.314 -0.954 . . . . 0.0 112.449 -176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.527 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 26.8 Cg_exo -62.89 94.74 0.15 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 121.93 1.753 . . . . 0.0 110.225 168.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 120.29 -28.33 6.33 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.892 -0.67 . . . . 0.0 112.042 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.604 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 16.7 mmt -122.4 152.65 40.0 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 97.3 mt -63.34 -166.89 0.02 OUTLIER 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.856 0.836 . . . . 0.0 112.561 -173.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.564 ' HB3' ' HG2' ' A' ' 60' ' ' LYS . 12.2 ptt180 -95.71 146.63 24.36 Favored 'General case' 0 N--CA 1.445 -0.685 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.45 176.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 29.3 tp -124.54 115.36 20.73 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.793 -177.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -92.76 109.75 21.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.619 0.723 . . . . 0.0 110.788 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 65.4 mt -104.73 113.81 64.55 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.243 -0.889 . . . . 0.0 109.361 175.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.47 123.04 12.7 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.258 1.972 . . . . 0.0 111.957 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.466 HD21 ' HB2' ' A' ' 57' ' ' LEU . 95.9 mt -66.04 -28.48 68.89 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.631 0.729 . . . . 0.0 109.12 176.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -85.01 90.55 7.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.88 -1.054 . . . . 0.0 109.199 171.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 21.3 t -94.93 143.97 10.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.048 -177.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 4.2 mt -81.63 148.04 5.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 174.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -138.67 61.0 1.59 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.177 0.513 . . . . 0.0 110.171 -174.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -146.03 -59.94 0.32 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.605 -0.438 . . . . 0.0 111.313 173.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 16.7 t70 -109.21 -62.61 1.46 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.666 0.269 . . . . 0.0 111.577 -175.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -83.05 32.99 0.44 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.957 0.884 . . . . 0.0 110.358 -176.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 33.3 t -107.94 97.34 7.06 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 172.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.636 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 45.1 t -71.88 99.79 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.116 -0.493 . . . . 0.0 109.92 -177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.539 ' HG2' ' HB2' ' A' ' 92' ' ' ASP . 52.7 ttp180 -88.8 90.68 8.51 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -93.11 130.0 38.89 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.895 -175.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -79.07 114.91 18.4 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.843 0.354 . . . . 0.0 110.405 179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.405 ' HG3' ' O ' ' A' ' 34' ' ' GLY . 2.4 tpt -105.22 154.94 19.54 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.754 -178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 49.3 tp -124.25 87.61 2.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.689 0.757 . . . . 0.0 109.559 -177.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.5 t -81.46 92.88 2.23 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.116 0 CA-C-N 115.182 -0.917 . . . . 0.0 109.736 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.27 -81.24 1.08 Allowed Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.57 -178.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -140.06 9.48 2.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.793 -0.203 . . . . 0.0 110.788 178.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 17.7 tt0 -111.48 110.53 21.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.855 0.359 . . . . 0.0 110.506 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.5 m -84.29 109.61 17.93 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.224 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 5.0 m -131.85 149.21 32.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.806 -176.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.539 ' HB2' ' HG2' ' A' ' 81' ' ' ARG . 7.1 p-10 -87.22 128.71 35.15 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.442 0.639 . . . . 0.0 111.06 -179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 115' ' ' LEU . 29.5 m -124.91 153.21 31.82 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.011 178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.492 HG23 ' HD2' ' A' ' 118' ' ' HIS . 98.8 t -96.33 137.3 24.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 110.361 -0.237 . . . . 0.0 110.361 179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.636 ' HB3' ' HB ' ' A' ' 80' ' ' VAL . 32.0 t70 -86.8 123.79 32.34 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 173.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.448 ' HG3' ' HE1' ' A' ' 27' ' ' TRP . 16.3 mm-40 -83.38 5.73 22.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.309 -174.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 138.78 126.65 2.41 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.211 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -67.47 -19.54 65.35 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.037 0.446 . . . . 0.0 110.244 178.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 48.7 tp -68.03 -33.47 74.66 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 173.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -68.42 -37.11 79.99 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.875 175.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.468 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -57.94 -54.26 48.92 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.5 174.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.92 -38.93 87.49 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.082 179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 55.8 t90 -54.32 -46.49 72.86 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.966 179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.564 HD12 ' HB3' ' A' ' 107' ' ' HIS . 1.5 tp -84.93 -21.54 7.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.692 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 68.4 m -67.12 -15.66 63.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.167 0.508 . . . . 0.0 109.699 173.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -90.39 -52.02 5.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.276 171.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.564 ' HB3' HD12 ' A' ' 104' ' ' ILE . 72.5 t60 -67.63 -46.66 71.84 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 116.233 -0.439 . . . . 0.0 112.02 -176.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.459 ' HB2' HD11 ' A' ' 45' ' ' LEU . . . -82.29 -42.22 19.1 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.046 0.45 . . . . 0.0 109.807 178.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 99.06 -12.36 62.2 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.694 -0.765 . . . . 0.0 113.055 174.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.544 HG23 ' SG ' ' A' ' 112' ' ' CYS . 15.4 m -112.78 159.42 34.49 Favored Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 122.788 -0.242 . . . . 0.0 110.353 179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.435 ' HB2' ' HB3' ' A' ' 32' ' ' ASP . 25.4 Cg_exo -63.18 93.11 0.15 Allowed 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.831 2.354 . . . . 0.0 112.42 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.544 ' SG ' HG23 ' A' ' 110' ' ' VAL . 68.6 m -134.8 155.86 49.88 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.955 177.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.468 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 10.5 ptm180 -141.16 146.8 37.47 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.605 HG12 HG22 ' A' ' 29' ' ' VAL . 35.2 mt -85.15 122.78 38.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.107 -177.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 93' ' ' VAL . 35.8 mt -126.06 152.23 46.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.139 -171.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.612 ' HZ3' ' HB3' ' A' ' 116' ' ' LYS . 7.8 ttpm? -119.09 123.16 43.76 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.104 177.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.2 t -66.67 137.55 24.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.764 -178.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.515 ' HA ' ' HD3' ' A' ' 119' ' ' PRO . 0.3 OUTLIER -76.49 134.25 70.0 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 120.787 0.327 . . . . 0.0 110.653 -179.76 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.515 ' HD3' ' HA ' ' A' ' 118' ' ' HIS . 3.7 Cg_exo -74.53 -8.05 20.17 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 123.231 2.621 . . . . 0.0 113.242 -175.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -64.79 -52.48 56.62 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.811 0.338 . . . . 0.0 111.077 -177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.429 ' SD ' ' N ' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -91.98 -45.43 8.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.959 178.052 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.429 ' N ' ' SD ' ' A' ' 121' ' ' MET . . . 58.94 -174.36 0.09 Allowed 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 123.078 0.551 . . . . 0.0 112.142 178.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 49.78 84.03 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 122.096 0.951 . . . . 0.0 112.992 178.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 23.7 t -132.19 131.8 60.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 CA-C-N 114.426 -1.261 . . . . 0.0 107.891 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.7 mtp180 -131.3 133.22 45.15 Favored 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 120.974 -0.29 . . . . 0.0 110.883 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.508 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 8.3 t90 -45.28 140.74 3.78 Favored Pre-proline 0 CA--C 1.535 0.384 0 O-C-N 124.196 0.935 . . . . 0.0 110.772 175.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.621 ' HB2' HD23 ' A' ' 129' ' ' LEU . 9.5 Cg_endo -47.73 115.42 1.43 Allowed 'Trans proline' 0 C--N 1.353 0.768 0 C-N-CA 123.607 2.871 . . . . 0.0 112.745 -176.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 17.4 m -85.7 37.84 0.72 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.383 0.611 . . . . 0.0 110.724 -173.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.621 HD23 ' HB2' ' A' ' 127' ' ' PRO . 3.2 pp -77.33 171.99 14.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.178 175.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.4 -0.81 . . . . 0.0 109.789 177.857 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.3 ptt? . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -73.41 107.97 6.01 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.99 0.424 . . . . 0.0 111.61 -176.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.669 ' O ' ' HB ' ' A' ' 4' ' ' THR . 0.1 OUTLIER -155.68 -83.55 0.06 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.042 175.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.669 ' HB ' ' O ' ' A' ' 3' ' ' THR . 6.9 t 147.97 146.29 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 124.438 1.095 . . . . 0.0 110.522 172.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -167.21 122.59 1.08 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.077 177.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.621 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 36.5 m-85 -103.25 140.37 37.47 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -176.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.25 95.76 14.06 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-O 120.947 0.404 . . . . 0.0 110.048 -178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.87 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 7.5 Cg_endo -90.06 -35.65 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.621 0 C-N-CA 123.449 2.766 . . . . 0.0 113.395 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 2.4 mm -115.93 135.78 54.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.146 0 O-C-N 123.9 0.75 . . . . 0.0 110.231 -170.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.451 ' O ' ' HD2' ' A' ' 39' ' ' ARG . . . -68.22 -56.23 9.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.322 0.49 . . . . 0.0 112.322 -172.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.618 ' H ' ' CD ' ' A' ' 11' ' ' GLU . 0.0 OUTLIER -70.86 -53.53 14.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.489 -178.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.835 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 39.7 m -56.48 -47.59 78.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.146 -178.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 106.37 -130.39 10.16 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.539 -0.838 . . . . 0.0 113.115 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.73 150.46 21.18 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.321 0.581 . . . . 0.0 112.034 -172.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.46 HG22 ' H ' ' A' ' 17' ' ' GLN . 10.7 m -121.65 139.09 53.98 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.491 176.19 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.8 m -90.44 8.47 33.59 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.36 0.6 . . . . 0.0 111.201 -175.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.46 ' H ' HG22 ' A' ' 15' ' ' THR . 1.2 mp0 -95.63 142.19 28.23 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.779 -179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 21.8 m -67.68 -15.95 63.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.081 -177.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.405 ' HB3' ' HE2' ' A' ' 23' ' ' TYR . 7.2 mm-40 -64.3 -36.1 83.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.288 178.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.87 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -62.08 -25.01 67.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.768 -171.035 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.03 -23.93 67.52 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.03 0.443 . . . . 0.0 111.093 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -108.05 1.04 22.12 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.685 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.405 ' HE2' ' HB3' ' A' ' 19' ' ' GLU . 35.3 m-85 -126.44 12.4 7.53 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.596 -0.442 . . . . 0.0 111.723 -177.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.51 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 14.0 pt20 -70.26 143.07 52.22 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 175.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.407 ' HG3' ' C ' ' A' ' 24' ' ' GLN . 83.1 mttt -160.67 173.14 15.9 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -172.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 87.4 mtt-85 -78.73 75.64 5.24 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 121.351 0.596 . . . . 0.0 109.742 173.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.44 ' HE1' ' HG3' ' A' ' 96' ' ' GLU . 0.0 OUTLIER -92.76 152.9 19.22 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.178 177.893 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.9 pp -175.58 177.39 1.77 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.468 0.651 . . . . 0.0 112.184 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.542 HG22 HG12 ' A' ' 114' ' ' ILE . 64.6 t -122.0 138.16 53.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 173.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.455 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -122.81 141.63 51.64 Favored 'General case' 0 C--N 1.321 -0.658 0 O-C-N 122.174 -0.328 . . . . 0.0 110.16 177.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -88.51 172.78 9.08 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.117 -174.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -47.79 -31.7 5.2 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 123.677 0.791 . . . . 0.0 112.631 178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -68.93 -14.79 63.25 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.709 0.29 . . . . 0.0 111.736 -178.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 90.53 5.85 68.81 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.559 -177.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -94.06 144.97 25.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.855 0.36 . . . . 0.0 110.562 -176.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.593 ' CH2' ' HB ' ' A' ' 124' ' ' VAL . 31.0 m0 -68.99 125.29 26.2 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.844 177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.447 ' HG ' ' SG ' ' A' ' 42' ' ' CYS . 29.5 tp -96.24 131.67 42.49 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -119.76 157.97 27.51 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.871 0.367 . . . . 0.0 111.126 -174.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.451 ' HD2' ' O ' ' A' ' 10' ' ' ALA . 11.4 ptm180 -64.64 -15.41 61.19 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.46 176.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -75.04 -37.66 61.66 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.487 0.66 . . . . 0.0 109.461 175.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.4 HD11 ' HZ2' ' A' ' 126' ' ' TRP . 68.3 mt -77.64 -50.4 12.57 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.885 178.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.447 ' SG ' ' HG ' ' A' ' 37' ' ' LEU . 13.1 p -116.7 92.98 39.62 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.371 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -63.58 -25.02 69.68 Favored 'Trans proline' 0 C--N 1.344 0.292 0 C-N-CA 123.068 2.512 . . . . 0.0 113.214 -175.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -71.36 -17.64 62.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.884 0.373 . . . . 0.0 111.734 -175.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.445 HD13 ' SG ' ' A' ' 42' ' ' CYS . 7.7 mp -72.46 -21.67 61.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.0 0.429 . . . . 0.0 110.599 177.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -71.81 -5.18 32.37 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.514 178.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.503 ' HB3' ' HG2' ' A' ' 62' ' ' PRO . 6.7 mm-40 -84.67 3.9 35.01 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.338 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.835 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 95.3 t -79.77 118.74 27.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.87 0.367 . . . . 0.0 110.969 -177.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.9 p -87.18 119.12 27.08 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.687 ' HB ' ' HB3' ' A' ' 12' ' ' CYS . 12.0 p -117.71 128.26 74.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.315 -171.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.496 ' HG2' ' HE2' ' A' ' 60' ' ' LYS . 35.2 mm-40 -120.87 129.84 53.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.561 177.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 20' ' ' ALA . 10.1 mp -97.78 125.89 42.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.499 0.666 . . . . 0.0 110.66 177.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.529 HH21 HG21 ' A' ' 58' ' ' VAL . 28.0 ttm-85 -110.09 164.66 12.41 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 114.569 -1.196 . . . . 0.0 108.373 179.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.43 88.9 0.09 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.483 0.658 . . . . 0.0 110.257 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 108.39 -13.7 36.3 Favored Glycine 0 N--CA 1.443 -0.835 0 CA-C-N 115.46 -0.791 . . . . 0.0 112.933 178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -131.75 138.3 48.56 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.621 0.724 . . . . 0.0 112.345 -174.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.411 ' HB2' HD23 ' A' ' 71' ' ' LEU . 61.3 tp -100.59 107.87 19.65 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.695 173.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.529 HG21 HH21 ' A' ' 53' ' ' ARG . 46.2 t -99.56 102.78 13.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.928 0.394 . . . . 0.0 110.685 -175.617 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.671 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 5.8 mp -90.88 140.54 29.71 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.715 176.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.496 ' HE2' ' HG2' ' A' ' 51' ' ' GLU . 39.6 mtmt -136.44 130.1 32.15 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 176.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.759 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -114.74 153.09 46.88 Favored Pre-proline 0 C--N 1.327 -0.393 0 C-N-CA 119.211 -0.995 . . . . 0.0 112.829 -176.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.503 ' HG2' ' HB3' ' A' ' 47' ' ' GLU . 20.0 Cg_exo -67.14 98.25 0.44 Allowed 'Trans proline' 0 N--CA 1.46 -0.455 0 C-N-CA 122.236 1.957 . . . . 0.0 110.618 170.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 108.7 -18.31 32.2 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.267 -177.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.759 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 14.3 mmt -121.73 144.84 48.56 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 70.2 mt -68.15 -149.93 0.01 OUTLIER 'General case' 0 C--O 1.249 1.067 0 CA-C-O 121.407 0.622 . . . . 0.0 111.971 -175.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 56.5 mtt180 -69.77 170.25 11.36 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 114.901 -1.045 . . . . 0.0 111.745 175.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.671 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 60.2 tp -151.71 87.72 1.38 Allowed 'General case' 0 C--N 1.315 -0.922 0 CA-C-N 114.04 -1.436 . . . . 0.0 107.894 166.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -84.0 104.98 14.51 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.447 -175.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 48.0 mt -115.81 136.75 22.93 Favored Pre-proline 0 C--N 1.321 -0.643 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.393 178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.22 139.72 91.58 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 121.66 1.573 . . . . 0.0 110.613 171.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.411 HD23 ' HB2' ' A' ' 57' ' ' LEU . 69.2 mt -52.69 -33.41 47.37 Favored 'General case' 0 N--CA 1.468 0.457 0 N-CA-C 112.187 0.439 . . . . 0.0 112.187 -175.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -140.02 110.17 6.54 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 172.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 46.4 t -59.21 123.1 10.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 175.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.611 ' HB ' ' HB2' ' A' ' 77' ' ' ASP . 24.2 mm -57.45 145.75 7.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.911 0.386 . . . . 0.0 110.409 -176.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -74.94 -2.28 26.35 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.765 0.793 . . . . 0.0 110.924 -170.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -129.07 -0.01 5.23 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 114.91 -1.041 . . . . 0.0 111.097 -178.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.611 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 25.1 t70 -85.09 -67.9 0.77 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 -179.69 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -160.23 44.34 0.21 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.518 0.675 . . . . 0.0 109.44 176.04 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 34.3 t -77.06 92.44 3.74 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.926 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.559 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 41.1 t -85.81 122.23 38.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.502 -177.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.7 104.33 16.34 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.373 0.606 . . . . 0.0 111.139 -179.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.515 ' O ' HG22 ' A' ' 93' ' ' VAL . 39.5 m-85 -94.95 116.4 28.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.103 173.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . 0.507 ' HG2' HG22 ' A' ' 90' ' ' THR . 31.6 tt0 -80.87 99.28 8.25 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 176.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.633 ' O ' ' HA ' ' A' ' 90' ' ' THR . 1.0 OUTLIER -86.96 159.31 19.05 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.881 -169.739 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 37.8 tp -117.99 87.36 2.7 Favored 'General case' 0 N--CA 1.44 -0.968 0 CA-C-O 121.885 0.85 . . . . 0.0 109.554 -173.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.495 ' CG1' ' HD3' ' A' ' 127' ' ' PRO . 2.8 t -78.99 86.84 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.701 -1.136 . . . . 0.0 109.874 -177.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.85 -68.9 2.48 Favored Glycine 0 N--CA 1.45 -0.43 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.592 -177.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -145.41 2.95 0.99 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.777 0.322 . . . . 0.0 110.367 177.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.642 HE21 HG22 ' A' ' 124' ' ' VAL . 15.8 tt0 -109.95 109.61 20.27 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.925 0.393 . . . . 0.0 111.025 -170.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.633 ' HA ' ' O ' ' A' ' 84' ' ' MET . 0.0 OUTLIER -85.13 104.83 15.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.655 178.942 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.692 HG21 HG21 ' A' ' 124' ' ' VAL . 2.7 m -118.93 144.99 25.65 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.062 -177.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -79.09 112.68 16.54 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.034 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.592 HG21 HD13 ' A' ' 115' ' ' LEU . 16.8 m -120.07 152.47 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.48 176.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 98.0 t -103.22 135.37 41.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.767 0.317 . . . . 0.0 111.176 -175.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.584 ' HA ' HD23 ' A' ' 115' ' ' LEU . 43.5 t0 -83.2 126.13 32.3 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 174.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' HG3' ' HE1' ' A' ' 27' ' ' TRP . 8.3 mm-40 -81.32 -5.91 58.33 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.495 -176.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 146.5 136.92 2.95 Favored Glycine 0 N--CA 1.442 -0.935 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.378 176.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.47 ' HG2' ' NH1' ' A' ' 113' ' ' ARG . 14.6 mt-10 -69.15 -23.13 63.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.826 0.346 . . . . 0.0 110.573 -179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -64.56 -30.91 71.94 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.082 0.467 . . . . 0.0 109.86 172.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.532 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -74.35 -37.95 63.36 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-N 115.903 -0.589 . . . . 0.0 109.9 177.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.509 ' HB2' ' HD3' ' A' ' 113' ' ' ARG . . . -59.51 -46.39 88.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.621 175.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.506 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -66.69 -36.5 82.66 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.351 0.596 . . . . 0.0 111.027 178.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.415 ' CZ2' ' HB2' ' A' ' 61' ' ' ALA . 76.1 t90 -57.45 -40.27 78.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.311 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.578 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.2 tp -93.23 -21.1 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.457 0 C-N-CA 120.379 -0.528 . . . . 0.0 111.528 -178.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.506 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 90.5 p -66.87 -19.87 65.82 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 121.488 -0.757 . . . . 0.0 109.237 175.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -83.65 -48.66 9.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.135 172.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.578 ' HB3' HD12 ' A' ' 104' ' ' ILE . 75.1 t60 -74.28 -51.98 13.66 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 111.796 0.295 . . . . 0.0 111.796 -178.012 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.401 ' HB2' HD11 ' A' ' 45' ' ' LEU . . . -71.78 -41.39 68.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 109.739 178.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 97.13 -22.94 38.03 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.45 -0.795 . . . . 0.0 112.74 174.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 27.5 m -97.22 157.03 35.58 Favored Pre-proline 0 C--N 1.318 -0.782 0 CA-C-O 120.532 0.206 . . . . 0.0 110.671 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -70.17 92.89 0.55 Allowed 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.464 2.11 . . . . 0.0 111.469 175.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.432 ' HB2' HG12 ' A' ' 29' ' ' VAL . 5.0 p -134.25 156.5 48.3 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.015 -179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.509 ' HD3' ' HB2' ' A' ' 101' ' ' ALA . 7.3 tpp180 -117.77 128.44 54.88 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.172 -175.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.542 HG12 HG22 ' A' ' 29' ' ' VAL . 54.5 mt -79.1 118.33 26.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.592 HD13 HG21 ' A' ' 93' ' ' VAL . 23.2 mt -130.46 142.1 50.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.286 0.565 . . . . 0.0 112.061 -168.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.466 ' HZ3' ' HB3' ' A' ' 116' ' ' LYS . 0.0 OUTLIER -117.1 117.33 29.33 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.206 175.109 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 38.4 t -61.91 137.56 23.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.522 -174.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -80.99 125.69 79.22 Favored Pre-proline 0 C--O 1.234 0.243 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 178.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -63.5 -4.46 6.86 Favored 'Trans proline' 0 CA--C 1.533 0.433 0 C-N-CA 123.377 2.718 . . . . 0.0 114.881 -171.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 41.5 m-20 -51.03 -57.33 8.91 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.347 0.594 . . . . 0.0 110.785 175.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 18.6 ptp -107.17 -54.19 2.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.077 -175.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 124' ' ' VAL . . . 54.7 -106.85 0.34 Allowed 'General case' 0 CA--C 1.531 0.23 0 O-C-N 123.489 0.493 . . . . 0.0 110.887 -174.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 66.72 -59.13 0.37 Allowed 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 123.816 0.846 . . . . 0.0 113.233 177.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.692 HG21 HG21 ' A' ' 91' ' ' VAL . 3.4 t -54.57 122.69 4.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.393 0.616 . . . . 0.0 112.504 -168.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -112.41 36.45 3.39 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.098 -0.956 . . . . 0.0 109.092 177.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.679 ' HB3' ' HG ' ' A' ' 129' ' ' LEU . 11.7 t90 72.35 152.41 0.14 Allowed Pre-proline 0 CA--C 1.54 0.581 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 -169.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.669 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 41.8 Cg_exo -25.86 -54.39 0.09 OUTLIER 'Trans proline' 0 C--N 1.365 1.399 0 C-N-CA 124.523 3.482 . . . . 0.0 114.438 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 5.3 p -171.84 82.69 0.07 Allowed 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 121.479 0.657 . . . . 0.0 110.931 177.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.679 ' HG ' ' HB3' ' A' ' 126' ' ' TRP . 70.3 mt -81.13 120.06 24.37 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.564 -0.743 . . . . 0.0 109.391 170.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.707 -0.663 . . . . 0.0 110.663 -176.388 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 28.0 ttt . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 120.763 0.316 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.7 t -147.6 169.76 18.93 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 120.78 0.324 . . . . 0.0 110.499 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 10.2 t -113.23 164.67 13.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.199 -178.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.4 m 64.59 23.33 12.83 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 122.211 1.005 . . . . 0.0 109.878 -176.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.688 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -103.09 111.65 24.1 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.928 -1.033 . . . . 0.0 109.869 -179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.712 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 61.8 m-85 -87.45 117.66 26.38 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 -178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.433 ' HG3' ' O ' ' A' ' 13' ' ' GLY . 10.3 tt0 -96.39 98.85 4.61 Favored Pre-proline 0 C--N 1.319 -0.741 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.266 -179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.758 ' HA ' ' CB ' ' A' ' 24' ' ' GLN . 21.4 Cg_exo -64.69 -60.59 0.13 Allowed 'Trans proline' 0 C--O 1.243 0.735 0 C-N-CA 122.67 2.247 . . . . 0.0 110.9 177.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.677 ' HA ' ' HB3' ' A' ' 27' ' ' TRP . 44.9 mt -114.54 136.01 52.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 CA-C-N 114.483 -1.235 . . . . 0.0 109.951 175.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.02 -58.74 5.97 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.759 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 16.9 mm-40 -70.61 -22.43 62.54 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.794 -174.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.859 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 73.6 m -73.6 -48.08 35.46 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.133 0.492 . . . . 0.0 110.087 178.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.433 ' O ' ' HG3' ' A' ' 7' ' ' GLN . . . 120.33 -153.72 16.63 Favored Glycine 0 N--CA 1.442 -0.931 0 C-N-CA 120.283 -0.96 . . . . 0.0 112.231 -179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.688 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -113.33 142.73 45.51 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.106 0.479 . . . . 0.0 111.909 -172.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.3 m -118.87 137.57 53.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.699 176.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 6.7 m -86.49 76.29 9.62 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.144 0.497 . . . . 0.0 110.126 177.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.401 ' HG2' ' H ' ' A' ' 19' ' ' GLU . 8.6 tt0 -160.19 120.7 2.97 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.858 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 19.7 m -68.49 -10.33 54.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.922 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.401 ' H ' ' HG2' ' A' ' 17' ' ' GLN . 22.2 tt0 -68.35 -28.54 67.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.287 0.565 . . . . 0.0 109.72 178.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.574 ' HA ' HD22 ' A' ' 52' ' ' LEU . . . -67.94 -24.22 65.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.632 -0.713 . . . . 0.0 111.624 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.84 -15.75 63.19 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -175.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -94.23 -3.84 50.0 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.631 0.253 . . . . 0.0 111.419 -178.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.426 ' CD2' HD13 ' A' ' 71' ' ' LEU . 74.3 m-85 -130.56 -25.67 2.35 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.882 0.327 . . . . 0.0 111.882 -175.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.758 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -66.0 155.35 36.89 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.581 -0.282 . . . . 0.0 110.989 -177.744 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.9 tptt -172.65 -160.63 0.14 Allowed 'General case' 0 N--CA 1.464 0.232 0 O-C-N 123.219 0.324 . . . . 0.0 110.169 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 31.3 ptt-85 -74.95 69.06 1.86 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 122.122 0.963 . . . . 0.0 109.729 175.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.677 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 1.3 t90 -100.51 144.84 29.02 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.36 -1.291 . . . . 0.0 108.452 -176.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 2.5 pp -170.31 -173.79 1.55 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 118.575 0.625 . . . . 0.0 112.243 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.508 HG22 HG12 ' A' ' 114' ' ' ILE . 80.7 t -113.2 144.23 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.758 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -116.02 150.13 37.74 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.011 0.434 . . . . 0.0 111.281 178.853 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.49 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 27.5 t30 -98.89 156.81 16.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.137 -174.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -46.13 -37.11 6.53 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 123.758 0.823 . . . . 0.0 112.683 176.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.09 -6.97 37.62 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.913 0.387 . . . . 0.0 111.401 -175.725 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.63 4.53 63.77 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.582 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -98.44 160.35 14.34 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -177.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.443 ' HB2' ' HD1' ' A' ' 126' ' ' TRP . 28.2 m0 -68.07 134.79 51.2 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 172.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.627 HD22 ' SG ' ' A' ' 112' ' ' CYS . 28.4 tp -99.19 131.59 45.11 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -124.39 152.86 42.7 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.351 0.596 . . . . 0.0 112.597 -173.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 18.2 ttm105 -48.8 -32.11 8.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.353 -1.294 . . . . 0.0 110.736 164.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -68.77 -17.8 64.1 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.492 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 75.5 mt -105.6 -39.6 6.04 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.12 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 50.5 t -132.29 101.59 14.71 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.029 177.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -64.72 -29.45 59.85 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.653 2.236 . . . . 0.0 112.138 -178.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 72.3 mtt180 -59.34 -30.74 68.59 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.398 0.618 . . . . 0.0 110.473 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.759 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 37.3 tp -66.79 -34.03 76.92 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.566 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.661 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -73.98 9.21 1.63 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.2 mm-40 -98.26 24.26 7.41 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.844 0.354 . . . . 0.0 111.203 177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.859 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 55.4 t -84.79 113.79 23.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-O 120.714 0.292 . . . . 0.0 110.409 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 4.8 t -77.54 132.06 38.17 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 174.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.28 138.25 53.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-O 121.559 0.695 . . . . 0.0 112.074 -175.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.421 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 35.3 tt0 -140.86 149.12 41.56 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.458 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.574 HD22 ' HA ' ' A' ' 20' ' ' ALA . 5.5 mp -128.61 158.03 39.63 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.687 0.756 . . . . 0.0 112.238 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 23.2 ttm180 -158.45 149.06 20.24 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.003 -1.453 . . . . 0.0 107.501 175.129 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 15.2 tpt -49.26 98.74 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 O-C-N 123.516 0.51 . . . . 0.0 110.992 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 116.51 -31.19 6.07 Favored Glycine 0 N--CA 1.443 -0.851 0 C-N-CA 120.815 -0.707 . . . . 0.0 113.486 178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 45.1 m-85 -127.88 137.76 52.44 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 118.092 0.946 . . . . 0.0 112.963 -172.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.488 ' HB2' ' CD2' ' A' ' 71' ' ' LEU . 37.9 tp -100.72 108.59 20.48 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 114.735 -1.12 . . . . 0.0 108.213 170.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.421 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 42.5 t -96.96 99.82 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-O 120.977 0.418 . . . . 0.0 110.95 -172.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.612 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 8.0 mp -91.86 141.74 28.33 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.048 175.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -137.44 130.27 30.24 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 179.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.637 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -126.0 151.67 71.88 Favored Pre-proline 0 C--O 1.221 -0.41 0 C-N-CA 118.68 -1.208 . . . . 0.0 113.247 -175.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -62.81 107.19 0.59 Allowed 'Trans proline' 0 N--CA 1.457 -0.659 0 C-N-CA 121.986 1.79 . . . . 0.0 110.228 168.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.23 -24.29 25.01 Favored Glycine 0 N--CA 1.447 -0.631 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.169 -178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.637 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 95.1 mmm -122.39 147.57 46.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.099 0.476 . . . . 0.0 110.327 -179.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 53.3 mt -68.34 -144.58 0.01 OUTLIER 'General case' 0 C--O 1.247 0.937 0 CA-C-O 121.548 0.69 . . . . 0.0 110.756 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.449 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 5.8 ptt180 -86.75 151.63 23.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.066 176.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.612 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 60.3 tp -124.32 93.53 3.94 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 168.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -85.59 97.95 10.38 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.891 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.447 HG13 ' HG ' ' A' ' 67' ' ' LEU . 65.9 mt -100.21 122.52 49.98 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.922 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -54.94 123.97 15.11 Favored 'Trans proline' 0 N--CA 1.46 -0.46 0 C-N-CA 122.006 1.804 . . . . 0.0 110.77 172.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.488 ' CD2' ' HB2' ' A' ' 57' ' ' LEU . 64.7 mt -67.72 -42.14 82.42 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.898 0.38 . . . . 0.0 110.707 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -92.39 64.3 4.33 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.699 0.762 . . . . 0.0 110.898 -179.224 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.1 t -64.33 130.53 29.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 115.508 -0.769 . . . . 0.0 109.718 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.648 ' HB ' ' HB2' ' A' ' 77' ' ' ASP . 7.6 mt -67.59 136.28 26.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -91.81 12.71 20.55 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-O 121.695 0.759 . . . . 0.0 110.368 -169.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -129.15 -8.72 4.8 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.83 -1.077 . . . . 0.0 109.773 177.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.648 ' HB2' ' HB ' ' A' ' 74' ' ' ILE . 38.3 t70 -81.36 -85.32 0.1 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.378 -170.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.11 34.34 5.24 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.169 0.509 . . . . 0.0 109.954 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.7 p -72.31 77.63 1.0 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.281 177.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.602 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 61.2 t -66.92 108.2 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.416 -178.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 39.0 ttt-85 -66.58 112.63 4.24 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 175.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.526 ' O ' HG22 ' A' ' 93' ' ' VAL . 3.1 t80 -105.15 107.97 19.24 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 25.2 tt0 -80.11 113.82 18.57 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -176.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.636 ' CE ' ' HA ' ' A' ' 84' ' ' MET . 5.3 mmt -103.68 169.59 8.43 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.195 -175.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 25.2 tp -139.38 88.04 2.23 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 12.9 t -89.39 103.24 13.87 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.812 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.785 -175.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 76.61 -77.76 1.4 Allowed Glycine 0 N--CA 1.445 -0.715 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 -176.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -146.27 4.19 0.92 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.51 0.195 . . . . 0.0 110.933 177.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.602 ' HG2' HG13 ' A' ' 91' ' ' VAL . 10.2 tt0 -105.26 120.48 41.66 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.493 -0.483 . . . . 0.0 111.849 -175.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 84' ' ' MET . 0.2 OUTLIER -79.93 116.33 20.01 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.264 174.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.602 HG13 ' HG2' ' A' ' 89' ' ' GLN . 3.6 m -129.74 164.29 32.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.926 0.713 . . . . 0.0 112.926 -171.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.39 112.69 24.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 114.789 -1.096 . . . . 0.0 111.754 -177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.53 HG21 HD13 ' A' ' 115' ' ' LEU . 7.1 m -125.81 152.13 32.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 71.7 t -106.21 142.17 19.8 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 O-C-N 122.237 -0.289 . . . . 0.0 110.743 -179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.649 ' OD1' ' HD3' ' A' ' 113' ' ' ARG . 26.4 t70 -92.94 125.86 37.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.56 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -70.98 -14.03 62.21 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.708 0.289 . . . . 0.0 111.652 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 137.46 149.21 5.53 Favored Glycine 0 N--CA 1.44 -1.086 0 C-N-CA 120.383 -0.913 . . . . 0.0 112.999 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -64.68 -13.54 54.63 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.934 0.397 . . . . 0.0 111.001 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 59.4 tp -66.04 -43.55 87.22 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 174.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -69.49 -36.53 76.6 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.388 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.5 -52.09 67.08 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.131 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.438 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -62.95 -39.35 94.37 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.247 0.546 . . . . 0.0 111.103 179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.417 ' HH2' HG13 ' A' ' 48' ' ' VAL . 49.8 t90 -57.81 -44.33 86.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.607 -0.724 . . . . 0.0 111.019 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.405 HD12 ' HA ' ' A' ' 104' ' ' ILE . 1.6 tp -87.12 -25.17 6.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 C-N-CA 120.207 -0.597 . . . . 0.0 111.571 -177.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.438 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 16.5 p -68.49 -15.85 63.68 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.533 -0.729 . . . . 0.0 109.959 176.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -88.99 -45.25 9.79 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.448 171.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -74.4 -49.51 22.29 Favored 'General case' 0 N--CA 1.468 0.448 0 N-CA-C 111.653 0.242 . . . . 0.0 111.653 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -75.64 -40.87 55.48 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 104.48 -38.22 3.38 Favored Glycine 0 N--CA 1.452 -0.271 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.614 174.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.512 HG23 ' SG ' ' A' ' 112' ' ' CYS . 18.7 m -87.64 157.85 51.88 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 110.615 -0.143 . . . . 0.0 110.615 -179.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -65.84 88.63 0.23 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.761 2.307 . . . . 0.0 111.923 177.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.627 ' SG ' HD22 ' A' ' 37' ' ' LEU . 73.8 m -134.83 168.73 18.53 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.586 -0.733 . . . . 0.0 109.939 177.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.649 ' HD3' ' OD1' ' A' ' 95' ' ' ASP . 11.1 ptp180 -149.14 151.23 34.01 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.606 0.241 . . . . 0.0 110.634 -179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.508 HG12 HG22 ' A' ' 29' ' ' VAL . 52.3 mt -82.85 131.88 32.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 177.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.596 HD23 ' HA ' ' A' ' 95' ' ' ASP . 64.7 mt -138.23 133.34 33.07 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-O 120.926 0.393 . . . . 0.0 111.214 -174.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -99.89 120.47 39.83 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.023 -0.535 . . . . 0.0 109.785 173.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 29.1 t -64.16 133.85 29.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.299 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.554 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 5.0 t-160 -55.99 126.65 67.08 Favored Pre-proline 0 C--N 1.332 -0.154 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.88 -177.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.554 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 6.1 Cg_endo -47.78 -32.49 17.09 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 123.679 2.919 . . . . 0.0 113.45 -175.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -62.21 -53.24 58.15 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.391 178.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 51.7 ttm -89.78 121.41 31.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.462 0.649 . . . . 0.0 110.636 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -115.4 -35.5 4.6 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.405 -175.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -82.63 103.23 11.99 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.227 0.537 . . . . 0.0 111.364 -174.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.556 HG13 HG11 ' A' ' 91' ' ' VAL . 51.4 t -130.47 -66.86 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.297 177.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 83.8 mtt-85 68.28 121.55 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.846 -1.07 . . . . 0.0 113.605 174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.616 ' HE3' ' H ' ' A' ' 128' ' ' SER . 2.9 t90 -58.37 145.62 74.61 Favored Pre-proline 0 C--N 1.326 -0.434 0 CA-C-N 115.094 -0.957 . . . . 0.0 108.47 165.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.47 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 4.9 Cg_endo -45.37 -32.33 7.57 Favored 'Trans proline' 0 C--N 1.351 0.688 0 C-N-CA 123.732 2.955 . . . . 0.0 113.386 -178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . 0.616 ' H ' ' HE3' ' A' ' 126' ' ' TRP . 20.3 m 61.88 27.63 16.83 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 122.99 0.516 . . . . 0.0 111.537 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 79.9 mt 62.94 91.86 0.07 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.141 -179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 . . . . . 0 C--O 1.248 0.979 0 CA-C-N 115.209 -0.905 . . . . 0.0 110.111 -178.934 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.3 mtt . . . . . 0 N--CA 1.483 1.188 0 N-CA-C 110.163 -0.31 . . . . 0.0 110.163 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.5 m -90.86 98.38 11.74 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.102 0.477 . . . . 0.0 109.811 175.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 11.4 t -89.41 -20.06 24.41 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.763 -175.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.1 m 64.29 92.03 0.07 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.592 0.71 . . . . 0.0 111.705 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -115.95 125.93 53.2 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.754 176.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.445 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 36.8 m-85 -89.98 138.17 31.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 51.0 mt-30 -114.54 93.24 31.71 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 120.735 0.302 . . . . 0.0 110.452 -178.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.585 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 1.1 Cg_endo -84.8 -38.23 0.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 122.871 2.38 . . . . 0.0 112.213 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.635 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 0.7 OUTLIER -114.75 147.12 18.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.381 -176.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -74.13 -69.22 0.46 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.689 0.625 . . . . 0.0 112.689 -172.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.849 ' HB2' ' HG ' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -65.46 -39.9 92.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.283 -176.664 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.851 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 34.2 m -60.55 -47.92 84.07 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.846 179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 108.55 -130.38 10.03 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.225 -0.988 . . . . 0.0 113.625 175.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.409 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -109.6 147.8 32.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.305 0.574 . . . . 0.0 112.112 -171.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.8 m -139.51 125.66 19.99 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.357 176.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -86.8 88.87 7.78 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 121.91 0.862 . . . . 0.0 110.639 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -148.19 135.97 20.87 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.794 -1.094 . . . . 0.0 109.194 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 p -56.46 -38.03 71.1 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 21.2 mm-40 -74.95 -23.35 58.29 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.417 -173.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.585 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -62.13 -27.35 68.88 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -173.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.31 -24.47 67.66 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.86 -176.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -106.2 3.11 27.48 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 111.823 0.305 . . . . 0.0 111.823 -176.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -118.31 13.83 13.72 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.839 0.352 . . . . 0.0 110.71 178.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.572 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 0.0 OUTLIER -77.07 153.54 34.24 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 177.08 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 mtpp -162.95 171.31 16.76 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.5 ' HD2' ' O ' ' A' ' 122' ' ' ALA . 58.6 mtt180 -76.81 76.84 3.42 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 122.145 0.974 . . . . 0.0 109.314 175.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -91.39 152.3 20.47 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 113.351 -1.749 . . . . 0.0 108.913 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.7 pp 179.49 -176.9 0.31 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.184 0.516 . . . . 0.0 111.097 178.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.813 HG23 ' HB3' ' A' ' 37' ' ' LEU . 0.2 OUTLIER -118.87 140.73 41.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.573 178.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -119.31 140.05 50.94 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 175.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.503 ' HA ' ' HA ' ' A' ' 112' ' ' CYS . 10.1 p30 -95.88 -177.52 4.05 Favored 'General case' 0 C--N 1.32 -0.68 0 C-N-CA 120.499 -0.48 . . . . 0.0 110.438 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -46.53 -41.44 14.24 Favored 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.81 0.694 . . . . 0.0 112.765 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -70.47 -8.13 48.73 Favored 'General case' 0 N--CA 1.464 0.261 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -176.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.09 8.78 87.33 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.76 -0.733 . . . . 0.0 111.704 -178.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -88.63 142.76 27.42 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.461 ' HB2' ' HD1' ' A' ' 126' ' ' TRP . 29.8 m0 -62.36 128.31 35.44 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.824 175.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.813 ' HB3' HG23 ' A' ' 29' ' ' VAL . 8.5 tp -87.42 131.45 34.31 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 177.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -120.64 162.8 19.05 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.648 -0.251 . . . . 0.0 110.47 -169.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -71.58 -21.55 61.85 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.258 0.551 . . . . 0.0 109.778 175.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -72.9 -27.16 61.72 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.378 -0.828 . . . . 0.0 109.825 173.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 71.9 mt -90.18 -45.39 9.13 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.525 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.699 ' SG ' ' HG ' ' A' ' 37' ' ' LEU . 1.7 p -130.44 96.83 23.22 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 115.317 -0.856 . . . . 0.0 111.105 178.681 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_exo -63.27 -37.14 52.55 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.948 2.432 . . . . 0.0 112.859 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 31.9 mtp85 -73.24 -6.29 44.99 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.231 0.539 . . . . 0.0 111.003 -176.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.849 ' HG ' ' HB2' ' A' ' 11' ' ' GLU . 33.8 tp -73.02 -24.23 60.7 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.919 178.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.529 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -72.19 -6.3 41.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.426 177.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -87.74 31.24 0.77 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.484 -176.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.851 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 88.8 t -93.49 127.86 45.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.644 0.259 . . . . 0.0 110.418 176.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.2 t -86.47 137.54 32.46 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.585 HG22 ' HB3' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -119.41 144.7 27.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 CA-C-O 121.182 0.515 . . . . 0.0 111.239 -173.751 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 35.0 tt0 -148.7 140.36 23.58 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 174.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.5 mp -111.36 125.04 53.44 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.734 0.778 . . . . 0.0 110.578 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.608 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 2.4 tpm_? -105.1 154.89 19.56 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 114.09 -1.414 . . . . 0.0 107.487 176.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 22.1 ttt -64.0 89.18 0.05 Allowed 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.917 0.389 . . . . 0.0 110.544 -177.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.35 -9.44 33.14 Favored Glycine 0 CA--C 1.52 0.344 0 CA-C-N 115.921 -0.581 . . . . 0.0 112.521 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.608 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 87.5 m-85 -132.24 147.85 52.43 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.174 0.511 . . . . 0.0 111.235 -174.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.599 ' HB3' HG13 ' A' ' 69' ' ' ILE . 45.8 tp -104.83 111.93 24.85 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 173.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 61.5 t -100.28 101.64 12.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.011 0.434 . . . . 0.0 110.778 -174.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.597 ' HB2' ' HB3' ' A' ' 67' ' ' LEU . 11.1 mp -90.64 145.19 25.05 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.431 177.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 78.5 mttt -137.34 129.23 28.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 177.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.615 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -120.54 144.75 39.21 Favored Pre-proline 0 C--O 1.219 -0.514 0 C-N-CA 118.946 -1.102 . . . . 0.0 113.35 -174.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_exo -63.35 97.32 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 121.743 1.628 . . . . 0.0 109.758 166.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 122.94 -33.98 3.88 Favored Glycine 0 N--CA 1.447 -0.605 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.768 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.615 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 91.7 mmm -122.19 149.6 43.41 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-O 120.865 0.364 . . . . 0.0 110.261 -178.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.446 ' H ' HD22 ' A' ' 65' ' ' LEU . 2.6 mm? -70.91 -144.59 0.01 OUTLIER 'General case' 0 C--O 1.246 0.873 0 CA-C-O 120.895 0.379 . . . . 0.0 110.635 -178.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.48 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 92.2 mtt180 -79.06 155.93 28.58 Favored 'General case' 0 N--CA 1.453 -0.288 0 CA-C-O 121.107 0.479 . . . . 0.0 110.563 176.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.597 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 59.9 tp -127.39 103.46 7.38 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 168.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -88.76 101.77 14.34 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.588 -176.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.599 HG13 ' HB3' ' A' ' 57' ' ' LEU . 8.5 pt -124.43 119.25 26.14 Favored Pre-proline 0 C--N 1.319 -0.743 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.444 178.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.538 ' HB2' ' O ' ' A' ' 73' ' ' VAL . 39.5 Cg_exo -57.15 144.64 89.8 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.354 2.036 . . . . 0.0 111.33 176.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.0 mt -50.33 -69.22 0.12 Allowed 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 -167.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -88.94 -48.07 7.7 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.293 -0.563 . . . . 0.0 111.813 -171.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.538 ' O ' ' HB2' ' A' ' 70' ' ' PRO . 25.7 m -140.54 155.91 23.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.661 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.515 HG13 ' N ' ' A' ' 75' ' ' GLU . 7.4 tp -70.45 162.22 4.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 173.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.515 ' N ' HG13 ' A' ' 74' ' ' ILE . 26.7 mt-10 -82.28 23.8 0.72 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.34 0.59 . . . . 0.0 111.323 -175.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -132.51 156.63 46.45 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -84.62 -2.0 56.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.791 0.805 . . . . 0.0 109.885 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -88.35 29.51 0.97 Allowed 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.143 -0.935 . . . . 0.0 110.902 -176.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 37.3 m -60.89 102.82 0.22 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 176.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 17.4 t -70.19 130.83 34.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.585 -174.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 13.7 ptm180 -104.31 111.17 23.69 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-O 121.217 0.532 . . . . 0.0 110.306 176.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.451 ' O ' HG22 ' A' ' 93' ' ' VAL . 33.0 m-85 -102.89 135.06 45.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.379 -179.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 97.5 mt-30 -88.32 128.1 35.49 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.286 0.565 . . . . 0.0 110.76 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.675 ' HE2' HD12 ' A' ' 115' ' ' LEU . 52.4 mtt -95.69 171.83 8.42 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.342 -0.845 . . . . 0.0 110.3 -178.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . . . . . . . . . 31.5 tp -139.96 87.26 2.15 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.435 0.636 . . . . 0.0 109.636 175.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.402 HG12 ' HD3' ' A' ' 127' ' ' PRO . 3.2 t -97.85 96.28 5.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.046 -177.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 60.63 48.06 88.09 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.648 -0.787 . . . . 0.0 111.719 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 74.71 7.88 4.35 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.543 0.737 . . . . 0.0 111.708 178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.56 ' HG2' HG13 ' A' ' 91' ' ' VAL . 9.8 tt0 -96.02 99.01 10.82 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 178.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . 0.438 ' HA ' ' O ' ' A' ' 84' ' ' MET . 30.3 m -77.14 105.97 8.56 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.314 0.578 . . . . 0.0 110.402 178.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.56 HG13 ' HG2' ' A' ' 89' ' ' GLN . 3.6 m -122.74 162.16 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.106 -175.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.633 ' O ' ' HB2' ' A' ' 118' ' ' HIS . 8.8 t70 -108.11 127.13 53.53 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 -174.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.584 HG12 ' HA ' ' A' ' 117' ' ' VAL . 23.1 m -132.74 154.11 39.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.921 0.391 . . . . 0.0 111.307 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 63.6 t -91.02 135.01 27.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.734 -178.577 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.542 ' HA ' ' CD2' ' A' ' 115' ' ' LEU . 18.2 t70 -88.43 133.28 34.16 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.799 178.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -80.52 -2.84 47.76 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.247 -176.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 125.91 141.59 5.57 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 111.268 -0.733 . . . . 0.0 111.268 -177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -69.0 -13.8 62.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.881 0.341 . . . . 0.0 111.078 -177.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . 0.697 HD23 ' H ' ' A' ' 99' ' ' LEU . 2.1 pt? -69.7 -32.94 71.81 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 171.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -76.55 -33.23 58.54 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.787 177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.549 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -57.36 -55.22 37.65 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.275 174.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -62.36 -43.07 99.68 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.805 179.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . 0.429 ' CZ3' HD13 ' A' ' 104' ' ' ILE . 84.4 t90 -49.25 -47.68 46.36 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.725 -178.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.542 HD12 ' HB3' ' A' ' 107' ' ' HIS . 3.3 tp -87.27 -22.51 6.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 119.69 -0.804 . . . . 0.0 111.122 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 64.5 m -66.44 -13.03 60.19 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 121.642 -0.661 . . . . 0.0 109.512 174.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -89.81 -49.93 6.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.472 -0.786 . . . . 0.0 110.602 173.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.542 ' HB3' HD12 ' A' ' 104' ' ' ILE . 78.1 t60 -76.18 -46.0 30.56 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -178.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.33 -36.78 71.69 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 175.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 100.72 -31.12 8.95 Favored Glycine 0 N--CA 1.454 -0.16 0 CA-C-N 115.247 -0.888 . . . . 0.0 113.203 170.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.645 HG23 ' SG ' ' A' ' 112' ' ' CYS . 31.2 m -103.83 157.18 34.47 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 178.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_exo -56.5 99.79 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.715 2.277 . . . . 0.0 112.265 -178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.645 ' SG ' HG23 ' A' ' 110' ' ' VAL . 57.2 m -134.56 -176.41 4.21 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.958 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 7.7 ptp180 -166.2 142.88 5.07 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.302 176.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.442 HG12 ' CG1' ' A' ' 29' ' ' VAL . 62.3 mt -79.44 123.03 35.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.675 HD12 ' HE2' ' A' ' 84' ' ' MET . 43.3 mt -134.83 150.29 50.47 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.004 -173.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -117.2 139.64 50.53 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.585 -0.446 . . . . 0.0 109.916 173.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.584 ' HA ' HG12 ' A' ' 93' ' ' VAL . 33.1 t -66.0 142.08 17.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.421 -175.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.633 ' HB2' ' O ' ' A' ' 92' ' ' ASP . 0.2 OUTLIER -61.74 142.32 94.7 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.537 179.287 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -64.27 -19.02 65.33 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.717 2.278 . . . . 0.0 111.773 174.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.1 -10.56 54.95 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.985 179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.42 ' SD ' ' HB ' ' A' ' 91' ' ' VAL . 11.4 ptp -144.72 -44.24 0.24 Allowed 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -176.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.5 ' O ' ' HD2' ' A' ' 26' ' ' ARG . . . 68.55 -64.45 0.31 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.963 1.097 . . . . 0.0 113.963 172.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.537 ' HG2' ' HG3' ' A' ' 125' ' ' ARG . 35.5 tt0 -70.47 -76.24 0.11 Allowed 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -168.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.502 HG22 HG11 ' A' ' 91' ' ' VAL . 58.8 t 67.43 -77.33 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 C-N-CA 122.758 0.423 . . . . 0.0 111.658 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.537 ' HG3' ' HG2' ' A' ' 123' ' ' GLU . 36.9 mtm180 81.96 131.89 0.05 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.26 1.024 . . . . 0.0 113.647 174.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.5 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 5.1 t90 -56.71 150.06 38.59 Favored Pre-proline 0 CA--C 1.536 0.407 0 CA-C-N 114.319 -1.31 . . . . 0.0 109.522 170.102 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.5 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 2.9 Cg_endo -44.14 120.29 2.44 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 123.106 2.537 . . . . 0.0 112.391 177.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 14.6 m -99.91 51.02 0.91 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.73 -173.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.679 HD23 ' H ' ' A' ' 129' ' ' LEU . 1.9 pt? -65.39 -0.11 1.73 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.032 178.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 C--N 1.312 -1.06 0 CA-C-O 118.334 -0.841 . . . . 0.0 109.141 175.735 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.7 tmm? . . . . . 0 N--CA 1.478 0.932 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 m -129.11 122.59 30.22 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.254 -0.43 . . . . 0.0 109.863 179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 24.7 m -89.01 -76.51 0.4 Allowed 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.838 -0.431 . . . . 0.0 109.838 177.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER 42.0 42.59 2.4 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 178.573 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.455 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -104.17 109.6 21.47 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.789 178.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.718 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 62.4 m-85 -91.54 142.5 27.58 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.476 -176.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.25 85.57 0.9 Allowed Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 109.681 -0.489 . . . . 0.0 109.681 178.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.907 ' HG3' ' HB1' ' A' ' 20' ' ' ALA . 3.3 Cg_exo -81.39 -59.32 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 122.726 2.284 . . . . 0.0 112.147 -177.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 12' ' ' CYS . 0.4 OUTLIER -99.71 138.7 23.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.582 -179.296 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -61.69 -56.41 20.0 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -170.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.877 ' HB2' ' HB3' ' A' ' 45' ' ' LEU . 0.0 OUTLIER -77.81 -41.53 36.9 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.735 -176.429 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.846 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 78.1 m -52.37 -45.97 66.0 Favored 'General case' 0 C--N 1.329 -0.314 0 O-C-N 123.742 0.651 . . . . 0.0 111.898 -177.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.545 ' HA2' HH12 ' A' ' 39' ' ' ARG . . . 108.5 -151.49 17.04 Favored Glycine 0 N--CA 1.444 -0.792 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.007 175.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.455 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -84.7 138.31 32.73 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.272 0.558 . . . . 0.0 111.525 -174.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.49 HG21 HD13 ' A' ' 52' ' ' LEU . 16.1 m -118.56 132.33 56.2 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.61 177.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.1 p -91.89 14.96 14.1 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.272 0.471 . . . . 0.0 112.272 -175.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.427 ' H ' HG22 ' A' ' 15' ' ' THR . 0.9 OUTLIER -101.55 139.05 37.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.814 0.34 . . . . 0.0 110.375 179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 5.1 p -61.96 -36.3 81.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -170.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -64.65 -21.25 66.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.622 0.249 . . . . 0.0 111.632 -176.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.907 ' HB1' ' HG3' ' A' ' 8' ' ' PRO . . . -61.83 -27.28 68.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.649 -176.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.98 -27.73 69.61 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.552 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -93.98 -13.83 26.58 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.429 -0.351 . . . . 0.0 111.375 -176.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.7 m-85 -113.57 6.66 17.11 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.747 -174.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.619 ' HA ' ' HA ' ' A' ' 8' ' ' PRO . 16.1 pt20 -67.29 140.95 57.34 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 171.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.427 ' HE2' ' HB2' ' A' ' 25' ' ' LYS . 0.5 OUTLIER -166.05 -179.29 5.09 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 120.695 -0.402 . . . . 0.0 110.905 -174.624 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 48.0 mtt180 -77.92 77.92 4.42 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.5 0.667 . . . . 0.0 110.715 178.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.429 ' O ' ' HB3' ' A' ' 28' ' ' LEU . 0.0 OUTLIER -102.03 162.53 12.84 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 114.891 -1.05 . . . . 0.0 109.992 177.557 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 29' ' ' VAL . 0.5 OUTLIER -179.49 178.52 0.67 Allowed 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 121.271 0.558 . . . . 0.0 111.25 172.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.549 HG22 HG12 ' A' ' 114' ' ' ILE . 60.4 t -112.69 146.34 17.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.028 173.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.632 ' HB3' HD12 ' A' ' 115' ' ' LEU . . . -126.9 147.03 50.09 Favored 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 121.02 -0.272 . . . . 0.0 110.283 176.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.518 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 5.7 p-10 -86.79 -179.58 6.57 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.045 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -46.03 -36.13 5.42 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.18 0.992 . . . . 0.0 113.367 -177.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.479 ' H ' ' ND2' ' A' ' 31' ' ' ASN . . . -79.3 -0.32 31.92 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.15 0.426 . . . . 0.0 112.15 -174.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.93 45.53 63.11 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.12 -1.038 . . . . 0.0 110.535 -174.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.468 ' HB3' ' OD1' ' A' ' 31' ' ' ASN . 25.1 tt0 -121.66 141.47 51.11 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.148 -0.526 . . . . 0.0 110.33 -177.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.727 ' CZ2' HG21 ' A' ' 124' ' ' VAL . 5.6 m95 -57.51 125.01 20.99 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.543 -0.753 . . . . 0.0 112.126 -179.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.524 ' HG ' ' SG ' ' A' ' 42' ' ' CYS . 9.9 tp -113.49 132.18 55.77 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.57 ' OD1' ' HG ' ' A' ' 41' ' ' LEU . 22.4 p-10 -130.4 -177.04 4.16 Favored 'General case' 0 C--O 1.208 -1.09 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -173.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.545 HH12 ' HA2' ' A' ' 13' ' ' GLY . 10.0 mmm-85 -64.68 -15.14 60.91 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.575 -176.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.428 ' HB2' HD21 ' A' ' 38' ' ' ASN . 11.7 m-20 -93.33 -29.73 15.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.757 0.313 . . . . 0.0 110.884 177.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.57 ' HG ' ' OD1' ' A' ' 38' ' ' ASN . 86.8 mt -89.04 -42.71 11.59 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 177.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.672 ' HB2' HD13 ' A' ' 45' ' ' LEU . 24.2 p -123.85 91.53 49.54 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.609 174.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.4 -39.86 0.51 Allowed 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 123.007 2.471 . . . . 0.0 113.776 -174.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.741 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 47.5 mtm-85 -67.12 -11.82 58.27 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 121.338 0.59 . . . . 0.0 111.745 -172.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.877 ' HB3' ' HB2' ' A' ' 11' ' ' GLU . 11.0 mp -68.59 -19.21 64.45 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.139 0.495 . . . . 0.0 110.402 177.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.528 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -67.8 -9.64 46.03 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.389 -0.823 . . . . 0.0 112.757 -177.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.741 ' HG2' ' O ' ' A' ' 44' ' ' ARG . 10.9 pt-20 -98.59 29.05 3.85 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.787 -178.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.846 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 98.5 t -81.12 138.11 20.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.662 0.268 . . . . 0.0 110.556 176.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 13.6 t -92.24 134.54 34.79 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 175.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.533 HG22 ' HB3' ' A' ' 12' ' ' CYS . 4.2 t -120.25 128.17 75.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 120.938 0.399 . . . . 0.0 111.598 -172.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.48 ' HB3' ' HB ' ' A' ' 58' ' ' VAL . 9.4 tp10 -123.61 143.61 50.12 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.184 172.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.49 HD13 HG21 ' A' ' 15' ' ' THR . 6.9 mp -124.75 125.82 44.67 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-O 121.546 0.689 . . . . 0.0 110.963 -178.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.592 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 19.7 tpp180 -109.29 154.45 22.46 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 66.1 mtt -62.03 89.59 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.075 0.464 . . . . 0.0 110.41 176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 112.57 -7.45 26.25 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.932 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.592 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 97.9 m-85 -138.01 137.75 38.19 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-N 117.414 0.607 . . . . 0.0 111.606 -176.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 53.0 tp -102.17 107.83 19.03 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.138 174.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.48 ' HB ' ' HB3' ' A' ' 51' ' ' GLU . 43.0 t -101.67 102.58 13.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.022 0.439 . . . . 0.0 111.031 -173.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 8.4 mp -87.64 147.71 25.14 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.27 176.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . . . . . . . . . 10.1 mtpm? -144.47 133.21 22.35 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.633 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -112.35 147.73 37.65 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 119.457 -0.897 . . . . 0.0 112.133 -175.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -65.43 93.33 0.24 Allowed 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 122.273 1.982 . . . . 0.0 110.67 172.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 115.93 -24.48 10.1 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.44 -178.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.633 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 13.0 mmt -120.07 157.36 29.11 Favored 'General case' 0 C--O 1.234 0.273 0 N-CA-C 109.662 -0.496 . . . . 0.0 109.662 -178.738 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 8.8 mp -67.07 -163.13 0.03 OUTLIER 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.171 -0.922 . . . . 0.0 112.315 -171.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 9.6 ptt-85 -90.31 165.84 13.66 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.518 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.7 tp -143.51 93.68 2.51 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 115.182 -0.917 . . . . 0.0 108.967 172.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -88.01 114.15 24.34 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.526 0.679 . . . . 0.0 110.248 -179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.552 HD13 ' HG2' ' A' ' 96' ' ' GLU . 55.0 mt -111.65 118.9 46.05 Favored Pre-proline 0 C--N 1.317 -0.843 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.396 -176.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.72 127.91 28.13 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.252 1.968 . . . . 0.0 111.296 172.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 96.5 mt -63.73 -27.55 69.28 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.98 0.419 . . . . 0.0 110.589 -178.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -106.47 103.12 12.51 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.216 174.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 6.2 t -84.67 162.05 3.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.189 -175.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 20.3 mt -60.98 152.42 5.82 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.277 0 CA-C-O 121.01 0.433 . . . . 0.0 111.499 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 55.6 tt0 -96.49 23.0 7.23 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.759 0.79 . . . . 0.0 110.854 -173.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -125.47 -176.45 3.6 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.328 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -74.69 2.7 9.33 Favored 'General case' 0 N--CA 1.47 0.557 0 CA-C-O 120.674 0.274 . . . . 0.0 111.387 -174.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -60.6 -40.86 93.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.199 -1.038 . . . . 0.0 108.199 168.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 29.2 t -81.06 82.54 6.98 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 171.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 95' ' ' ASP . 48.5 t -60.21 130.6 24.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.122 -0.945 . . . . 0.0 111.484 -174.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . 0.709 ' HB2' ' HB2' ' A' ' 92' ' ' ASP . 0.0 OUTLIER -97.17 97.59 9.32 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.797 0.808 . . . . 0.0 109.124 170.162 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -76.98 121.57 23.68 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.715 -1.13 . . . . 0.0 109.334 -174.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -68.91 105.24 2.31 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.251 0.548 . . . . 0.0 110.058 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.486 ' HE1' HD13 ' A' ' 115' ' ' LEU . 23.4 tpp -93.17 150.73 20.29 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.816 -175.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.445 ' N ' ' HG3' ' A' ' 84' ' ' MET . 42.3 tp -125.9 89.2 2.98 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-O 121.695 0.759 . . . . 0.0 109.241 176.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.777 HG21 ' HB ' ' A' ' 124' ' ' VAL . 2.1 t -80.94 87.49 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 114.8 -1.091 . . . . 0.0 109.099 -178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 77.31 -86.83 1.01 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.146 -0.782 . . . . 0.0 111.146 -175.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -137.63 16.33 2.91 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.062 0.458 . . . . 0.0 110.763 175.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -102.15 119.27 38.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.167 0.508 . . . . 0.0 110.538 177.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 6.1 m -92.98 109.5 20.95 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.078 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.609 HG21 HG12 ' A' ' 124' ' ' VAL . 3.9 m -142.58 139.44 28.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.605 -177.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.709 ' HB2' ' HB2' ' A' ' 81' ' ' ARG . 5.3 p-10 -83.3 141.73 31.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.163 0.506 . . . . 0.0 110.334 177.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.58 HG23 HD22 ' A' ' 115' ' ' LEU . 18.6 m -128.94 152.71 37.49 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.571 176.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 85.0 t -81.4 123.62 38.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 120.949 0.404 . . . . 0.0 111.46 -174.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.762 ' HA ' HD23 ' A' ' 115' ' ' LEU . 59.3 t0 -87.07 129.26 34.99 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.79 177.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.552 ' HG2' HD13 ' A' ' 69' ' ' ILE . 0.3 OUTLIER -75.73 -6.55 51.11 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.215 178.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 121.59 158.47 10.37 Favored Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.546 173.022 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -69.76 -11.14 60.63 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.049 0.452 . . . . 0.0 110.373 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 17.3 mt -65.5 -41.59 93.04 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 171.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -71.97 -34.42 68.95 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 114.865 -1.061 . . . . 0.0 110.046 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . . . . . . . . . . . -59.65 -50.22 74.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.514 175.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.412 ' HA ' ' OG ' ' A' ' 105' ' ' SER . . . -62.17 -44.65 96.14 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-O 120.99 0.424 . . . . 0.0 110.698 178.048 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 49.0 t90 -53.85 -44.51 70.38 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.39 -178.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.617 HD12 ' HB3' ' A' ' 107' ' ' HIS . 2.1 tp -92.84 -21.01 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.987 -176.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 102' ' ' ALA . 40.5 p -68.3 -13.41 62.24 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 119.599 -0.84 . . . . 0.0 109.578 174.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 22.8 m-80 -85.43 -45.62 11.68 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.362 170.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.617 ' HB3' HD12 ' A' ' 104' ' ' ILE . 84.4 t60 -79.68 -45.45 18.97 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 120.934 0.397 . . . . 0.0 111.692 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -78.98 -34.87 43.77 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 88.87 -3.83 84.82 Favored Glycine 0 C--N 1.325 -0.049 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.841 174.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.534 HG23 ' SG ' ' A' ' 112' ' ' CYS . 13.7 m -120.47 159.61 47.31 Favored Pre-proline 0 C--N 1.32 -0.701 0 N-CA-C 110.178 -0.305 . . . . 0.0 110.178 -179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -67.88 87.57 0.37 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.772 2.315 . . . . 0.0 112.083 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.534 ' SG ' HG23 ' A' ' 110' ' ' VAL . 75.1 m -134.52 154.53 51.4 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.128 179.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.6 ptp180 -135.37 151.98 51.0 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.549 HG12 HG22 ' A' ' 29' ' ' VAL . 55.4 mt -83.11 119.79 33.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 121.03 0.443 . . . . 0.0 109.947 -178.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.762 HD23 ' HA ' ' A' ' 95' ' ' ASP . 52.3 mt -122.1 133.97 54.76 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.74 -173.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.42 ' HB2' ' NE1' ' A' ' 27' ' ' TRP . 6.5 ttpm? -107.05 128.4 54.33 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.347 179.09 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 61.2 t -71.21 119.17 17.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.184 179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . . . . . . . . . 35.5 t-80 -61.97 124.96 84.03 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.679 -0.691 . . . . 0.0 109.195 177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . . . . . . . . . 58.6 Cg_endo -69.76 35.52 0.22 Allowed 'Trans proline' 0 N--CA 1.48 0.68 0 C-N-CA 123.723 2.948 . . . . 0.0 114.143 -172.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -118.76 -32.01 4.65 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 174.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . . . . . . . . . 26.3 mmt -77.49 -57.97 3.53 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.476 176.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 68.21 -66.99 0.21 Allowed 'General case' 0 N--CA 1.469 0.511 0 O-C-N 124.084 0.865 . . . . 0.0 112.417 178.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -86.44 113.5 22.44 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.681 0.753 . . . . 0.0 111.288 -176.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.777 ' HB ' HG21 ' A' ' 86' ' ' VAL . 12.3 m -115.62 -22.48 4.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.943 0 CA-C-N 114.674 -1.148 . . . . 0.0 109.807 178.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 48.2 mtp180 60.94 66.05 0.94 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.487 177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.493 ' CG ' ' HD2' ' A' ' 127' ' ' PRO . 46.6 t90 -47.71 138.97 9.12 Favored Pre-proline 0 CA--C 1.537 0.466 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 170.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.493 ' HD2' ' CG ' ' A' ' 126' ' ' TRP . 9.0 Cg_endo -44.52 127.92 7.98 Favored 'Trans proline' 0 C--N 1.35 0.658 0 C-N-CA 123.987 3.125 . . . . 0.0 113.769 -173.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.1 m -82.61 12.95 4.07 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.232 0.539 . . . . 0.0 110.592 179.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 85.3 mt 56.27 26.13 10.12 Favored 'General case' 0 N--CA 1.467 0.408 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.28 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 43.3 tt0 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.56 -0.733 . . . . 0.0 109.638 -179.171 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.8 mtt . . . . . 0 N--CA 1.484 1.232 0 CA-C-O 120.792 0.329 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.3 t -93.42 88.22 5.87 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.022 0.439 . . . . 0.0 111.047 -175.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.7 p -147.55 0.77 0.69 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.937 174.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 4' ' ' THR . 12.0 m 64.44 15.86 9.83 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.522 1.153 . . . . 0.0 109.479 -169.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.729 ' HB1' ' HB1' ' A' ' 14' ' ' ALA . . . -127.79 113.2 15.65 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.337 -1.301 . . . . 0.0 108.869 177.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -96.04 140.42 30.8 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.479 -174.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 -100.4 97.46 6.46 Favored Pre-proline 0 C--N 1.324 -0.528 0 CA-C-N 116.71 -0.223 . . . . 0.0 110.538 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.592 ' HA ' ' CB ' ' A' ' 24' ' ' GLN . 38.5 Cg_endo -70.18 -59.81 0.07 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 121.825 1.684 . . . . 0.0 110.103 174.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.637 HD11 HD21 ' A' ' 57' ' ' LEU . 18.4 mt -103.76 146.48 11.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.633 173.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -67.24 -55.05 15.63 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -175.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.742 ' HB3' ' HG ' ' A' ' 45' ' ' LEU . 1.4 mp0 -60.21 -42.58 95.42 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.689 -177.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.832 ' HA ' ' HB ' ' A' ' 48' ' ' VAL . 52.7 m -60.84 -44.74 96.55 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.56 -0.746 . . . . 0.0 110.447 -178.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 96.04 -134.25 11.78 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.484 -0.865 . . . . 0.0 113.003 174.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.729 ' HB1' ' HB1' ' A' ' 5' ' ' ALA . . . -84.81 121.68 28.06 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.586 0.708 . . . . 0.0 112.331 -170.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.483 HG21 HD13 ' A' ' 52' ' ' LEU . 8.6 m -123.02 119.13 29.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.764 173.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.488 ' HA ' ' HA ' ' A' ' 5' ' ' ALA . 9.8 t -85.85 -6.6 59.06 Favored 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 120.741 -0.384 . . . . 0.0 111.169 -170.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -60.74 122.38 14.63 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 174.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 47.4 t -61.45 -25.88 67.51 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.794 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.2 mp0 -59.36 -30.52 68.46 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.835 178.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.41 -30.04 70.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.295 -0.412 . . . . 0.0 111.278 -177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.53 -17.03 64.26 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.936 0.398 . . . . 0.0 111.566 -177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -98.99 -22.1 15.91 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.233 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -105.54 -11.3 16.44 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.916 -0.314 . . . . 0.0 110.974 -173.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.592 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . 3.4 pt20 -64.16 155.8 30.54 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.137 -178.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.451 ' HD3' ' HA ' ' A' ' 25' ' ' LYS . 51.1 mmtt -162.91 179.73 7.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.225 -179.538 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.464 ' HB3' ' HB ' ' A' ' 117' ' ' VAL . 0.5 OUTLIER -71.13 76.21 0.69 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 171.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TRP . . . . . 0.565 ' HB3' ' HA ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER -95.06 147.75 23.08 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 114.606 -1.179 . . . . 0.0 109.359 -176.597 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.724 ' HA ' ' OE2' ' A' ' 11' ' ' GLU . 2.2 pp -176.83 166.58 2.54 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.395 0.616 . . . . 0.0 112.578 174.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.597 HG21 HG12 ' A' ' 104' ' ' ILE . 56.1 t -98.28 129.59 48.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 114.965 -1.016 . . . . 0.0 109.782 175.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -111.11 133.69 53.28 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.582 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.46 ' HA ' ' SG ' ' A' ' 112' ' ' CYS . 12.0 t30 -77.59 154.45 32.3 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 177.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -47.18 -30.1 2.71 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -177.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.452 ' H ' ' ND2' ' A' ' 31' ' ' ASN . . . -58.86 -23.4 60.78 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-O 121.054 0.454 . . . . 0.0 111.543 176.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.69 5.72 55.13 Favored Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 110.97 -0.852 . . . . 0.0 110.97 -174.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -92.19 149.16 21.63 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.842 0.353 . . . . 0.0 111.025 -174.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.461 ' CD1' HG13 ' A' ' 86' ' ' VAL . 12.0 m0 -70.79 122.27 19.57 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.945 176.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.45 HD13 ' HB2' ' A' ' 31' ' ' ASN . 4.4 tp -82.49 133.91 35.21 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 174.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.473 ' H ' ' HB2' ' A' ' 41' ' ' LEU . 1.8 t-20 -119.93 161.96 19.99 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.465 -0.494 . . . . 0.0 111.432 -170.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.472 ' HG3' ' HB2' ' A' ' 46' ' ' ALA . 24.7 ttm180 -65.55 -26.33 67.83 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.655 177.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -92.92 -11.33 33.67 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.492 178.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.473 ' HB2' ' H ' ' A' ' 38' ' ' ASN . 80.2 mt -82.64 -50.57 8.61 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 174.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . . . . . . . . . 74.1 m -131.33 100.24 16.92 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.485 175.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_exo -59.39 -36.39 94.12 Favored 'Trans proline' 0 C--N 1.343 0.239 0 C-N-CA 122.987 2.458 . . . . 0.0 112.66 179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 1.6 ptp180 -61.94 -21.63 64.95 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.057 0.456 . . . . 0.0 111.264 179.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.742 ' HG ' ' HB3' ' A' ' 11' ' ' GLU . 37.1 tp -68.54 -29.88 68.55 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.524 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.703 ' HA ' ' O ' ' A' ' 11' ' ' GLU . . . -87.64 10.35 18.35 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.595 -178.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -96.62 18.96 13.11 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.679 0.276 . . . . 0.0 111.299 -179.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.832 ' HB ' ' HA ' ' A' ' 12' ' ' CYS . 56.8 t -75.84 127.46 37.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 120.83 0.348 . . . . 0.0 110.699 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.543 ' HB2' ' HB2' ' A' ' 60' ' ' LYS . 14.0 m -85.87 122.15 29.53 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.697 HG22 ' HB3' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -101.12 140.62 19.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.02 0.438 . . . . 0.0 111.263 -172.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -145.77 129.93 17.53 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.468 175.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.483 HD13 HG21 ' A' ' 15' ' ' THR . 10.9 mp -107.63 125.05 50.87 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-O 121.558 0.694 . . . . 0.0 110.677 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' HB3' ' HB2' ' A' ' 56' ' ' TYR . 36.3 ttm180 -105.29 150.85 24.8 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' MET . . . . . . . . . . . . . 26.0 ttt -65.35 97.2 0.27 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.695 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 109.37 -12.8 33.45 Favored Glycine 0 N--CA 1.447 -0.632 0 CA-C-N 115.605 -0.725 . . . . 0.0 112.95 -178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.497 ' HB2' ' HB3' ' A' ' 53' ' ' ARG . 78.5 m-85 -137.2 137.64 39.35 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-N 117.486 0.643 . . . . 0.0 111.571 -174.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.637 HD21 HD11 ' A' ' 9' ' ' ILE . 42.0 tp -100.65 108.38 20.24 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.072 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 26.3 t -102.01 111.35 31.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.154 0.502 . . . . 0.0 111.293 -172.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.581 ' O ' ' HA ' ' A' ' 66' ' ' ARG . 8.1 mp -98.06 140.16 32.79 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.101 176.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LYS . . . . . 0.543 ' HB2' ' HB2' ' A' ' 49' ' ' SER . 39.5 mttm -129.6 133.56 47.23 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . 0.806 ' HB3' ' HB2' ' A' ' 64' ' ' MET . . . -122.04 148.76 52.44 Favored Pre-proline 0 C--N 1.326 -0.44 0 C-N-CA 118.897 -1.121 . . . . 0.0 113.254 -176.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . 0.44 ' HD2' ' CE1' ' A' ' 107' ' ' HIS . 23.1 Cg_exo -65.37 85.01 0.2 Allowed 'Trans proline' 0 N--CA 1.462 -0.331 0 C-N-CA 122.312 2.008 . . . . 0.0 110.648 168.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 129.38 -26.66 4.34 Favored Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.663 -0.698 . . . . 0.0 111.792 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.806 ' HB2' ' HB3' ' A' ' 61' ' ' ALA . 94.8 mmm -117.47 154.12 31.96 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.403 ' N ' HD22 ' A' ' 65' ' ' LEU . 3.3 mm? -77.12 -144.34 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.535 -0.542 . . . . 0.0 109.535 178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.581 ' HA ' ' O ' ' A' ' 59' ' ' LEU . 49.2 ptt85 -83.55 149.68 26.43 Favored 'General case' 0 N--CA 1.449 -0.515 0 CA-C-O 121.272 0.558 . . . . 0.0 111.14 176.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.486 ' HB3' ' HB2' ' A' ' 59' ' ' LEU . 59.9 tp -121.95 102.79 8.39 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.637 170.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.488 ' OD1' ' HD2' ' A' ' 66' ' ' ARG . 0.8 OUTLIER -81.11 100.92 9.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.758 -179.123 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.516 ' HB ' ' HB3' ' A' ' 57' ' ' LEU . 64.2 mt -100.3 105.17 34.55 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.927 176.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.6 ' HB3' ' HB ' ' A' ' 73' ' ' VAL . 15.7 Cg_exo -68.3 125.4 12.87 Favored 'Trans proline' 0 N--CA 1.456 -0.717 0 C-N-CA 122.172 1.915 . . . . 0.0 110.881 176.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.7 mt -52.22 -48.09 65.32 Favored 'General case' 0 N--CA 1.465 0.295 0 O-C-N 123.513 0.508 . . . . 0.0 111.979 -172.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -140.97 15.29 2.28 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.331 0.586 . . . . 0.0 110.682 176.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.6 ' HB ' ' HB3' ' A' ' 70' ' ' PRO . 15.7 t -99.82 69.35 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.969 -177.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 13.4 mt -107.4 155.02 8.24 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.094 -176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -85.97 13.22 7.87 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.789 0.804 . . . . 0.0 109.813 177.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -137.63 -167.76 2.19 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-N 114.389 -1.278 . . . . 0.0 108.984 178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -107.34 152.76 23.72 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.31 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -82.02 13.0 3.62 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.24 0.543 . . . . 0.0 110.76 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.8 p -95.63 15.22 20.52 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.409 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.437 ' O ' ' HA ' ' A' ' 94' ' ' VAL . 48.0 t -70.55 98.8 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ARG . . . . . . . . . . . . . 76.3 mtp180 -97.38 113.94 25.68 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.89 -175.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.402 ' O ' HG22 ' A' ' 93' ' ' VAL . 6.3 t80 -112.11 120.1 40.69 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.258 -0.883 . . . . 0.0 108.701 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -78.85 118.09 20.57 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.457 0.646 . . . . 0.0 110.541 -179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.579 ' HE3' HG11 ' A' ' 93' ' ' VAL . 53.7 ttm -98.1 159.89 14.65 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.313 -176.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LEU . . . . . 0.409 ' HG ' ' HA ' ' A' ' 88' ' ' GLU . 14.2 tp -135.7 87.11 2.29 Favored 'General case' 0 N--CA 1.445 -0.698 0 CA-C-O 121.153 0.501 . . . . 0.0 110.278 -175.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.681 HG12 ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -72.3 90.54 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.692 -0.685 . . . . 0.0 109.261 -179.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . 74.73 -75.18 1.27 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -170.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLU . . . . . 0.409 ' HA ' ' HG ' ' A' ' 85' ' ' LEU . 8.8 pt-20 -152.1 18.76 0.67 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.027 0.441 . . . . 0.0 110.242 171.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLN . . . . . 0.739 HE21 HG13 ' A' ' 124' ' ' VAL . 19.2 tt0 -92.03 107.25 19.07 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 108.976 -0.75 . . . . 0.0 108.976 178.383 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' THR . . . . . . . . . . . . . 2.8 m -80.36 108.61 14.12 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.099 -175.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 84' ' ' MET . 5.8 m -123.94 151.65 28.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.507 -174.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -93.82 112.8 24.71 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.543 -174.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.579 HG11 ' HE3' ' A' ' 84' ' ' MET . 14.6 m -131.26 154.22 40.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.807 0.337 . . . . 0.0 110.527 -179.27 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 80' ' ' VAL . 91.1 t -101.48 135.38 38.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.603 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.471 ' HA ' ' CD2' ' A' ' 115' ' ' LEU . 16.7 t70 -80.39 135.92 36.27 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 175.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -106.55 10.43 31.23 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.97 0.414 . . . . 0.0 111.703 -172.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 128.81 136.74 4.21 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 119.401 -1.381 . . . . 0.0 114.294 174.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -61.85 -25.0 67.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 114.827 -0.687 . . . . 0.0 110.714 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LEU . . . . . . . . . . . . . 54.8 tp -62.31 -45.47 93.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.085 177.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . 0.511 ' HB1' HD12 ' A' ' 114' ' ' ILE . . . -69.33 -33.54 73.28 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.177 178.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ALA . . . . . 0.62 ' HA ' ' HA ' ' A' ' 113' ' ' ARG . . . -59.37 -57.96 10.72 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.164 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -61.01 -38.75 87.16 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.369 -178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -57.28 -46.01 83.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.949 -178.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.597 HG12 HG21 ' A' ' 29' ' ' VAL . 2.8 tp -83.69 -25.81 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.769 -178.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 73.3 m -59.93 -26.85 66.27 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.171 0.51 . . . . 0.0 109.713 174.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 -88.99 -40.36 13.07 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.496 176.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.571 ' HB3' HD12 ' A' ' 104' ' ' ILE . 77.7 t60 -77.41 -53.16 7.99 Favored 'General case' 0 N--CA 1.468 0.455 0 O-C-N 122.162 -0.336 . . . . 0.0 111.789 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . 0.422 ' HB2' HG13 ' A' ' 104' ' ' ILE . . . -62.55 -40.21 96.11 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 108.32 -16.61 34.99 Favored Glycine 0 N--CA 1.453 -0.186 0 C-N-CA 120.336 -0.935 . . . . 0.0 113.421 170.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.679 HG23 ' SG ' ' A' ' 112' ' ' CYS . 16.6 m -121.67 160.87 44.66 Favored Pre-proline 0 C--N 1.318 -0.771 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 179.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 110' ' ' VAL . 18.0 Cg_endo -58.36 96.5 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.81 2.34 . . . . 0.0 112.168 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' CYS . . . . . 0.679 ' SG ' HG23 ' A' ' 110' ' ' VAL . 73.9 m -135.22 173.22 11.97 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.708 -178.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.62 ' HA ' ' HA ' ' A' ' 101' ' ' ALA . 9.5 ptp85 -149.95 140.15 22.17 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.815 176.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.554 HG12 HG22 ' A' ' 29' ' ' VAL . 60.8 mt -75.79 120.95 26.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 176.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.471 ' CD2' ' HA ' ' A' ' 95' ' ' ASP . 96.5 mt -124.81 151.26 45.42 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 121.442 0.639 . . . . 0.0 111.097 -174.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 29.4 tttt -108.58 105.3 14.87 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.131 -177.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . 0.493 ' HA ' HG12 ' A' ' 93' ' ' VAL . 86.3 t -64.01 118.43 6.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.392 0.615 . . . . 0.0 110.34 -177.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' HIS . . . . . 0.685 ' CD2' ' HD2' ' A' ' 119' ' ' PRO . 7.4 t-160 -69.9 132.3 88.75 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.103 -178.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PRO . . . . . 0.685 ' HD2' ' CD2' ' A' ' 118' ' ' HIS . 28.5 Cg_endo -62.5 15.02 0.05 OUTLIER 'Trans proline' 0 N--CA 1.481 0.748 0 C-N-CA 123.687 2.925 . . . . 0.0 114.259 -176.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.459 ' H ' ' C ' ' A' ' 118' ' ' HIS . 9.9 t70 -60.0 -60.77 3.29 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.271 0.558 . . . . 0.0 109.515 176.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' MET . . . . . 0.493 ' HG3' HG12 ' A' ' 91' ' ' VAL . 0.3 OUTLIER -99.73 -30.4 12.1 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.313 173.004 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 69.28 -77.94 0.05 OUTLIER 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 113.732 1.012 . . . . 0.0 113.732 172.143 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -59.06 -72.17 0.11 Allowed 'General case' 0 C--O 1.236 0.358 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -170.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.739 HG13 HE21 ' A' ' 89' ' ' GLN . 58.3 t 70.99 -58.29 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 O-C-N 123.558 0.536 . . . . 0.0 111.924 179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . 0.609 ' O ' ' HB2' ' A' ' 126' ' ' TRP . 66.8 ttt180 79.03 -89.35 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 124.999 1.319 . . . . 0.0 111.745 179.157 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' TRP . . . . . 0.609 ' HB2' ' O ' ' A' ' 125' ' ' ARG . 9.5 t90 162.79 142.57 0.03 OUTLIER Pre-proline 0 N--CA 1.47 0.566 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 -174.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.681 ' HD3' HG12 ' A' ' 86' ' ' VAL . 38.0 Cg_endo -59.04 118.4 5.29 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 123.513 2.809 . . . . 0.0 112.777 -177.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' SER . . . . . . . . . . . . . 15.1 m -102.74 46.38 0.92 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-O 121.486 0.66 . . . . 0.0 110.128 -175.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.728 HD23 ' H ' ' A' ' 129' ' ' LEU . 1.6 pt? -74.18 65.06 1.12 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.869 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 . . . . . 0 C--O 1.247 0.955 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 177.324 . . . . . . . . 0 0 . 1 stop_ save_